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Abstract 
Mycobacterium tuberculosis (M. tuberculosis) is responsible for 2 million 
deaths annually. In recent years co-infection with HIV and drug-resistant strains 
has led to the increase in clinical cases of tuberculosis. BCG is the only vaccine 
currently available but is ineffective against adult pulmonary forms of the disease. 
Understanding the principle components of the host immune response against the 
pathogen  will aid in the design of a  better vaccine. Dendritic  cells are potent 
antigen presenting cells that play a key role in priming naïve T cells. Effective T 
cell priming is necessary for a successful protective immune response in the host 
against the pathogen.  
 
 
I  have  been  investigating  the  interaction  of  dendritic  cells  with  M. 
tuberculosis, with a view to better understanding the signalling pathways affecting 
priming of anti-mycobacterial T cells by dendritic cells. Using DNA microarray 
and bio-informatics, I have been able to study early transcriptional signatures of 
bone  marrow-derived  dendritic  cells  (BMDCs)  in  response  to  M.  tuberculois 
infection. Interferon Regulatory Factors (IRFs) and NFkB (Nuclear Factor kappa 
B)  appear  to  be  the  principal  transcription  factors  involved  in  regulating  the 
cellular responses in M. tuberculosis infected BMDCs.  It has been found that 
IRFs can function independent of the adaptor MyD88 (Myeloid Differentiation 
Factor 88) in M. tuberculosis infected BMDCs, which is surprising considering 
the important role played by MyD88 in the Toll mediated signalling pathway. Ex-
vivo  experiments  also  show  that  MyD88  may  not  be  absolutely  essential  for 
mounting  anti-mycobacterial  T  cell  responses.  Hence  immune  responses 
generated  by  M.  tuberculosis  infected  BMDCs  appear  to  be  mediated  via  the 
MyD88 dependent and independent pathways.  
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1.1– Tuberculosis- a global disease 
               Tuberculosis (TB) is an ancient disease known for over 4000 years. One 
of the earliest records comments on identifying decay in the spinal cord fragments 
of Egyptian mummies from around 2400BC (Zink, Sola et al. 2003). The disease 
also called “consumption” or “white plague” is still responsible for approximately 
2  million  deaths  every  year.  Overall,  one  third  of  the  world’s  population  is 
infected with Mycobacterium tuberculosis (M. tuberculosis), generally with no 
recognisable symptoms. The World Health Organisation (WHO) estimates that in 
2004,  approximately  14.6  million  people  were  living  with  TB  and  about  1.7 
million people died from the disease. About 80% of the world burden of TB is 
borne by 22 countries with one-third of the burden in India and China (WHO 
2006). In recent years co-infection with human immunodeficiency virus (HIV) 
and appearance of multi-drug resistant (MDR) strains have led to the increased 
number of clinical cases. TB is the most common cause of death in HIV patients. 
Thus there is a lethal synergy between HIV and M. tuberculosis, which causes 
problems  in  the  administration  of  TB  control  programmes.  The  rise  in  drug 
resistant strains, amounting to 300,000 new cases every year, alongside the recent 
cases of extensively drug-resistant tuberculosis (XDR-TB) has also contributed to 
increased problems in control of TB (WHO 2006). Chemotherapy for TB patients 
was  established  with  the  discovery  of  streptomycin  in  the  1940s.  Standard 
tuberculosis  chemotherapy  involves  (WHO  2006)  taking  isoniazid,  rifampicin, 
pyrazinamide  and  ethambutol  for  two  months  and  subsequently  followed  by 
isoniazid and rifampicin for four months. Strains categorised as MDR are resistant 
to at least the two front line drugs (rifampicin and isoniazid) and XDR-TB strains 
are  resistant  to  the  front-line  drugs  and  in  addition,  are  also  resistant  to 
fluoroquinolones and either capreomycin, kanamycin or amikacin (WHO 2006).  
 
Conventional  methods  of  diagnosis  of  TB  include  microscopy  and 
bacterial culture. Microscopy is commonly used for identifying bacteria in sputum 
samples  either  using  Ziehl-Neelsen  or  auramine-rhodamine  staining,  the  latter 
being the current preferred option as it is quicker  and more sensitive than  Ziehl-
Neelsen staining (Steingart, Henry et al. 2006). Bacteria from clinical specimens 
can be cultured conventionally in Löwenstein-Jensen, Kirchner, or Middlebrook 
media  (7H10  or  7H11).  In  recent  years,  new  automated  systems  such  as   21 
MB/BacT,  BACTEC  9000,  and  the  mycobacterial  growth  indicator  tube  offer 
faster  methods  of  diagnosis.  Chest  X-rays  are  generally  non-specific  and 
expensive  thus  making  them  inaccessible  to  large  proportion  of  patients  in 
developing  countries.  Abnormalities  in  radiographs  are  suggestive  but  do  not 
provide  a  conclusive  diagnosis  of  TB  infection.  The  other  main  method  of 
detecting  TB  infection  is  by  using  the  Mantoux  test  but  this  method  lacks 
specificity  and  is  highly  variable  in  populations  of  immunocompromised 
individuals.  Purified  protein  derivative  (PPD),  the  major  component  of  the 
tuberculin  reagent  used  for  the  Mantoux  test,  cross-reacts  with  antigens  from 
environmental mycobacteria thus increasing the risk of false positives (Andersen, 
Munk et al. 2000).  
 
New assays based on detecting IFN-g produced by T cells in response to 
early secreted antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-
10) are more specific and thus provide more accurate testing than the Mantoux 
skin  test.  T-SPOT  TB  (developed  by  Oxford  Immunotech,  UK)  and 
QuantiFERON-TB  Gold  (developed  by  Cellestis,  Australia)  have  based  their 
assays on these two antigens, ESAT-6 and CFP-10, encoded within the region of 
difference-1  locus  of  M.  tuberculosis,  which  is  absent  from  Bacille  Calmette 
Guérin  (BCG)  and  most  other  strains  of  mycobacteria;  thus  these  tests  offer 
increased specificity and reduced risk of false positives (Liu, Dosanjh et al. 2004). 
Despite advances in detection of TB infection in recent years, it remains difficult 
to distinguish between active vs latent TB.  
 
In  a  recent  report,  messenger  RNA  (mRNA)  transcripts  for  IL-8  (a 
chemoattractant for neutrophils, monocytes and T cells), forkhead box P3 (Foxp3, 
a regulatory T cell specific transcription factor) and IL-12p40 were consistently 
shown to have different expression levels between active and latent TB cases and 
thus were able to distinguish between these two disease states quite accurately 
(Wu, Huang et al. 2007). It was further suggested that measuring the expression of 
these three genes in response to TB antigens would offer an accurate method of 
distinguishing between latent and active TB cases but the feasibility of such a test 
would have to be assessed by including individuals co-infected with HIV, which 
were excluded from the present study (Wu, Huang et al. 2007).    22 
TB control can be achieved using a suitable pre-exposure (prophylactic 
vaccine) or post-exposure vaccine. The current vaccine BCG is the only approved 
vaccine  for  the  prevention  of  TB.  BCG  has  had  varying  degrees  of  efficacy 
against adult pulmonary TB, ranging from providing no protection in South India 
to 80% protection in trials conducted by the UK Medical Research Council (Hart 
and  Sutherland  1977).  BCG  is  consistently  effective  against  severe  childhood 
forms of TB meningitis (Colditz, Brewer et al. 1994) although in 2005, routine 
BCG vaccination of school children was ended in the UK and now vaccination is 
only offered to children in high risk groups (TB incidence of more than 40 cases 
per 1000,000 individuals) in the UK. The low efficacy of BCG has been attributed 
to a number of factors including differences in the BCG strain that is being used 
for vaccination (Behr 2002) and exposure to environmental mycobacteria. The 
exposure  to  environmental  mycobacteria  primes  the  immune  system  against 
mycobacterial antigens shared with BCG and subsequently vaccination with BCG 
results  in  the  rapid  clearance  of  this  strain,  due  to  rapid  recall  responses 
(Demangel, Garnier et al. 2005). Another reason for the failure of BCG has been 
attributed to the increased levels of the cytokine IL-4, which can dampen T-helper 
1 (Th-1) type immune response induced by BCG, thus leading to the reduced 
efficacy of the vaccine (Rook, Dheda et al. 2006). Due to the varying efficacy of 
BCG and the inability of the vaccine to protect against adult pulmonary TB, it is 
vital that a new vaccine is available soon. A number of new vaccine candidates 
are in the pipeline being currently evaluated in clinical trials and the hope is at 
least  one  vaccine  would  complete  phase  III  trials  and  be  licensed  by  2015 
(Bioventures 2006).  
 
1.2 - M. tuberculosis 
1.2.1- M.  tuberculosis - aetiological agent of TB 
M. tuberculosis, the causative agent of TB, is a non-motile and acid-fast 
actinomycete (Russell 2001). The bacterium was discovered by Robert Koch in 
1882. This bacterium is part of the M. tuberculosis complex which encompasses 
M. tuberculosis, M. bovis, BCG, M. africanum, M. canettii and M. microti, all of 
which share >99% identity at the nucleotide level. M. tuberculosis is an aerobic, 
facultative  intracellular  pathogen  with  a  generation  time  of  approximately  20   23 
hours.  This  lengthy  generation  time  contributes  to  the  chronic  nature  of  the 
disease, thus contributing to the extensive duration of treatment regime. These 
bacteria  possess  a  unique  cell  wall  rich  in  mycolic  acids,  lipoarabinomannan 
(LAM),  arabinogalactan  and  phosphatidylinositol  mannosides  (PIM).  The 
mycobacterial genome of CDC1551 (Fleischmann, Alland et al. 2002), M. bovis 
(Garnier,  Eiglmeier  et  al.  2003)  and  H37Rv  (Cole,  Brosch  et  al.  1998),  a 
commonly  used  laboratory  strain  of  M.  tuberculosis  has  been  sequenced.  The 
genome of H37Rv consists of approximately 4000 genes. Of these 4000 genes, 
40%  have  a  clearly  defined  function,  40%  have  been  shown  to  belong  to 
previously  identified  classes  of  genes  and  20%  are  completely  unknown. 
Comparative genomic analysis of M. bovis BCG with H37Rv, has revealed 11 
deletions  from  the  genome  of  M.  bovis  BCG  and  the  variation  in  physiology 
between these two strains may be attributed to the differences in gene expression. 
 
1.22- Pathogenesis of tuberculosis  
Approximately  one-third  of  the  world’s  population  is  infected  with  M. 
tuberculosis. Individuals who are infected have a 5-10% risk of developing the 
active  form  of  the  disease.  Smoking  and  HIV  infection  can  predispose  an 
individual to acquiring infection, with overcrowding and poverty increasing the 
risk of exposure to M. tuberculosis (Cantwell, Mckenna et al. 1998; Lienhardt, 
Fielding et al. 2003).  
 
The first stage of interaction between the host and bacteria is initiated after 
the inhalation of the bacilli via aerosol droplets, measuring 1-2mm, from infectious 
individuals. In the lung, bacteria are phagocytosed by alveolar macrophages and the 
generation of a localised inflammatory immune response results in the recruitment of 
immune cells to the sites of infection. Accumulation of immune cells at the foci of 
infection, results in the development of a granuloma, which limits the dissemination 
of  the  bacteria  and  localises  the  inflammation  and  damage  to  the  lung  tissue. 
Granulomas are composed of infected macrophages, surrounded by foamy giant cells 
with lymphocytes on the periphery of the structure (Co, Hogan et al. 2004). 
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The bacteria are contained within these granulomas and the host no longer 
transmits the infection. Latent, viable bacteria can survive in granulomas for very 
long  periods  of  time.  An  alternative  possibility  is  that  the  bacteria  can  multiply 
leading to the development of active TB shortly after infection and this is most likely 
to happen in with a compromised immune system. 
 
Latency is a hallmark of M. tuberculosis infection and re-activation can occur 
due to a number of reasons such as alcohol abuse and corticosteroid therapy (Flynn 
and Chan 2001). Under reactivation circumstances, the granuloma becomes caseous 
and these reactivating granulomas are sites of enhanced bacterial replication. This 
reactivation leads to clinical symptoms and  thus the formation  of secondary TB.   
The different outcomes of the infection reflect the fine balance between the pathogen 
and  host  immune  responses  and  any  shift  in  the  balance  in  favour  of  bacterial 
replication can lead to reactivation of the disease (Kaufmann 2001; Russell 2001). 
 
1.2.3 - Interplay between host and pathogen 
  M. tuberculosis is an old foe of man and as a pathogen is highly adapted 
for  survival  within  an  immunocompetent  host.  Following  infection  with  M. 
tuberculosis there are four potential outcomes: 
 
·  Initial response is completely effective and thus bacilli are eliminated  
·  Mycobacteria can grow and multiply thus causing primary clinical disease 
(active TB) 
·  Bacteria become dormant in granulomas leading to latent TB infection 
·  Latent bacilli reactivate as a failure of immune surveillance thus leading to 
reactivation TB  
 
Only  10%  of  infected  individuals  progress  to  develop  active  TB,  with  a 
significant  proportion  of  the  remaining  infected  individuals  harbouring  latent 
bacilli which pose a reactivation threat in the future. The immune response to M. 
tuberculosis  is  composed  of  the  early  innate  immune  response,  during  which 
bacteria  are  taken  up  by  phagocytic  cells  resulting  in  the  production  of 
inflammatory  cytokines  and  induction  of  antimycobacterial  mechanisms  by   25 
macrophages.    This  is  followed  by  a  late  response  in  which  M.  tuberculosis 
specific T cells are activated leading to the priming of a cell mediated immune 
response accompanied by the production of effector cytokines including IFN-g. In 
the final stages of infection, mycobacteria are contained within granulomas thus 
preventing dissemination of bacteria (latent phase). 
 
1.2.4- Interaction between macrophages and M. tuberculosis 
  Macrophages  are  considered  the  primary  host  cells  for  mycobacteria. 
Inhaled  mycobacteria  within  small  droplets  are  phagocytosed  by  alveolar 
macrophages  where  they  are  confronted  by  an  array  of  anti-mycobacterial 
mechanisms. Failure to kill mycobacteria, results in survival of bacteria within 
macrophages,  leading  to  the  establishment  of  a  latent  infection.  A  number  of 
macrophage receptors are involved in the uptake of mycobacteria. Complement 
receptors CR1, CR3 and CR4 take up opsonised bacteria; monoclonal antibodies 
against CR3, markedly reduced phagocytosis of M. tuberculosis by monocytes 
thus, showing the relative importance of this phagocytic receptor in taking up 
mycobacteria (Schlesinger, Bellinger-Kawahara et al. 1990).   
 
The macrophage mannose receptor aids in the uptake of non-opsonised 
bacteria. This receptor recognises the mannose-capped LAM (manLAM) present 
on virulent strains of mycobacteria. Other receptors including CD14, macrophage 
receptor with collagenous structure and fragment crystallisable gamma receptor 
(Fcg)  receptors,  have  all  been  shown  to  have  roles  in  the  phagocytosis  of 
mycobacteria (Ernst 1998). The selective use of receptors by different strains of 
mycobacteria may hold clues to the different signalling pathways induced, thus 
influencing the survival of the bacteria within this host cell. 
 
1.2.5- Antimycobacterial mechanisms of the macrophage 
Macrophages are considered to be the main effector cells involved in the 
killing of mycobacteria. Macrophages when activated by interferon-g (IFN-g) and 
tumor necrosis factor-a (TNF-a) can exert various microbicidal mechanisms. Of 
importance,  are  the  induction  of  reactive  nitrogen  intermediates  (RNI)  and   26 
formation of reactive oxygen intermediates (ROI). Hydrogen peroxide is one of 
the  key  effector  molecules  generated  as  part  of  the  ROI  pathway  alongside 
superoxide anions. ROI effectors cause lipid peroxidation, cell membrane, DNA 
and protein damage.  But the role of ROI in killing mycobacteria is controversial, 
when  the  data  is  restricted  to  human  studies,  which  show  that  patients  with 
chronic granulomatous disease, who have a defective ROI mechanism, show no 
increased susceptibility to TB (Winkelstein, Marino et al. 2000). In contrast,  a 
role  for  ROI  in  killing  mycobacteria  is  demonstrated  by  the  increased 
susceptibility  of  mice  to  mycobacterial  infections,  when  deficient  in  the  p47 
subunit  of  nicotinamide  adenine  dinucleotide  phosphate  (NADPH)  oxidase 
needed for superoxide production (Cooper, Segal et al. 2000) . 
 
  The  production  of  increased  nitric  oxide  (NO)  is  another  anti-
mycobacterial mechanism employed by an activated macrophage. Activation of 
macrophages by  IFN-g  and TNF-a  generates  NO and related RNIs  which are 
generated during the conversion of L-arginine to citrullene by inducible nitric-
oxide  synthase  (iNOS).  Murine  macrophages  have  been  previously  shown  to 
produce  RNI  in  response  to  M.  tuberculosis  infection,  which  subsequently 
induced killing of mycobacteria (Chan, Xing et al. 1992). RNI has been shown to 
contribute to the protective immune responses during acute and chronic stages of 
infection (MacMicking, North et al. 1997). The role of iNOS in murine infections 
is fairly well documented but its role in human host defence remains unresolved. 
In vitro, human alveolar macrophages infected with M. bovis BCG up regulate 
iNOS  mRNA  and  the  use  of  iNOS  inhibitors  resulted  in  increased  bacterial 
outgrowth (Nozaki, Hasegawa et al. 1997). In contrast, studies have also shown 
that  in  murine  but  not  human  macrophages  the  anti-mycobacterial  activity  is 
mediated principally by NO (Liu, Stenger et al. 2006). Thus, further work needs 
to be carried out to elucidate the importance of iNOS in human TB.  
   
Non-oxidative mechanisms are also employed by activated macrophages 
in order to kill mycobacteria; for example, the induction of autophagy in activated 
macrophages resulted in the delivery of the bacteria into lysosomes and thus led to 
the  killing  of  the  bacteria  by  acid  hydrolases  (Gutierrez,  Master  et  al.  2004; 
Alonso, Pethe et al. 2007).     27 
1.2.6- Immune evasion mechanisms employed by M. tuberculosis   
M. tuberculosis is able to survive within macrophages even though a range 
of effector mechanisms exist in these host cells to control the growth of invading 
bacteria. Normally, during the process of phagocytosis, microorganisms are taken 
up into phagocytic vacuoles which eventually fuse with lysosomes resulting in the 
formation of a phagolysosome. The phagolysosome environment is highly acidic 
and  phagocytosed  microbes  are  degraded  by  acid  hydrolases.  This  event 
represents  an  integral  part  of  the  antimicrobial  mechanism  of  phagocytes. 
However,  M.  tuberculosis  employs  various  mechanisms  to  survive  in  the 
phagosome such as the modification of the phagosome it resides in by exclusion 
of vesicular H
+ ATPases (Crowle, Dahl et al. 1991; Koszycki-Sturgill, Schlesinger 
et  al.  1994).  The  exclusion  of  H
+  ATPases  from  phagosomes  containing  live 
mycobacteria  leads  to  the  incomplete  acidification  of  the  phagosome,  thus 
allowing the bacteria to survive. It has been additionally shown that, mycobacteria 
inhibit the formation of the phagolysosome,  thus avoiding enzymatic degradation 
(Armstrong and Hart 1971). The block in maturation of mycobacterial phagosome 
occurs between the small GTP-binding proteins, Rab5 (early endocytic) and Rab7 
(late endocytic), which directs trafficking in eukaryotic cells. 
 
However, during M. tuberculosis infection, following the phagocytosis of 
the bacteria by macrophages, the bacilli are retained within phagocytic vacuoles 
which tend to be at a pH of 6.2-6.3 (Sturgill-Koszycki, Schlesinger et al. 1994). 
These vacuoles are not completely isolated from the rest of the host cell as they 
have  been  shown  to  contain  lysosomal-associated  membrane  protein-1,  major 
histocompatibility 2, class II antigen (MHC-II) and transferrin receptor, and are 
thus  able  to  access  transferrin  internalised  at  the  cell  surface  (Russell  2001). 
Consequently, these vacuoles fail to fuse with lysosomes but they remain fusion 
competent (Clemens and Horwitz 1996). Thus, mycobacteria-containing vesicles 
are highly dynamic and fuse with early endosomes although these vesicles do not 
fuse with lysosomes. 
 
The  retention  of  the  host  cell  protein  tryptophan  aspartate  rich  coat 
proteins (TACO), on phagosomes, has been proposed as a possible reason for the 
failure of mycobacterial phagosomes to fuse with lysosomes. The association of   28 
TACO to phagosomal membrane is by means of cholesterol rich domains which 
may provide a docking site for the mycobacteria to gain entry into phagosomes 
(Ferrari, Langen et al. 1999).  
 
Mycobacterial components LAM and PIM have been shown to intercalate 
into endosome membranes and traffic within mycobacteria-infected cells (Beatty, 
Rhoades  et  al.  2000).  LAM  has  been  demonstrated  to  inhibit  phagosomal 
maturation and PIM stimulates fusion of early endosomes thus maintaining the 
early endosomal nature of the phagosome (Fratti, Chua et al. 2003). Additionally, 
it has been reported that the serine/threonine protein kinase G from pathogenic 
mycobacteria  secreted  into  the  macrophage  phagosomes  prevents  phagosome-
lysosome fusion (Walburger, Koul et al. 2004). Hence, the bacteria exploit their 
lipids to modulate host cell membrane and phagolysosome biogenesis processes. 
 
Inhibiting antigen presentation is also known to contribute to the survival 
of M. tuberculosis within macrophages. Recent evidence suggests, that the 19kDa 
lipoprotein of M. tuberculosis inhibits IFN-g mediated up-regulation of MHC-II 
molecules and this response seems to be dependent on toll-like receptor 2 (TLR 2) 
(Noss, Pai et al. 2001; Fulton, Reba et al. 2004). M. tuberculosis and the 19kDa 
lipoprotein have been shown to inhibit IFN-g induced genes, which are involved 
in MHC-II antigen processing and presentation such as the class-II transactivator, 
which is involved in transcriptional regulation of MHC-II genes (Harton and Ting 
2000; Pai, Pennini et al. 2004). It has also been reported that post-Golgi transit of 
nascent MHC-II molecules into the endocytic pathway for antigen loading was 
impaired in M. tuberculosis infected macrophages, thus resulting in intracellular 
sequestration of MHC-II molecules and a reduced expression of MHC-II on the 
surface (Hmama, Gabathuler et al.1998). 
 
Targeting specific receptors is another mechanism used by mycobacteria 
to evade immune surveillance mechanisms. Opsonised mycobacteria taken up by 
Fcg receptors are targeted to vacuoles which readily fuse with lysosomes and thus 
entry of  mycobacteria through Fcg receptors into the host cell can result in a 
distinct pattern of trafficking but this was found to have no adverse effect on the   29 
growth  rate  of  the  bacteria  (Armstrong  and  Hart  1975).  The  selective  use  of 
complement receptors CR1 and CR3 has been shown not to trigger the oxidative 
burst and additionally, it has been reported that binding of ManLAM on human 
macrophage  mannose  receptor  leads  to  the  inhibition  phagosome-lysosome 
fusion, thus resulting in survival (Kang, Azad et al. 2005).  
Mycobacteria are able to evade the toxic effects of ROI via the use of 
LAM and phenolic glycolipids which act as ROI scavengers (Chan, Fan et al. 
1991)  and  mycobacterial  sulphatides  interfere  with  ROI  dependent  anti-
mycobacterial mechanism of macrophages.  M. tuberculosis additionally produces 
superoxide dismutase which catalyses the conversion of superoxide free radical to 
hydrogen peroxide and oxygen, thus enabling the bacteria to evade the oxidative 
burst in activated macrophages (Harth and Horwitz 1999). 
Employing these immune evasion mechanisms enables M. tuberculosis to 
survive, replicate and avoid immunological detection in the host. 
 
1.3- Dendritic cells- sentinels of the immune system 
  Macrophages are known to be the primary host cells for mycobacteria but 
dendritic  cells  have  also  been  reported  to  be  infected  with  mycobacteria 
(Henderson, Watkins et al. 1997; Bodnar, Serbina et al. 2001). Dendritic cells are 
bone marrow immune cells which populate lymphoid and non-lymphoid tissues of 
the  body  (Lipscomb  and  Masten  2002).  They  are  referred  to  as  “professional 
antigen presenting cells” and possess the unique capability of activating naïve T-
cells. These cells are capable of integrating innate immune responses to initiate 
adaptive immunity in the host. Dendritic cells are a heterogeneous family of cells, 
which exist at different developmental and functional stages within the host: 
 
- Proliferating dendritic cell progenitors arise from bone marrow stem cells 
and these precursor cells migrate to the tissues via the blood stream where 
they give rise to immature dendritic cells   30 
- Immature dendritic cells serve as sentinels of the immune system where 
they take up antigens in the peripheral tissues that triggers their maturation 
and migration to secondary lymphoid tissues 
- Mature dendritic cells function as antigen presenting cells in secondary 
lymphoid tissues 
 
1.3.1 - Dendritic cell subsets 
Multiple subsets of dendritic cells exist, all of which exhibit considerable 
plasticity and trigger diverse immune responses.  Precursor dendritic cells from 
mouse bone marrow, cultured in the presence of granulocyte macrophage colony 
stimulating  factor  (GM-CSF),  give  rise  to  the  myeloid  dendritic  cell  subset 
(CD11c
+,  CD11b
+ B220
-) but when cultured with  Flt-3 ligand  yields  CD11c
+, 
CD11b
+, B220
+ dendritic cells also commonly known as plasmacytoid dendritic 
cells  (Shortman  and  Liu  2002).  Plasmacytoid  dendritic  cells  have  the  unique 
ability to produce large amounts of type I interferons (IFNs) and thus they are 
primarily involved in anti-viral immunity. 
 
Dendritic cell subsets isolated from murine spleens can influence the type 
of T cell response generated (Table 1.1). The CD8a
+, CD11c
+, CD11b
- subset, 
prime principally naïve CD4
+ T cells to generate a Th-1 type response but the 
CD8a
-, CD11c
+, CD11b
+ subset prime naïve CD4 T cells to produce principally a 
Th-2 type response (Shortman and  Liu 2002; Naik,  Proietto et al. 2005). The 
different subsets can also regulate the amount of cytokines produced by T cells;  
the CD4
-CD8
+ dendritic cell subset induces less interleukin-2 (IL-2) and IFN-g 
from CD8
+ and CD4
+ T cells than the CD4
-CD8
- DC subset (Shortman and Liu 
2002; Naik, Proietto et al. 2005). In a similar manner, plasmacytoid dendritic cells 
can induce a strong Th-1 type immune response in the presence of CpG but not 
lipopolysaccharide (LPS),  whereas myeloid dendritic cells initiate a Th-1 type 
immune  response  when  stimulated  with  LPS  (Boonstra,  Asselin-Paturel  et  al. 
2003).  It  was  additionally  demonstrated  that  both  subsets  of  dendritic  cells 
initiated a Th-1 type immune response when exposed to high doses of antigen 
(ovalbumin) and in contrast, low doses of antigen induced a Th-2 type immune 
response  (Boonstra,  Asselin-Paturel  et  al.  2003).  This  set  of  experiments   31 
demonstrated that the resulting T cell response is influenced by a combination of 
factors including subset of dendritic cell, type and dose of antigen and the nature 
of the stimulus.  
 
Table 1.1- Murine dendritic cell subsets 
Dendritic  cells  are  a  heterogeneous  population  of  cells  that  are  capable  of 
processing and presenting antigens to T cells. The different subsets of dendritic 
cells differ in their location and immunological properties. Table modified from 
(Villadangos and Schnorrer 2007)  
 
 
 
 
 
Features 
Lymphoid-organ-resident DC 
subsets 
Migratory DC subsets 
Monocyte 
derived 
 
CD4
+ 
DCs 
CD8
+ 
DCs 
DN DCs 
Interstitial 
DCs 
Langerhans 
cells 
  
Location 
Spleen  Yes  Yes  Yes  No  No  Sites of 
inflammation 
Surface markers 
CD11c  +++  +++  +++  +++  +++  +++ 
CD4  +  -  -  -  -  - 
CD8  -  ++  -  -  -/+  - 
CD205  -  ++  -/+  +  +++  -/+ 
CD11b  ++  -  ++  ++
‡  ++  ++ 
Functional features in the steady state 
Maturity  Immature  Immature  Immature  Mature  Mature  N/A 
Co-
stimulatory 
+  +  +  ++  ++  N/A 
Antigen 
processing 
and 
presentation 
+++  +++  +++  +/-  +/-  N/A 
MHC class II  ++  ++  ++  +++  +++  N/A 
In vitro equivalent 
  
Bone-
marrow 
precursors 
plus 
FLT3L 
Bone-
marrow 
precursors 
plus 
FLT3L 
Bone-
marrow 
precursors 
plus 
FLT3L 
Bone-
marrow 
precursors 
plus GM-
CSF, TNF 
and TGF  
Bone-
marrow 
precursors 
plus GM-
CSF, TNF 
and TGF  
Bone-
marrow, 
spleen or 
blood 
precursors 
plus GM-CSF   32 
Several human dendritic cell subtypes have also been characterised. In the 
presence of GM-CSF and IL-4, monocytes differentiate into immature dendritic 
cells;  characterised  by  low  levels  of  CD86  and  MHC-II  (Sallusto  and 
Lanzavecchia 1994) and these dendritic cells when stimulated with inflammatory 
products can mature, expressing increased levels of CD86 and MHC-II. A second 
sub-type of dendritic cell found in blood is the type I IFN producing plasmacytoid 
subset,  which  are  characterised  as  being  CD11c
-CD45RA
+CD123
+  (Kadowaki 
and Liu 2002). 
 
1.3.2—Immature dendritic cells  
  Immature  dendritic  cells  are  present  in  the  periphery,  where  they  can 
phagocytose microbes using an array of receptors, such as FcγRs, complement 
receptors and toll-like receptors (TLRs). Immature dendritic cells have the ability 
to take up antigens via different mechanisms such as macropinocytosis, receptor 
mediated  endocytosis  (via  mannose  receptor  and  DEC  205)  and  phagocytosis 
(uptake  of  apoptotic/necrotic  material  through  CD36  and  avb5).  Immature 
dendritic cells express low levels of surface MHC-II and co-stimulatory molecules 
CD80/CD86,  thus  they  are  not  capable  of  functioning  as  efficient  antigen 
presenting cells at this developmental stage (Banchereau, Briere et al. 2000).  
 
1.3.3 – Dendritic cell maturation and migration 
Following interaction with antigens, immature dendritic cells undergo a 
series of functional and phenotypic changes, which result in the transition from 
antigen capturing cell to antigen presenting cell. Activation of dendritic cells is 
linked with their migration to the lymphoid organs. Dendritic cell activation is 
initiated in the peripheral tissues and continues to completion during interaction 
with  T-cells.  In  response  to  pathogen  derived  products  like  LPS  from  gram 
negative bacteria, dsRNA, inflammatory cytokines such as TNFa and IL-1, and T 
cell  derived  signals  in  the  form  of  CD40-CD40L  interaction,  dendritic  cells 
mature and migrate via the lymphatics to secondary lymphoid tissues (Banchereau 
and Steinman 1998; Banchereau, Briere et al. 2000). Extravasation of these cells 
from peripheral tissues to secondary lymphoid organs is mediated by chemokines   33 
and their receptors. One of the key chemokine receptors, chemokine (C-C motif) 
receptor 7 (CCR7) is expressed on dendritic cells and plays an important role in 
promoting the migration of these cells to lymph nodes; CCR7 deficient mouse 
studies  revealed  a  marked  defect  in  migration  of  dendritic  cells  to  the  lymph 
nodes (Forster, Schubel et al. 1999). Migration of dendritic cells to the lymph 
nodes occurs via a chemotactic gradient of CCR7 ligands- CCL19 and CCL21. 
Mature dendritic cells down regulate expression of chemokine receptors such as 
CCR1, CCR5 and up-regulate the expression of CCR4 and CCR7, which aids the 
migration of dendritic cells to lymphoid organs (Banchereau, Briere et al. 2000). 
 
1.3.4 Phagocytic receptors on dendritic cells 
Phagocytosis can trigger an inflammatory response, which depends on the 
stimulus  in  question.  Interaction  between  certain  ligands  and  their  receptors, 
during  the  process  of  phagocytosis,  initiates  the  maturation  of  dendritic  cells. 
Engagement  of  Fc  receptors  and  mannose  receptors,  trigger  an  inflammatory 
immune cytokine response, resulting in the production of IL-1β, TNF-α and IL-12 
(van Crevel, Ottenhoff et al. 2002).C-type lectin receptors on dendritic cells are 
either  type  II  transmembrane  proteins  with  a  single,  carboxy  terminal  lectin 
domain or type I receptors with multiple lectin domains. Type I transmembrane 
receptors include the mannose receptor and DEC-205, and type II transmembrane 
receptors  include  DC-SIGN  (dendritic  cell-specific  ICAM3-grabbing  non-
integrin)  and  dectin-2.  The  expression  of  these  receptors  varies  with  the 
developmental  stage  of  the  dendritic  cell.  Immature  dendritic  cells  express 
abundant  mannose  receptors  and  DC-SIGN  on  the  surface,  the  expression  of 
which decreases on maturation (Kato, Neil et al. 2000). DC-SIGN first gained 
attention as a receptor that was capable of  binding to the HIV-1 glycoprotein 
gp120. DC-SIGN interacts with intercellular adhesion molecule-2 (ICAM-2) on 
vascular endothelial cells mediating dendritic cell migration and interacts with 
ICAM-3 aiding in dendritic cell-T cell interaction. Antigens internalised by DC-
SIGN are targeted to lysosomal compartments where antigens are processed and 
loaded via the MHC-II pathway (Engering, Geijtenbeek et al. 2002).  
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DC-SIGN as a c-type lectin shows specificity for the ligands it interacts 
with.  DC-SIGN  is  able  to  bind  dimeric  and  trimeric  mannose  residues  in 
ManLAM but it does not recognise ManLAM from M. avium, as the ManLAM is 
capped with a single mannose residues (Maeda, Nigou et al. 2003). ManLAM is a 
unique  component  of  cell  walls  from  virulent  mycobacteria  (slow-growing 
bacteria)  as  opposed  to  AraLAM  from  avirulent  mycobacteria  (fast-growing 
bacteria). It has been reported that BCG induced dendritic cell maturation was 
inhibited  by  the  binding  of  ManLAM  to  DC-SIGN  on  human  dendritic  cells 
(Geijtenbeek, van Vliet et al. 2003) and additionally, ManLAM binding to DC-
SIGN  triggers  intracellular  signalling  pathways  that  lead  to  the  increased 
production  of  anti-inflammatory  cytokines  such  as  IL-10.  The  binding  of 
ManLAM  to  DC-SIGN  results  in  the  inhibition  of  TLR  mediated  IL-12 
production by LPS matured dendritic cells (Geijtenbeek, van Vliet et al. 2003). 
Interaction between DC-SIGN and mycobacteria possibly is a route utilised by 
virulent  mycobacteria,  to  undermine  dendritic  cell  induced  immune  responses 
which might enhance survival of the pathogen.  
 
Additional interactions can occur between receptors such as the mannose 
receptor and pathogen associated mannose structures on mycobacteria. A study in 
reference to the interaction of LAM and mannose receptor, has demonstrated that 
LAM  is  taken  up  by  mannose  receptors,  which  led  to  its  transport  to  late 
endosomes for antigen presentation on CD1b molecules (Prigozy, Sieling et al. 
1997).  Mannose  receptor  recognises  surface  polysaccharides  of  gram  positive 
bacteria,  gram  negative  bacteria  and  parasites.  On  the  surface  of  immature 
dendritic cells, this receptor functions to take up antigens and target them to early 
endosomes  away  from  MHC-II  compartments  (Tan,  Mommaas  et  al.  1997; 
Hawiger,  Inaba  et  al.  2001).  The  low  pH  within  endosomes  results  in  the 
dissociation of the receptor and ligand and subsequently, the mannose receptor 
recycles back to the cell surface. Expression of the mannose receptor is down 
regulated  by  inflammatory  cytokines  and  up  regulated  by  anti-inflammatory 
cytokines such as IL-4 and IL-10 (Martinez-Pomares, Reid et al. 2003). 
 
Dendritic  cells  also  express  FCγRs  and  FCεRs  which  mediate  the 
presentation  of  antibody  coated  and  immune  complexes  on  both  MHC-I  and   35 
MHC-II (Regnault, Lankar et al. 1999). It has been proposed that internalisation 
of  ovalbumin immune complexes via Fc receptors can lead to the delivery  of 
antigens  to  the  cytosol  via  a  pathway  unique  to  dendritic  cells.  Antigens  are 
trafficked  to  the  cytosol  directly  from  the  lumen  of  the  endosome  and 
subsequently  degraded  by  the  proteasome  and  loaded  on  MHC-I  molecules 
(Rodriguez, Regnault et al. 1999).  
 
1.4- Activation of cellular signalling pathways 
In addition, to the above mentioned family of receptors, dendritic cells 
express a family of pattern recognition receptors: TLRs. Toll was first identified 
as a gene required for dorsal-ventral patterning during embryonic development 
and subsequently, was also shown  to play a key  role in anti-fungal immunity 
(Lemaitre,  Nicolas  et  al.  1996).  A  homologous  family  of  genes  was  then 
discovered in mammals and was named TLRs. TLRs are type I membrane integral 
glycoproteins and to-date, there are 10 TLRs identified in humans and 13 in mice. 
TLRs 1, 2 and 4 are located on the cell surface and are recruited to the phagosome 
after activation and TLRs 3, 7 and 9 are localised on endosomal and lysosomal 
compartments.  
 
 The  structurally  conserved  motifs  recognised  by  TLRs  usually  have 
essential roles in the invading agents and thus are not subjected to high mutation 
rates.  The  various  ligands  recognised  by  TLRs  include  peptidoglycan  and 
lipoteichoic acid from gram positive bacteria recognised by TLR 2 (Schwandner, 
Dziarski et al. 1999) and double stranded RNA from virus which is recognised by 
TLR 3 (Alexopoulou, Holt et al. 2001). Single stranded RNA is recognised by 
TLR 7 (Diebold, Kaisho et al. 2004), LPS from gram negative bacteria is the main 
ligand for TLR 4 (Poltorak, He et al. 1998) and CpG motifs are recognised by 
TLR9 (Hemmi, Takeuchi et al. 2000).  
 
1.4.1 Adaptors involved in TLR signalling pathways 
In total 5 adaptors are known to mediate TLR signalling pathways  and the 
utilisation  of  different  combinations  of  adaptors  lead  to  the  distinct  gene   36 
expression  patterns  observed  in  response  to  TLR  agonists.  The  myeloid 
differentiation primary response gene 88 (MyD88) was originally isolated as a 
gene,  which  was  shown  to  play  an  important  role  during  myeloid  cell 
differentiation and was rapidly induced during the IL-6 stimulated differentiation 
of M1 myeloleukaemia cells into macrophages (Lord, Hoffman-Liebermann et al. 
1990).  MyD88  was  shown  as  the  adaptor  molecule  that  functions  to  recruit 
interleukin-1  receptor-associated  kinase  (IRAK)  to  the  IL-1  receptor  complex 
following  stimulation  with  IL-1  (Wesche,  Henzel  et  al.  1997).  In  addition  to 
MyD88 there are 4 other adaptors which are involved in TLR signalling: TIR 
domain containing adaptor inducing interferon beta (TRIF), TRIF-related adapter 
molecule (TRAM), MyD88 adapter like (MAL) and sterile α and armadillo motifs 
(SARM). MAL is essential for TLR 2 and TLR 4 signalling routes, serving as a 
link to recruit MyD88 (Yamamoto, Sato et al. 2002) and thus plays a  role in the 
MyD88 dependent pathway of TLR4 signalling. TRIF is important in the TLR4 
mediated MyD88 independent pathway and is also the adaptor used for initiation 
of signalling via TLR 3 (Yamamoto, Sato et al. 2003). TRAM is another TLR 4 
pathway  adaptor  whose  role  includes  induction  of  IL-6,  TNF  and  CD86 
(Yamamoto, Sato et al. 2003). Similar to TRIF, TRAM is also required for the late 
activation of NFkB. SARM, in contrast to the other TLR adaptors, is a negative 
regulator of  TLR signalling and its expression is specifically shown to block 
TRIF dependent gene activation.  
 
1.4.2- MyD88 dependent and independent TLR signalling pathways 
The cytoplasmic portion of TLRs exhibit a high degree of similarity to that 
of the IL-1 receptor family and is known as the Toll/IL-1 receptor (TIR) domain. 
Extracellular portions of the TLRs and IL-1 receptor are structurally unrelated, 
with  TLRs  possessing  leucine  rich  repeats  and  the  IL-1  receptor  having 
immunoglobulin  like  domains.  Binding  of  ligands  to  TLRs  leads  to  its 
dimerisation and conformational change, which triggers its association with the 
adaptor  MyD88.  This  in  turn  recruits  IRAK-4,  which  subsequently  associates 
itself with IRAK-1 (Barton and Medzhitov 2003). Binding of IRAK-4 to MyD88 
induces the phosphorylation of IRAK-1. TNF receptor associated factor-6 (TRAF-  37 
6), a signalling mediator adaptor protein is also recruited to the IRAK-1/4-MyD88 
complex and associates itself with IRAK-1 (Figure 1.1).  
 
Phosphorylated IRAK-1 and TRAF-6 then dissociate and form a complex 
with  members  of  the  mitogen  activated  protein  kinase family  (MAPK):  TGF-
activated kinase 1 (TAK-1), TAK-1 binding protein 1 (TAB-1) and TAB-2. This 
subsequently  leads  to  the  phosphorylation  of  TAB-2  and  TAK-1.  IRAK-1  is 
degraded and following this TRAF-6 forms a complex with the ubiquitin ligases, 
ubiquitin-conjugating enzyme 13 (UBC13) and ubiquitin-conjugating enzyme E2 
variant 1 (UEV1A). Ubiquitylated TRAF-6 results in the activation of TAK-1 
which phosphorylates both the MAPK and inhibitor of nuclear factor kappa-B 
kinase (IKK) complex (IKK-a, IKK-b and IKK-g). Phosphorylation of inhibitor 
of kappa light polypeptide gene enhancer in B-cells (IkB) by the IKK complex 
results in its degradation, which results in the translocation of nuclear factor kappa 
B (NFkB) to the nucleus, thus resulting in the transcription of NFkB dependent 
target genes (e.g. inflammatory cytokines), as illustrated in figure 1.1. 
 
             Recognition  of  microbial  components  through  TLRs  can  result  in 
signalling  via  the  MyD88  dependent  or  independent  pathways.  The  MyD88 
dependent pathway involves the early phase activation of NFkB and the MyD88 
independent pathway leads to the late phase activation of NFkB, with delayed 
kinetics compared to wild-type mice (Covert, Leung et al. 2005). Engagement of 
TLR3 and TLR4 is known to activate the MyD88 independent signalling pathway. 
As part of the MyD88 independent pathway, TANK binding kinase 1 (TBK-1) 
and  IKKe/IKKi  induces  interferon  regulatory-3  (IRF-3)  phosphorylation  thus 
leading to the activation of IRF-3. Activated IRF-3 translocates to the nucleus and 
initiates the cascade of events leading to type I IFN production (Figure 1.1).   
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Figure 1.1- Overview of the TLR signalling pathways 
 
TLRs  are  type  I  transmembrane  receptors  involved  in  innate  immunity.  Upon 
engagement  of TLRs  with microbial products, several signalling  pathways are 
activated; this results in the activation of NFkB or IRF-3. Activation of NFkB via 
TLR signalling pathways represents an integral part of the host innate immune 
response.  
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1.4.3- Negative regulators of the TLR signalling pathway 
  A balance must be achieved between activation and inhibition of immune 
and inflammatory responses mediated by TLRs. This is important in preventing 
the induction of detrimental inflammatory responses in the host. Thus, the TLR 
signalling pathway is tightly regulated by various negative regulatory components 
such  as,  soluble  decoy  TLRs,  which  attenuate  TLR  function  by  blocking  the 
interaction  between  the  ligand  and  TLR,  even  though  the  finer  details  of  the 
mechanism by which this is achieved still remains unclear (Iwami, Matsuguchi et 
al.  2000).  Other  negative  regulators  include  MyD88s  (short  form  of  MyD88), 
IRAKM, suppressor of cytokine signalling 1 (SOCS 1), phosphoinositide 3-kinase 
(PI3K), toll interacting protein (TOLLIP) and A20.  
 
  MyD88s has been shown to be induced in the THP-1, monocytic cell line 
in response to LPS stimulation and over expression of this regulator leads to the 
inhibition of LPS and IL-1 induced NFkB activation (Janssens, Burns et al. 2002).  
Many immune cell receptors relay intracellular signals via PI3K, which results in 
a variety of biological effects including chemotaxis, growth, survival and cytokine 
synthesis (Katso, Okkenhaug et al. 2001). Mice deficient in PI3K (p85) show 
enhanced TLR signalling, which results in enhanced IL-12 production in dendritic 
cells in response to LPS, and a dominant Th-1 cell response (Fukao, Tanabe et al. 
2002).  A20  is  a  unique  negative  regulator  that  regulates  both  the  MyD88 
dependent and independent pathways by interacting with TRAF6 (Boone, Turer et 
al. 2004). Macrophages from A20 deficient mice produce elevated levels of pro-
inflammatory cytokines in response to peptidoglycan, CpG and poly I:C (Boone, 
Turer et al. 2004).  
 
The presence of negative regulators maintains a delicate balance between 
inflammatory and immune responses generated by the TLR signalling pathway.   
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1.4.4- Interaction between TLRs and microbes   
            TLRs maybe expressed as homodimers or heterodimers and function, as 
mentioned above, in recognising an array of microbial ligands. An overview of 
the three TLRs (TLR 2, TLR 4 and TLR 9), which are known to be key players in 
the recognition of mycobacterial components is addressed below.  
 
TLR 2 is able to recognise a diverse range of microbial components which 
include  lipoteichoic  acid,  lipoproteins  from  gram  positive  and  gram  negative 
bacteria and peptidoglycan. This unique ability to recognise various ligands can 
be attributed to its ability to form heterodimeric interactions with TLR 1 and TLR 
6  (Ozinsky,  Underhill  et  al.  2000).  The  different  heterodimeric  combinations 
enable recognition of different bacterial lipopoproteins. TLR 2/TLR 6, along with 
CD36, facilitate the recognition of diacylated lipoproteins, in contrast, triacylated 
lipoproteins induce the activation of the immune system through interaction with 
TLR 1/TLR 2 dimers (Hoebe, Georgel et al. 2005). A role for TLR 2 during 
bacterial  infections  has  been  demonstrated  in  various  studies.  The  enhanced 
growth of Legionella pneumophila in TLR 2
-/- macrophages, in conjunction with 
decreased production of IL-12p40 production, led to the proposal of a role for 
TLR  2  in  mediating  host  resistance  to  L.  pneumophila  at  early  stages  of  the 
infection (Akamine, Higa et al. 2005). In another bacterial infection model, mice 
infected with Streptococcus pneumoniae had an increased level of TLR 2 mRNA 
in  the  brain,  with  TLR  2
-/-  mice  exhibiting  an  increased  disease  severity, 
accompanied by higher bacterial titres in both the cerebellar and blood (Koedel, 
Angele et al. 2003).  
 
One of the most extensively studied TLRs is TLR 4, whose primary ligand 
is the hexacetylated form of the lipid A component of LPS. TLR 4 also requires 
co-receptors  including  CD14,  (a  glycosylphosphatidyl  inositol  anchored 
glycoprotein) and MD-2, to respond to LPS (Wright, Ramos et al. 1990). Murine 
models have provided evidence that TLR 4 is the receptor for LPS; C3H/HeJ mice 
has a point mutation in the TIR domain of TLR 4 and another strain of mice 
B10.ScCR  lack  the  genomic  region  consisting  of  the  TLR  4  gene;  these  two 
strains of mice have been shown to be hypo-responsive to LPS (Poltorak, He et al. 
1998) . An important role for TLR 4 was demonstrated during Candida albicans    41 
infection using TLR 4
-/- mice (Netea, Van Der Graaf et al. 2002). The increased 
fungal load in TLR 4
-/- mice was associated with impaired chemokine production 
(lower  levels  of  CXCL1  and  macrophage  inhibitory  protein-2)  and  reduced 
neutrophil recruitment to the sites of infection. Host defence against respiratory 
syncitial virus is impaired in TLR 4
-/- mice due to defective IL-12 release and 
natural killer cells (NK cell) trafficking and function in the lungs of these mice 
(Haynes, Moore et al. 2001). This observed defect in NK cells was proposed to be 
due to  the reduced  NFkB activation  in the lungs  of TLR 4
-/- mice (Haeberle, 
Takizawa et al. 2002).  
 
TLR  9  was  initially  described  as  an  endosomal  receptor  recognising 
unmethylated CpG motifs in bacterial DNA (Krieg, Yi et al. 1995). The fact that 
vertebrate DNA is likely to be methylated provides the discrimination needed for 
TLR 9 to identify self from foreign DNA. TLR 9
-/- macrophages were defective in 
their ability to produce inflammatory cytokines in response to CpG DNA and 
furthermore,  dendritic  cells failed  to  enhance  the  expression  of  co-stimulatory 
molecules thus indicating that TLR 9 played a crucial role in inducing cellular 
responses to CpG DNA (Hemmi, Takeuchi et al. 2000).  
 
1.4.5- Role of TLRs in the immune response to mycobacteria 
Studies in TLR knock out mice have demonstrated the importance of this 
family of receptors in mediating host resistance during M. tuberculosis infections. 
Mycobacterial  ligands  including  LAM,  lipomannan  (LM)  and  the  19kDa 
lipoprotein (Brightbill, Libraty et al. 1999) are recognised by TLR 2 and TLR 4, 
and mycobacterial DNA is recognised by TLR 9 (Bafica, Scanga et al. 2005). 
 
TLR 2
-/- and TLR 4
-/- mice displayed no increased susceptibility to low 
dose aerosol M. tuberculosis infections and survived for up to 200 days post-
infection similar to wild-type mice (Reiling, Holscher et al. 2002). In response to 
a high dose aerosol challenge, TLR 2
-/- mice were found to be significantly more 
susceptible to M. tuberculosis infection than TLR 4
-/-. TLR 9
-/- mice were more 
susceptible  to  a  high  dose  (500CFU/mouse)  aerosol  challenge  succumbing  to 
infection after about 70 days and in contrast, TLR 9
-/- mice infected with a low   42 
aerosol dose showed no changes in pathology and had similar survival levels to 
wild-type mice.  In addition, antigen presenting cells (splenic dendritic cells, bone 
marrow dendritic cells and macrophages) from TLR 9
-/- mice did not display any 
defects in TNF-α production in vitro (Bafica, Scanga et al. 2005). In general, TLR 
knockout studies have shown that, defects in a single TLR does not have a critical 
impact on the host resistance to M. tuberculosis infection at low dose of infection 
(Reiling, Holscher et al. 2002; Drennan, Nicolle et al. 2004).  
 
The  use  of  double  TLR  knockout  mice  has  shown  the  importance  of 
synergism  between  TLRs  and  the  critical  role  of  this  synergism  in  mediating 
immune responses to M. tuberculosis (Drennan, Nicolle et al. 2004). TLR 2 and 
TLR 9 double knock out mice had significantly increased bacterial loads and a 
mean survival time of 120 days with a low dose of M. tuberculosis. In addition, 
these mice had widespread inflammation, focal necrosis and abundant acid fast 
bacilli in lung tissues (Bafica, Scanga et al. 2005). All synergistic responses of 
TLRs  may  not  play  an  important  role  during  mycobacterial  infections.  TLR 
2/TLR 4
-/- double knock out mice were resistant to BCG infection, which was 
similar to wild-type mice (Nicolle, Fremond et al. 2004).  
 
Human  case  studies  have  indicated  a  possible  link  between  a  TLR  2 
polymorphism Arg753Gln (arginine to glutamine substitution at residue 753) and 
increased susceptibility to tuberculosis (Ogus, Yoldas et al. 2004) with a more 
recent  study,  suggesting  a  strong  association  between  TLR  2  T597C 
polymorphism and the development of tuberculosis meningitis (Thuong, Hawn et 
al. 2007). The identification of TLR 2 polymorphisms highlights the role played 
by this receptor in tuberculosis disease.   
 
The current literature provides evidence for the role of various TLRs in the 
host resistance to mycobacterial infections.  
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1.5- Type I IFNs 
Signalling via the TLR mediated, MyD88 independent pathway, can lead 
to the induction of type I IFNs. IFNs were first described in 1957 by Isaacs and 
Lindemann and were  described as proteins that interfere with viral replication 
(Isaacs A 1957). Interferons are divided into two main classes: type I interferons 
(IFN alpha and IFN beta) and type II interferon (IFN-g). In addition, there are 
reports of another class of human, type I like interferons termed IFNl1 (IL-28A), 
IFNl2 (IL-28B) and IFNl3 (IL-29) (Sheppard, Kindsvogel et al. 2003).   
 
Genes encoding type I IFNs are clustered on chromosome 9 in humans and 
on chromosome 4 in mice. IFN alpha and IFN beta are the main type I interferons 
that  are  synthesised  during  viral  and  bacterial  infections  thus  making  them 
interesting candidates for further study, from an immunological perspective. 
 
The production of type I interferons is not restricted to a single cell type 
and it is plausible that a wide range of cells produce these cytokines in response to 
viral and bacterial infections. Type I IFNs can be produced by B-cells, monocytes, 
macrophages, myeloid and plasmacytoid dendritic cells. The amount of type I 
IFNs produced varies between cell types, where plasmacytoid dendritic cells tend 
to produce higher levels of type I  IFNs in  response  to infection and are  thus 
known  as  ‘natural  interferon  producing  cells’  (Asselin-Paturel  and  Trinchieri 
2005). Recently, a class of cells which are distinct from conventional dendritic 
cells  and  plasmacytoid  dendritic  cells  were  described as  ‘interferon  producing 
killer dendritic cells’. These hybrid cells have molecular features of both natural 
killer cells (NK cells) and dendritic cells in particular the ability of these cells to 
produce high levels of type I IFNs upon activation (Chan, Crafton et al. 2006). 
Thus, it is well established that a range of cells possess the capacity to produce 
type I IFNs upon activation.  
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1.5.1- Type I IFN signalling pathway 
  Type I IFN signal transduction occurs through a ubiquitously expressed 
heterodimeric receptor– interferon (alpha and beta) receptor 1 (IFNAR), which is 
composed of two subunits IFNAR1 and IFNAR2 (Sen 2001). Binding of type I 
IFNs to their cognate receptor leads to the induction of transcriptional responses 
through the JAK-STAT signalling pathway. The JAK-STAT signalling pathway is 
a universal pathway utilised by all cytokines to induce cell type specific cytokine 
induced gene expression patterns. There are 4 mammalian janus kinases (JAKs) 
and 7 members of the signal transducers and activators of transcription (STAT) 
family identified to date (Darnell 1997; Stark, Kerr et al. 1998).  
 
 IFN alpha/beta binds to IFNAR, which leads to ligand induced receptor 
dimerization, resulting in phosphorylation of JAK-1 and tyrosine kinase 2 (Tyk2), 
two members of the Janus protein tyrosine kinase family. Phosphorylation and 
activation  of  JAK-1  and  Tyk2,  leads  to  the  phosphorylation  of  IFNAR1,  thus 
creating  binding  sites  for  STAT-2,  as  illustrated  in  figure  1.2.  Subsequently, 
STAT-2 is phosphorylated and serves as a platform for recruitment and tyrosine 
phosphorylation of STAT-1. The STAT 1-STAT 2 heterodimer dissociates from 
the  IFNAR  and  translocates  to  the  nucleus  resulting  in  the  association  of  the 
heterodimer with IRF-9 to form a heterotrimeric complex known as interferon 
stimulated gene factor 3 (ISGF3) as shown in figure 1.2. This complex binds to 
the DNA sequence, interferon-stimulated response element (ISRE) which results 
in the initiation of transcription of the type I IFNs and IFN alpha/beta inducible 
genes. ISRE sequence is found in the promoters of several type I IFN inducible 
genes, the consensus sequence of which is 5’AANNGAAA 3’ where N denotes 
any nucleotide (Tailor, Tamura et al. 2006).  
 
The  production  of  type  I  interferons  is  primarily  regulated  at  the 
transcriptional  level.  IFN  beta  promoter  consists  of  four  positive  regulatory 
domains [PRD I, II, III and IV] and these regulatory cis elements provide binding 
sites for specific transcription factors. PRD I and III are binding sites for IRFs, 
NFkB  binds  to  PRDII  and  activating  protein-1  (AP-1)  docks  onto  PRD  IV 
(Honda, Yanai et al. 2005) . The binding of these transcription factors results in   45 
the  recruitment  of  transcriptional  machinery  and  chromatin  modifiers  which 
results in the induction of IFN beta.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2- Type I IFN signal transduction pathway 
The binding of type I IFNs to the IFNAR receptor, triggers the activation of the 
cardinal  JAK-STAT  signalling  pathway,  thus  leading  to  the  downstream 
activation of type I IFN inducible genes. 
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1.5.2- IRFs - transcriptional regulators of the type I IFN pathway 
  IRFs play an important role in the transcription of type I IFN inducible 
genes.  The  IRF  family  consists  of  9  members:  IRF  1-IRF  9.  The  two  highly 
homologous proteins IRF-3 and IRF-7 are considered to be the key transcriptional 
proteins that play a role in the induction of the type I IFN pathway (Taniguchi, 
Ogasawara et al. 2001). IRF-3 is constitutively expressed in the cytoplasm of all 
cell  types  and  in  response  to  stimulation,  is  post-translationally  modified  by 
phosphorylation at serine residues, which results in the translocation of the protein 
from the cytosol into the nucleus. Phosphorylation of IRF-3 is by one of the two 
IkB kinases- TBK1 and IKK-i. Upon entry into the nucleus, IRF-3 associates with 
CREB binding protein (CBP)/p300, NFkB and AP-1. The resulting complex binds 
to the promoter of type I IFN genes thus inducing their expression (Taniguchi, 
Ogasawara et al. 2001) . IRF-7 also plays a pivotal role in the type I IFN gene 
induction. IRF-7 unlike IRF-3, is absent from most cells or expressed at very low 
levels constitutively. In response to viral infection, IRF-7 is phosphorylated and 
activated  by  the  kinases  TBK1,  IkB  or  IRAK-1  at  serine/threonine  residues. 
Phosphorylated IRF-7 undergoes nuclear translocation and binds to PRD I and 
PRD  III  elements  in  the  promoter  of  the  type  I  genes.  Most  cells  utilise  an 
amplification  loop  in  order  to  increase  the  available  amount  of  IRF-7  thus 
increasing the production of IFN alpha and IFN beta (Tailor, Tamura et al. 2006).  
 
1.5.3- Type I interferons and their role in host defence 
The activation stimuli for the production of type I IFNs can be in the form 
of viral infections and as shown more recently in the last few years, bacterial 
components  such  as  LPS  and  bacterial  DNA  (unmethylated  CpG  motifs  in 
bacterial DNA). The induction of host antiviral immunity utilises either the TLR 
signalling pathway or the retinoic acid-inducible gene I - mitochondrial antiviral 
protein signalling pathway which functions to recognise cytosolic double stranded 
RNA to induce the production of type I IFNs (Creagh and O'Neill 2006).   
 
Induction of type I IFNs leads to the assembly of antiviral proteins like 2’-
5’-oligoadenylate synthetase (OAS), a dsRNA dependent synthetase that activates 
endoribonuclease RNase L to degrade ssRNA and myxovirus (influenza virus)   47 
resistance  (Mx)  proteins,  which  bind  to  viral  proteins  thus  inhibiting  their 
replication (Stark, Kerr et al. 1998). Mx proteins have been shown to bind to the 
nucleocapsid  proteins  of  bunyaviruses  and  causes  re-distribution  of  the  viral 
nucleocapsid, thus inhibiting the replication of these viruses (Kochs, Janzen et al. 
2002). Type I IFNs contribute to immune responses against Leishmania major by 
inducing the expression of iNOS during the innate phase of the immune response 
(Diefenbach, Schindler et al. 1998) and additionally it has been demonstrated, that 
application of low doses of IFN beta protects mice from progressive cutaneous 
leishmaniasis (Mattner, Wandersee-Steinhauser et al. 2004). In contrast, during 
infection with Listeria monocytogenes, elevated levels of type I IFN production 
are accompanied by increased levels of apoptosis in the spleens of infected mice 
thus leading to enhanced susceptibility to infection (O'Connell, Saha et al. 2004). 
Other  studies  with  extracellular  bacteria  which  include  Streptococcus 
pneumoniae, encapsulated E. coli and group B streptococci demonstrated that in 
the absence of type I IFN signalling there was a defect in the production of TNF-a 
and  IFN-g,  which  contributed  to  the  impaired  responses  to  these  bacteria 
(Mancuso, Midiri et al. 2007). Furthermore, it has been reported that interferon 
(alpha and beta) receptor knock out mice exhibited a delay in controlling BCG 
growth and this defect in controlling early growth is thought to be attributed to the 
defect in nitric oxide production (Kuchtey, Fulton et al. 2006) .  
 
   
Thus, type I IFNs have shown to have important roles in both viral and 
bacterial infections. Both protective and detrimental effects of type I IFNs have 
been observed, depending on the microbial pathogen.  
 
 
1.5.4- Immunomodulatory effects of type I IFNs 
  Type I IFNs can have both immunostimulatory and immunospuppressive 
effects which forms the basis for their role during various microbial infections. 
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Type I IFNs can induce the production of IL-15 which plays a role in the 
proliferation and maintenance of NK cells and memory CD8
+T cells (Nguyen, 
Salazar-Mather et al. 2002). Similarly, type I IFNs are known to play a role in the 
differentiation and function of effector CD8
+T cells; this was demonstrated in a 
model of lymphocytic choriomeningitis virus infection, where CD8
+T cells from 
interferon (alpha and beta) receptor knockout mice, displayed impaired ability to 
differentiate and expand into functional effector CD8
+T cells (Kolumam, Thomas 
et al. 2005). It has also been demonstrated that, IFN alpha/beta can induce the 
maturation  of  dendritic  cells  and  furthermore,  endogenously  expressed  type  I 
IFNs by dendritic cells can act in an autocrine manner to activate more type I IFN 
production (Gallucci, Lolkema et al. 1999; Montoya, Schiavoni et al. 2002). 
 
Low level constitutive expression of IFN alpha/beta has been reported to 
be critical for IFN-g mediated signalling, as the IFNAR1 provides a docking site 
for  STAT-1,  which  is  a  crucial  component  of  the  IFN-g  signalling  pathway 
(Takaoka,  Mitani  et  al.  2000).  The  production  of  very  high  physiologically 
relevant amounts of type I IFNs can have a negative effect on the production of 
IL-12; a decrease in IL-12 production occurs due to the specific inhibition of the 
transcription of the IL-12p40 gene (Adriana A. Byrnes 2001). Thus the amount of 
type I IFN produced is crucial, with very high levels negatively regulating IL-12 
production. 
 
1.5.5- Clinical applications of type I interferons 
  IFN alpha has been approved for the treatment of viral infections such as 
chronic hepatitis B and hepatitis C. Additionally, IFN beta has also been approved 
for treatment of relapsing-remitting multiple sclerosis, the mechanism by which it 
works is still not clear (Wingerchuk and Noseworthy 2002). 
  
 
Thus in general, type I interferons represent a family of cytokines which 
elicit multifaceted responses in the host and have important roles in both innate 
and adaptive immune responses in the host.     49 
1.6- Principal cytokines modulating the immune response to M. 
tuberculosis 
The  modulation  of  the  immune  response  to  pathogens  is  critically 
dependent on the production of cytokines. Dendritic cell maturation, in addition to 
the  altered  expression  of  chemokine  receptors,  is  also  characterised  by  the 
production of pro-inflammatory cytokines. Recognition of microbial patterns via 
TLRs leads to signalling via the NFkB pathway resulting in the production of 
inflammatory cytokines.  
 
1.6.1-IL-12  
The IL-12 family of cytokines is composed of IL-12p40, IL-12p70 and IL-
23. IL-12p40 can be secreted as a monomer or as a dimmer. IL-12p40 is always 
produced in excess, at much higher levels compared to the other IL-12 family 
members, which is partially attributed to the fact that it forms part of the bioactive 
complex of IL-12p70 and IL-23.  
 
The role of IL-12 as part of the immune response is wide and varied. It has 
been reported that IL-12p40 is an important promoter of dendritic cell migration 
from the lung to the draining lymph nodes during M. tuberculosis infection, as 
this migratory process was impaired in IL-12p40
-/- mice (Khader, Partida-Sanchez 
et al. 2006). The reduced ability of IL-12p40
-/- dendritic cells to migrate, may be 
partly linked to the fact that these dendritic cells also produce increased levels of 
IL-10 compared to the wild-type mice. IL-10 specifically inhibits migration of 
dendritic cells by preventing the downregulation of CCR1, CCR2 and CCR5, and 
up regulation of CCR7 (D'Amico, Frascaroli et al. 2000). IL-12p40 deficiency 
also results in the reduced ability of IL-12p40 
-/- dendritic cells to activate naïve T 
cells,  thus  linking  the  chemokine  responsiveness  and  IL-12p40  production  by 
dendritic cells.  
 
  IL-12p70, the bioactive IL-12 molecule, plays a key role in the priming of 
CD4
+T  cells  (Flynn,  Goldstein  et  al.  1995;  Holscher,  Atkinson  et  al.  2001; 
Cooper, Kipnis et al. 2002). Lack of IL-12p35 has a less critical effect on the host, 
compared  with  IL-12p40  deficiency  during  M.  tuberculosis  infection,  possibly   50 
reinforcing  the  importance  of  the  IL-12p40  subunit  and  suggesting  IL-12p40 
activity independent of IL-12p35 (Holscher, Atkinson et al. 2001; Cooper, Kipnis 
et al. 2002). IL-12p35
-/- mice were less susceptible to BCG and H37Rv infection 
compared to IL-12p35
-/-p40
-/- mice. Furthermore, IL-12p35
-/- mice were able to 
mount antigen specific Th-1 responses and granuloma formation was normal in 
these mice. In addition, gene polymorphisms in the IL-12B gene have been linked 
to the increased susceptibility in humans (Tso, Lau et al. 2004).  
 
1.6.2-IL-6 
IL-6  is  thought  to  play  a  role  in  controlling  M.  tuberculosis  infection 
during the initial stages. In a low dose aerosol model of infection, IL-6
-/- mice had 
increased bacterial burden in the lungs, at early time points post-infection. The 
bacterial counts stabilised at later time points post-infection, which coincided with 
the induction of the acquired immune response (Saunders, Frank et al. 2000).  
 
1.6.3-TNF-a a a a 
  TNF-a contributes to the immunity and the pathology of TB infections. M. 
tuberculosis induces the production of TNF-a by macrophages and dendritic cells  
and this cytokine plays a key role in the acute stage of M. tuberculosis infection 
(Henderson,  Watkins  et  al.  1997).  This  role  has  been  highlighted  in  TNF-a 
deficient mice, which exhibited increased mortality and extensive necrosis in the 
lungs, with defects in granuloma formation and overall higher bacterial burdens 
compared to control mice (Flynn, Goldstein et al. 1995; Roach, Bean et al. 2002).  
 
TNF-a as part of the innate immune response has roles as the mediator of 
macrophage activator and in synergy with IFN-g stimulates inducible nitric oxide 
synthase expression (Chan, Xing et al. 1992). Additional studies in TNF-a
-/- mice 
have  demonstrated  that  this  cytokine  plays  a  role  in  the  early  induction  of 
chemokines (CCL2, CCL3, CCL4, CCL5 and CCL8) and initial recruitment of 
leukocytes like macrophages, which are essential for the production of RNI to 
clear the bacterial infection.  
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Anti-TNF antibody therapy is commonly used in rheumatoid arthritis and 
Crohn’s disease but the use of such therapy has been presented with problems of 
reactivation of latent TB infections. It has been proposed that TNF blockers could 
compromise the integrity of the granuloma, thus contributing to the reactivation of 
the  latent  bacilli  (Keane  2005).  The  cytokine  TNF-a  can  be  considered  as  a 
double edged sword, where on one side it has constructive roles in the formation 
and  maintenance  of  granulomas  but  in  addition,  contributes  to  increased  lung 
pathology and necrosis (Bekker, Moreira et al. 2000).  
 
1.6.4- IL-10 
IL-10 is principally an anti-inflammatory cytokine that is produced by T 
cells,  dendritic  cells  and  macrophages  during  M.  tuberculosis  infection.  The 
engagement of TLR 2, TLR 7, TLR 9 and DC-SIGN induces the production of IL-
10 by dendritic cells (Geijtenbeek, van Vliet et al. 2003; Samarasinghe, Tailor et 
al.  2006).  IL-10  inhibits  production  of  cytokines  and  chemokines  from 
macrophages in vitro (Moore, O'Garra et al. 1993). Importantly, IL-12 production 
is modulated by IL-10 in response to M. tuberculosis infection. Additionally, it 
has been shown that IL-10 production can interfere with dendritic cell trafficking 
thus reducing their migration to the draining lymph nodes (Demangel, Bertolino et 
al. 2002). Most of  the inhibitory properties of IL-10 are dependent on STAT-3 
pathways and are specific to a defined set of genes, as approximately 40% of LPS 
induced genes remained unchanged in response to IL-10 in a microarray profiling 
study (Lang, Patel et al. 2002). The interference of IL-10 in the host defence 
against  mycobacteria  was  demonstrated in a  mouse model  of infection, which 
showed that IL-10 transgenic mice (constitutively expressing IL-10) were unable 
to clear BCG infection and thus developed higher bacterial burdens. In contrast, 
the absence of IL-10 had no effect on the course of M. tuberculosis infection 
(Murray,  Wang  et  al.  1997;  North  1998).  It  is  postulated  that  IL-10  plays  an 
important role during the chronic stage of infection, promoting reactivation of the 
disease (Turner, Gonzalez-Juarrero et al. 2002).    52 
 
1.6.5-IL-4 
IL-4  is  a  Th-2  cytokine,  playing  an  important  role  in  directing 
development  of  Th-2  cells.  Contrasting  observations  have  been  reported  with 
regard  to  the  role  of  IL-4  during  M.  tuberculosis  infection.  It  has  been 
demonstrated  that  IL-4  expression  is  increased  in  patients  with  TB,  with  a 
possibility that these higher IL-4 levels are found in patients closer to the equator, 
as a consequence of simultaneous infection with helminths (Schauf, Rom et al. 
1993; Sanchez, Rodriguez et al. 1994; Malhotra, Mungai et al. 1999). In murine 
models  of  infection,  the  detection  of  IL-4  coincides  with  the  appearance  of 
pneumonia and necrosis, leading to increased mortality. But, in the absence of IL-
4 (disrupted IL-4 gene) in mice, there is no effect on the course of TB infection 
(North 1998). It has also being shown that IL-4 can down regulate the expression 
of  iNOS,  thus  down  regulating  macrophage  mediated  anti-mycobacterial 
immunity (Bogdan, Vodovotz et al. 1994). Hence the precise roles of IL-4 during 
M. tuberculosis infection still remain to be elucidated. 
 
1.6.6-IFN-g g g g 
  The  type  II  interferon-  IFN-g  has  a  critical  role  in  mediating  the  host 
resistance  to  M.  tuberculosis  infection.  The  binding  of  IFN-g  triggers  the 
rearrangement  and  dimerisation  of  the  interferon  gamma  receptor  (IFNGR) 
subunits  and  autophosphorylation  of  the  associated  JAKs.  JAK1  and  JAK2 
regulate the phosphorylation of STAT-1,  thus resulting in the formation of STAT 
1-STAT  1  homodimers  (Stark,  Kerr  et  al.  1998).  The  homodimer  of  STAT-1 
translocates  to  the  nucleus  and  binds  to  the  IFN-g  activated  sequence  (GAS) 
elements, to initiate transcription as illustrated in figure 1.3 (Stark, Kerr et al. 
1998).   
 
In the absence of IFN-g, there is defective macrophage activation and thus 
reduced expression of inducible nitric oxide synthase. A role for IFN-g in the 
expression of MHC-II has also been suggested, with peritoneal macrophages from 
IFN-g  receptor
-/-  mice  having  lower  levels  of  MHC-II  in  response  to  BCG   53 
infection (Kamijo, Shapiro et al. 1993).  IFN-g is produced mainly by T-cells and 
NK cells (Orme, Roberts et al. 1993; Lalvani, Brookes et al. 1998).  
 
IFN-g receptor knock out mice are highly susceptible to M. tuberculosis 
infection. These mice display increased bacterial burdens, with a mean survival 
time of approximately 20 days and although granulomas form, they tend to be 
necrotic.  Furthermore, IFN-g receptor knock out mice fail to produce RNIs in 
response to M. tuberculosis infection, contributing to the failure to control M. 
tuberculosis infection (Flynn, Chan et al. 1993). IFN-g receptor knock out mice 
are also susceptible to infection with Legionella pneumophila and Toxoplasma 
gondii, where IFN-g was shown to contribute to the activation of macrophages, 
with a reduction in TNF-a, iNOS and IL-1b in the livers of these knock out mice 
(Deckert-Schluter, Rang et al. 1996). The importance of this cytokine has also 
been demonstrated in humans with defective genes for IFN-g, as these individuals 
are prone to suffer from mycobacterial infections (Ottenhoff, Kumararatne et al. 
1998). Patients possessing a mutation in the IFNGR1 gene at nucleotide position 
395, introduced a stop codon, leading to the formation of a truncated protein and 
these individuals were found to be more susceptible to mycobacterial infections 
(Newport, Huxley et al. 1996). In addition null, recessive IFNGR2 mutation has 
also  been  postulated  to  contribute  to  severe  mycobacterial  infection  (Altare, 
Jouanguy et al. 1998).   Thus IFN-g is a critical cytokine is mediating macrophage 
based anti-mycobacterial responses.  
 
 
 
 
 
 
 
 
 
 
   54 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 – The Type II IFN signalling pathway 
 
The binding of IFN-g to the IFNGR receptor triggers the activation of the STAT 
phosphorylation and formation of STAT homodimers, which translocate to the 
nucleus and initiates transcription of type II IFN inducible genes.  
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1.6.7- IL-18 and IL-15 
  Other cytokines such as IL-18 and IL-15 have also been implicated in the 
host response to M. tuberculosis. IL-18 is an IFN-g inducing factor and augments 
Th-1 type immune responses induced by IL-12. In response to M. tuberculosis 
infection,  IL-18
-/-  mice  exhibited  a  decrease  in  IFN-g  synthesis,  which  was 
partially  attributed  to  the  defect  in  IL-12  production  in  these  mice.  Thus  this 
cytokine is thought to contribute to the induction of Th-1 type immune response 
against M. tuberculosis infection (Kinjo, Kawakami et al. 2002).  
 
IL-15  has  many  biological  roles  including  stimulating  proliferation  of 
memory CD8
+ T cells (Zhang, Sun et al. 1998) and promoting optimal dendritic 
cell activation thus influencing antigen presentation functions (Mattei, Schiavoni 
et al. 2001). In addition, IFN alpha/beta is capable of inducing IL-15 via a STAT-
1 mediated mechanism which contributes to the accumulation of NK cells.  IL-15 
transgenic mice (overexpressing IL-15 under the control of a MHC-I promoter), 
increased  the  efficacy  of  BCG  vaccination  with  memory  CD8
+  T  cells  being 
maintained for a prolonged period of time after BCG vaccination. Hence a role for 
IL-15  in  the  maintenance  of  memory  CD8
+T  cells  was  proposed  (Umemura, 
Nishimura  et  al.  2003).  In  addition,  it  has  been  reported  that  IL-15
-/-  mice  in 
response to M. tuberculosis infection recruit CD4
+ and CD8
+ T cells to the lungs 
but the recruitment of these cells is delayed, although the induction of cytotoxic 
CD8
+  T  cell  responses  was  normal  after  the  primary  infection  with  M. 
tuberculosis.  It was thus  proposed that IL-15 plays  a role in the  recall T cell 
responses during M. tuberculosis infection (Lazarevic, Yankura et al. 2005).   
 
 
1.7- Antigen presentation and T cell stimulation  
Analysis  of  entire  kinetic  sets  of  data  has  revealed  that  dendritic  cells 
undergo  extensive  re-organisation  of  gene  expression  with  dendritic  cell 
maturation being almost complete 24 hours after activation (Granucci, Vizzardelli 
et  al.  2001).  In  addition  to  cytokine  production,  mature  dendritic  cells  down-
regulate  mechanisms  of  antigen  capture  and  express  high  levels  of  long-lived 
surface  MHC-II  and  co-stimulatory  molecules  making  them  potent  T  cell   56 
stimulators  (Banchereau,  Briere  et  al.  2000).  Dendritic  cells  can  process  and 
present antigens in the context of both MHC-I and MHC-II molecules to CD8
+ 
and CD4
+ T cells respectively. T cell activation requires two signals: signal one 
involves the recognition of peptide–MHC complexes on the antigen presenting 
cell by antigen specific T-cell receptor, and signal two, involves the interaction of 
co-stimulatory molecules on the antigen presenting cell with their ligands on the T 
cell (Banchereau and Steinman 1998). Since dendritic cells express high levels of 
co-stimulatory and MHC molecules, they are equipped with the ability to provide 
both signals required for stimulation and amplification of T cell responses.  
 
Other  factors  which  can  influence  the  T  cell  stimulatory  capacity  of 
dendritic cells include, the release of cytokines into the local environment and 
expression of high levels of adhesion molecules, which may facilitate clustering 
and TCR engagement (Cella, Sallusto et al. 1997). During dendritic cell-T cell 
interactions,  dendritic  cells  enter  their  final  maturation  stage  by  receiving 
additional signals from T cells in the form of CD40-CD40L interactions (Cella, 
Scheidegger et al. 1996). Thus, mature dendritic cells possess increased T-cell 
stimulatory capacity and produce inflammatory cytokines which further modulate 
the outcome of the immune response. 
 
 
1.7.1-T-cell subsets 
M.  tuberculosis  infected  antigen  presenting  cells  present  mycobacterial 
antigens  on  MHC-I,  MHC-II  and  CD1  molecules  to  CD8
+,  CD4
+,  and  CD1 
restricted  T  cells  respectively.  However,  immunity  against  M.  tuberculosis  is 
primarily mediated via a Th-1 response. CD4
+ T cells are known to be important 
in generating protective immune responses in  the host primarily by producing 
IFN-g, a protective cytokine known to activate macrophages, thus leading to the 
control  of  the  pathogen.  Antibody  mediated  depletion  of  CD4
+  T  cells  has 
demonstrated that these cells may be important in preventing reactivation of the 
infection (Scanga, Mohan et al. 2000).  CD8
+ T cells probably have two effector 
mechanisms which are important during a M. tuberculosis infection; the first is 
the production of IFN-g similar to the CD4
+T cell population and the second is the   57 
lysing of target cells via granzyme/perforin and Fas/Fas L pathway (Flynn and 
Chan  2001;  Kaufmann  2001).  The  CD1  restricted  T  cells  are  specific  for 
mycobacterial lipids and can produce IFN-g and exhibit cytolytic activity. In the 
mouse model of M. tuberculosis infection, there is an increase in the number of 
CD4
+  and  CD8
+  T  cells  in  the  draining  lymph  nodes,  within  the  first  week. 
Activated CD4
+ and CD8
+ T cells migrate to the lungs, between 2-4 weeks post-
infection and interact with antigen presenting cells at the site of infection. The 
granuloma  also  consists  of  CD4
+  and  CD8
+  T  cells  which,  as  part  of  the 
granuloma  composition,  encloses  the  bacteria and  prevents  reactivation  (Feng, 
Bean et al. 1999; Serbina, Liu et al. 2000). An overview of the T cell responses 
during M. tuberculosis infection is illustrated in figure 1.4.    
 
 
 
Figure 1.4- An overview of the T cell responses during M. tuberculosis 
infection 
The immune response to M. tuberculosis is for the most part dependent on T cell 
responses which mainly activate macrophages by secreting cytokines or exhibit 
direct cytolytic activity. Figure modified from (Kaufmann 2001).    58 
1.7.1.1-CD4
+ T cells 
  Mycobacteria are phagocytosed and reside within phagosomes. Bacterial 
derived  proteins  from  these  intracellular  vesicles  in  macrophages  are  not 
accessible to the proteasomes in the cytosol and MHC-I loading complex. But 
mycobacterial antigens are readily accessible to the MHC-II antigen processing 
and presentation complex, thus resulting in the presentation of antigens to CD4
+ T 
cells. The importance of this subset of cells has been demonstrated by antibody 
depletion, adoptive transfer and the use of mouse strains deficient in CD4
+ T cells 
or  MHC-II  (Caruso,  Serbina  et  al.  1999;  Scanga,  Mohan  et  al.  2000).  The 
increased susceptibility of patients to TB, during the course of HIV infection, 
further highlights the importance of this subset of T cells. IFN-g production by 
these  cells  is  proposed  to  play  a  major  role  during  M.  tuberculosis  infection, 
which is supported by the work, which showed that CD4
+ T cell–depleted  and 
MHC-II
-/- mice exhibited approximately 50% reduced IFN-g levels at 2 weeks 
post-infection but at later time points the level of IFN-g was similar between the 
wild-type and knockout strains of mice (Scanga, Mohan et al. 2000). Thus it was 
demonstrated that CD4
+ T cells are required early in infection for the production 
of IFN-g. 
 
 In a model of latent TB, antibody mediated depletion of CD4
+ T cells led 
to reactivation of a persistent infection although, the levels of IFN-g and iNOS 
remained  unaffected  (Scanga,  Mohan  et  al.  2000).  This  work  showed  an 
additional role for CD4
+ T cells in the prevention of TB reactivation. This role has 
been further supported by work, which demonstrated that in the absence of this 
subset of T cells mice formed abnormal lesions, which were unable to control 
bacterial burden and prevent dissemination of the bacteria (Mogues, Goodrich et 
al. 2001; Saunders, Frank et al. 2002). One of the mechanisms utilised by M. 
tuberculosis  to  survive  in  the  macrophages  is  by  down  regulating  MHC-II 
expression  on  the  surface  (discussed  in  section  1.2.6).  Hence,  infected 
macrophages are defective in their ability to present antigens to CD4
+ T cells and 
thus  contribute  to  the  inability  of  the  host  to  eliminate  persistent  infection. 
Experimental evidence from human studies has also shown that CD4
+ T cells can 
perform cytolytic functions in the lung. One possible mechanism is via the Fas-
ligand-induced apoptosis of infected macrophages, thus reducing the viability of   59 
intracellular  bacteria  (Tan,  Canaday  et  al.  1997;  Oddo,  Renno  et  al.  1998). 
However, the primary function of CD4
+ T cells during mycobacterial infection 
appears to be the production of IFN-g which activates macrophages resulting in 
the induction of anti-mycobacterial killing mechanisms within the host.  
 
1.7.1.2-CD8
+ T cells 
Cytosolic  pathogen  derived  peptides  are  presented  on  MHC-I  and 
recognised by CD8
+ T cells. Although M. tuberculosis is not a cytosolic pathogen, 
it  is  widely  recognised  that  CD8
+  T  cells  are  important  in  the  host  mediated 
immune  response  against  this  bacteria.  A  number  of  reports  have  provided 
evidence to support the importance of this subset of T cell in mediating the host 
immune response. Mice deficient in b2-microglobulin (aids in the folding and 
assembly of MHC-I molecule), TAP (transports peptides from the cytosol into the 
lumen of endoplasmic reticulum for loading onto MHC-I) and perforin, display 
enhanced susceptibility to M. tuberculosis infection in comparison to wild-type 
mice (Flynn, Goldstein et al. 1992; Cooper, D'Souza et al. 1997; Behar, Dascher 
et al. 1999).    
 
Previous  work  has  also  shown  that  CD8
+  T  cells  are  important  in 
generating  protective  immune  responses  in  the  host  against  M.  tuberculosis 
infection by producing IFN-g (Tascon, Stavropoulos et al. 1998). Mice lacking 
MHC-Ia were less susceptible over the course of the infection compared to b2-
microglobulin knockout mice, suggesting that other cells apart from classically 
MHC-I restricted CD8
+ T cells were playing a role in the resistance mechanism to 
TB infection (Perarnau, Saron et al. 1999). The effector mechanisms of this subset 
of T cells include cytokine production in the form of IFN-g and TNF which have 
important roles in mediating anti-mycobacterial immunity (roles of TNF and IFN-
g discussed in sections 1.6.3 and 1.6.6) and in TB patients, IFN-g secreting MHC-I 
restricted CD8
+ T cells could be detected by enzyme-linked immunosorbent spot 
(ELISPOT) from the peripheral blood (Pathan, Wilkinson et al. 2000). The killing 
of mycobacteria was dependent on perforin and granulysin and this direct killing 
of M. tuberculosis could also be demonstrated by incubating M. tuberculosis with 
granulysin alone (Stenger, Hanson et al. 1998).    60 
1.7.1.3-Unconventional T cells  
  Mycobacterial  glycolipids  such  as  LAM,  PIM  and  mycolic  acids  are 
presented on CD1 molecules. There exists two main groups of CD1 molecules, 
with group 1 comprising of CD1a, CD1b and CD1c, found in primates and guinea 
pigs  and  group  2  –  CD1d  found  in  mice  (Porcelli  and  Modlin  1999).  CD1 
molecules  are  present  in  distinct  intracellular  compartments  with  CD1a  being 
expressed in the early recycling endosomes, CD1b in late endosomes/lysosomes 
and CD1c being localised in endosomes. CD1a and CD1c have ready access to 
mycobacterial lipids from these compartments. A correlation between CD1 T cells 
in the peripheral blood and prior M. tuberculosis infection, with CD1 responses 
being reduced during active TB infection, has been reported (Ulrichs, Moody et 
al. 2003).  
 
Double  negative  (CD4
-  CD8
-)  CD1  restricted  T  cells  which  recognise 
mycobacterial antigens are capable of producing IFN-g and expressing cytotoxic 
activity (Stenger, Mazzaccaro et al. 1997). In contrast, to CD8
+ T cells, these cells 
exert their cytotoxic activity via the Fas-FasL pathway.   
 
  In  addition,  to the above mentioned subsets of T cells, a minor  T cell 
population expressing the gd T cell receptor has been implicated in response to 
mycobacterial infections and shown to accumulate during early infection of mice. 
d T cell receptor gene-disrupted mice infected with M. tuberculosis did not exhibit 
increased susceptibility to infection compared with wild-type animals, although at 
the site of granuloma formation, there was an increased neutrophil infiltration, 
suggesting  a  potential  role  for  these  cells  in  directing  cellular  trafficking  and 
granuloma formation (D'Souza, Cooper et al. 1997).  
 
  Another sub-population of T cells, which represent approximately 5-10% 
of the circulating CD4
+T cells in healthy individuals are the regulatory T cells 
(Baecher-Allan,  Brown  et  al.  2001).  These  cells  are  characterised  as  being 
Foxp3
+CD4
+CD25
+ or CD8
+. Foxp3 is a T cell lineage specification factor, with 
an essential role in the development of CD4
+CD25
+ regulatory T cells. A recent 
study reported an increased frequency of CD4
+CD25
+ T cells in patients with 
active TB and depletion of this subset of T cells improved IFN-g production from   61 
CD4
+T  cells  (Ribeiro-Rodrigues,  Resende  Co  et  al.  2006).  Another  set  of 
experiments  demonstrated  an  increase  in  the  frequency  of  Foxp3
+CD4
+  in  the 
spleen and lungs of mice infected with M. tuberculosis. Hence, it was suggested 
that, regulatory T cells limited the function of CD4
+ T cells during the course of 
infection (Kursar, Koch et al. 2007). The role of regulatory T cells during M. 
tuberculosis infection remains unclear but a common consensus seems to be, the 
depression  of  protection  afforded  by  CD4
+  T  cells,  during  the  course  of  TB 
infection, by regulatory T cells.  
 
1.8-Involvement of other immune cells in the host mediated 
response to M. tuberculosis 
Additional subsets of immune cells are also thought to contribute to the 
host  immune  response  during  M.  tuberculosis  infection.  In  the  inflammatory 
response during the course of infection, neutrophils are the first phagocytes to 
arrive at the site. Neutrophils are present early at sites of TB infections, as well as 
in granulomas (Peters and Ernst 2003). They also appear to be recruited to the 
lung, where they have a role during acute TB infection (Fulton, Reba et al. 2002). 
Additionally, neutrophils are thought to have an immunomodulatory role, as they 
produce cytokines and chemokines thus contributing to the global responses to M. 
tuberculosis infection (Petrofsky and Bermudez 1999).  
 
B-cells were thought not to play a role during mycobacterial infection as 
B-cell mice deficient displayed similar bacterial loads to the wild-type mice. But a 
recent  report  demonstrated  that  B  cell
-/-  mice  displayed  profound 
immunopathology and increased IL-10 production in the lung in response to M. 
tuberculosis infection. Furthermore B cell 
-/- mice were susceptible to a high dose 
of  M. tuberculosis which was reflected in the elevated bacterial  counts in the 
lungs  (Maglione,  Xu et  al.  2007).   The  contribution  of  antibodies  to  the  host 
response  during  mycobacterial  infection  is  still  not  clear.  Recent  reports  have 
demonstrated  a  use  for  high  dose  intravenous  immunoglobulin  in  reducing 
bacterial loads at early and late phase of infection and could be used as an adjunct 
to therapy of TB (Roy, Stavropoulos et al. 2005; Roy, De Silva et al. 2006).  
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NK  cells  have  been  associated  with  early  resistance  to  intracellular 
pathogens and are thought to be an early source of IFN-g prior to the emergence 
of antigen specific T cells. In the aerosol infection model, it was found that NK 
cells  increase  initially  over  a  3  week  period  in  the  lung  and  then  subsequent 
depletion of NK cells had no effect on the bacterial load in the lungs (Junqueira-
Kipnis, Kipnis et al. 2003). NK cells also exhibit enhanced lytic capability against 
M.  tuberculosis  infected  macrophages  following  stimulation  with  IL-12 
(Bermudez, Wu et al. 1995).  
 
The protective role against M. tuberculosis is generally accepted to be cell 
mediated  with  dendritic  cells  among  the  key  subsets  of  innate  immune  cells 
bridging the gap between innate and adaptive immune responses.  
 
1.9-Dendritic cells and mycobacteria 
  M. tuberculosis can readily infect dendritic cells (Bodnar, Serbina et al. 
2001; Jiao, Lo-Man et al. 2002). Dendritic cells are not considered the natural host 
cells for mycobacteria. Thus, less is know about the interface between dendritic 
cells and mycobacteria, when compared to the wealth of information available for 
the  interaction  between  macrophages  (primary  host  cells  for  the  bacilli)  and 
mycobacteria.  
 
Key aspects of dendritic cells underlie the importance of studying this subset 
of immune cells during mycobacterial infections. These include: 
 
1.  The ability of these cells to secrete IL-12, which plays a key role in the 
development of a protective immune response 
2.  The capability to transport antigens from the periphery into the draining 
lymph nodes and activate naïve T cells,  as these cells are equipped with 
an  array  of  antigen  presenting  molecules  (MHC-I,  MHC-II  and  CD1 
molecules) and co-stimulatory molecules 
3.  The  possibility  that  these  cells  act  as  “Trojan  horses”,  harbouring 
mycobacteria,  thus  providing  a  safe  environment  for  the  bacilli  by 
preventing uptake and destruction by activated macrophages.    63 
A  study  comparing  the  ability  of  activated  murine  macrophages  and 
dendritic cells demonstrated that, dendritic cells were able to restrict the growth of 
the bacteria  but in comparison activated  macrophages were highly efficient in 
killing M. tuberculosis (Bodnar, Serbina et al. 2001). Dendritic cells utilise TLRs 
to recognise mycobacteria and it has been reported that stimulation of TLR 2 and 
TLR  4  on  human  dendritic  cells,  with  BCG  cell  wall  skeleton,  (consists  of 
mycolic acids, arabinogalactan and peptidoglycan) induces the secretion of TNF-
a which leads to the maturation of dendritic cells. Other receptors like DC-SIGN 
aid  in  the  uptake  of  mycobacteria  and  engagement  of  this  receptor  has  been 
reported to suppress dendritic cell maturation by inducing production of IL-10. 
The  interaction  between  DC-SIGN  and  mycobacteria  has  been  discussed  in 
section 1.3.4).  
 
Maturation  of  dendritic  cells  via  engaging  the  TLRs,  results  in  the 
induction of signalling via NF-kB. It has been previously reported that dendritic 
cells in response to M. tuberculosis infection exhibited a mature phenotype.  In 
contrast to these studies, a study has reported that dendritic cells derived from 
monocytes exhibit a limited maturation capacity in response to M. tuberculosis 
infection which was reversible upon removal of IL-4 and GM-CSF from dendritic 
cell cultures (Hanekom, Mendillo et al. 2003). 
 
It has been postulated that dendritic cells function to transport the bacilli 
from the lungs which is usually the primary site of infection to the draining lymph 
nodes. A recent report provides evidence to this statement. This study reported 
that a significant proportion of BCG was detected in dendritic cells in the draining 
lymph  nodes.  In  the  draining  lymph  nodes  dendritic  cells  would  present 
mycobacterial antigens to T cells thus evoking a protective T cell response or act 
as  bystander  cells  to  present  antigens  from  other  mycobacterial  infected  cells 
(Humphreys, Stewart et al. 2006).  
 
M. tuberculosis infected dendritic cells can prime naïve T cells in vitro and 
induce  an  IFN-g  producing  Th-1  type  response  (Giacomini,  Iona  et  al.  2001; 
Hickman, Chan et al. 2002). In addition, mycobacteria infected dendritic cells   64 
prime protective T cell responses when administered into mice with priming of 
both CD4
+ and CD8
+ T cells (Roy, De Silva et al. 2006). T cell responses primed 
in  this  manner  are  protective  against  a  subsequent  challenge  with  virulent  M. 
tuberculosis,  achieving  levels  of  protection  similar  to,  or  improved  upon  that 
conferred by BCG (Roy, De Silva et al. 2006).  
 
The  process  of  cross-priming  has  been  shown  to  be  an  essential 
component of priming T cells thus an integral part of the immune response against 
pathogens (Sigal, Crotty et al. 1999; den Haan and Bevan 2001). Apoptotic blebs 
derived  from  mycobacteria  infected  cells  are  phagocytosed  by  uninfected 
dendritic cells and presented to MHC-I and CD1 restricted T cells. Dendritic cells 
were found to be indispensable for this new detour pathway of priming T cells, as 
dendritic  cells  possess  a  unique  endosome  to  cytosol  pathway,  and  they  are 
superior to macrophages in priming T cell responses (den Haan and Bevan 2001; 
Aaronson and Horvath  2002; Schaible, Winau et al. 2003).  Hence, uninfected 
dendritic cells are also important in cross-priming in vivo during M. tuberculosis 
infection thus, contributing to the T cell mediated immune responses generated by 
the host.   
 
1.10-Microarrays 
Global transcriptional responses of immune cells to a pathogen like M. 
tuberculosis can be deciphered using microarrays. Microarrays represent a high 
throughput  screening  method  to  monitor  the  whole  genome  on  a  single  chip. 
Affymetrix  arrays  provide  high  reproducibility  and  specific  detection  of  gene 
expression but the downside being that they cannot be produced in-house. They 
have  to  be  purchased  from  commercial  sources  hence  making  them  very 
expensive thus limiting the number of analysis that can be carried out.  
 
Affymetrix GeneChips are manufactured using semiconductor fabrication 
technology,  combining  this  with  photolithography  to  enable  a  vast  amount  of 
information to be accommodated on a single chip. Mouse genome 430 2.0 array is 
a 11mm sized chip representing approximately 39,000 transcripts thus, providing 
coverage  of  the  entire  transcribed  mouse  genome  on  a  single  chip  (source  -  65 
Affymetrix data sheet). Expression chips consist of 11 probe pairs; each probe is 
about 25 basepairs long, weighted towards the 3’ end of the transcript and spans 
the  entire  length  of  each  gene  measured.  One  probe  from  the  pair  perfectly 
matches the target gene, while the other has a single mismatch located in the 
middle of the sequence, thus serving as an internal control for correcting non-
specific binding. The mismatch probe differs from the perfect match probe in the 
13
th base. The expression level for each gene is a summary of the entire probe set 
hybridisation data.  
 
Microarray  analysis  is  useful  in  uncovering  pathways  and  identifying 
biomarkers of gene expression patterns under a given experimental condition or in 
human  diseases.  Using  Affymetrix  arrays,  it  has  been  possible  to  identify 
transcriptional  responses  for  infections  with  influenza  A  and  systemic  lupus 
erythematosus (SLE). The analysis of peripheral blood mononuclear cell profiles 
from patients with influenza A or SLE, allowed for the identification of genes 
common to both these dieases and also unique gene patterns which were then 
further translated into functional modules, to obtain a distinct gene expression 
signature  for  each  disease  (Chaussabel,  Allman  et  al.  2005).  Profiling  gene 
expression of human dendritic cells and macrophages, in response to a group of 
diverse microbes including Toxoplasma gondii, Leishmania major, Leishmania 
donovani, Brugia malayi and M. tuberculosis, identified clusters of genes which 
showed cell type specificity. A greater change in gene expression was observed in 
dendritic  cells  (1519  genes)  in  comparison  to  macrophages  (1060  genes) 
(Chaussabel, Semnani et al. 2003).  
 
 
Additionally,  microarrays  can  be  used  to  assign  probable  functions  to 
genes with no known biological role by comparing expression patterns to genes 
with  known  function,  to  discover  vaccine  targets  and  to  elucidate  genetic 
differences between pathogens. It has been possible to use microarrays to identify 
genes at the various stages of infection with Neisseria meningitides (Kurz, Hubner 
et  al.  2003)  and  Plasmodium  falciparum  (Le  Roch,  Zhou  et  al.  2003),  which 
served as the basis of identification of a number of vaccine candidates. 
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Microarray technology had made it possible to have a genome-wide view 
of  complex  interactions  rather  than  focussing  on  a  single  aspect  of  the  host-
pathogen relationship. The biggest limiting step in microarray based experiments 
is the post-analytical step. With the advent of microarrays, the interest in the use 
of various bioinformatics tools to identify transcription factors regulating gene 
expression  changes  also  increased  exponentially.  Identifying  cis-regulatory 
sequences  is  crucial  to  understanding  gene  expression.  Transcription  factor 
binding sites are usually short sequences (5-15 bases) and hence potentially these 
sites  can  occur  frequently  by  chance  thus  leading  to  a  large  number  of  false 
positives.  A  approach  that  could  be  used  is  to  identify  over-represented 
transcription  factor  binding  motifs  in  the  promoters  of  differentially  regulated 
genes by using position weight matrices which are available as databases such as 
JASPAR (Sandelin, Alkema et al. 2004) and TRANSFAC (Wingender, Chen et 
al. 2000).  
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1.11- Aims of the project 
The  main  objective  of  the  project  was  to  study  the  global  interactions 
between  bone  marrow  derived  dendritic  cells  and  M.  tuberculosis.  Particular 
emphasis was placed on characterising the immune signalling pathways that are 
evoked by dendritic cells in response to M. tuberculosis infection.  
 
The specific objectives of the project were: 
 
1  To  use  Affymetrix  gene  expression  profiling  to  identify  differentially 
expressed genes in response to infection on a global scale 
 
2  To utilize a bioinformatic approach to identify potential transcription factor 
binding domains within genes  that are differentially regulated by dendritic 
cells infected with M. tuberculosis 
 
3  To validate selected gene expression data from microarray analysis using real-
time PCR,  ELISA , FACS  and biochemical approaches 
 
4  To  investigate  the  role  of  MyD88  independent  signalling  pathway  in  the 
priming  of  anti-mycobacterial  immunity,  in  an  intravenous  model  of  M. 
tuberculosis infection.  
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2.1- Mice  
  Adult 6-8 week old male C57BL/6 and MyD88
-/- mice were obtained from 
breeding  colonies  maintained  under  specific  pathogen-free  conditions  in  the 
animal facilities at the National Institute for Medical Research (NIMR). MyD88
-/- 
mice (Adachi, Kawai et al. 1998) were kindly provided by Dr.Jean Langhorne, 
NIMR.   
 
2.2-Bacteria 
   The  M.  tuberculosis  strain  H37Rv  was  grown  in  Dubos  media 
supplemented with 0.2% (v/v) glycerol (Merck, Germany) and Dubos medium 
albumin (Difco, New Jersey) in roller bottles at 37
0C. Aliquots of H37Rv (optical 
density 0.55-0.60) were stored at –80
0C.  
 
2.3- Dendritic cells  
2.3.1-Generation of bone marrow derived dendritic cells (BMDCs)  
Dendritic cells were cultured using the protocol adapted from Inaba et al 
(Inaba, Inaba et al. 1992). Briefly, bone marrow cells were derived from murine 
femurs  and  cultured  for  6  days  in  Iscove’s  modified  Dulbecco’s  medium 
(Invitrogen,  UK)  supplemented  with  5%  fetal  calf  serum,  200mM  glutamine, 
2mM  mercaptoethanol  and  10ng/ml  of  recombinant  GM-CSF  (R&D  systems, 
UK). Media and non-adherent cells were removed on day 3 and then replaced 
with fresh media containing GM-CSF. Non-adherent cells were harvested on day 
5 and these clusters of cells were sub-cultured in fresh medium with recombinant 
GM-CSF for a further 24 hours and on day 6 these cells were used as a source of 
dendritic cells. Using the above method, approximately 8x10
6 dendritic cells were 
generated per mouse. The cells were cultured in media free of antibiotics.   
 
2.3.2-Isolation of CD11c
+ dendritic cells from bone marrow 
  CD11c  antigen  is  commonly  used  as  a  marker  of  dendritic  cells. 
Purification of CD11c
+ dendritic cells was performed by the method adapted from 
the protocol supplied by Miltenyi Biotec. Day 6 dendritic cells were pooled and   70 
washed  extensively  with  sorting  buffer  (PBS  pH7.2,  supplemented  with  0.5% 
fetal calf serum and 0.5mM EDTA).   After washing the supernatant was removed 
and  the  pellet  re-suspended  in  400ml  of  sorting  buffer  per  10
8  total  cells.  Fc 
receptors were blocked with anti-mouse CD16/CD32 (Clone 2.4G2, Pharmingen, 
San Diego) for 20 minutes at 4
0C. The cells were then further incubated with 
100ml MACS CD11C beads (Miltenyibiotec, clone N418) per 10
8 cells at 4
0C for 
15- 20minutes. The cells underwent a final wash using sorting buffer and were 
then re-suspended in 500ml per 10
8 cells. The cells were then separated using 
magnetic LS columns (Miltenyi Biotec, UK) on a SuperMACS(Miltenyi Biotec, 
UK) magnetic separator . As shown in figure 2.1, dendritic cells after sorting, 
were consistently 95 ±3% CD11c
+. 
  
 
 
 
 
 
 
 
 
 
Figure 2.1- Flow cytometric analysis of bone marrow cells  
A) before magnetic sorting B) after magnetic sorting using CD11c beads. Results 
shown percentage of total cells and represent a typical experiment. Consistently, 
the purity of the cells was 95± 3%.  
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2.3.3-Flow cytometry 
  Cells were pooled and washed with PBS supplemented with 1% fetal calf 
serum  (Gibco,  Paisley,  UK)  and  after  extensive  washing  the  pellet  was  re-
suspended  in  0.1ml  of  PBS  supplemented  with  1%  fetal  calf  serum.  The  cell 
suspension was incubated with anti-CD16/CD32 (clone 2.4G2) for 20 minutes at 
4
0C  to  prevent  non-specific  antibody  binding  and  then  stained  with  directly 
conjugated  antibodies  for  1  hour  at  4
0C.  The  following  directly  conjugated 
antibodies were  used for the experiments: PE CD11c (Clone HL3), PE CD80 
(Clone  16-10A1),  PE  CD86  (Clone  GL1),  FITC  I-A
b  (Clone  25-9-17),  FITC 
F4/80 (Clone BM8), FITC IgG2a (Clone R19-15), PE IgG1 (Clone A85-1). After 
the staining process the cells were washed with PBS supplemented with 1% fetal 
calf serum and subsequently the cells were fixed in 4% paraformaldehyde and 
analysed using a FACScan flow cytometer (Becton Dickinson, United Kingdom). 
Data  analysis  was  performed  using  WinMDI  (Scripps  Research  Institute, 
California). All the antibodies used for flow cyometry were purchased from B.D 
Pharmingen, San Diego. 
 
2.3.4-Cytokine measurement  
  BMDCs at a concentration of 1x10
6/ml were stimulated with 1µg/ml LPS 
from E.coli 026:B6 (Sigma-Aldrich, USA), 25µg/ml poly I:C – synthetic double 
stranded RNA (Autogen Bioclear, UK), infected with H37Rv 10:1 (10 bacteria 
per  cell)  or  left  uninfected  (negative  control)  and  supernatants  were  collected 
usually  between  6-72  hours  post-stimulation,  unless  specified.  All  cytokine 
measurements were carried out by enzyme-linked immunosorbent assay (ELISA) 
using  commercial  kits  according  to  the  manufacturer’s  protocol.  IL-12p40 
(sensitivity 8 pg/ml), IL-12p70 (sensitivity 15pg/ml), IL-6 (sensitivity 4pg/ml), 
TNF-a (sensitivity 8pg/ml) and IL-10 (sensitivity 30pg/ml) were purchased from 
eBioscience  (San  Diego).  CXCL10  (sensitivity  30pg/ml)  ELISA  kit  was 
purchased  from  R&D  systems  (Oxford,  UK)  and  IFN  alpha  (sensitivity 
12.5pg/ml),  IFN  beta  (sensitivity  15.6  pg/ml)  kits  were  acquired  from  PBL 
Biomedical Laboratories ,New Jersey.  
   72 
 
2.4- RNA and DNA microarray hybridisation and analysis 
 
2.4.1- RNA isolation  
Total  RNA  was  extracted  using  TRIzol  reagent  (Invitrogen  Ltd,  UK) 
according  to  the  manufacturer’s  protocol.  Briefly,  TRIzol  is  a  mono-phasic 
solution of phenol and guanidine isothiocyanate used for the isolation of total 
RNA from cells. 5x10
6 cells were lysed in 1ml of TRIzol at room temperature for 
5 minutes. Subsequently, 200ml of cholorform per 1ml of TRIzol was added and 
then further incubated at room temperature for 3 minutes. This was followed by a 
centrifugation step at 12,000g for 15 minutes at 4
0C which separates the mixture 
into three phases and the RNA remains in the upper aqueous phase. The aqueous 
phase was carefully pipetted into a fresh tube and RNA was precipitated out of the 
aqueous  phase  with  the  addition  of  0.5ml  of  isopropanol.  The  sample  was 
incubated at room temperature for 10 minutes and then centrifuged at 12,000g for 
10 minutes at 4
0C. The RNA pellet which is visible after the centrifugation step 
was  washed  with  1ml  of  75%  ethanol  per  1ml  of  TRIzol  and  then  further 
centrifuged at 7,500g at 4
0C for 5 minutes. The RNA pellet was air-dried and re-
suspended in 100ml of RNase free water and stored at -70
0C . RNA was cleaned 
up to remove any contaminants such as phenol or proteins using the RNeasy Mini 
Kit (Qiagen Ltd, UK) according to the manufacturer’s protocol. The total amount 
of RNA in each sample was determined using the Nanodrop spectrophotometer 
(Nanodrop technologies, USA).  
 
2.4.2- Determining the quality of RNA 
The quality of RNA was determined using the Agilent 2100 Bioanalyzer 
(Agilent  technologies  Inc,  Santa  Clara,  CA).  The  bioanalyzer  generates  an 
electropherogram for each RNA sample and key characteristics of the graph aids 
in  the  confirmation  of  the  quality  of  RNA  like  the  presence  of  well-defined 
28S/18S peaks, low noise between 18S/28S peaks, minimal low molecular weight 
contamination.  A  28S:18S, ribosomal RNA (rRNA)  ratio of 1.8-2.1, generally 
indicates a good quality of RNA. An example of an electropherogram is given in 
figure 2.2.    73 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2- Electropherogram of a RNA sample generated by the Agilent 
bioanalyzer. 
 
Above is a typical plot generated by the bioanalyzer which depicts sharp peaks for 
18S and 28S and additionally the lack of noise between the peaks indicates a good 
quality RNA sample which can be used for processing and hybridisation to the 
Affymetrix GeneChip.  
 
 
 
 
2.4.3 - Microarray hybridisation and analysis 
Three  independent  experiments  were  conducted  using  4-6  mice  per 
experiment on different days, to generate triplicate biological RNA samples for 
microarrays.  
 
 
2.4.4- MyD88
-/- BMDCs -two-cycle target labelling and hybridisation 
 Triplicate biological samples were prepared from MyD88
-/- BMDCs and 
from each biological sample, 50ng of total RNA from MyD88 
-/- BMDCs  was 
used for two cycle target labelling and hybridisation to the Affymetrix Mouse 
Time (seconds)
F
l
u
o
r
e
s
c
e
n
c
e
28s peak
18s peak
Time (seconds)
F
l
u
o
r
e
s
c
e
n
c
e
28s peak
18s peak  74 
genome 430 2.0 array as per the manufacturer’s protocol (Affymetrix Inc, Santa 
Clara, CA). Two cycle target labelling was used due to the limited availability of 
MyD88
-/- mice which was required to carry out the experiments. Briefly, 50 ng of 
RNA  was  reverse  transcribed  into  cDNA  using  the  Affymetrix  two-cycle 
synthesis  kit  (Affymetrix  Inc,  CA)  and  T7-Oligo(dT)  primer  (Affymetrix  Inc, 
Santa Clara, CA).cRNA was subsequently generated from the cDNA sample by 
an  in  vitro  transcription  reaction  using  MEGAscript  T7  kit  (Ambion,  Austin, 
USA).  A  further  step  of  cDNA  synthesis  was  needed  in  the  2-cycle  cDNA 
synthesis cycle to generate sufficient amounts of cRNA for target labelling and 
hybridisation. Subsequently, the unlabelled cRNA was reverse transcribed into 
first strand cDNA using random primers (Invitrogen Ltd, UK followed by the 2
nd 
strand cDNA synthesis using T7-Oligo(dT) primer (Affymetrix Inc, Santa Clara, 
CA).  The  amplified  cDNA  was  labelled  with  biotin  during  an  in-vitro 
transcription  reaction  to  produce  biotin  labelled  cRNA  which  was  then 
fragmented and hybridised to the Affymetrix Mouse genome 430 2.0 array. The 
fluorescence was measured using the Affymetrix GeneChip scanner 3000.  
 
 
2.4.5- C57BL/6 BMDCs-one-cycle target labelling and hybridisation  
Triplicate  biological  samples  were  prepared  from  C57BL/6  (wild-type) 
BMDCs and from each sample 5-8mg of total RNA was used for one cycle target 
labelling and hybridisation to the GeneChip (Affymetrix, UK).The further step for 
the cDNA synthesis was not needed in the one cycle labelling and hybridisation 
reactions. The rest of the protocol is the same as described above for the two-cycle 
target labelling and hybridisation.   
 
 
2.4.6- Analysis of microarray data 
Microarray data was analysed using GeneSpring version 7.3 expression 
analysis platform (Agilent technologies Inc, Santa Clara, CA). The algorithm GC-
Robust  Multiarray  Analysis  (GCRMA)  was  computed  from  GeneSpring  7.3 
(Agilent technologies, Santa Clara) to generate the absolute values from the .cel 
files  (contains  fluorescence  intensities  for  each  probe  on  the  microarray)  for   75 
further normalisation. The GCRMA algorithm was chosen as it provides a good 
signal-noise ratio thus giving the best signal specificity and also achieves a more 
accurate coverage of the low expressing genes (Wu and Irizarry 2004). The MAS 
5.0 algorithm was used to obtain the flagged data for each gene (genes are flagged 
as  present,  marginal  or  absent).  The  following  normalisation  parameters  were 
applied to each experimental sample: 
1. Data transformation- cut-off value set at 10 (Enables transformation of data into 
the log scale by eliminating any zero or negative values) 
2. Per chip- Normalise to 50
th percentile (Removes non-biological variation across 
GeneChips) 
3. Per gene- Normalise  to median (Enables all transcript values to  be centred 
around 1, thus making comparisons of gene expression patterns straightforward)  
 
Individual  GeneChips  and  each  gene  were  normalised  to  50%  median 
intensity. The normalised data was transformed to the log scale. All the GeneChip 
data was normalised and log transformed before averaging and comparing each 
gene’s expression value.  
 
After normalisation of the data, the following filtering parameters were used 
to identify differentially regulated genes.   
1.  Flag filter- selects for gene flags which are either ‘Present’ or ‘Marginal’ 
in 3 out of the 6 samples 
2.  Expression level filter- removes genes which are non-changing across the 
GeneChips 
3.  AFFX  control  genes  filter-  enables  removal  of  the  Affymetrix  control 
genes  
 
Following filtering, differentially regulated genes were identified by analysing 
a change in transcript expression level between the uninfected (control) and M. 
tuberculosis  infected  group  by  a  factor  of  1.4  fold  (minimum  cut-off  value 
suggested by Affymetrix consultant, Dr. Euan Hunter, personal communication) 
with a p value cut-off set at £0.05. The level of significance (p value-£0.05) for 
each  gene  was  tested  using  the  one-way  analysis  of  variance;  Welch  t-test 
(parametric t-test; assuming variances are unequal).    76 
 
 
Quality control of all the samples was assessed using RNA digestion plots and 
differences in the distribution of intensities across arrays were evaluated using 
box plots for samples from C57BL/6 BMDCs (Appendix I) and MyD88
-/- BMDCs 
(Appendix II).  
 
2.4.6.1- Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways 
  KEGG  pathways  are  a  collection  of  biological  pathways  depicting  the 
molecular interactions for various biological processes within an organism. These 
biological pathways are available for use as plug-in feature of GeneSpring 7.3. 
Differentially  regulated  genes  can  be  superimposed  onto  these  biological 
pathways,  thus  providing  an  overview  of  the  various  pathways  that  exhibit  a 
change in response to M. tuberculosis infection of BMDCs.  
 
 
2.5- Real-time PCR 
 
2.5.1- Real-time PCR using SYBR green based method 
Selected genes of interest were obtained from microarray data analysis and 
their  expression  levels  were  then  examined  using  quantitative  real-time  PCR. 
Real-time PCR was performed on cDNA generated from RNA samples that were 
prepared independently of the RNA used for microarray analysis. Total RNA was 
reverse  transcribed  using  random  primers  (Invitrogen,  Paisley,  UK)  and 
superscript II reverse transcriptase (Invitrogen, Paisley, UK). Quantitect SYBR 
green PCR kit (Qiagen,  UK) was used to produce fluorescently labelled PCR 
products. The quantification of PCR products was done using the ABI PRISM 
7000  sequence  detection  system  (Applied  Bisosystems,  U.S.A).  Commercially 
available primers (SuperArray Biosciences, U.S.A) were used for the real-time 
PCR reactions. The following temperature cycling profile was used for all the 
primers: 95
0C, 15 minutes and 40 cycles of (95
0C, 30 seconds; 55
0C, 30 seconds 
and 72
0C, 30 seconds).   77 
 
Real-time  PCR  reactions  were  performed  with  reverse  transcriptase 
negative samples to exclude any DNA contamination. All amplifications  were 
done in optical reaction plates (Applied Biosystems, U.S.A) in duplicates. The 
expression values of individual genes were normalised to the 18S rRNA, house-
keeping gene and the transcript level of each gene was expressed as a fold change 
for the M. tuberculosis infected sample relative to the uninfected sample.  
 
Expression value of the gene of interest (GOI) = 10 
[(C
t
-b)/m] 
(Ct- threshold cycle) 
 
2.5.2- RT profiler PCR array system (IFN array) 
  Total  RNA  was  reverse  transcribed  using  random  primers  (Invitrogen, 
Paisley, UK) and superscript II reverse transcriptase (Invitrogen, Paisley, UK) to 
generate  first  strand  cDNA.  Diluted  cDNA  with  RT  (Real-time)  SYBR  green 
/ROX (SuperArray biosciences, Maryland) and water was used to generate the 
experimental cocktail which was added to the 96 well reaction PCR plate pre-
coated with IFN  genes  and controls (SuperArray  Biosciences,  Maryland). The 
thermal cycling was performed using the following temperature profile: Cycle 1- 
10 minutes at 95
0C and 40 cycles of 15 seconds at 95
0C followed by 1 minute at 
60
0C.  The  expression  value  for  each  gene  was  normalised  to  a  housekeeping 
gene- glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the fold change 
was expressed relative to the M. tuberculosis infected sample.  
 
The following formula was used to calculate the relative expression level for each 
gene- 2^ 
(-DDCt). 
 
 DCt = Ct (GOI) - average (Ct (HKG)), where HKG- housekeeping gene 
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2.6- Transcription Element Listening system (TELiS) 
  TELiS (www.telis.ucla.edu) identifies transcription factor binding motifs 
in  the  promoters  of  genes  differentially  regulated  under  a  given  experimental 
condition  which  allows  inferences  about  transcription  factors  mediating  the 
observed  changes  in  gene  expression  (Cole,  Yan  et  al.  2005).  The  database 
computes a statistical list of transcription factor binding motifs in the promoters of 
differentially regulated genes. Representation of transcription factors is calculated 
relative  to  the  basal  level  of  prevalence  of  transcription factor  binding  motifs 
represented on the Affymetrix microarray platform.  The following parameters 
were supplied to the bioinformatics database: 
 
Sampling frame: Affymetrix Mouse Genome 430.2 array 
Gene list: Genes with a fold change of 1.4 or more with a p value of less than 
0.05 
Promoter size: -1000 to +200 nucleotides 
Stringency of analysis: 0.90 (90% confidence limit) 
 
The above parameters were chosen to maximise detection sensitivity.  
A  z-test  (used  to  determine  if  changes  detected  between  the  population  and 
sample mean are statistically significant) is used to identify the significance of the 
representation of each transcription factor binding motif in the gene list compared 
to the sampling frame. Additionally the risk of false positives of the gene list that 
is considered to be significant (p value <0.01) is calculated using False discovery 
rate (Benjamini and Hochberg test). The data retrieval function in TELiS is useful 
for  the  identification of genes and  their respective transcription factor binding 
sites.  
 
2.7- Western Blot 
2.7.1- Extraction of nuclear lysates 
  Nuclear  lysates  were  prepared  using  the  Transfactor  Extraction  Kit 
(Clontech, California) according to the manufacturer’s protocol. Briefly, 1x10
7 
cells were lysed for 15 minutes on ice in 1ml of lysis buffer (100mM HEPES 
pH7.9, 15mM MgCl2, 100mM KCl) supplemented with 0.1M dithiothreitol and   79 
15µl  of  protease  inhibitor  cocktails  (Aprotinin,  Pepstatin  A,  Bestatin,  trans-
Epoxysuccinyl-L-  leucylamido  (4-guanidino)  butane,  and  4-(2-aminoethyl) 
benzenesulfonyl fluoride hydrochloride in dimethyl sulfoxide) for 15 minutes and 
then  centrifuged  at  11,000g  for  20  minutes.  The  resulting  supernatant  is  the 
cytosolic  fraction  which  was  removed  and  the  crude  nuclear  pellet  was  then 
further  re-suspended  in  pre-extraction  buffer  (20mM  HEPES  pH  7.9,  1.5mM 
MgCl2,  0.42M  NaCl,  0.2mM  EDTA,  25%  [v/v]  glycerol)  supplemented  with 
0.1M dithiothreitol and 1.5µl of protease inhibitor cocktails for 30 minutes on ice. 
The  nuclear  suspension  was  centrifuged  at  21,000g  for  5  minutes  and  the 
supernatant was frozen in aliquots at -80
0C.  
 
2.7.2- Determining protein concentration in nuclear lysates 
Concentration of protein was determined using Coomassie Plus Bradford 
assay reagent (Pierce, Illinois) according to the manufacturer’s protocol. Briefly, 
the  protein  sample  was  mixed  with  Coomassie  plus  reagent  and  then  the 
absorbance  at  595nm  was  determined  using  a  Benchmark  plus  microplate 
spectrophotometer  (Bio-Rad,  UK).  Protein  concentrations  were  estimated  by 
reference to absorbance measurements obtained for a series of Albumin (Pierce, 
Illinois) protein dilutions which served as the standard.   
 
2.7.3- Gel electrophoresis 
  Nuclear lysates were mixed with NuPage LDS sample buffer (Invitrogen, 
Paisley, UK) and then incubated at 70 
0C for 10 minutes. A protein concentration 
of  15mg/well  was  resolved  using  Tris-HCl  Gels  10%  (Bio-Rad,  UK)  in  Tris-
glycine  SDS  buffer.  Separated  proteins  were  transferred  onto  nitrocellulose 
membranes  in  transfer  buffer  (GE  Healthcare,  Buckinghamshire).  Following 
transfer, the membrane was blocked overnight at 4
0C with 5% skimmed milk + 
0.05% Tween 20 in PBS. After blocking the membrane was washed and incubated 
with anti-IRF-3 (Santa Cruz biotechnology, California) or anti-IRF-7 (Santa Cruz 
biotechnology,  California)  followed  by  incubation  with  HRP  conjugated  anti-
rabbit IgG (Santa Cruz biotechnology, California) or anti-goat IgG (Santa Cruz 
biotechnology, California). The membranes were then developed with enhanced 
chemiluminescent  western  blot  detecting  reagents  (GE  Healthcare,   80 
Buckinghamshire)  and  exposed  to  Lumi-Film  chemiluminescent  detection  film 
(Roche, USA). Detailed compositions of western blotting reagents are listed in 
Appendix-III.  
 
2.8- In vivo experiments  
 
2.8.1- In vivo infection procedure 
Six to eight week old female C57BL/6 and MyD88
-/- mice were obtained 
from breeding colonies maintained under specific pathogen-free conditions in the 
Division of Biological Services, NIMR. Mice were injected intravenously with 
10
6 viable H37Rv and spleens and lungs were harvested at 14 and 30 days post-
infection. 
 
2.8.2- Determining colony forming units from M. tuberculosis infected 
murine tissues 
Tissues were homogenised by shaking with 2mm glass beads in ice cold 
saline using a ribolyser (Hybaid) for 30 seconds and 10 fold serial dilutions of the 
homogenate in saline was  plated  on 7H11 Middlebrook medium supplemented 
with Dubos oleic albumin complex supplement . The number of colony forming 
units was determined after the plates had been incubated at 37
0C for 14-21 days. 
 
 
2.8.3- Lung histology 
Mice  were  administered  with  a  lethal  injection  of  anaesthetic  (Sagatal, 
RMB Animal health, United Kingdom) via the intra-peritoneal route and the lungs 
were  perfused  with  1ml  of  10%  neutral  buffered  formalin  solution  (Sigma-
Aldrich, UK) via the trachea in situ and with an additional 1ml on the removal of 
the lungs. The lungs were then placed in 10ml of neutral buffered formalin for 3 
days prior to histology. Following dehydration in a graded series of ethanol and 
clearing in xylene, the lungs were embedded in fibrowax (VWR International, 
UK). Sections of the embedded lungs were stained with hematoxylin and eosin.  
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2.8.4- Ex-vivo whole spleen cell assay 
Spleens were harvested from three mice at 14 and 30 days post-infection, 
homogenised via a 40mm strainer (Falcon, San Jose), washed and re-suspended in 
red blood cell lysing buffer (Sigma, UK) for 2 minutes. Cells were washed and re-
suspended in AIM-v serum free media (Gibco life technologies, Paisley).  In 24 
well plates, whole spleen cells were treated with saline (negative control), PPD at 
various  concentrations  (0.1mg/ml,  1mg/ml  and  10mg/ml)  or  1mg/ml  of  anti-
CD3/CD28 (Pharmingen, San Diego) which served as the positive control. PPD 
was  a  kind  gift  from  Dr.Martin  Vordermier  (VLA  laboratories,  Weybridge).  
Supernatants  were  collected  at  24  and  72  hours  post-infection.  Culture 
supernatants were run on commercially available ELISA’s from e-Bioscience for 
quantification of IL-2 (sensitivity 2pg/ml) and IFN-g (sensitivity 15pg/ml).  
 
 
2.9- Statistics 
 Statistical analysis was carried out using a Student’s t-test (Sigma plot 
version 10, San Jose) with a p value < 0.05 being considered significant.   
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Chapter 3 
 
 
 
 
 
 
 
 
Activation of dendritic cells in response to M. tuberculosis 
infection 
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3.1 -Introduction 
Dendritic cells are potent antigen presenting cells that play a key role in 
priming immune responses to various pathogens. Dendritic cells in their immature 
state  function  as  effective  phagocytic  cells  ingesting  microbes  or  their 
components. It has been previously reported that dendritic cells can efficiently 
take up microbes such as Borrelia burdorferria (Filgueira, Nestle et al. 1996), 
Salmonella Dublin (Ian Marriott 1999) and M. tuberculosis (Bodnar, Serbina et al. 
2001).  By  using  green  fluorescent  protein  tagged  BCG,  it  has  also  been 
demonstrated  that  lung  dendritic  cells  can  phagocytose  mycobacteria,  in  vivo 
(Reljic, Di Sano et al. 2005).  
 
  Pathogen derived products including LPS, bacterial DNA and viral dsRNA 
can promote dendritic cell activation (Brunner, Seiderer et al. 2000). Hallmarks of 
dendritic  cell  activation  include:  increased  surface  expression  of  antigen 
presenting molecules like MHC-II and co-stimulatory molecules such as CD80 
and CD86 on the surface and the production of inflammatory cytokines such as 
IL-12. It has been demonstrated that following phagocytosis of bacteria such as 
Salmonella  typhimurium  (Ian  Marriott  1999)  and  M.  tuberculosis  (Henderson, 
Watkins  et  al.  1997),  dendritic  cells  can  produce  inflammatory  cytokines.  M. 
tuberculosis  infection  of  an  immortalised  dendritic  cell  line  also  resulted  in 
increased inflammatory cytokine production, similar to the observation made with 
primary dendritic cells (Tascon, Soares et al. 2000). 
 
The  main aim  of  the  work  described  in  this chapter,  was  to  study  the 
activation of primary murine BMDCs in response to M. tuberculosis infection, by 
determining the expression of co-stimulatory and MHC-II molecules and assaying 
levels of inflammatory cytokine production both of which function as indicators 
of dendritic cell activation. The experiments described in this thesis were done 
using BMDCs which were grown in recombinant GM-CSF, as described in the 
materials and methods section (chapter 2, section 2.3.1). BMDCs are commonly 
used as a model to study murine dendritic cells, in vitro. The major advantage of 
using bone marrow as the source of dendritic cells is the ease of obtaining large 
numbers of dendritic cells from relatively low numbers of mice.  
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3.2-Characterisation of BMDCs using flow cytometry 
  BMDCs were generated by culturing bone marrow cells in the presence of 
GM-CSF  for  6  days.  To  characterise  day  6  BMDCs,  non-adherent  cells  were 
stained with directly conjugated fluorescent antibodies and analysed using flow 
cytometry. BMDCs were determined by primarily gating on forward scatter (FSC) 
vs side scatter (SSC), as shown in figure 3.1, A. Visible on the FSC vs SSC plots 
in figure 3.1, A, are also two populations of cells outside the gate. These cells 
have a low FSC and thus most likely indicative of the granulocyte population 
(Inaba,  Inaba  et  al.  1992)  and  hence  were  not  included  within  the  gated 
population. CD11c antigen, also known an integrin alpha X was used to initially 
identify  the  dendritic  cell  population.  Day  6  BMDCs  were  70±  5%  CD11c
+ 
(Figure 3.1, B). In addition, these cells were also 30.29 ±10% CD80
+, 28.95 ±8% 
CD86
+, 24.57% ±5% MHC-II
+ and 5.62 ±2% CD11c
+F4/80
+ (Figure 3.2). 
   
   
  Thus, day 6 BMDCs exhibit an immature phenotype as indicated by the 
low expression of CD86 and MHC-II. Although a small portion of cells stained 
positive for the macrophage specific marker, F4/80 (Figure 3.2, D), the majority 
of the cells were characteristic of dendritic cells.  
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Figure 3.1- Expression of CD11c on BMDCs. 
 
Day 6 BMDCs were gated on A) FSC vs SSC and B) the expression of CD11c 
was  quantified  using  flow  cytometry.  Data  shown  are  representative  of  3 
independent experiments.    
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Figure 3.2-Analysis of day 6 BMDCs using flow cytometry.  
Non-adherent cells, on day 6 were stained with fluorescent antibodies and the 
surface expression of A) CD80 B) CD86 C) MHC-II and D) CD11c F4/80 were 
analysed using flow cytometry. Data shown are representative of 3 independent 
experiments.    
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3.3-Phenotypic analysis of M. tuberculosis infected BMDCs using 
flow cytometry 
In the previous section it was shown that BMDCs expressed low levels of 
co-stimulatory  and  antigen  presenting  molecules  thus  identifying  them  as 
immature dendritic cells. In order to investigate whether BMDCs can be activated 
in  response  to  M.  tuberculosis  infection,  day  6  BMDCs  were  either  left 
uninfected, stimulated with LPS (1mg/ml) or infected with H37Rv at a multiplicity 
of  infection  (M.O.I)  of  10:1  and  the  expression  of  activation  markers  were 
assessed by flow cytometry 24 hours later. LPS has shown to be an effective 
activator  of  dendritic  cells  and  was  thus  used  as  a  positive  control  for  the 
experiments (Francesca Granucci 2001). The time-point, 24 hours and the ratio of 
infection (M.O.I 10:1) was chosen as an early time point to assess dendritic cell 
responses to M. tuberculosis infection, as a result of previous work in our lab, 
which identified 24 hours and 10:1 as an optimal time point for measuring the 
activation status of dendritic cells in response to M. tuberculosis infection (Dr. 
Ricardo Tascon, personal communication).  
 
M. tuberculosis infection of BMDCs, up regulated the expression of CD80 
to 83% , CD86 to 82% and MHC-II to 80%, thus indicating that these immature 
cells are activated in response to infection. These results allows us to conclude 
that  M.  tuberculosis  infection  provides  the  microbial  stimuli  needed  for  the 
activation of dendritic cells thus providing transition to a mature phenotype.  
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Figure 3.3- Cell surface phenotype of BMDCs infected with H37Rv. 
 Day  6  BMDCs  were  either  left  uninfected,  stimulated  with  LPS  (1µg/ml)  or 
infected with H37Rv at a M.O.I of 10:1. 24 hours post-infection the expression of 
co-stimulatory  molecules  and  MHC-II  were  analysed  using  flow  cytometry. 
Histograms compare the expression of A) CD80 B) CD86 and C) MHC-II on 
uninfected cells (black line), LPS stimulated cells (green line) and H37Rv infected 
BMDCs (blue line). Gray filled histogram represents the isotype IgG control. Data 
are representative of 3 independent experiments.  
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3.4- A kinetic analysis of cytokines induced by M. tuberculosis 
infection of BMDCs  
  Dendritic  cell  activation  triggers  the  production  of  inflammatory 
cytokines, which play a role in the polarisation of T cell responses either towards 
a Th-1 or Th-2 type. In the previous section it was shown that immature dendritic 
cells when exposed to microbial stimuli during M. tuberculosis infection were 
activated  hence  acquiring  increased  antigen  presenting  and  co-stimulatory 
capacity thus moulding these cells to become effective stimulators of T cells. We 
also  studied  the  repertoire  of  cytokines  that  are  produced  in  response  to  M. 
tuberculosis infection as another indicator of dendritic cell activation.  
 
   
  Day 6 unsorted BMDCs (70± 5% CD11c
+) were infected with H37Rv at a 
M.O.I  of  10:1  and  uninfected  and  LPS  stimulated  BMDCs  were  included  as 
control groups. At various time points post-infection (6-72 hours), supernatants 
were collected and the production of cytokines was assayed using ELISA.  
 
 
3.4.1- IL-6 and TNF-a a a a production by M. tuberculosis infected BMDCs 
  In  response  to  M.  tuberculosis  infection,  BMDCs  consistently  produced 
significantly high levels of IL-6 and TNF-a, in comparison to uninfected BMDCs 
over the time points assayed (6-72 hours), as shown in figure 3.4. Uninfected 
BMDCs produced negligible amounts of IL-6 and TNF-a at all the time points 
examined. LPS stimulated BMDCs also produced similar levels of IL-6 to M. 
tuberculosis infected BMDCs over the course of infection (6-72 hours). Although, 
the  production  of  TNF-a  is  comparable  between  LPS  stimulated  and  M. 
tuberculosis infected BMDCs between 6 and 24 hours, there is a decrease in the 
level of TNF-a by 48 hours (3.9 ±1.9 ng/ml) only in LPS stimulated BMDCs 
(Figure 3.4, B). Similar levels of TNF-a were secreted by M. tuberculosis infected 
BMDCs between 6-72 hours of infection, as shown in figure 3.4, B.   
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Figure 3.4- IL-6 and TNF-a a a a secretion by BMDCs in response to                     
M. tuberculosis infection.  
Day 6 BMDCs were either left uninfected, stimulated with LPS or infected with 
H37Rv at a M.O.I of 10:1. Supernatants were collected at various time points and 
quantified by ELISA for the amount of A) IL-6 and B) TNF-a produced.  Results 
are  the  mean  of  ±SE  of  3  independent  experiments.  Statistical  analysis  was 
performed  between  H37Rv  infected  group  and  uninfected  group  with  the 
Student’s t-test, *- p value <0.05. 
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3.4.2- Induction of IL-10 secretion by M. tuberculosis infected BMDCs 
  The production of IL-10 by M. tuberculosis infected BMDCs reached a 
peak at 24 hours post-infection (0.19 ±0.05 ng/ml) and decreased over later time 
points, as shown in figure 3.5. IL-10 was produced by LPS stimulated BMDCs by 
24 hours (0.2 ±0.05 ng/ml), with decreased production at later time points. The 
levels  of  IL-10  produced  by  M.  tuberculosis  infected  BMDCs  were  not 
significantly different statistically, to the uninfected group.  
 
 
 
 
 
Figure 3.5- IL-10 secretion by unsorted BMDCs in response to                       
M. tuberculosis infection.  
Day 6 BMDCs were either left uninfected, stimulated with LPS or infected with 
H37Rv (M.O.I 10:1). IL-10 levels were quantified using ELISA. Results are the 
mean of ±SE of 3 independent experiments. 
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3.4.3- The production of IL-12 in response to M. tuberculosis infection of 
BMDCs 
  M. tuberculosis infected unsorted BMDCs, consistently produced, lower 
levels of IL-12p70 in comparison to LPS stimulated cells, as shown in figure 3.6, 
A. The maximum IL-12p70 production was detected at 24 hours in both LPS 
stimulated  and  M.  tuberculosis  infected  BMDCs.  High  levels  of  IL-12p40 
secretion were detected as early as 6 hours in LPS stimulated BMDCs (5.7±1.4 
ng/ml) and only by 24 hours in M. tuberculosis infected BMDCs (5.1±1.4 ng/ml), 
as shown in figure 3.6, B. At later time points (48-72 hours), the production of IL-
12p40  was  comparable  in  both  LPS  stimulated  and  M.  tuberculosis  infected 
BMDCs.  
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Figure 3.6- Production of IL-12 by BMDCs in response to M. tuberculosis 
infection.  
Day 6 BMDCs were either left uninfected, stimulated with LPS or infected with 
H37Rv and the amount of IL-12 were determined using ELISA. The production 
of A) IL-12p70 and B) IL-12p40 was analysed using ELISA. Results are the mean 
of ±SE of 3 independent experiments. Statistical analysis was performed between 
H37Rv infected group and uninfected group with the Student’s t-test, *- p value 
<0.05. 
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3.5-Discussion 
  The  experiments  described  in  chapter  3  were  carried  out  to  study  the 
activation of murine BMDCs in response to M. tuberculosis infection. Analysis of 
BMDCs  using  flow  cytometry,  demonstrated  that  these  cells  displayed  an 
immature  phenotype  (low  expression  of  CD86  and  MHC-II)  before  microbial 
stimulation. Following M. tuberculosis infection, BMDCs up regulated the co-
stimulatory  molecules  and  MHC-II.  This  is  in  agreement  with  published  data 
which  also  demonstrated  similar  up  regulation  of  co-stimulatory  and  MHC-II 
molecules on murine dendritic cells (Bodnar, Serbina et al. 2001).   
 
  In addition to the acquisition of increased surface expression of activation 
markers, BMDCs also produced increased inflammatory cytokines in response to 
M.  tuberculosis  infection.  IL-6  and  TNF-a  were  induced  at  significantly  high 
levels as early as 6 hours post-infection. The early production of IL-6 and TNF-a 
represents  rapid  induction  of  the  synthesis  followed  an  accumulation  of  these 
cytokines  even  at  72  hours  post-infection.  In  contrast,  IL-10  and  IL-12p70 
production  peaked at 24 hours,  with decreased production at later time points  
(Figure 3.5 and Figure 3.6, A) . The amount of IL-12p70 produced in response to 
infection is very low in comparison to IL-6, TNF-a and IL-12p40. This could be 
attributed to the increased IL-10 production observed at 24 hours post-infection 
(Figure 3.5). It has been previously shown that IL-12 production by dendritic cells 
could be augmented by the addition of neutralising anti-IL-10 antibodies in the 
presence of LPS (Corinti, Albanesi et al. 2001). Thus, it is likely that the increased 
levels of IL-10 between 6- 24 hours post-infection could be responsible for the 
low  IL-12p70  production  between  6-48  hours  by  M.  tuberculosis  infected 
BMDCs.  
 
  In  conclusion,  BMDCs  are  activated  in  response  to  M.  tuberculosis 
infection as denoted by the up regulation of co-stimulatory molecules, MHC-II 
and increased inflammatory cytokine production.  
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Chapter 4 
 
 
 
 
 
Profiling transcriptional responses of M. tuberculosis infected 
dendritic cells 
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4.1 Introduction 
Using a global approach to study transcriptional responses, it was possible 
to have an overview of the gene expression profiles of M. tuberculosis infected 
dendritic cells. In recent years, a number of studies have been performed using 
microarrays  which  have  allowed  the  profiling  of  genes,  that  are  differentially 
regulated  under  experimental  conditions  and  genes  that  are  tightly  regulated 
across different experimental conditions simultaneously (Chaussabel, Semnani et 
al.  2003;  Chaussabel,  Allman  et  al.  2005).  The  possibility  of  acquiring  gene 
expression data across various parameters (e.g. different stimuli and time course 
analysis) for a vast number of genes in a single experiment is probably the major 
advantage of using microarrays. 
   
Experiments described in the previous chapter demonstrated that BMDCs 
were  activated  in  response  to  M.  tuberculosis  infection  as,  depicted  by  the 
increased level  of co-stimulatory molecules (CD80,  CD86), antigen  presenting 
molecule (MHC-II) and augmented levels of cytokine production. The process of 
dendritic cell activation in response to a pathogen like M. tuberculosis, results in 
an  array  of  co-ordinated  gene  expression  patterns.  In  order  to  have  a  global 
understanding of these transcriptional events, a microarray based approach was 
used to profile genes that are differentially regulated in dendritic cells in response 
to M. tuberculosis infection.  
 
The  Affymetrix  Mouse  430.2  GeneChip  was  used  to  profile  gene 
expression of BMDCs in response to M. tuberculosis infection at a single time 
point (24 hours). The Mouse GeneChip 430.2 has over 39,000 transcripts on a 
single  chip,  so  comprehending  such  vast  amounts  of  data  is  complex.  Thus  a 
single time point analysis was chosen to act as a starting point for future work, in 
understanding  the cohort of  signalling pathways and  gene  expression patterns, 
which  are  evoked  in  response  to  M.  tuberculosis  infection  of  BMDCs.  After 
evaluating  the  cytokine  and  dendritic  cell  activation  profiles  using  a  kinetic 
approach,  24  hours  was  chosen  as  a  time  point  of  optimum  dendritic  cell 
activation in response to M. tuberculosis infection (Figures 3.3, 3.4 and 3.6).    97 
 
  The microarray analysis method is described in detail in the Materials and 
Methods (section 2.4.6). Briefly, day 6 unsorted BMDCs (70±5% CD11c
+) were 
infected with H37Rv at a M.O.I of 10:1 and 24 hours post-infection, total RNA 
was extracted. Triplicate RNA samples from biological replicates were used for 
Affymetrix  GeneChip  labelling  and  hybridisation.  The  microarray  data  was 
processed with the GCRMA algorithm and differentially regulated genes were 
considered as those, which had a change in expression of at least 1.4 fold in M. 
tuberculosis infected samples, when compared to the control group (uninfected 
sample). Differentially regulated genes were statistically analysed using the 1-way 
ANOVA t-test, with a p value cut-off set at 0.05, in order to select genes with a 
high level of statistical significance. Differentially regulated genes were grouped 
into KEGG biological pathways using BioScript library 2.2, a plug-in feature of 
the GeneSpring software. The use of KEGG pathways allows for visualisation of 
gene  clusters  that  are  differentially  regulated  as  part  of  various  biological 
pathways. 
 
4.2- An overview of the KEGG biological pathways for 
differentially expressed genes in response to M. tuberculosis 
infection of BMDCs 
Differentially  regulated  genes  were  organised  into  KEGG  biological 
pathways. There were 29 pathways which contained genes being differentially 
regulated in response to M. tuberculosis infection of BMDCs. Each pathway was 
designated a p value, which indicated the level of confidence that the pathway is 
part of the cellular response generated by BMDCs in response to infection. A list 
of the top 10 significant KEGG pathways is displayed in table 4.1 and a more 
complete  list  of  all  the  KEGG  pathways  is  in  Appendix-IV.  In  response  to 
infection,  pathways  which  are  components  of  the  immune  response  (toll-like 
receptor,  hematopoietic  cell  lineage  and  antigen  processing  and  presentation 
pathways),  signal  transduction  (JAK-STAT  signalling  and  cytokine-cytokine 
receptor  interaction  pathways),  cell  adhesion  and  membrane  transport  (cell 
adhesion molecules, ABC transporters) and others (type I diabetes mellitus, type   98 
II diabetes mellitus and adipocytokine signalling pathway) were among the most 
significant biological pathways, which contained genes displaying a change in 
expression in response to M. tuberculosis infection of BMDCs.  
 
 
 
 
 
 
 
Table 4.1 – List of the top 10 significant biological pathways identified from 
microarray analysis of M. tuberculosis infected BMDCs.  
 Genes  which  displayed  differential  regulation  in  response  to  M.  tuberculosis 
infection  were  integrated  within  KEGG  pathways.  The  p  value  indicates  the 
statistical significance; the likelihood of the pathway being part of the cellular 
response generated by BMDCs in response to M. tuberculosis infection 
 
 
 
 
 
 
 
Genes overlapping with Pathways  p-value
 Toll-like receptor signaling pathway  8.68E-12
Jak-STAT signaling pathway 1.17E-10
 Cytokine-cytokine receptor interaction  2.06E-09
 Type I diabetes mellitus 3.44E-06
 Hematopoietic cell lineage  1.14E-04
 Antigen processing and presentation  4.89E-04
Cell adhesion molecules (CAMs) 7.68E-04
Adipocytokine signaling pathway 1.01E-03
 Type II diabetes mellitus 9.52E-03
ABC transporters 1.17E-02  99 
4.3- Transcription patterns of M. tuberculosis infected BMDCs 
In  the  previous  section,  an  overview  of  the  10  most  significantly 
represented  biological  pathways  in  response  to  M.  tuberculosis  infection  was 
highlighted. The following sections examine in detail, patterns of toll-like receptor 
signalling pathway, JAK-STAT and cytokine-cytokine receptor pathway genes as 
these pathways are the 3 most significantly represented pathways identified from 
microarray  analysis  (Table  4.1).  In  addition,  expression  of  phagocytosis  and 
pattern recognition receptors in response to infection was also explored.  
 
 
4.3.1- Gene expression patterns of phagocytosis and pattern recognition 
receptors 
Dendritic  cells  as  sentinels  of  the  immune  system  circulate  in  the 
periphery and use an array of receptors (e.g TLRs) to recognise foreign antigens 
and utilise receptors like the c-type lectin receptors and complement receptors for 
phagocytosis of pathogens. GeneChip profiles of receptor expression involved in 
microbial  pattern  recognition  and  phagocytosis  are  shown  in  figure  4.1.  In 
response  to  infection,  BMDCs  up  regulated  complement  component  1,  s 
subcomponent  (C1s)  and  TLR  2  but  interestingly  phagocytic  receptors  like 
mannose receptor, C type 1 (Mrc1), C1qr1 (CD93) and CD209a (DC-SIGN) were 
down  regulated.  C1qr1  is  a  surface  glycoprotein  which  acts  as  a  phagocytic 
receptor on monocytes. The expression of C1qr1 is down regulated on mature 
human dendritic cells (Steinberger,  Szekeres  et  al. 2002) and furthermore, the 
murine orthologue has been shown to play a role in the clearance of apoptotic 
cells  in vivo (Norsworthy, Fossati-Jimack et al.  2004).  The  binding  of c1q to 
antigen: antibody complex results in the activation of the serine protease, C1s (up-
regulated  by  a  factor  of  3  fold)  which  aids  in  the  initiation  of  the  classical 
complement pathway.    
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Figure 4.1 – Clustering of phagocytic and pattern recognition receptor genes 
differentially regulated in M. tuberculosis infected BMDCs.  
Differentially regulated phagocytic and pattern recognition receptor genes were 
identified  using  the  GCRMA  algorithm  and  normalised  fold  change  values  in 
response  to  M.  tuberculosis  infection  are  displayed  in  the  clustering  diagram. 
Differentially regulated genes have a 1.4 fold change and a p value of £0.05.  
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4.3.2- Gene expression patterns of TLR signalling pathway genes in response 
to M. tuberculosis infection 
Engagement  of  TLRs  results  in  the  induction  of  signalling  pathways, 
which leads to the production of a strong inflammatory response. A number of 
genes differentially regulated in response to M. tuberculosis infection which are 
part of the TLR signalling pathway, also converge with other pathways like the 
JAK-STAT signalling pathway and cytokine receptor interaction pathway. This 
overlap  of  genes  highlights  the  cross  talk  that  takes  place  between  signalling 
pathways, thus adding to the complexity of the analysis of data. In this section, 
only genes which are primarily part of the TLR signalling pathway have been 
clustered and displayed in figure 4.2. Components of the MyD88 independent 
signalling pathway, Tbk1 and Ikbke are significantly up regulated in response to 
infection (up regulated by a factor >1.9 fold). phosphatidylinositol 3-kinase-p85 
alpha (Pik3r1), a negative regulator of the TLR signalling pathway is up regulated 
in response to infection (up regulated by a factor of 2.5 fold), as shown in figure 
4.2. TLR 4 is reported to recognise lipomannan and TLR 2 recognises LAM from 
mycobacterial cell walls (Quesniaux, Nicolle et al. 2004). Although TLR 4 was up 
regulated in response to infection, the fold change was not statistically significant 
and thus was excluded from the final gene list. However, TLR 2 was significantly 
up regulated by 2.3 fold in response to infection as shown in figure 4.2.  
 
 
The up regulation of CD86 (downstream response of the TLR signalling 
pathway) at the mRNA level, (3.5 fold up regulation) is in good agreement with 
increased  CD86  protein  expression  on  the  surface  of  M.  tuberculosis  infected 
BMDCs, (Figure 3.3, B) as measured using flow cytometry.  
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Figure 4.2– Clustering of differentially regulated TLR pathway genes. 
 GeneChip  profiles  of TLR pathway genes  were identified  using the GCRMA 
algorithm and normalised values for fold change in response to M. tuberculosis 
infection of unsorted BMDCs are displayed for each gene. Differentially regulated 
genes have a 1.4 fold change and a p value of £0.05.  
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4.3.3- JAK-STAT signalling pathway genes differentially regulated in M. 
tuberculosis infected BMDCs 
The JAK-STAT signalling pathway has an important role in the control of 
immune responses, as it is a common signalling pathway used by an array of 
cytokines (e.g. IL-4, IFN-g). As shown figure 4.3, differentially regulated genes 
that are part of the JAK-STAT pathway show high induction levels in response to 
infection.  STAT-1,  STAT-2,  STAT-3  and  SOCS  2  all  display  a  fold  change 
greater than 2. Mutations in the STAT 1 gene can enhance patient susceptibility to 
mycobacterial infections and this was attributed to inability to produce or respond 
to IFN-g in vitro (Dupuis, Jouanguy et al. 2003). SOCS are negative regulators of 
the JAK-STAT signalling pathway and in response to mycobacterial infection; 
SOCS 2 was up regulated by a factor of 2 fold. Isgf3g (IRF-9), up regulated by a 
factor of 2.5 fold, is part of the complex comprised of Isgf3g –STAT 1-STAT 2. 
This complex binds to the interferon stimulated response element and initiates 
transcription of type I IFN genes.  
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Figure 4.3 - Clustering of JAK-STAT signalling pathway genes regulated in  
M. tuberculosis infected BMDCs.  
GeneChip profiles for JAK-STAT signalling pathway genes were identified using 
the GCRMA algorithm and normalised values for fold change in response to M. 
tuberculosis infection are displayed for each gene. Differentially regulated genes 
have a 1.4 fold change and a p value of £0.05.  
   105 
 
 
4.3.4 Clustering of cytokine and chemokine genes differentially regulated in 
M. tuberculosis infected BMDCs 
The  induction  of  inflammatory  cytokines  is  a  key  part  of  an  efficient 
immune  response  and  up  regulation  of  chemokines,  aids  in  the  migration  of 
dendritic cells out of the periphery into secondary lymphoid organs, and in the 
recruitment  of  immune  cells  to  the  sites  of  infection.  The  microarray  results 
demonstrate that in response to M. tuberculosis infection, numerous cytokine and 
chemokine genes were differentially regulated. 
 
 
As shown in the clustering diagram (Figure 4.4), inflammatory cytokines 
like IL-6, IL-12b (IL12p40) and TNF-a were up regulated by >6 fold in response 
to M. tuberculosis infection. TNF-a has been reported to play an important role in 
granuloma formation during mycobacterial infections (Roach, Bean et al. 2002) 
and IL-12p40 has been suggested to be involved in dendritic cell migration from 
the lungs to the draining lymph nodes (Khader, Partida-Sanchez et al. 2006). Two 
sub-families of chemokines including the C-C sub family of cytokines (CCL12, 
CCL4) up regulated >5 fold and the CXC family of cytokines (CXCL1, CXCL2, 
CXCL5, CXCL9, CXCL10) were up regulated >2 fold in response to infection. 
The chemokines CXCL9 and CXCL10 are ligands for the receptors CXCR3 and 
are involved in preferentially attracting CXCR3
+ T cells to the site of infection 
(Lande, Giacomini et al. 2003). Tgfbr2 (transforming growth factorb, receptor II), 
the receptor for the cytokine transforming growth factor b was down regulated by 
1.9 fold in response to infection.  
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Figure 4.4 - Clustering of cytokine and chemokine genes regulated in           
M. tuberculosis infected BMDCs.  
Differentially regulated cytokine and chemokine genes were identified using the 
GCRMA  algorithm  and  normalised  fold  change  values  in  response  to  M. 
tuberculosis  infection  are  displayed  in  the  clustering  diagram.  Differentially 
regulated genes have a 1.4 fold change and a p value of £0.05.  
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In  conclusion,  a  range  of  immune  response  and  signal  transduction 
pathways  are  significantly  represented  in  M.  tuberculosis  infected  BMDCs. 
Expression  of  TLR  2  and  cytokines  (TNF,  IL12b)  with  know  roles  in 
mycobacterial infections were significantly up regulated. In contrast, phagocytic 
receptors (Mrc1, CD209a) were down regulated in response to infection as shown 
in figure 4.1. An array of chemokines with roles in attracting immune cells to sites 
of infection e.g. CXCL2, CXCL5, CXCL9 and CXCL10 were highly up regulated 
(>5 fold) in response to infection, as shown in figure 4.4. Additionally, the co-
stimulatory molecule CD86 was up regulated by 3.5 fold in response to infection. 
The differential expression of these genes highlights the roles played by dendritic 
cells as microbial sensors, immune modulators and T cell stimulators.  
 
 
4.4-Validation of microarray results using real time PCR  
Confirmation of microarray data was carried out using real time PCR. Day 
6, unsorted (70±5% CD11c
+) BMDCs were infected with H37Rv (M.O.I 10:1) or 
left  uninfected  (control  sample)  and  24  hours  post-infection,  total  RNA  was 
extracted as described in the materials and methods (Chapter 2, section 2.4.1). 
cDNA was generated from the RNA samples for real time PCR and expression of 
selected genes were measured using the SYBR Green method (Chapter 2, section 
2.5.1). All gene expression values were normalised to an endogenous control gene 
18S rRNA. The relative fold change was calculated as the degree of up regulation 
or  down  regulation  in  the  M.  tuberculosis  infected  sample  relative,  to  the 
uninfected sample.  
 
 
CXCL9 and CXCL10 were the two most highly up regulated genes (up 
regulated by 81 and 91 fold respectively) obtained from the microarray analysis 
and thus their expression was confirmed using real-time PCR. IL-6, IL-10, IL-
12p35, IL-12p40, TNF, TLR 2, TLR 4 and STAT-1 were chosen on the basis of 
their importance during mycobacterial infections (Reiling, Holscher et al. 2002; 
Sugawara, Yamada et al. 2004).    108 
Microarray and real time PCR data are displayed for each of the genes as 
shown  in  figure  4.5.  The  gene  expression  patterns  obtained  using  both 
microarrays and real time PCR displayed the same trend. Although microarray 
represents a useful tool for analysing global gene expression patters, some genes 
fail to be included in the final gene list due to the lack of statistical significance 
(TLR 4, IL-10) or they are detectable only in one experiment (IL12p35). But TLR 
4 and IL-12p35, a sub-component of IL-12p70 (IL-12p35/IL-12p40) involved in 
the  CD4
+  T  cell  response  (Flynn,  Goldstein  et  al.  1995)  play  important  roles 
during mycobacterial infections. TLR4, IL-12p35 and IL-10 were induced at 24 
hours post-infection, as shown in figure 4.5. Additionally, the induction of IL-6, 
TNF, IL-10, IL-12p70 and CXCL10 was quantified using ELISA (Figures 3.4, 
3.5, 3.6 and 4.6). At 24 hours post-infection, increased levels of the cytokines and 
CXCL10  were  detected  at  both  the  mRNA  and  protein  level  M.  tuberculosis 
infected BMDCs compared to uninfected BMDCs.  
 
 
Using real-time PCR, expression of key cytokines, chemokines and TLR 
genes were confirmed. Additionally, gene expression of IL-10, IL-12p35 and TLR 
4 were quantified using real-time PCR, even though the expression of these genes 
was not detected using microarrays.  
 
 
 
 
 
 
 
 
 
 
 
 
 
   109 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 – Quantitative real time PCR and microarray gene expression 
profiles A) cytokines and chemokines B) Toll-like receptors and STAT-1 in 
M. tuberculosis infected BMDCs.  
RNA was extracted from BMDCs 24 hour’s post- infection, converted to cDNA 
and  gene  expression  values  as  indicated  were  measured,  by  SYBR  Green 
incorporation during PCR. For real time PCR, the expression of each gene was 
normalized  to  the  internal  control,  18S  rRNA.  Fold  change  for  each  gene  in 
response to infection was calculated relative to the uninfected sample. Results are 
representative of 2 independent experiments. Fold change obtained using real-
time PCR for each gene was compared with the fold induction values obtained 
using microarray anlaysis.  ND- genes showed no statistically significant change 
in the microarray analysis.  
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Figure 4.6- CXCL10 production by M. tuberculosis infected BMDCs  
 
Day 6 unsorted BMDCs were either left uninfected or infected with H37Rv at a 
M.O.I of 10:1. Supernatants were collected at 24 hours and quantified by ELISA 
for the amount of CXCL10 produced. Data shown are the mean ±SD of duplicate 
determinations  in  one  experiment,  representative  of  three  independent 
experiments.  
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4.5- In silico promoter analysis of differentially expressed genes  
  Transcriptional  regulation  of  genes  is  mediated  by  transcription  factor 
proteins that form protein-DNA or protein-protein interactions. Each transcription 
factor binds to its associated transcription factor binding sites, which are located 
near the gene usually in defined clusters. Using differential expression analysis, it 
was possible to identify transcription factor binding motifs, represented  in the 
promoter of differentially regulated genes identified from the microarray data. The 
identification  of  transcription  factors,  contributed  to  the  identification  of 
signalling  pathways  that  might  be  playing  important  roles,  in  modulating  the 
variation in gene expression observed from the microarray data. 
 
 
  Genes differentially regulated in response to infection (fold change 1.4 and 
a p value £0.05) were analysed using the TELiS  database in order to identify the 
transcription  factor  binding  motifs  that  are  represented  in  the  promoters  of 
differentially regulated genes, as described in materials and methods (chapter 2, 
section  2.6).  Briefly,  the  following  parameters  were  supplied  to  the  TELiS 
database for the identification of transcription factor binding motifs: 
 
·  Sampling frame- Affymetrix Mouse Genome 430-2 array 
·  Gene list- Genes with a fold change ≥ 1.4 and a p value ≤ 0.05  
·  Promoter size-   -1000 to +200 nucleotides 
·  Stringency of analysis- 0.90 
 
The  NFkB  transcription  factor  binding  motif  was  one  of  the  most 
significantly  represented  motifs  as  shown  in  table  4.2.  The  NFkB  family  is 
comprised  of  multiple  subunits  and  binding  motifs  for  NFkB  p65  and 
reticuloendotheliosis  oncogene  (CREL)  were  significantly  represented  in  the 
promoters of genes that were differentially regulated in response to infection. This 
is not surprising, as the NFkB family of transcription factors are considered to be 
central regulators of the both the innate and adaptive immune response. NFkB 
proteins play key roles in dendritic cell development and survival (Ouaaz, Arron 
et al. 2002) and  T cell proliferation (Gerondakis, Grumont et al. 1998).     112 
Interestingly,  in  addition  to  NFkB,  ISRE  binding  motif  was  also 
significantly  represented  in  the  promoters  of  genes  differentially  regulated  in 
response to infection (Table 4.2). ISRE sequences are DNA binding motifs for 
IRFs which are known  to be  important regulators of the type I IFN response 
(Taniguchi, Ogasawara et al. 2001).  
 
 
The other significant binding motif that was represented in the promoters 
was  AP-1,  which  is  a  heterodimer  formed  by  jun  oncogene  (c-jun)  and  FBJ 
osteosarcoma oncogene (c-fos) that plays a key role in the binding to the IFN beta 
promoter along with NFkB and IRF-3/7 and thus plays a role in IFN beta (type I 
IFN) induction (Wathelet, Lin et al. 1998). Other indentified motifs include CEBP 
binding sites, which are specific for CEBP (CCAAT/enhancer binding protein) 
family of transcription factors,  with known functions in cell  proliferation, cell 
cycle  arrest  and  response  to  inflammatory  stimuli  (Lekstrom-Himes  and 
Xanthopoulos  1998),  ecotropic  viral  integration  site  1  (EVI1),  a  transcription 
factor which has a role in cell cycle progression and myeloid differentiation and 
heat  shock factor-1 (Hsf-1)  binding  motifs  which bind the  transcription  factor 
Hsf-1 which is known to play a role in modulating NFkB responses . 
 
 
 In conclusion, IRFs and NFκB appear to be the principal transcription 
factors  mediating  gene  changes  in  response  to  M.  tuberculosis  infection  of 
BMDCs. 
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Transcription factors binding motifs  P- value  Z-test score 
 
ISRE (Interferon stimulated response element) 
 
1.00x10
-10  11.86 
 
NFKB (Nuclear factor kappa B) 
 
1.00x10
-10  5.42 
 
NFKAPPAB65 (Nuclear factor kappa B- p65) 
 
1.48x10
-5  4.33 
 
CEBP_C (C/EBP binding site) 
 
3.86x10
-5  4.12 
 
CREL 
 
2.00x10
-4  3.76 
 
EVI1( Ectopic viral integration site 1 encoded factor) 
 
1.4x10
-3  3.19 
 
AP1_C (AP-1 binding site) 
 
3.70x10
-3  2.91 
 
HSF-1 (Heat shock factor 1) 
  
5.80x10
-3  2.76 
 
 
IRF-2 (Interferon regulatory factor-2) 
 
7.60x10
-3  2.67 
 
                  IRF-1 (Interferon regulatory factor-1) 
 
4.72x10
-2  1.98 
 
Table 4.2- Transcription factor binding motifs represented in M. tuberculosis 
infected BMDCs.  
Significant  transcription  factor  binding  motifs  prevalent  in  the  promoters  of 
differentially  regulated  genes  in  response  to  M.  tuberculosis  infection  was 
identified using the bioinformatic database TELiS. The positive values obtained 
with the Z-test indicate an increased prevalence of the individual transcription 
factor binding motifs and the p value represents the level of significance.  
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4.6- Data mining of type I IFN inducible cluster of genes from 
microarray data 
ISRE  sequences  were  found  to  be  significantly  represented  in  the 
promoters of genes differentially regulated in response to infection, as shown by 
TELiS  analysis.  The  microarray  data  was  used  to  mine  type  I  IFN  inducible 
genes. Genes were identified as being type I IFN inducible using literature based 
evidence  or  if  the  genes  have  ISRE  sequences  in  their  promoter.    The  ISRE 
sequences were detected using the data retrieval function in TELiS which makes it 
possible to identify the prevalence of ISRE motifs in the promoters of the type I 
IFN cluster of genes.  
 
 
There  were  39  genes  mined  from  the  microarray  data  which  could  be 
classified as type I IFN inducible genes (Table 4.3). Identification of this cluster 
of type I IFN inducible genes was unanticipated as type I IFNs are associated with 
mediating anti-viral immunity and only recently, been documented in relation to 
intracellular bacterial infections (Smith, Lombardi et al. 2005).  
 
 
Type I IFN inducible genes identified from the microarrays was clustered 
into  6  groups  (Table  4.3).  Genes  involved  in  anti-viral  immunity  (e.g. 
Isg20,OAS1c,OAS2, Mx2), MHC-I antigen processing and presentation (H2-Q10, 
H2-Q8, H2-T10, H2-T24, Psme2, Tap1) and regulators of transcription (Adar, 
Ell2, Sp100) were all up regulated in response to M. tuberculosis infection. H2-
T24, H2-T10, H2-Q8, H2-Q10 genes were identified by TELiS as having ISRE 
sequences in their promoters.  These genes are predicted to have roles in antigen 
processing and presentation of peptides via MHC-I proteins, thus promoting the 
development  of  CD8
+ T  cell  responses.  MHC-I  synthesis  has  been  previously 
reported in response to type I IFNs (Kuchtey, Chefalo et al. 2005). 
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Table 4.3 – Profiling IFN inducible gene expression levels in M. tuberculosis 
infected BMDCs.  
GeneChip  profiles  for  type  I  IFN  genes  were  calculated  using  the  GCRMA 
algorithm and all genes displayed have a p value≤ 0.05. Fold change indicates the 
degree of differential regulation in response to M. tuberculosis infection (positive 
value  indicates  up-regulation  and  negative  value  indicates  down-regulation). 
Displayed values for each gene is an average of three biological replicates. 
 
 
 
 
 
Affymetrix ID Fold change Common name Description 
1426278_at 6.14 2310061N23Rik interferon, alpha-inducible protein 27
1423555_a_at 90.56 A430056A10Rik interferon-induced protein 44
1418240_at 3.97 Gbp2 guanylate nucleotide binding protein 2
1450783_at 84.62 Ifit1 interferon-induced protein with tetratricopeptide repeats 1
1418293_at 62.53 Ifit2 interferon-induced protein with tetratricopeptide repeats 2
1419569_a_at 32.59 Isg20 interferon-stimulated protein 20
1419676_at 11.78 Mx2 myxovirus (influenza virus) resistance 2 Antiviral immunity
1418686_at 5.48 Oas1c 2'-5' oligoadenylate synthetase 1C
1425065_at 8.00 Oas2 2'-5' oligoadenylate synthetase 2
1424339_at 56.58 Oasl1 2'-5' oligoadenylate synthetase-like 1
1422005_at 5.34 Prkr eukaryotic translation initiation factor 2-alpha kinase 2
1418587_at 1.97 Traf3 Tnf receptor-associated factor 3
1427736_a_at 5.84 Ccrl2 chemokine (C-C motif) receptor-like 2
1418930_at 91.05 Cxcl10 chemokine (C-X-C motif) ligand 10 Cytokines and chemokines
1449497_at 23.95 Il12b interleukin 12b
1417244_a_at 65.58 Irf7 interferon regulatory factor 7
1421322_a_at 2.53 Isgf3g interferon dependent positive acting transcription factor 3 gamma
1420915_at 5.01 Stat1 signal transducer and activator of transcription 1 IRFs and Type I IFN pathway
1421911_at 10.22 Stat2 signal transducer and activator of transcription 2
1426324_at 1.79 H2-Q10 histocompatibility 2, D region locus 1
1430802_at 5.85 H2-Q8 histocompatibility 2, Q region locus 8
1449875_s_at 3.05 H2-T10 histocompatibility 2, T region locus 10 
1422160_at 6.47 H2-T24 histocompatibility 2, T region locus 24
1417189_at 2.03 Psme2 proteasome (prosome, macropain) 28 subunit, beta
Antigen processing and 
presentation via MHC-I
1416016_at 2.90 Tap1 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
1434268_at 2.58 Adar adenosine deaminase, RNA-specific
1450744_at 2.64 Ell2 elongation factor RNA polymerase II 2
1451821_a_at 3.48 Sp100 nuclear antigen Sp100 Regulation of transcription
1425053_at 2.12 2610034N03Rik isochorismatase domain containing 1
1435446_a_at 2.67 Chpt1 choline phosphotransferase 1
1451426_at 11.86 D11Lgp2e DNA segment, Chr 11, Lothar Hennighausen 2, expressed
1417314_at 50.13 H2-Bf histocompatibility 2, complement component factor B
1422433_s_at -1.78 Idh1 isocitrate dehydrogenase 1 (NADP+), soluble Miscellenaeous
1421207_at 2.94 Lif leukemia inhibitory factor
1452178_at 6.04 Plec1 plectin 1
1434015_at 3.30 Slc2a6 solute carrier family 2 (facilitated glucose transporter), member 6
1417961_a_at 8.49 Trim30 tripartite motif protein 30
1421550_a_at 5.98 Trim34 tripartite motif protein 34 
1418191_at 7.15 Usp18 ubiquitin specific peptidase 18  116 
Another cluster includes the cytokines and chemokines (CXCL10, IL12b) 
and  the  type  I  IFN  pathway  genes  (IRF-7,  STAT-1,  STAT-2  and  Isgf3g).  As 
shown in table 4.3, these genes are significantly up regulated in M. tuberculosis 
infected BMDCs. The expression  of STAT-1, CXCL10 and IL-12b  (IL12p40) 
was verified using real time PCR, as shown previously in figure 4.5.  
 
 
From the list of genes, it is evident that an array of type I IFN pathway 
genes are highly up regulated (Table 4.3). A cartoon representation of the type I 
IFN  pathway  and  the  genes exhibiting  differential  regulation are  illustrated  in 
figure 4.7. The expression of IFN beta, IFN alpha, IRF-3 and type I IFN receptors 
(IFNAR1 and IFNAR2) were not significantly represented in the microarray data 
and thus not represented in figure 4.7.   
 
 
Thus, the significant up regulation of type I IFN inducible genes in M. 
tuberculosis  infected  BMDCs,  strongly  indicates  induction  of  the  type  I  IFN 
pathway as part of the cellular response of BMDCs in response to infection.  
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Figure 4.7 – Schematic representation of the type I IFN pathway depicting 
expression of type I IFN pathway genes induced in M. tuberculosis infected 
BMDCs  
Expression of type I IFN pathway genes were extracted from microarray 
data. All the genes displayed have a fold change of ³ 1.4 and a p value of 
£0.05.  
           - Up regulated genes 
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4.7-Validation of selected type I IFN pathway genes using real 
time PCR  
Real time PCR was used for the validation of type I IFN pathway gene 
expression,  in  response  to  M.  tuberculosis  infection  of  BMDCs.  IFNAR1, 
IFNAR2, IFN beta and IRF-3 were not significantly represented in the microarray 
data and hence the expression of these genes was quantified using real time PCR. 
The expression of IRF-7 was confirmed using real time PCR because IRF-7 is 
considered to be a “master regulator” of the type I IFN response induced during 
viral  infections  (Honda,  Yanai  et  al.  2005)  and  IRF-7  was  additionally,  up 
regulated during M. tuberculosis infection of BMDCs (Table 4.3).  
 
 
To  extend  the  gene  expression  analysis,  day  6  unsorted  BMDCs  were 
either left uninfected or infected with H37Rv at a M.O.I of 10:1 and RNA was 
isolated at 4 and 24 hours post infection. Using cDNA generated from 4 hours and 
24  hours  post-infection,  it  was  possible  to  quantitatively  assess  the  gene 
expression across two different time points. The time point 4 hours was chosen to 
represent an early time point of interferon beta induction (Remoli, Giacomini et 
al. 2002) and 24 hours correlated with the time point of microarray analysis.  
 
 
The expression of IFNAR1, IFN beta, IRF-3 and IRF-7 was detected at 24 
hours, in response to M. tuberculosis infection and in addition, the expression of 
IFNAR1, IFNAR2 and IRF-3 was down regulated at 4 hours in response to M. 
tuberculosis  infection  (Figure  4.8).  Nevertheless,  the  expression  IFN  beta  and 
IRF-7 increased over a period of time as shown in figure 4.8.  
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Figure 4.8 – Time course analysis of selected type I IFN pathway genes  
RNA  was  extracted  from  unsorted  BMDCs  at  4  hours  and  24  hours  post- 
infection, converted to cDNA and real-time PCR was performed using the SYBR 
green detection method. Each gene was normalised to the internal control 18S 
rRNA.  Fold  induction  of  each  gene,  in  response  to  infection,  was  calculated 
relative to its normalised value in the uninfected sample. Data is representative of 
2 independent experiments.  
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4.8- Quantifying IFN beta levels in M. tuberculosis infected 
BMDCs 
  IFN beta is one of the type I IFNs and is a by-product of the type I IFN 
pathway. This cytokine also plays a key role in the induction of the feedback loop 
mechanism, leading to the amplification of type I IFN responses (Stark, Kerr et al. 
1998). Day 6  unsorted BMDCs, were  either stimulated with LPS (1mg/ml) or 
infected with H37Rv at a M.O.I of 10:1 and at various time points post-infection 
supernatants  were  collected  and  the  amount  of  IFN  beta  was  measured  using 
ELISA. 
 
 
  As shown in figure 4.9, IFN beta is secreted from BMDCs in response to 
M. tuberculosis infection, albeit at lower levels compared  to LPS stimulation, 
between 6-72 hours. The amount of IFN beta produced in response to infection 
peaks at 24 hours (60 ±7.3 pg/ml) and then slightly decreases at later time points 
post-infection, whereas the production of IFN beta was detected as early as 6 
hours (545 ±1.3 pg/ml) in response to LPS stimulation. In contrast, significant 
production  of  IFN  beta  was  not  detected  until  24  hours,  in  response  to  M. 
tuberculosis infection.   
 
 
 
  At  24  hours  post-infection,  there  is  a  clear  correlation  between  the 
secretion of IFN beta (Figure 4.9) and up regulation of its transcript (Figure 4.8).  
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Figure  4.9  –  Quantifying  IFN  beta  secretion  in  the  supernatants  of  M. 
tuberculosis infected BMDCs 
BMDCs  were  cultured  in  vitro  and  day  6  unsorted  cells  were  either  left 
uninfected,  stimulated  with  LPS  or  infected  with  H37Rv  at  a  M.O.I  of  10:1. 
Supernatants  were  collected  at  various  time  points  post-infection  for  the 
quantification  of  IFN  beta  using  ELISA.  Results  are  the  mean  of  ±SE  of  3 
independent  experiments.  Statistical  analysis  was  preformed  between  M. 
tuberculosis infected group and uninfected group with the Student’s t-test, *- p 
value <0.05.  
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4.9- RT profiler PCR expression profiles of type I IFN inducible 
genes in CD11c sorted BMDCs 
To extend the analysis and obtain a more comprehensive list of type I IFN 
inducible genes, real time PCR was carried out as described in the materials and 
methods  (section  2.5.2),  using  the  RT  profiler  PCR  array  on  a  population  of 
dendritic cells that was 95± 3% CD11c
+. This process also allowed for further 
validation of the type I IFN inducible genes in a sorted population of dendritic 
cells, thus excluding the possible influence of contaminating cell types.  
 
4.9.1- Expression of type I IFN inducible genes in M. tuberculosis infected 
BMDCs (CD11c sorted) 
BMDCs  were  sorted  using  CD11c  magnetic  beads  and  either  left 
uninfected or H37Rv infected at a M.O.I of 10:1. RNA was isolated 24 hours 
post-infection  and  real  time  PCR  was  carried  out  the  SYBR  green  method 
utilising the RT  profiler PCR array system. All  genes were normalised  to the 
house keeping gene, GAPDH.  
 
IFN  inducible  genes  were  divided  into  4  gene  clusters  and  the  gene 
expression  profiles  are  displayed  in  figures  4.10  and  4.11.  Interferons  and 
interferon  related  genes  (Figure  4.10)  were  up  regulated  in  response  to  M. 
tuberculosis  infection.  Exceptions  to  this  statement  include  IL-4,  IFN  alpha  7 
(Ifna7) and IFN alpha 11 (Ifna11), which were down regulated in response to 
infection. Multiple sub-types of IFN-alpha (ifna2, ifna4, ifna9) were up regulated 
in response to infection but this cytokine was not detected in the supernatants of 
infected BMDCs using ELISA. The role of all the different IFN alpha sub-types in 
dendritic cells is not yet fully understood. However, IFNa2 is known to induce 
CXCL9  and  CXCL10  production  from  monocyte  derived  dendritic  cells 
(Padovan, Spagnoli et al. 2002). Both of these chemokines were significantly up 
regulated in response to M. tuberculosis infection in BMDCs (Figure 4.4).   123 
 
Figure 4.10- Real-time PCR expression profiles of IFN genes in M. 
tuberculosis infected BMDCs.  
RNA was isolated from CD11c sorted uninfected BMDCS and M. tuberculosis 
infected BMDCs, converted to cDNA and real-time PCR was performed using RT 
profiler PCR array. Expression of individual interferon genes were normalised to 
the  house  keeping  gene  GAPDH.  Fold  change  of  a  gene  in  response  to  M. 
tuberculosis infection relative to the uninfected sample is displayed. Genes were 
grouped into functional clusters:          Group 1- type I Interferons,            
Group 2- Interferon related genes 
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The expression of interferon regulatory factor family (group 3) and IFN 
inducible genes (group 4) were also assayed and most of the genes from these 
clusters were up regulated in  response to  infection. Cellular immune response 
genes Ifit1, Ifit2 and G1p2 are significantly up regulated in response to infection. 
All the assayed IRFs were up regulated in response to infection with the exception 
of IRF-2 and IRF2bp2. IRF-2, described as a negative regulator of many type I 
IFN  responsive  genes  is  down  regulated  in  response  to  infection.  The  co-
repressors of IRF-2: Irf2bp1 and Irf2bp2 show contrasting levels of expression. It 
has  been  demonstrated  that  binding  of  Irf2bp1  (up  regulated  by  1.08  fold)  is 
sufficient for minimal IRF-2 repression (Childs and Goodbourn 2003).    
 
 
Quantification  of  type  I  IFN  inducible  genes  using  real-time  PCR  in 
CD11c sorted BMDCs, also made it possible to confirm the microarray analysis 
carried  out using unsorted BMDCs  (Figure 4.12).  This provided an  additional 
level of confirmation, of the IFN signature, that is observed in response to M. 
tuberculosis infection.  Gene expression data obtained for CXCL10, Ifi44, Ifit1, 
Ifit2, IL12b (IL12p40) and IRF-7 was similar from both microarray analysis and 
real-time PCR (from CD11c sorted BMDCs). Although, the fold change values 
obtained using microarrays were much higher than that obtained using real time 
PCR (Figure 4.12).  
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Figure 4.11- Real time PCR expression profiles of IFN induced genes in       
M. tuberculosis infected BMDCs.  
RNA was isolated from CD11c sorted uninfected BMDCS and M. tuberculosis 
infected BMDCs, converted to cDNA and real-time PCR was performed using RT 
profiler  PCR  array.  Expression  levels  of  individual  interferon  genes  were 
normalised to the house keeping gene GAPDH. Fold change of a gene in response 
to M. tuberculosis infection relative to the uninfected sample is displayed. Genes 
were  grouped  into  functional  clusters:      Group  3-  Interferon  regulatory 
factors,    Group 4- Interferon inducible genes.   126 
 
 
Figure 4.12 – Quantitative real-time PCR and microarray gene expression 
profiles of M. tuberculosis infected BMDCs.  
RNA  was  extracted  from  CD11c  sorted  BMDCs  24  hour’s  post-  infection, 
converted to cDNA and gene expression values as indicated were measured, by 
SYBR Green incorporation during PCR. For real time PCR, the expression of 
each gene was normalized to the internal control, GAPDH. Results obtained using 
real  time  PCR  for  each  gene  was  compared  with  the  fold  induction  values 
obtained using microarray analysis.   
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4.10- Discussion 
Using high density oligonucleotide arrays, genes differentially expressed 
in response to M. tuberculosis infection of BMDCs, were identified. This global 
approach identified 522 genes that were up regulated and 163 genes which were 
down  regulated  in  M.  tuberculosis  infected  BMDCs.  A  complete  list  of  the 
differentially regulated genes, in response to M. tuberculosis infection, is listed in 
Appendix- VII. These differentially regulated genes were, in large part, related to 
regulation of immune responses, signal transduction, cell adhesion and membrane 
transport. Specifically, the TLR signalling, JAK-STAT signalling and cytokine-
cytokine  receptor  interaction  pathways,  were  among  the  most  significantly 
represented cellular response pathways in M. tuberculosis infected BMDCs.  
 
Gene  expression  profiling  revealed  that  BMDCs  down  regulated 
phagocytic receptors (mannose receptor and CD209a). CD209a is reported to be 
involved in the recognition of ManLAM from virulent mycobacteria leading to 
the increased production of IL-10. Thus, it is believed that engagement of this 
receptor could result in interfering with dendritic cell based host immune response 
thus enhancing the survival of the pathogen (van Kooyk and Geijtenbeek 2003). It 
seems contradictory that dendritic cells, which are efficient in taking up antigens, 
would down regulate phagocytic receptors and thus their phagocytic capacity in 
response  to  a  pathogen  like  M.  tuberculosis.  This  phenomenon  is  possibly 
explained by the fact, that when dendritic cells are activated by TLR ligands, there 
is a short burst in the uptake of antigens, which is followed by a long term down 
regulation of endocytic capacity, which coincides with maturation of dendritic 
cells (West, Wallin et al. 2004). Activated dendritic cells become efficient antigen 
presenting cells as opposed to effective phagocytic cells. 
 
 M. tuberculosis infection of BMDCs induced the expression of a large 
number of cytokine and chemokine genes. CXCL9 (up regulated 81.27 fold) and 
CXCL10 (up regulated 91.05 fold) are ligands for the receptor CXCR3 and are 
involved  in  preferentially  attracting  CXCR3
+  T  cells  to  the  site  of  infection 
(Lande,  Giacomini  et  al.  2003).  It  has  been  previously  shown  that  CXCL5, 
CXCL2 and CCL4 were more prominent in the lungs of mice challenged with M. 
bovis PPD beads. It is possible that secretion of chemokines CXCL2 (up regulated   128 
by 5.4 fold) and CXCL5 (up regulated by 11.9 fold), which are known neutrophil 
chemoattractants, preferentially attract neutrophils to the site of infection (Chiu, 
Freeman et al. 2004). 
 
Mature dendritic cells up regulate co-stimulatory molecules Tnfrsf5 (up 
regulated 12.5 fold) and CD86 (up regulated 3.5 fold), thus performing a critical 
role of providing co-stimulatory signals for the activation of T cells. Induction of 
inflammatory  cytokines,  like  TNF-α  (up  regulated  6.4  fold)  required  for  the 
integrity of the granuloma during mycobacterial infection and IL-12 (up regulated 
by a factor of 23.95 fold), which has been associated with the development of host 
Th-1 immunity and production of IFN-γ, represents a key part of the host immune 
response to M. tuberculosis infection. The up regulation of cytokines has also 
been  substantiated  at  the  protein  level.  In  response  to  infection,  there  was 
increased production of both IL-12 and TNF-a at the protein level by BMDCs 
(Figures 3.4 and 3.6). The down regulation of phagocytic receptors and increased 
inflammatory cytokine production (both at the mRNA and protein levels), implies 
that  BMDCs  are  activated  in  response  to  infection.    This  is  accordance  with 
previous reports that demonstrate activation of human dendritic cells in response 
to M. tuberculosis infection (Henderson, Watkins et al. 1997). 
 
 To extend the microarray analysis, a bioinformatics approach was used 
(TELiS),  to  identify  the  transcription  factors  regulating  the  changes  in  gene 
expression profiles. Binding motifs members of the NFκB family of transcription 
factors  (NFκB  p65,  CREL),  one  of  the  most  well  documented  transcription 
factors, which plays multiple roles in innate immune responses were significantly 
over represented in the promoters. TELiS also identified the transcription factor 
binding  motif  ISRE,  which  is  a  DNA  binding  motif  for  the  IRF  family  of 
transcription factors. IRFs are known to have a principal role in the induction of 
type  I  IFN  genes  (Honda  and  Taniguchi  2006).  Significant  representation  of 
NFκB and IRF binding motifs, suggests that these two transcription factors play a 
key role in regulating gene expression in M. tuberculosis infected BMDCs.  
 
Since  it  was  demonstrated  that  IRF  binding  sites  were  significantly 
represented in the promoters of differentially regulated genes, this was used as the   129 
basis for the subsequent mining of type I IFN inducible genes from the microarray 
data. The function of type I IFNs has been well documented during viral infection 
but  increasingly  it  has  become  clear  that  type I  IFNs  play  a  role  in  bacterial 
infections  (Stetson  and  Medzhitov  2006).  M.  tuberculosis  infection  of  human 
dendritic cells resulted in induction of early IFN beta production followed by a 
delayed IFN alpha production (Remoli, Giacomini et al. 2002). An array of type I 
IFN inducible genes and genes which are components of the type I IFN pathway 
including IRF-7, STAT-1, STAT-2 and Isgf3g, were significantly up regulated in 
response to M. tuberculosis infection of BMDCs. IRF-7, known as the “master 
regulator  of  the  type  I  IFN  response”  (Honda,  Yanai  et  al.  2005)  and  the 
components  of  the  ISGF3  complex  (STAT-1,  STAT-2,  Isgf3g)  which  is 
responsible for  initiating  the  transcription  of  IFN  inducible  genes  were  all  up 
regulated in M. tuberculosis infected BMDCs.  
 
Although the expression of IFN alpha and IFN beta was confirmed using 
real time PCR (Figure 4.10) in M. tuberculosis infected BMDCs, only IFN beta 
was  detected  at  the  protein  level  with  maximum  production  at  24  hours  post 
infection (Figure 4.9). The differential expression of IFNAR possibly represents a 
mechanism by which dendritic cells modulate their responsiveness to different 
sub-type  of  type  I  IFNs  (Severa,  Remoli  et  al.  2006).  The  observed  down 
regulation of these receptors at early time points is linked with their maturation 
status, as it has been previously that LPS matured human dendritic cells, down 
regulate  IFNAR1  and  IFNAR2  as  early  as  4  hours  post-stimulation  (Gauzzi, 
Canini et al. 2002).  
 
Similarly, the effect of down regulation of IRF-3 at 4 hours post-infection 
and then the up regulation at 24 hours  (Figure 4.8) on dendritic cell responses in 
unclear. IRF-3 is thought to be mainly responsible for the initial induction of the 
IFN beta gene, whereas IRF-7 is involved in the late phase of IFN induction. In 
this study, down regulation of IRF-3 at 4 hours post-infection has no effect on the 
induction  of  IFN  beta,  which  is  up  regulated  by  4  hours  in  M.  tuberculosis, 
infected BMDCs (Figure 4.8).  
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The  role  of  type  I  IFNs  during  mycobacterial  infection  remains 
unresolved.  Previous  studies  have  shown  that  hypervirulent,  Beijing  strains  of 
mycobacteria, produce high levels of type I IFNs, which was associated with the 
failure to stimulate Th-1 type immunity (Manca, Tsenova et al. 2001). It has also 
been demonstrated that, IFN (alpha and beta) receptor knock-out mice have less 
bacterial loads in the spleens compared to wild-type mice and thus, type I IFNs 
was  suggested  to  have  a  role  in  promoting  mycobacterial  growth  (Stanley, 
Johndrow et al. 2007). In contrast, other studies have shown that type I IFNs may 
facilitate a protective inflammatory response as it is required for the expression of 
CXCL10, a known activator of NK and T cell recruitment (Lande, Giacomini et 
al. 2003). The up regulation of an array of type I IFN inducible genes in this 
study, strongly indicates the induction of the type I IFN pathway, as an integral 
part of the dendritic cell based response to M. tuberculosis.  
 
Neutrophil  specific  genes  including  neutrophil  elastase  2, 
myeloperoxidase, neutrophil specific defensin and neutrophil cytosolic factor 2 
showed no significant change in expression in the microarray dataset in response 
to M. tuberculosis infection. In addition, key observations with the type I IFN 
family of genes were confirmed using CD11c
+ sorted cells and thus it can be 
concluded,  that  the  observed  gene  expression  changes  are  a  consequence  of 
dendritic cell based responses to M. tuberculosis infection. 
 
In figure 4.13, a summary of the key responses of M. tuberculosis infected 
BMDCs is illustrated. As shown by microarray, real time PCR and bioinformatic 
analysis,  the  type  I  IFN  pathway  and  IFN  inducible  genes  were  significantly 
induced  by  BMDCs  in  response  to  infection.  Overall,  the  transcriptome  of 
dendritic  cells  reveal  a  shift  towards  and  inflammation  and  immune  related 
functions in response to M. tuberculosis infection.     
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Figure 4.13- Overall schematics of differentially expressed immune response 
and signal transduction genes in response to M. tuberculosis infection (24 
hours post-infection) 
 
 Data was mined from microarray and real-time PCR data.  
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Profiling transcriptional responses of M. tuberculosis infected 
MyD88
-/- BMDCs 
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5.1- Introduction 
 In response to M. tuberculosis infection, an array of different signalling 
pathways which incorporated TLR signalling pathway and type I IFN pathway 
were  differentially  regulated  (as  described  in  chapter  4).  Most  TLRs  signal 
through MyD88, a critical adaptor in the TLR signalling pathway but TLR4 is 
also able to signal via a MyD88 independent pathway utilising additional adaptors 
TRAM and TRIF.  In addition, LPS stimulation of MyD88 deficient macrophages 
has identified a number of IFN inducible genes like IP-10 and GARG16 which are 
induced  in  a  MyD88  independent  manner  (Kawai,  Takeuchi  et al.  2001).  We 
hypothesised that M. tuberculosis infection could similarly induce the production 
of type I IFNs and IFN inducible genes independent of MyD88 in dendritic cells.  
 
  To test the hypothesis, microarrays were used to analyse the expression of 
genes that were differentially induced in response to M. tuberculosis infection of 
MyD88
-/-  BMDCs.  MyD88
-/-  mice  possess  a  disrupted  MyD88  gene  (Adachi, 
Kawai et al. 1998). Bone marrow from these mice was used as the source of 
dendritic  cells,  to  study  the  MyD88  independent  induction  of  type  I  IFNs,  in 
response to M. tuberculosis infection. Day 6 unsorted MyD88
-/- BMDCs were 
infected with H37Rv (M.O.I 10:1) and  24 hours later, RNA  was  extracted as 
described  in  the  material  and  methods  (section  2.4.1).  The  uninfected  BMDC 
group served as the control for the experiments. The analysis of the microarray 
data  was  carried out as previously described for  the  analysis  of the wild-type 
BMDCs microarray data (chapter 4, section 4.1).  
 
In this chapter, expression of co-stimulatory molecules and production of 
inflammatory  cytokines  by  MyD88
-/-  BMDCs  in  response  to  infection  are 
described  first,  followed  by  the  gene  expression  profiles  of  M.  tuberculosis 
infected MyD88
-/- BMDCs, as determined by microarray analysis.    
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5.2- Expression of co-stimulatory molecules and MHC-II by 
MyD88
-/- BMDCs in response to M. tuberculosis infection 
  BMDCs were generated in the presence of GM-CSF as described in the 
materials and methods (section 2.3.1). BMDCs were gated on FSC vs SSC and 
were 68 ±6% CD11c
+.  As shown in figure 5.1, BMDCs generated from MyD88
-/- 
mice expressed 74.42 ±4% CD80, 36.54 ±4% CD86 and 10.50 ±3% MHC-II in 
the absence of microbial stimulation. Two populations of BMDCs are observed at 
day 6, the first population which is CD80
low CD86
low and the second population 
which is CD80 
mid/high CD86 
mid/high ,as depicted in the histograms (Figures 5.1, A 
and  B).  The  basal  expression  of  MHC-II  was  lower  in  MyD88
-/-  BMDCs 
compared to  wild-type  mice (Figure 5.1  and Figure 3.1). Thus, BMDCs from 
MyD88
-/- mice displayed an immature phenotype, with low expression levels of 
co-stimulatory and MHC-II molecules.  
 
  In order to determine whether these immature dendritic cells are capable of 
being  activated  in  response  to  M.  tuberculosis  infection,  day  6  BMDCs  were 
either left uninfected (negative control), stimulated with LPS (positive control) or 
infected  with  H37Rv  (M.O.I  10:1)  and  24  hours  later,  the  up  regulation  of 
activation markers was measured using flow cytometry. In response to infection 
BMDCs up regulated the expression of CD80 to 83.09 ±1.76%, CD86 to 81.12 
±1.71% and MHC-II to 74.15 ±11.4% and a similar degree of up regulation was 
observed in response to LPS stimulation (Figure 5.2, A, B and C). The expression 
of CD80, CD86 and MHC-II observed in MyD88
-/- BMDCs was similar to wild-
type BMDCs in response to M. tuberculosis infection (Figure 5.2, A, B, C and 
Figure 3.3, A, B, C).  
 
 
  Hence,  MyD88
-/-  dendritic  cells  are  activated  in  response  to  M. 
tuberculosis infection, with the degree of activation similar to that observed in 
wild-type BMDCs.  
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Figure 5.1- Expression of CD80, CD86 and MHC-II on MyD88
-/- BMDCs 
  BMDCs were generated from MyD88
-/- bone marrow cells by culturing in 
medium containing GM-CSF for 6 days. The expression of A) CD11c CD80 B) 
CD11c CD86 and C) CD11c MHC-II were analysed using flow cytometry. Data 
is representative of 3 independent experiments.  
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Figure 5.2- Up regulation of co-stimulatory and MHC-II by MyD88
-/- 
BMDCs in response to M. tuberculosis infection. 
Day 6 BMDCs were either LPS stimulated (1mg/ml), infected with H37Rv (M.O.I 
10:1) or left uninfected and the expression of A) CD80 B) CD86 and C)MHC-II 
were assessed 24 hours later, using flow cytometry. The gray filled histograms 
represent  isotype  control  staining.  Data  is  representative  of  3  independent 
experiments.  
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5.3- Analysis of inflammatory cytokine production by MyD88
-/- 
BMDCs in response to M. tuberculosis infection 
In order to evaluate the production of inflammatory cytokines by MyD88
-/- 
BMDCs in response to M. tuberculosis infection, day 6 BMDCs were uninfected, 
stimulated  with  LPS  (positive  control)  or  infected  with  H37Rv  10:1  and 
supernatants were collected at various time points post-infection (6-72 hours).  
 
 
5.3.1- Impaired production of TNF-a a a a and IL-6 by MyD88
-/- M. tuberculosis 
infected BMDCs 
M.  tuberculosis  infection  of  MyD88
-/-  BMDCs  induced  production  of 
cytokines  (IL-6  and  TNF-a)  as  shown  in  figure  5.3.  However,  cytokine 
production was severely impaired in response to infection of MyD88
-/- BMDCs in 
comparison  to  wild-type  BMDCs  (Figure  3.4).  TNF-a  production  by  M. 
tuberculosis  infected  MyD88
-/-  BMDCs  increased  over  time  and  subsequently 
decreased  by  72  hours  post  infection  (Figure  5.3,  A).  A  similar  trend  was 
observed  for  IL-6  production,  in  response  to  infection  and  LPS  stimulation 
(Figure 5.3, B). Uninfected MyD88
-/- BMDCs produced negligible amounts of 
TNF-a and IL-6. 
 
 
Interestingly, the production of TNF-a and IL-6 was delayed in MyD88
-/- 
BMDCs with a maximum production at 48 hours post-infection (Figure 5.3); in 
comparison, production of these cytokines from wild-type BMDCs were detected 
by 6 hours, in response to M. tuberculosis infection (Figure 3.4). In addition, at all 
the time points examined there was considerably higher production of TNF-a and 
IL-6  by  wild-type  BMDCs  infected  with  M.  tuberculosis  in  comparison  to 
MyD88
-/- BMDCs (Figures 3.4 and 5.3).   
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Figure  5.3-  Production  of  TNF-a a a a  and  IL-6  in  response  to  M.  tuberculosis 
infection of MyD88
-/- BMDCs.  
Day 6 unsorted BMDCs were either left uninfected, stimulated with LPS (1mg/ml) 
or infected with H37Rv (M.O.I 10:1) and the production of A) TNF-a and  B) IL-
6 was measured using ELISA. Results are the mean of ±SE of 3 independent 
experiments. 
 
 
A) 
B) 
0
0.5
1
1.5
6 24 48 72
Hours
I
L
-
6
 
n
g
/
m
l
Uninfected
LPS
H37Rv 
0
1
2
3
4
6 24 48 72
Hours
T
N
F
 
a
l
p
h
a
 
n
g
/
m
l
Uninfected
LPS
H37Rv   139 
0
1
2
3
4
5
6 24 48 72
Hours
I
L
-
1
2
p
4
0
 
n
g
/
m
l
Uninfected
LPS
H37Rv 
5.3.2- Production of IL-12p40 by MyD88
-/- M. tuberculosis infected BMDCs 
IL-12p40 was produced by 24 hours in response to infection of MyD88
-/- 
BMDCs and increased over the course of the experiment. But in the presence of 
LPS,  IL-12p40  was  produced  steadily  between  6-48  hours,  with  decreased 
production at later time points (72 hours) as shown in figure 5.4. In addition, the 
production of IL-12p40 by uninfected BMDCs also increased over the course of 
the experiment.  
 
In contrast, wild-type BMDCs produced at least 3.2 fold higher IL-12p40 
in comparison to MyD88
-/- BMDCs at 24 hours post infection.  In general, the 
production of IL-12p40 by MyD88
-/- BMDCs followed a similar trend to that of 
the wild-type, although the level of IL-12p40 produced by wild-type BMDCs was 
higher than MyD88
-/- BMDCs at all  the  time points examined, in response to 
infection (Figure 5.4 and Figure 3.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4- Production of IL-12p40 in response to M. tuberculosis infection of 
MyD88
-/- BMDCs.  
Day 6 unsorted BMDCs were either left uninfected, stimulated with LPS (1mg/ml) 
or  infected  with  H37Rv  (M.O.I  10:1)  and  the  production  of  IL-12p40  was 
measured  using  ELISA.  Results  are  the  mean  of  ±SE  of  3  independent 
experiments.   140 
5.3.3- Absence of IL-12p70 and IL-10 production by M. tuberculosis 
infected MyD88
-/-BMDCs 
No measurable levels of IL-12p70 and IL-10 were detected in MyD88
-/- 
BMDCs in response to M. tuberculosis infection or stimulation with LPS. This is 
in contrast to wild-type BMDCs which produced IL-12p70 and IL-10 in response 
to M. tuberculosis infection (Figures 3.5 and 3.6, A).  
 
 
In  conclusion,  MyD88
-/-  BMDCs  are  impaired  in  their  production  of 
cytokines. Furthermore, the secretion of TNF-a and IL-6 was delayed, with a 
complete  absence of IL-12p70 and IL-10 production by  MyD88
-/-  BMDCs, in 
response to M. tuberculosis infection.  
 
5.4- An overview of the KEGG biological pathways represented in 
M. tuberculosis infected MyD88
-/- BMDCs 
  In  response to infection, 33 pathways were significantly  represented in 
MyD88
-/- BMDCS as identified from the microarray analysis. The top ten most 
significant pathways are listed in table 5.1. A more complete list of the highly 
represented  KEGG  pathways  is  listed  in  Appendix-V.  Interestingly,  the  JAK-
STAT  signalling  pathway,  cytokine-cytokine  receptor  interaction  and  TLR 
signalling pathways were the most significantly represented in MyD88
-/- BMDCs 
in response to infection (Table 5.1), which is similar to the KEGG pathway data 
obtained from wild-type BMDCs in response to infection (Table 4.1).  
 
  In M. tuberculosis infected MyD88
-/- BMDCs, biological pathways which 
are  part  of  the  immune  response  (B-cell  receptor  signalling  pathway,  T  cell 
receptor  signalling  pathway,  complement  and  coagulation  cascades,  leukocyte 
transendothelial  migration),  cell  adhesion  (focal  adhesion)  and  other  pathways 
(cell cycle, apoptosis) were highly represented (Table 5.1).  
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Table 5.1 – List of the top 10 significant biological pathways identified from 
microarray analysis of M. tuberculosis infected MyD88
-/- BMDCs.   
Genes  which  displayed  differential  regulation  in  response  to  M.  tuberculosis 
infection  were  integrated  within  KEGG  pathways.  The  p  value  indicates  the 
statistical significance; the likelihood of the pathway being part of the cellular 
response generated by MyD88
-/- BMDCs in response to M. tuberculosis infection. 
 
 
 
 
 
 
 
 
5.5- Gene expression profiles of M. tuberculosis infected MyD88
-/- 
BMDCs 
  From  the  list  of  KEGG  biological  pathways  (Table  5.1),  the  3  most 
significantly represented pathways (JAK-STAT pathway, TLR signalling pathway 
and cytokine- cytokine receptor interaction pathway) and phagocytic and pattern 
recognition receptors are described in more detail in the following sections. In the 
following sections, fold change of genes identified as having a significant change 
in expression  denotes that the fold change  is statistically significant,  with a p 
value of £0.05.   
KEGG pathways  p-value
 Jak-STAT signaling pathway 6.52E-11
Cytokine-cytokine receptor interaction 1.02E-09
Toll-like receptor signaling pathway  7.45E-09
B cell receptor signaling pathway  1.97E-06
T cell receptor signaling pathway 1.05E-05
Complement and coagulation cascades 4.31E-05
 Focal adhesion  1.32E-04
Leukocyte transendothelial migration 2.94E-04
 Cell cycle  3.27E-04
Apoptosis  4.93E-04  142 
 
5.5.1- Differential expression of phagocytosis and pattern recognition 
receptors in M. tuberculosis infected MyD88
-/- BMDCs 
  In response to infection, components of the classical complement pathway 
(c1qa, c1qg, c1qb) and Fcg receptors (Fcgr1, Fcgr2 and Fcgr3) were significantly 
down regulated in MyD88
-/- BMDCs (Table 5.2, A). In contrast, C1qbp, which is 
involved in generating the first component of the serum complement system, is up 
regulated by a factor of 3.7 fold in response to infection of MyD88
-/- BMDCs. The 
pattern recognition receptors (TLR1, TLR6 and TLR7) were also down regulated 
in MyD88
-/- BMDCs in response to infection (Table 5.2, A). In comparison, these 
genes did not show a statistically significant change in expression, in wild-type 
BMDCs, in response to infection. 
 
  Nevertheless, phagocytic receptors (c1qr1 and mrc1) were down regulated 
in both wild-type and MyD88 deficient BMDCs by a factor of 3 fold or more, in 
response to infection (Table 5.2, B). Of interest, was the differential regulation of 
TLR2.  TLR2 was up regulated by a factor of 2 fold in response to infection in 
wild-type BMDCs but down regulated by a factor of 5.6 fold in MyD88
-/- BMDCs 
(Table 5.2, B).  
 
The down regulation of TLR2 (Table 5.2, B) on MyD88
-/- BMDCs was in 
response to M. tuberculosis infection and does not correlate with the difference in 
expression on uninfected BMDCs (Figure 5.5). Furthermore, the basal expression 
of TLR2 was marginally higher in MyD88
-/- uninfected BMDCs (Figure 5.5). 
 
In response to M. tuberculosis infection, MyD88 deficient BMDCs down 
regulate phagocytic receptors, which correlate with the down regulation of antigen 
uptake, as dendritic cells mature.  
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Table 5.2-  Gene expression profiles of pattern  recognition  and  phagocytic 
receptors A) significantly, differentially expressed in M. tuberculosis infected 
MyD88
-/- BMDCs  B) significantly, differentially expressed in both wild-type 
and MyD88
-/- BMDCs in response to infection.  
 
Differentially regulated phagocytic and pattern recognition receptor genes were 
identified  using  the  GCRMA  algorithm  and  normalised  fold  change  values  in 
response to M. tuberculosis infection, are displayed. Differentially regulated genes 
have a 1.4 fold change and a p value of £0.05. 
 
 
 
Affymterix Id Common name Description Fold change
1417381_at C1qa complement component 1, q subcomponent, alpha polypeptide -180.83
1448274_at C1qbp complement component 1, q subcomponent binding protein 3.72
1417063_at C1qb complement component 1, q subcomponent, beta polypeptide -751.88
1449401_at C1qg complement component 1, q subcomponent, gamma polypeptide -353.36
1419482_at C3ar1 complement component 3a receptor 1 -9.43
1436625_at Fcgr1 Fc receptor, IgG, high affinity I -7.75
1455332_x_at Fcgr2b Fc receptor, IgG, low affinity IIb -4.17
1448620_at Fcgr3 Fc receptor, IgG, low affinity III -3.61
1449049_at Tlr1 toll-like receptor 1 -5.52
1418162_at Tlr4 toll-like receptor 4 -3.02
1421352_at Tlr6 toll-like receptor 6 -7.57
1422010_at Tlr7 toll-like receptor 7 -16.6
Affymterix Id Common name Description
Wild-type MyD88-/-
1419132_at Tlr2 toll-like receptor 2 2.33 -5.68
1419589_at C1qr1 complement component 1, q subcomponent, receptor 1 -3.83 -12.13
1450430_at Mrc1 mannose receptor, C type 1 -14.85 -86.95
Fold change
A) 
B)   144 
 
 
 
 
 
 
Figure 5.5- Basal expression of TLR 2 in wild-type and MyD88
-/- , uninfected 
BMDCs 
Normalised TLR 2 values were obtained from microarray data. Results are an 
average of 3 independent experiments.  
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5.5.2- Differential expression of TLR signalling pathway genes in                   
M. tuberculosis infected MyD88
-/- BMDCs 
  The expression of TLR signalling pathway genes, IRAK-4, LPS binding 
protein (LBP) were down regulated by a factor of >3 fold in MyD88
-/- BMDCs in 
response to infection (Table 5.3, A)  and moreover, these genes did not display a 
statistically  significant  change  in  expression  in  wild-type  infected  BMDCs. 
Expression  of  Nfkb1  (subunit  p50  of  NFkB)  ,  TRAF-6    and  Ikbkg  was  up 
regulated by a factor of 2.6 fold or more in MyD88
-/- BMDCs, in response to 
infection. Ikbkg, also known as NEMO is the regulatory sub-unit of IkB kinase 
family and is involved in activating the NFkB complex (Akira and Takeda 2004). 
 
Pik3r1  (p85  subunit)  and  CD86  (co-stimulatory  molecule)  were 
significantly up regulated by >2.5 fold in both wild-type and MyD88 deficient 
BMDCs in response to infection (Table 5.3, B). The up regulation of CD86 at the 
mRNA level correlates with increased expression of CD86 as determined by flow 
cytometry in MyD88
-/- BMDCs infected with M. tuberculosis (Figure 5.2, B). The 
expression  of  Ikbke,  an  important  component  of  the  IFN  mediated  anti-viral 
responses is up regulated in wild-type BMDCs (1.95 fold) and down regulated  
(-3.98 fold) in MyD88 deficient BMDCs in response to infection (Table 5.3, B).  
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Table 5.3- Gene expression profiles of TLR pathway genes A) significantly, 
differentially expressed in M. tuberculosis infected MyD88
-/- BMDCs B) 
significantly, differentially expressed in both wild-type and MyD88
-/- BMDCs 
in response to infection.  
 
Differentially regulated TLR pathway genes were identified using the GCRMA 
algorithm  and  normalised  fold  change  values  in  response  to  M.  tuberculosis 
infection are displayed. Differentially regulated genes have a 1.4 fold change and 
a p value of £0.05. 
 
 
 
 
 
 
 
 
Affymterix Id Common name Description Fold change
1427691_a_at Ifnar2 interferon (alpha and beta) receptor 2 -3.14
1435647_at Ikbkg inhibitor of kappaB kinase gamma 2.62
1451750_at Irak4 interleukin-1 receptor-associated kinase 4 -5.98
1448550_at Lbp lipopolysaccharide binding protein -7.57
1427705_at Nfkb1 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105 4.15
1435350_at Traf6 Tnf receptor-associated factor 6 2.80
Affymterix Id Common name Description
Wild-type MyD88-/-
1420404_at Cd86 CD86 antigen 3.52 15.06
1417813_at Ikbke inhibitor of kappaB kinase epsilon 1.95 -3.98
1425515_at Pik3r1
phosphatidylinositol 3-kinase,
 regulatory subunit, polypeptide 1 (p85 alpha) 2.54 4.91
Fold change
A) 
B)   147 
5.5.3- Differential expression of JAK-STAT signalling pathway genes in M. 
tuberculosis infected MyD88
-/- BMDCs 
  A number of negative regulators (miz-1, pias1 and SOCS 6) of the JAK-
STAT signalling pathways were down regulated in infected MyD88
-/- BMDCs 
(Table 5.4, A), in contrast, other negative regulators of the JAK-STAT signalling 
pathway including cish and SOCS 3 were up regulated > than 4 fold in MyD88 
deficient  BMDCs,  in  response  to  M.  tuberculosis  infection.  Additionally,  a 
number of members of the JAKs and STATs family were also up regulated (Table 
5.4, A) in infected MyD88 deficient BMDCs.  
 
 
  SOCS  2,  STAT-1  and  STAT-2  were  significantly  represented  in  both 
wild-type and MyD88 deficient BMDCs in response to infection (Table 5.4, B). 
SOCS  2  is  the  only  negative  regulator  of  the  JAK-STAT  pathway  that  was 
significantly  represented  in  both  wild-type  and  MyD88
-/-  BMDCs.  SOCS  2, 
although a negative regulator of the JAK-STAT signalling pathway, is also known 
to  be  involved  in  enhancing  STAT  phosphorylation  in  response  to  cytokine 
treatment (Johnston 2004), thus it possible that SOCS 2 contributes to the delicate 
balance  maintained  in  the  induction  of  the  JAK-STAT  signalling  pathway  in 
response to infection.  
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Table 5.4- Gene expression profiles of JAK-STAT signalling pathway genes 
A) significantly, differentially expressed in M. tuberculosis infected MyD88
-/- 
BMDCs B) significantly, differentially expressed in both wild-type and 
MyD88
-/- BMDCs in response to infection.  
 
Differentially  regulated  JAK-STAT  signalling  pathway  genes  were  identified 
using the GCRMA algorithm and normalised fold change values in response to M. 
tuberculosis infection are displayed. Differentially regulated genes have a 1.4 fold 
change and a p value of £0.05. 
 
 
 
 
 
 
 
 
 
Affymterix Id Common name Description Fold change
1448724_at Cish cytokine inducible SH2-containing protein 8.93
1421066_at Jak2 Janus kinase 2 2.44
1428725_at Miz1 protein inhibitor of activated STAT 2 -2.27
1455486_at Pias1 protein inhibitor of activated STAT 1 -1.71
1456212_x_at Socs3 suppressor of cytokine signaling 3 4.04
1452764_at Socs6 suppressor of cytokine signaling 6 -4.78
1426587_a_at Stat3 signal transducer and activator of transcription 3 2.38
1448713_at Stat4 signal transducer and activator of transcription 4 5.38
1421469_a_at Stat5a signal transducer and activator of transcription 5A 4.9
1422103_a_at Stat5b signal transducer and activator of transcription 5B 2.1
Affymterix Id Common name Description
Wild-type MyD88-/-
1441476_at Socs2 suppressor of cytokine signaling 2 2.19 5.43
1420915_at Stat1 signal transducer and activator of transcription 1 5.09 3.24
1421911_at Stat2 signal transducer and activator of transcription 2 10.22 4.32
Fold change
A) 
B)   149 
 
5.5.4- Differential expression of cytokine and chemokine genes in M. 
tuberculosis infected MyD88
-/- BMDCs 
  M.  tuberculosis  infected  MyD88
-/-  BMDCs  significantly  up  regulated 
members of the CC family of chemokines (CCL17, CCL22) and CXC family 
(CXCL16) by a > 3 fold (Table 5.5, A). Down regulation of chemokine receptors 
CCR5 (-3.93 fold) and up regulation of CXCR4 (3.47 fold) signifies the transition 
of BMDCs from an immature to mature state (Allavena, Sica et al. 2000). Anti-
inflammatory cytokines IL-4 and Tgfb2 were up regulated in MyD88 deficient 
BMDCs in response to infection. In contrast, the expression of IL-4 was down 
regulated in wild-type BMDCs, in response to M. tuberculosis infection, as shown 
by real-time PCR (Figure 4.10). 
 
  Other chemokines including, CXCL1, CXCL9 and CXCL10 and cytokines 
(IL12b,  IL-6,  Lif)  were  up  regulated  in  both  wild-type  and  MyD88  deficient 
BMDCs in response to infection (Table 5.5, B). Furthermore, the change in gene 
expression of CXCL9, CXCL10 and IL12b was considerably reduced in MyD88 
deficient BMDCs (Table 5.5, B). But the reduced expression of CXCL10 at the 
mRNA levels is not reflected at the protein level, as in response to infection, 
MyD88  deficient  BMDCs  produce  similar  levels  of  CXCL10  to  wild-type 
BMDCs (Figures 5.6 and 4.6). However, the reduced expression of IL12b (IL-
12p40), as shown in table 5.5, B, correlates with the reduced IL-12p40 production 
from MyD88
-/- BMDCs in response to infection (Figure 5.4).  
 
  Expression of genes (mRNA expression) does not always correlate with 
protein expression. This is highlighted by the expression of IL-6 (up regulated by 
89 fold) in MyD88 deficient BMDCs in response to infection, as shown in table 
5.5, B. This up regulation of IL-6 is not representative of the small amounts of IL-
6,  that  are  produced  at  24  hours  post-infection  in  infected  MyD88
-/-  BMDCs 
(Figure 5.3, B).   
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Table  5.5-  Gene  expression  profiles  of  cytokine  and  chemokine  genes  A) 
significantly,  differentially  expressed  in  M.  tuberculosis  infected  MyD88
-/- 
BMDCs  B)  significantly,  differentially  expressed  in  both  wild-type  and 
MyD88
-/- BMDCs in response to infection.  
 
Differentially regulated cytokine and chemokine genes were identified using the 
GCRMA  algorithm  and  normalised  fold  change  values  in  response  to  M. 
tuberculosis infection are displayed. Differentially regulated genes have a 1.4 fold 
change and a p value of £0.05. 
 
 
Affymterix Id Common name Description Fold change
1419413_at Ccl17 chemokine (C-C motif) ligand 17 21.53
1417925_at Ccl22 chemokine (C-C motif) ligand 22 3.54
1419610_at Ccr1 chemokine (C-C motif) receptor 1 -12.7
1421188_at Ccr2 chemokine (C-C motif) receptor 2 -55.8
1422259_a_at Ccr5 chemokine (C-C motif) receptor 5 -3.93
1449195_s_at Cxcl16 chemokine (C-X-C motif) ligand 16 6.78
1448995_at Cxcl4 chemokine (C-X-C motif) ligand 4 -3.11
1448710_at Cxcr4 chemokine (C-X-C motif) receptor 4 3.47
1417932_at Il18 interleukin 18 -4.54
1449864_at Il4 interleukin 4 12.4
1450923_at Tgfb2 transforming growth factor, beta 2 3.64
Affymterix Id Common name Description
Wild-type MyD88-/-
1441855_x_at Cxcl1 chemokine (C-X-C motif) ligand 1 2.46 2.65
1418930_at Cxcl10 chemokine (C-X-C motif) ligand 10 91.05 7.22
1418652_at Cxcl9 chemokine (C-X-C motif) ligand 9 81.27 12.14
1449497_at Il12b interleukin 12b 23.95 12.24
1448681_at Il15ra interleukin 15 receptor, alpha chain 5.21 5.46
1450297_at Il-6 interleukin 6 31.49 89.89
1421207_at Lif leukemia inhibitory factor 2.94 10.46
1425444_a_at Tgfbr2 transforming growth factor, beta receptor II -1.99 -5.55
Fold change
A) 
B)   151 
 
Figure 5.6- CXCL10 production by M. tuberculosis infected MyD88
-/- BMDCs 
at 24 hours post-infection 
Day 6 unsorted BMDCs were either left uninfected or infected with H37Rv at a 
M.O.I  of  10:1.  Supernatants  were  collected  at  24  hours  and  CXCL10  were 
quantified by ELISA. Data shown are the mean ±SD of duplicate determinations 
in one experiment, representative of three independent experiments.  
 
 
 
 
  In  conclusion,  the  up  regulation  of  co-stimulatory  molecules  and 
chemokines in the absence of MyD88, in response to M. tuberculosis infection, 
suggest that BMDCs retain their ability to migrate in response to infection and 
function  as  efficient  T  cell  stimulators.  A  complete  list  of  the  differentially 
regulated  genes,  in  response  to  M.  tuberculosis  infection,  in  the  absence  of 
MyD88, is listed in Appendix- VIII. 
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5.6- Validation of microarray data from M. tuberculosis MyD88
-/- 
BMDCs using real-time PCR 
To confirm expression of a set of immunologically important genes, real 
time  PCR  was  carried  out  as  described  previously  (chapter  2,  section  2.5.1). 
Briefly, RNA was extracted from day 6 unsorted MyD88
-/- BMDCs, which were 
either uninfected or infected with M. tuberculosis. RNA was extracted at 24 hours 
post-infection to correlate with the time point of microarray analysis.  Expression 
of  individual  genes  was  normalised  to  the  internal  control,  18S  rRNA.  The 
expression  of  cytokines  (IL-10,  IL-12p35  and  TNF)  was  not  detected  by 
microarray  analysis,  however,  these  genes  are  important  during  mycobacterial 
infections  (Cooper,  Magram  et  al.  1997;  Roach,  Bean  et  al.  2002;  Turner, 
Gonzalez-Juarrero  et  al.  2002)  and  thus  the  expression  of  these  genes  were 
quantified using real-time PCR. The expression of TLR 2 and TLR 4 were down 
regulated in MyD88
-/- BMDCs, which is in contrast to the data obtained from 
wild-type BMDCs and thus to confirm this interesting observation, the expression 
of these genes were verified using real-time PCR.  
 
  Gene expression data obtained using real-time PCR and microarrays are 
displayed  in  figure  5.7.  Cytokine  and  chemokine  genes  displayed  a  modest 
increase in  expression  levels  in  response  to  infection  of  MyD88
-/-  BMDCs  as 
quantified using real time PCR (Figure 5.7, A). Although, the expression of IL-6 
was increased by a factor of 89 fold, as determined from the microarray analysis, 
a much smaller increase in expression (3 fold) was detected using real-time PCR 
(Figure 5.6, A). IL-6 was induced 14 fold in wild-type BMDCs in response to 
infection  (Figure  4.5),  which  is  higher  than  the  induction  levels  observed  in 
MyD88
-/- BMDCs. Nevertheless, the modest induction of IL-6 as quantified using 
real-time PCR, in MyD88
-/- BMDCs correlates with the levels of IL-6 protein 
quantified using ELISA (Figure 5.3, B).  
 
Transcripts for IL-10, IL-12p35 and TNF were not significantly different 
in infected vs uninfected samples in microarray anlaysis but an increase of 1.5 
fold (IL-12p35) and 1.7 fold (TNF) was identified using real-time PCR (Figure 
5.7,  A).  Since,  real-time  PCR  is  a  more  sensitive  technique  in comparison  to   153 
microarray analysis, it is possible that such small increases in expression is below 
the detection level of the microarrays.  
 
  The TLR 2 and STAT-1 gene expression profiles obtained using real time 
PCR were comparable to those obtained using microarray analysis, although the 
expression  of  TLR  4  was  considerably  underestimated  by  microarray  analysis 
(decreased fold change -3 fold) in comparison to a down regulation of -142 fold 
quantified using real-time PCR (Figure 5.7, B).    
 
 
In general, the fold change of gene expression detected by microarrays is 
higher  than  the  gene  expression  values  quantified  using  real-time  PCR. 
Furthermore,  real-time  PCR  is  a  useful  technique  for  detecting  expression  of 
genes which are induced at very low levels (TNF and IL-12p35).   
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Figure  5.7-  Quantitative  real-time  PCR  and  microarray  profiles  of  A) 
cytokines and chemokines B) toll-like receptors and STAT-1 in   
M.tuberculosis infected MyD88
-/- BMDCs.  
Day  6  unsorted  BMDCs  were  either  left  uninfected  or  infected  with 
H37Rv at a M.O.I of 10: 1 and RNA was extracted at 24 hours post-infection. 
Gene  expression  data  was  determined  using  the  SYBR  green  incorporation 
method. Expression of each gene was normalised to the endogenous control, 18S 
rRNA  and  subsequently  fold  change  in  response  to  infection  was  calculated 
relative to the uninfected sample. Results are representative of two independent 
experiments  (mean  ±SD  of  duplicate  determinations  in  one  experiment).  Fold 
change values obtained for each gene using microarray analysis was compared to 
the real time PCR data. ND- no statistically significant change in gene expression 
was detected from microarray analysis.  
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5.7- In silico promoter analysis of differentially regulated genes in 
M. tuberculosis infected MyD88
-/- BMDCs 
  Genes  differentially  regulated  in  response  to  infection  in  MyD88
-/- 
BMDCs  were  analysed  using  TELiS  database,  in  order  to  identify  the 
transcription factor binding motifs represented in the promoters of differentially 
regulated genes. Details of the database and the method are described in section 
2.6.  Listed  in  the  table  5.6,  are  significant  transcription  factor  binding  motifs 
represented  in  the  promoters  of  genes  differentially  regulated  in  response  to 
infection, of MyD88
-/- BMDCs.  
 
 
Similar to the wild-type data (Table 4.2), ISRE and NFkB binding motifs 
were among the transcription factors that were significantly represented in the 
promoters of differentially regulated genes (Table 5.6).  
 
 
Other transcription factor binding motifs that were significantly regulated 
belonged to the Ets family of transcription factors, Elk-1. Its activity is thought to 
be important for cell proliferation and blocking of apoptotic cell death. Myeloid 
zinc finger gene 1 (mzf1) has a role as a transcriptional regulator of hematopoiesis 
(Morris, Hromas et al. 1994).  
 
 
  From  the  TELiS data,  it  is evident that  IRFs and NFkB are important 
regulating the transcriptional responses of MyD88
 -/- BMDCs in response to M. 
tuberculosis infection. 
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Transcription factor binding motifs  P value  Z –test score 
 
AP-2 (Activator protein 2) 
 
 
1.00x10
-10 
 
5.62 
 
NFKB (Nuclear factor kappa B) 
 
 
1.10x10
-5 
 
4.40 
 
CREL 
 
 
2.00x10
-4 
 
3.77 
 
MZF1 (myeloid zinc finger 1) 
 
 
2.10x10
-3 
 
3.08 
 
Elk1(member of ETS oncogene family) 
 
 
2.70x10
-3 
 
3.00 
 
 
ISRE (Interferon stimulated response element) 
 
 
1.46x10
-2 
 
2.44 
 
NFKAPPAB65 (Nuclear factor kappa B- p65) 
 
 
1.87x10
-2 
 
2.35 
   
 
 
 
Table 5.6- Transcription factor binding motifs represented in M. tuberculosis 
infected MyD88
 -/- BMDCs.  
Significant  transcription  factor  binding  motifs,  prevalent  in  the  promoters  of 
differentially  regulated  genes,  in  response  to  M.  tuberculosis  infection,  was 
identified using the bioinformatic database TELiS. The positive values obtained 
with the Z-test indicate an increased prevalence of the individual transcription 
factor binding motifs and the p value represents the level of significance.  
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5.8- Profiling type I IFN inducible genes in M. tuberculosis 
infected MyD88
-/- BMDCs 
 
Using microarray analysis it was possible to identify type I IFN inducible 
genes that were induced in the absence of MyD88. All the genes were mined from 
microarray data and were identified as type I IFN inducible genes using the same 
criteria, as previously described for wild-type type I IFN cluster of genes (Chapter 
4, section 4.6).  
 
 
5.8.1 -MyD88 independent induction of type I IFN genes in M. tuberculosis 
infected BMDCs: a comparative analysis between wild-type and MyD88
-/- 
BMDCs 
   The type I IFN inducible genes were grouped together in 6 clusters (Table 
5.7) and this set of genes were induced in both MyD88
-/- and wild-type BMDCs in 
response to M. tuberculosis infection. All the names of the genes abbreviated in 
the text can be found in table 5.7.  Normalised values of the genes, displayed in 
the table 5.7 are listed in Appendix- VI.  
 
Genes involved in antiviral immunity (Gbp2, Ifit1, Isg20, Oasl1, Traf3), 
cytokines and chemokines (CXCL10, IL12b) and type I IFN pathway genes (IRF-
7, STAT-1, STAT-2) were up regulated in both M. tuberculosis infected MyD88
-/- 
and wild-type BMDCs. Traf-3 has a role in the regulation of IRF-3 activation via 
TLR pathways (Oganesyan, Saha et al. 2006) and Isg20, a 3’-5’ exonuclease with 
specificity for ssRNA, was up regulated over 7 fold in MyD88
-/- BMDCs (Table 
5.7).   
 
Other sub-groups consist of genes implicated in MHC-I processing and 
presentation (H2-Q10, Psme2, Tap1), and regulation of transcription (Adar, Ell2), 
had  similar  expression  profiles  in  both  wild-type  and  MyD88
-/-  BMDCs  in 
response to M. tuberculosis infection.  
   158 
Affymetrix ID Common name Description 
Wild-type MyD88
-/-
1423555_a_at 90.56 4.50 A430056A10Rik interferon-induced protein 44
1418240_at 3.97 2.90 Gbp2 guanylate nucleotide binding protein 2 Antiviral immunity
1450783_at 84.62 7.21 Ifit1 interferon-induced protein with tetratricopeptide repeats 1
1419569_a_at 32.59 10.24 Isg20 interferon-stimulated protein 20
1424339_at 56.58 13.62 Oasl1 2'-5' oligoadenylate synthetase-like 1
1418587_at 1.97 7.77 Traf3 Tnf receptor-associated factor 3
1418930_at 91.05 7.22 Cxcl10 chemokine (C-X-C motif) ligand 10 Cytokines and chemokines
1449497_at 23.95 12.24 Il12b interleukin 12b
1417244_a_at 65.58 5.24 Irf7 interferon regulatory factor 7
1420915_at 5.01 3.24 Stat1 signal transducer and activator of transcription 1 IRFs and Type I IFN pathway
1421911_at 10.22 4.32 Stat2 signal transducer and activator of transcription 2
1426324_at 1.79 2.21 H2-Q10 histocompatibility 2, D region locus 1
Antigen processing and 
presentation via MHC-I
1417189_at 2.03 3.14 Psme2 proteasome (prosome, macropain) 28 subunit, beta
1416016_at 2.9 3.34 Tap1 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
1434268_at 2.58 2.11 Adar adenosine deaminase, RNA-specific Regulation of transcription
1450744_at 2.64 3.95 Ell2 elongation factor RNA polymerase II 2
1435446_a_at 2.67 1.87 Chpt1 choline phosphotransferase 1
1451426_at 11.86 4.05 D11Lgp2e DNA segment, Chr 11, Lothar Hennighausen 2, expressed
1422433_s_at -1.78 -2.50 Idh1 isocitrate dehydrogenase 1 (NADP+), soluble Miscellenaeous
1421207_at 2.94 10.46 Lif
1452178_at 6.04 2.22 Plec1 plectin 1
1434015_at 3.3 2.03 Slc2a6 solute carrier family 2 (facilitated glucose transporter), member 6
1417961_a_at 8.49 2.55 Trim30 tripartite motif protein 30
1418191_at 7.15 4.42 Usp18 ubiquitin specific peptidase 18
Fold change
  The expression of CXCL10, IL12b and STAT-1 was confirmed using real 
time  PCR,  as  shown  previously  in  figure  5.7.  From  the  microarray  gene 
expression profiles it can be concluded that a large number of type I IFN inducible 
genes  can  be  induced  independent  of  MyD88  in  response  to  M.  tuberculosis 
infection. 
 
 
 
 
 
 
 
 
 
Table  5.7-  Expression  of  type  I  IFN  inducible  genes  in  M.  tuberculosis 
infected MyD88
-/- BMDCs- a comparative analysis to wild-type type I IFN 
gene profiles. 
Expression profiles of type I IFN inducible genes were mined from the microarray 
data. Genes were grouped into functional clusters. Relative change in expression 
level in response to M. tuberculosis infection is displayed for each gene. Positive 
values for fold change indicate up regulation and negative value implies down 
regulation. All genes displayed have a p value of £ 0.05.     159 
5.8.2- Profiling type I IFN inducible genes induced by M. tuberculosis infected 
MyD88
-/- BMDCs but absent from infected wild-type BMDCs.  
  Type  I  IFN  inducible  genes  induced  in  response  to  M.  tuberculosis 
infection  of  MyD88
-/-  BMDCs,  with  no  statistically  significant  change  in 
expression  in  wild-type  BMDCs,  are  listed  in  table  5.8.  All  the  gene  names 
abbreviated in the text are in table 5.8.   
 
 
The  expression  levels  for  the  cytidine  deaminase  family  member  1 
(Apobec3),  and  mtmr9,  which  is  involved  in  phospholipid  de-phosphorylation 
was significantly up regulated over a factor of 3 fold but the type I IFN receptor, 
sububit 2 (IFNAR2) was down regulated in response to infection of MyD88
-/- 
BMDCs (Table 5.8).  Other genes which showed significant up regulation was, 
plek 2, involved in cell adhesion and spreading, psmb 7, a proteasome subunit 
which  possess  endopeptidase  activity,  tjp2,  involved  in  the  organisation  of 
epithelial and endothelial intercellular junctions and stxbp6 which has roles in 
SNARE (soluble NSF attachment receptor) complex formation.  
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Table 5.8 – Profiling type I IFN genes which showed significant expression in 
response to M. tuberculosis infection of MyD88
-/- BMDCs.  
Expression  of  type  I  IFN  inducible  genes  were  mined  from  microarray  data. 
Relative change in expression level in response to M. tuberculosis infection is 
displayed for each gene. All genes displayed has a fold change of >1.4 and p 
value of £0.05.  
 
 
 
 
 
5.8.3- Profiling type I IFN inducible genes induced by M. tuberculosis infected 
wild-type BMDCs but absent from infected MyD88
-/- BMDCs.  
  Type  I  IFN  inducible  genes,  which  showed  a  significant  change  in 
expression only in infected wild-type BMDCs were mined from the microarray 
data (Table 5.9).  
   
Wild-type  BMDCs  in  response  to  infection  induced  a  cluster  of  genes 
which are classically known to be part of the innate immune response to viruses 
(Prkr,  OAS1c, OAS2 and  Mx2). Oas1c, the synthesis of  which is induced  by 
interferons,  displayed  a  significant  change  in  expression  only  in  wild-type 
BMDCs,  in  response  to  infection.  MHC-I  genes  (H2-Q8,  H2-T10,H2-T24) 
induced by type I IFNs were  also  up regulated over 3 fold in wild-type BMDCs, 
in response to infection.  
Affymetrix ID Fold change Common name Description Function
1417470_at 3.72 Apobec3 Apolipoprotein B editing complex 3 Miscellaneous
1427691_a_at -3.14 Ifnar2 Interferon (alpha and beta) receptor 2 Type I IFN receptor
1433446_at 3.96 Hmgcs1
3-hydroxy-3-methylglutaryl-Coenzyme A 
synthase 1 Miscellaneous
1452254_at 2.71 Mtmr9 Myotubularin related protein 9 Miscellaneous
1449424_at 45.50 Plek2 Pleckstrin 2 Cell adhesion
1449424_at 2.23 Psmb7 Proteasome subunit, beta type 7 Peptidase activity
1425749_at 3.96 Stxbp6 Syntaxin binding protein 6 (amisyn) SNARE complex formation
1434599_a_at 5.19 Tjp2 Tight junction protein 2
Organisation of 
intercellular junctions  161 
Affymetrix ID Fold change Common name Description 
1422005_at 5.34 Prkr eukaryotic translation initiation factor 2-alpha kinase 2
1418686_at 5.48 Oas1c 2'-5' oligoadenylate synthetase 1C
1426278_at 6.14 2310061N23Rik interferon, alpha-inducible protein 27
1425065_at 8.00 Oas2 2'-5' oligoadenylate synthetase 2 Antiviral immunity
1419676_at 11.78 Mx2 myxovirus (influenza virus) resistance 2
1418293_at 62.53 Ifit2 interferon-induced protein with tetratricopeptide repeats 2
1427736_a_at 5.84 Ccrl2 chemokine (C-C motif) receptor-like 2 Cytokine receptor
1421322_a_at 2.53 Isgf3g interferon dependent positive acting transcription factor 3 gamma Type I IFN pathway
1449875_s_at 3.05 H2-T10 histocompatibility 2, T region locus 10 
1430802_at 5.85 H2-Q8 histocompatibility 2, Q region locus 8
1422160_at 6.47 H2-T24 histocompatibility 2, T region locus 24
Antigen processing and 
presentation via MHC-I
1451821_a_at 3.48 Sp100 nuclear antigen Sp100 Regulation of transcription
1425053_at 2.12 2610034N03Rik isochorismatase domain containing 1
1421550_a_at 5.98 Trim34 tripartite motif protein 34  Miscellaneous
1417314_at 50.13 H2-Bf histocompatibility 2, complement component factor B
 
  In conclusion, although a large proportion of type I IFN inducible genes 
was induced in both wild-type and MyD88
-/- BMDCs in response to infection, key 
anti-viral genes (Prkr, Mx2, OAS 1c and OAS2) displayed a significant change in 
expression only in wild-type BMDCs, thus possibly indicating an inefficiency by 
MyD88
-/- mice to mount innate immune responses .  
 
 
 
 
 
 
 
 
 
 
 
Table  5.9  –  Profiling  type  I  IFN  inducible  genes which  were  significantly 
induced only in M. tuberculosis infected wild-type BMDCs 
Expression  of  type  I  IFN  inducible  genes  were  mined  from  microarray  data. 
Relative change in expression level in response to M. tuberculosis infection is 
displayed for each gene. All genes were grouped into function clusters and genes 
displayed have a fold change of >1.4 and p value £0.05.    162 
 
5.9-  Validation  of  type  I  IFN  pathway  genes  expressed  in  M. 
tuberculosis infected MyD88
-/- BMDCs using real time PCR 
  The expression of type I IFN receptor (IFNAR1 and IFNAR2), IFN beta, 
IRF-3 and IRF-7 was quantified using real-time PCR. IFNAR1, IRF-3, and IFN 
beta  were  not  significantly  represented  in  the  microarray  data  and  thus  the 
expression of these genes was quantified using real-time PCR.  As outlined in 
chapter 4, (section 4.7), the real-time PCR analysis was extended to incorporate 
expression of these genes at both 4 hours and 24 hours post-infection.  
 
 
  In brief, unsorted MyD88
-/- BMDCs was infected with H37Rv at a M.O.I 
of 10:1 and RNA was extracted at 4 and 24 hours post-infection. Real-time PCR 
was  carried  out  using  the  SYBR  green  incorporation  method  as  described  in 
materials and methods (section 2.5.1).  
 
 
  The  expression  of  IFNAR1,  IFNAR2,  IFN  beta  and  IRF-3  was  down 
regulated at 4 hours post-infection in MyD88
-/- BMDCs , the only exception being 
IRF-7, which was up regulated as early as 4 hours post-infection (Figure 5.8). 
Similarly, the expression of the type I IFN receptor subunits and IRF-3 was also 
down regulated in wild-type BMDCs but IFN beta and IRF-7 was up regulated at 
4 hours post-infection (Figure 4.8).  At 24 hours post-infection, expression of type 
I IFN receptors subunits was still down regulated but IFN beta , IRF-3 and IRF-7 
were up regulated in M. tuberculosis infected MyD88
-/- BMDCs (Figure 4.8). The 
down regulation of type I IFN receptors seem to be an inherent process that occurs 
during  the  maturation  of  dendritic  cells  and  thus  represents  an  intricate 
mechanism to regulate responsiveness to type I IFNs (Gauzzi, Canini et al. 2002). 
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The expression of IFN beta, IRF-3 and IRF-7 in MyD88
-/- BMDCs was 
similar to wild-type BMDCs although, the up regulation of IFN beta was higher in 
wild-type BMDCs (Figures 4.8 and 5.8).  
 
 
  Although,  the  transcripts  for  IFN  beta,  IFNAR1,  and  IRF-3  were  not 
significantly  represented  using  microarrays,  it  was  possible  to  quantify  the 
expression of these genes using real-time PCR. Furthermore, the expression of 
IFNAR2 and IRF-7 from microarray data was confirmed using real-time PCR.    
 
 
Figure 5.8 – Real-time PCR expression profiles of type I interferon genes in 
M. tuberculosis infected MyD88
-/- BMDCs. 
 RNA was extracted from unsorted MyD88
-/- BMDCs at 4 hours and 24 hours 
post- infection, converted to cDNA and real-time PCR was performed using the 
SYBR green detection method. All values were normalised to the house keeping 
gene-  18S  rRNA.  Fold  induction  of  each  gene  in  response  to  infection  was 
calculated  relative  to  its  normalised  value  in  the  uninfected  sample.  Data  is 
representative of 2 independent experiments.  
-8
-6
-4
-2
0
2
4
6
8
Ifnar 1 Ifnar 2 IFN beta IRF-3 IRF-7
F
o
l
d
 
c
h
a
n
g
e
i
n
 
r
e
s
p
o
n
s
e
 
t
o
 
 
M
.
 
t
u
b
e
r
c
u
l
o
s
i
s
 
i
n
f
e
c
t
i
o
n
4 hours
24 hours  164 
5.10-  Quantification  of  IFN  beta  production  by  M.  tuberculosis 
infected MyD88
-/- BMDCs 
  IFN beta mRNA was induced by  24 hours in  M. tuberculosis infected 
BMDCs  (Figure  5.8).  To  analyse  IFN  beta  production,  unsorted  MyD88
-/- 
BMDCs were either left uninfected, stimulated with LPS (1mg/ml) or infected 
with  H37Rv  10:1  and  supernatants  were  collected  between  6-72  hours  post-
infection and IFN beta production was measured using ELISA.  
 
 
  As shown in figure 5.9, IFN beta was detectable by 24 hours post-infection 
(115 ±3.86pg/ml), with decreased production at later time points. In contrast, IFN 
beta was detected by 6 hours in LPS stimulated MyD88
-/- BMDCs (280 ±1 pg/ml) 
with  a  rapid  reduction  in  IFN  beta  protein  levels  by  24  hours  (Figure  5.9). 
Uninfected  MyD88
-/-  BMDCs  produced  negligible  amounts  of  IFN  beta.  In 
contrast, LPS stimulated wild-type BMDCs produced higher levels of IFN beta 
with a more gradual decrease in IFN beta production at later time points (Figure 
4.9).  In  wild-type  BMDCs,  the  induction  of  IFN  beta  in  response  to  M. 
tuberculosis infection was not significantly different to MyD88
-/- BMDCs at any 
of the time points examined (Figure 4.9 and Figure 5.9).  
  
 
  Thus, IFN beta was induced in M. tuberculosis infected MyD88
-/- BMDCs 
at 24 hours, both at the mRNA (Figure 5.8) and protein level (Figure 5.9). Hence 
the induction of IFN beta is independent of MyD88 in M. tuberculosis infected 
BMDCs.  
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Figure 5.9- Induction of IFN beta in M. tuberculosis infected MyD88
-/- 
BMDCs. 
 
MyD88
-/- unsorted BMDCs were cultured in vitro and day 6 cells were either left 
uninfected, stimulated with LPS (1mg/ml) or infected with H37Rv at a M.O.I of 
10:1. Supernatants  were collected at various  time points  post-infection  for the 
quantification  of  IFN  beta  using  ELISA.    Results  are  the  mean  of  ±SE  of  3 
independent  experiments.  Statistical  analysis  was  preformed  between  M. 
tuberculosis infected group and uninfected group with the Student’s t-test, *- p 
value <0.05.  
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5.11-  Real-time  PCR  analysis  of  type  I  IFN  inducible  genes  in 
CD11c sorted MyD88
-/- BMDCs  
  In  order  to  obtain  a  more  comprehensive  list  and  substantiate  the 
expression  of  selected  type  I  IFN  inducible  genes,  obtained  from  microarray 
analysis using unsorted BMDCs (68 ±6% CD11c
+), real-time PCR was carried out 
using  RNA  extracted  from  a  population  of  sorted  dendritic  cells  (95  ±3% 
CD11c
+). 
 
  Day 6, BMDCs were sorted based on their CD11c expression and RNA 
was extracted from cells that were either left uninfected or infected with H37Rv 
(M.O.I 10:1) for 24 hours. Real-time PCR was carried out using the RT profiler 
PCR  array  system  and  all  genes  were  normalised  to  the  endogenous  control, 
GAPDH.  
 
  Similar to the wild-type real-time PCR data (Figures 4.10 and 4.11), IFN 
inducible  genes  were  sub-divided  into  4  sub-groups  and  the  gene  expression 
profiles are displayed in figure 5.10 and figure 5.12. The type I IFNs , IFN alpha 
(IFNa2, a4, a9 and a11) and IFN beta were up regulated but IFN alpha sub-type 
IFNa7 was down regulated in M. tuberculosis infected MyD88
-/- BMDCs (CD11c
 
sorted). In contrast, the expression of IFNa7 and IFNa11 was down regulated in 
wild-type CD11c
+ BMDCs (Figure 4.10) nonetheless, IFNa2, IFNa4 and IFNa9 
were  up  regulated  in  both  wild-type  and  MyD88
-/-  CD11c
  sorted
  BMDCs,  in 
response to infection (Figures 4.10 and 5.10).  
 
As shown in figure 5.11, low amounts of IFN alpha (14.31 ±1.59pg/ml) 
protein  was  detected  at  later  time  points  post-infection  (72  hours).  This  is  in 
contrast to wild-type M. tuberculosis infected BMDCs where IFN alpha was not 
measurable at the protein level using ELISA. 
 
  Cytokines IL12b (IL-12p40) and IL-4 were both up regulated in response 
to  infection  of  MyD88
-/-  CD11c  sorted  BMDCs  (Figure  5.10),  however,  the 
expression  of  IL-4  was  down  regulated  in  wild-type  M.  tuberculosis  infected 
CD11c
 sorted BMDCs (Figure 4.10). But similar to the wild-type, IL-4 protein   167 
was not detected in the supernatants of M. tuberculosis infected MyD88
-/- CD11c 
sorted BMDCs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  5.10-  Real-time  PCR  expression  profiles  of  type  I  IFNs  and  IFN 
inducible genes in CD11c
 sorted MyD88
-/- BMDCs.  
RNA was isolated from CD11c sorted uninfected BMDCs and M. tuberculosis 
infected BMDCs (24 hours post-infection), converted to cDNA and real-time PCR 
was performed using RT profiler PCR array. Expression of individual interferon 
genes were normalised to the house keeping gene GAPDH. Fold change of a gene 
in  response  to  M.  tuberculosis  infection  relative  to  the  uninfected  sample  is 
displayed. Genes were grouped into functional clusters:    Group 1- type I 
interferons,   Group 2- Interferon related genes. Results are representative of 
two independent experiments.  
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Figure 5.11- Induction of IFN alpha in M. tuberculosis infected MyD88
-/- 
BMDCs 
 
MyD88
-/-  BMDCs  were  cultured  in  vitro  and  day  6  cells  were  either  left 
uninfected,  or  infected  with  H37Rv  at  a  M.O.I  of  10:1.  Supernatants  were 
collected at various time points post-infection for the quantification of IFN alpha 
using ELISA.  Results are the mean of ±SE of 3 independent experiments.  
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Expression of interferon regulatory factors (group 3) was similar between 
MyD88
-/- and  wild-type CD11c sorted BMDCs with the exception of Irf2bp1, 
which was up regulated by a factor of 16 fold in wild-type BMDCs but was down 
regulated in MyD88
-/- BMDCs in response to infection (Figures 4.11 and 5.12).   
   
 
  In  group  4,  key  anti-viral  genes,  Mx1,  OAS1a  and  cellular  immune 
response  genes,  Ifit2,  Ifit3,  Ifi27  and  H28  were  down  regulated  in  MyD88
-/- 
BMDCs, in  response to  infection but were  up regulated in  wild-type BMDCs 
(Figure 4.11 and figure 5.12).  
 
 
As outlined previously in chapter 4 (section 4.9.1), real-time PCR profiles 
of type I IFN inducible genes in CD11c sorted BMDCs also made it possible to 
validate the microarray analysis carried out using unsorted BMDCs. As shown in 
figure 5.13, gene expression data obtained for CXCL10, IL12b, Ifi44, Ifit1 and 
IRF-7 was similar in both microarray analysis and real-time PCR data (obtained 
from CD11c sorted BMDCs). Thus, gene expression profiles from real time PCR, 
carried out using CD11c sorted BMDCs and microarray analysis, with unsorted 
BMDCs, were comparable.  
 
 
In general, the induction of type I IFNs (IFN alpha and IFN beta), IRF-7 
and other type I IFN inducible genes substantiates the induction of the type I IFN 
pathway but the down regulation of key anti-viral genes and the general reduced 
fold change of type I  IFN  genes like CXCL10  suggests  that  there are crucial 
differences that exist between MyD88 deficient and wild-type BMDCs.  
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Figure  5.12  -  Real-time  PCR  expression  profiles  of  Interferon  regulatory 
factors and type I IFN inducible genes in M. tuberculosis infected MyD88
-/- 
CD11c sorted BMDCs 
 
RNA  was  isolated  from  CD11c  sorted  uninfected  MyD88
-/-  BMDCS  and  M. 
tuberculosis infected  MyD88
-/-   BMDCs, converted to cDNA and real-time PCR 
was performed using RT profiler PCR array. Expression of individual interferon 
genes were normalised to the house keeping gene GAPDH. Fold change of a gene 
in  response  to  M.  tuberculosis  infection  relative  to  the  uninfected  sample  is 
displayed. Genes were grouped into functional clusters:   Group 3-Interferon 
regulatory  factors,          Group  4-  Interferon  inducible  genes.  Results  are 
representative of two independent experiments. 
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Figure 5.13 – Quantitative real-time PCR and microarray gene expression 
profiles of M. tuberculosis infected MyD88
-/- BMDCs.  
RNA  was  extracted  from  CD11c  sorted  BMDCs  24  hour’s  post-  infection, 
converted to cDNA and gene expression values as indicated were measured, by 
SYBR Green incorporation during PCR. For real time PCR, the expression of 
each gene was normalized to the internal control, GAPDH. Results obtained using 
real-time  PCR  for  each  gene  was  compared  with  the  fold  induction  values 
obtained using microarray anlaysis. 
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5.12- Discussion 
  In the absence of MyD88, dendritic cells in response to M. tuberculosis 
infection reveal no impairment in up regulating the co-stimulatory and MHC-II 
expression and this degree of up regulation is comparable to wild-type BMDCs. 
Hence, this feature of dendritic cell maturation is independent of MyD88. This 
correlates with previous studies which have shown that MyD88
-/- dendritic cells, 
show similar up regulation of co-stimulatory and antigen presenting molecules in 
response to LPS and M. tuberculosis infection (Kaisho and Akira 2001; Fremond, 
Yeremeev et al. 2004). 
 
  However,  MyD88  deficient  BMDCs  exhibit  a  profound 
impairment  and  delay  in  producing  inflammatory  cytokines.  The  reduced 
induction of cytokines in reflected at both the mRNA and protein level (Figures, 
5.3, 5.4 and 5.7, A). IL-6 and TNF-a were highly induced in response to M. 
tuberculosis infection, of wild-type BMDCs by 6 hours post-infection, with the 
exception of IL-12p40, which peaked around 48 hours post-infection. In contrast, 
IL-6 and TNF-a peaked around 48 hours with a profound reduction in cytokine 
levels in MyD88
-/- BMDCs. Additionally, the anti-inflammatory cytokine IL-10 
and the bioactive IL-12p70 were not detected in response to infection of MyD88
-/- 
BMDCs.  Hence  it  appears  that  the  induction  of  inflammatory  cytokines  is 
partially dependent on MyD88 and requires the MyD88 dependent pathway for 
optimal cytokine production,  as seen  in the wild-type  BMDCs, in response to 
infection.  
 
  Gene expression analysis of wild-type BMDCs identified a large number 
of type I IFN inducible genes which were induced in response to M. tuberculosis 
infection.  Previous  reports  have  suggested  that  LPS  stimulation  and  M. 
tuberculosis  infection  of  macrophages  can  induce  IFN  inducible  genes 
independent of MyD88 (Kawai, Takeuchi et al. 2001; Shi, Nathan et al. 2003). 
Since no similar studies have been performed with murine dendritic cells, the 
induction of type I IFN genes was determined in M. tuberculosis infected MyD88 
deficient  BMDCs  using  a  combination  of  microarray,  real-time  PCR  and 
bioinformatics approaches.  
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  Following a similar pattern to wild-type BMDCs, the most significantly 
represented KEGG pathways were that of TLR signalling, JAK-STAT signalling 
and cytokine-cytokine receptor interaction pathway. Although a large proportion 
of  genes  within  these  pathways  exhibited  similarities  between  wild-type  and 
MyD88 deficient BMDCs, some key differences did exist in the gene expression 
profiles.  
 
  Pattern  recognition  receptors  TLR  2  and  TLR  4  are  important  during 
mycobacterial  infections.  In  response  to  infection,  these  receptors  were  down 
regulated in MyD88 deficient BMDCs and in contrast, these receptors were up 
regulated  in  wild-type  BMDCs  in  response  to  M.  tuberculosis  infection.  In 
MyD88  deficient  BMDCs  it  is  possible,  that  delayed  kinetics  in  TLR  gene 
expression is responsible for this observation. This is likely, as other aspects of 
dendritic cell responses such as cytokine production by MyD88 deficient BMDCs 
is  induced  with  delayed  kinetics,  when  compared  to  wild-type  BMDCs,  in 
response to infection.  
 
 In the absence of MyD88, a proportion of type I IFN inducible genes and 
type I IFNs were up regulated in response to infection. These genes were further 
divided into functional gene clusters and genes involved in anti-viral immunity, 
cytokines/chemokines and genes which are part of the type I IFN pathway were 
differentially expressed in response to infection. A large number of genes in these 
clusters were induced in the absence of MyD88.  
 
But a detailed look, also highlighted certain differences in gene expression 
patterns,  between  wild-type  and  MyD88
-/-  BMDCs.  Cellular  immune  response 
genes Ifit2, OAS1a and Mx1 were down regulated in response to infection, as 
shown by real-time PCR (Figure 5.12). 
 
OAS encodes a family of 2’-5’oligoadenylate synthetase enzymes, which 
is induced in response to type I interferons and functions to activate RNase L that 
degrades viral RNA. The transcript for OAS1a was up regulated by 1.6 fold in 
wild-type  mice  but  was  down  regulated  by  a  factor  of  1.8  fold  in  MyD88
-/- 
BMDCs, OAS1c and OAS2 was up regulated by a more than a factor of 5 fold in   174 
wild-type  BMDCs  and  these  genes  did  not  display  a  significant  change  in 
expression, in MyD88
-/- BMDCs. Mx proteins which are part of the family of 
GTpases, was up regulated 1.13 fold in wild-type BMDCs and down regulated by 
a  factor  of  3  fold  in  MyD88
-/-  BMDCs,  as  shown  by  real-time  PCR.  The 
expression of SOCS 3 (up regulated by 4.0 fold) is known to suppress IFN alpha 
induced antiviral proteins like 2’-5’ oligoadenylate synthetase and Mx proteins. It 
is possible that up regulation of SOCS 3 contributes to the down regulation of 
these key anti-viral immune genes in MyD88
-/- BMDCs.  
 
Transcription of IFN beta appears to follow different kinetics of induction 
in MyD88
-/- and wild-type BMDCs, with this gene being down regulated at 4 
hours post-infection in MyD88
-/- BMDCs
 but is up regulated at later time points. 
In contrast, there is an increased induction of IFN beta at 4 and 24 hours post-
infection of wild-type BMDCs. At 24 hours, the induction of IFN beta and IFN 
alpha sub types in MyD88
-/- mice, suggests MyD88 independence in inducing 
specific sub-sets of type I IFNs.  
    
  In line with the induction of type I IFN inducible genes, ISRE motifs were 
significantly  present  in  promoters  of  differentially  regulated  genes  in  MyD88 
deficient BMDCs, as shown by TELiS analysis. Similar to wild-type BMDCs, 
IRFs  and  NFkB  transcription  factors  contribute  to  the  regulation  of  cellular 
response in MyD88 deficient BMDCs.  
 
  An overview of the key immune responses of M. tuberculosis infected 
MyD88
-/- BMDCs is illustrated in figure 5.14. Previous studies have shown that 
M. tuberculosis mediates gene expression in macrophages largely independent of 
MyD88 (Shi, Evans et al. 2003).  Similarly, M. tuberculosis infection of BMDCs 
also  mediates  the  expression  of  a  large  proportion  of  genes  independent  of 
MyD88 but the overall optimum immune response, as highlighted by the defective 
cytokine production and down regulation of key antiviral genes, seem to be still 
dependent on MyD88.   
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Figure 5.14- Overall schematics of differentially expressed immune response 
and signal transduction genes by M. tuberculosis infected MyD88
-/- BMDCs 
(24 hours post-infection) 
 
Gene expression values were obtained from microarray and real-time PCR data. 
 
 
 
 
 
 
 
 
 
 
 
TLR2
NFk k k kB (late phase)
IRF-3
MyD88
TRAF-6
TRIF
TRAM
TRAF-6
TBK-1
IKKe
TNF-a a a a
IL-1b b b b
IL-6
IL-12
MIP-1b b b b
CXCL9
CXCL10
IFN-b b b b
CD 40
CD 86
IFNa/bR
STAT-1
STAT-2
IFN inducible genes
TLR9 TLR4
Complement 
receptors
Mannose 
receptor
DC-SIGN
NFk k k kB NFk k k kB
NFk k k kB (early phase)
IRF-3
Cytoplasm
Nucleus
12.13
86.95
5.68 Ifnar1
2.1
-3.98
1.70
89.89
12.24
51.09
15.06
12.14
7.22
4.32
3.24
Up regulated genes
Down  regulated genes
Ifnar2
3.14
3.02
7.29
ISGF3
2.80 2.80
4.15 4.15
2.01
TLR2
NFk k k kB (late phase)
IRF-3
MyD88
TRAF-6
TRIF
TRAM
TRAF-6
TBK-1
IKKe
TNF-a a a a
IL-1b b b b
IL-6
IL-12
TNF-a a a a
IL-1b b b b
IL-6
IL-12
MIP-1b b b b
CXCL9
CXCL10
IFN-b b b b
MIP-1b b b b
CXCL9
CXCL10
IFN-b b b b
CD 40
CD 86
CD 40
CD 86
IFNa/bR
STAT-1
STAT-2
IFN inducible genes
TLR9 TLR4
Complement 
receptors
Mannose 
receptor
DC-SIGN
NFk k k kB NFk k k kB
NFk k k kB (early phase)
IRF-3
Cytoplasm
Nucleus
12.13
86.95
5.68 Ifnar1
2.1
-3.98
1.70
89.89
12.24
51.09
15.06
12.14
7.22
4.32
3.24
Up regulated genes
Down  regulated genes
Ifnar2
3.14
3.02
7.29
ISGF3
2.80 2.80
4.15 4.15
2.01  176 
 
 
 
 
 
 
Chapter 6 
 
 
 
 
 
Expression of IRF-3 and IRF-7 in M. tuberculosis infected BMDCs 
in the absence of MyD88 
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6.1- Introduction 
  The  expression  of  a  number  of  type  I  IFN  inducible  genes  is 
dependent on a set of transcription factors. Transcriptional induction of type I IFN 
genes is mediated by two main transcription factors IRF-3 and IRF-7. These two 
transcription  factors  are  structurally  related  and  belong  to  the  IRF  family  of 
transcription factors. IRF-3 is expressed constitutively, in its latent form, in the 
cytoplasm and undergoes nuclear translocation in response to viral stimulation. In 
contrast, IRF-7 is present in low levels in most cells and its expression is strongly 
induced  in  response  to  type  I  IFN  signalling.  Both  these  transcription  factors 
undergo  serine  phosphorylation  and  dimerisation,  before  translocation  to  the 
nucleus. IRF 3 is classically thought to be important in the activation of IFN beta 
and IRF-7 is responsible for the activation of IFN alpha genes.  
 
 
LPS, a TLR 4 ligand (Poltorak, He et al. 1998) and poly I:C, a TLR 3 
ligand  (Alexopoulou,  Holt  et  al.  2001),  are  potent  inducers  of  type  I  IFN 
responses. There is a lack of IFN beta mRNA induction in IRF3
-/- dendritic cells 
in response to LPS stimulation. This led to the suggestion that IRF-3 is important 
in the LPS mediated IFN beta induction via TLR 4 (Sakaguchi, Negishi et al. 
2003).  Type I IFN induction is mediated by a positive feed back loop mechanism 
and  recent  studies  have  shown,  that  heterodimers  of  IRF-3/IRF-7  or  the 
homodimer of IRF-7, are important in mediating the full induction of the type I 
IFN genes. IRF-7
-/- mice were highly susceptible to viral infection more so than 
MyD88
-/- mice, which coincide with decreased serum levels of IFNs. This paper 
also further demonstrated the dispensable role of IRF-3 during the induction of 
type I IFN genes in plasmacytoid dendritic cells via TLR9. Thus this key piece of 
work revealed the importance of IRF-7 in mediating innate anti-viral responses 
(Honda, Yanai et al. 2005).  
 
 
 
In the previous chapters an account of the induction of the type I IFN 
pathway has been given, with particular reference to the induction of the type I 
IFN  inducible  genes.  A  proportion  of  these  genes  have  been  found  to  be   178 
independent  of  the  adaptor  MyD88.  Additionally,  transcription  factor  binding 
motifs for IRFs, the ISRE sequence, was significantly present in the promoters of 
genes differentially regulated in response to M. tuberculosis infection, in both 
wild-type and MyD88
-/- BMDCs. In light of this evidence and what is known from 
the literature, the expression of the two key transcription factors regulating the 
induction of type I IFN inducible genes was characterised at the protein level 
using western blotting.  
 
6.2- Induction of IFN beta in response to stimulation by TLR3 and 
TLR4 ligands 
  In order to determine the ability of poly I:C (TLR 3 ligand) and LPS (TLR 
4 ligand) to induce type I IFNs ,  day 6 unsorted BMDCs were stimulated with 
either LPS or poly I:C and the levels of IFN beta were assessed using ELISA at 24 
hours post-stimulation.  
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Figure  6.1-  Induction  of  IFN  beta  in  response  to  LPS  and  poly  I:C 
stimulation of BMDCs.  
Day 6 BMDCs were either stimulated with LPS or poly I:C or left un-stimulated 
and supernatants were collected at 24 hours. IFN beta levels were determined 
using ELISA. Data is representative of 2 independent experiments.  
 
 
As shown in figure 6.1, LPS and poly I:C are capable of stimulating high 
levels of IFN beta, with poly I:C inducing higher levels of type I IFNs, especially 
in MyD88
-/- BMDCs. LPS stimulated MyD88 deficient BMDCs produced much 
lower levels of IFN beta in comparison to poly I:C stimulation. Thus, both LPS 
and  poly  I:C  were  able  to  induce  IFN  beta  production,  with  poly  I:C  being 
superior in inducing IFN beta production from BMDCs.  
 
 
6.3 Activation of IRF-3 and IRF-7 in response to M. tuberculosis 
infection 
Day 6 BMDCs from wild-type and MyD88
-/- unsorted BMDCs were either 
left uninfected, stimulated with LPS, poly I:C or infected with H37Rv at a M.O.I 
of 10:1 and nuclear extracts were obtained 4 hours and 24 hours post-infection. 
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The  expression  of  IRF-3  and  IRF-7  was  detected  using  western  blots  with 
antibodies against IRF-3 and IRF-7.  
 
 
IRF-3 was expressed at low levels in its non phosphorylated form in wild-
type uninfected cells and in contrast MyD88
-/- uninfected cells showed a higher 
expression level of IRF-3 (Figure 6.2). Overall, IRF-3 was highly expressed in 
response to poly I:C stimulation with slightly weaker expression in response to 
LPS stimulation of wild-type BMDCs (Figure 6.2, A). At 4 hours, in response to 
M.  tuberculosis  infection,  there  was  an  increase  in  IRF-3  phosphorylation,  as 
represented by the slower migrating band on the gel in wild-type BMDCs (Figure 
6.2, A). In MyD88
-/- BMDCs, the expression of IRF-3 was similar in response to 
LPS and poly I:C stimulation. IRF-3 expression was weaker in M. tuberculosis 
infected MyD88
-/- BMDCs. At 24 hours post-infection, the expression of IRF-3 
was  decreased  in  response  to  M.  tuberculosis  infection  of  MyD88
-/-  BMDCs 
(Figure 6.2, B). The phosphorylated form of IRF-3 was not detected in MyD88
-/- 
BMDCs in response to infection.  
 
 
IRF-7 was not expressed in uninfected wild-type cells and there was a 
faint expression of IRF-7, in MyD88
-/- uninfected BMDCs. At 4 hours, IRF-7 was 
expressed at very low levels in response to LPS and poly I:C stimulation in wild-
type and MyD88
-/- BMDCs (Figure 6.3). There was no expression of IRF-7 in 
response  to  M.  tuberculosis  stimulation  in  both  the  wild-type  and  MyD88 
knockout BMDCs at 4 hours. In contrast, there was an increase in expression of 
IRF-7 in response to M. tuberculosis infection at 24 hours as shown in figure 6.3, 
A and figure 6.3, B with an additional band appearing at 100kda. 
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Figure 6.2- Expression of IRF-3 in response to M. tuberculosis infection of A) 
wild-type B) MyD88
-/- BMDCs.  
BMDCs were uninfected, stimulated with LPS, poly I:C or infected with H37Rv 
at a M.O.I of 10:1 and nuclear extracts were isolated 4 and 24 hours later. Nuclear 
extracts were analysed using gel electrophoresis and IRF-3 was detected using 
anti-IRF-3 antibody.  
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Figure 6.3- Expression of IRF-7 in response to M. tuberculosis infection of A) 
wild-type B) MyD88
-/- BMDCs.  
BMDCs were uninfected, stimulated with LPS, poly I:C or infected with H37Rv 
at a M.O.I of 10:1 and nuclear extracts were isolated at 4 and 24 hours later. 
Nuclear extracts were analysed using gel electrophoresis and IRF-7 was detected 
using anti-IRF-7 antibody.  
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6.4-Discussion 
IRF-3  and  IRF-7  are  the  two  key  transcription  factors  involved  in  the 
induction of type I IFN inducible genes. The presence of these two proteins was 
detected using western blots from nuclear lysates of BMDCs. Since LPS and poly 
I:C are capable of inducing IFN beta , they were selected as positive controls for 
the western blot experiments. There was expression of IRF-3 in both wild-type 
and MyD88
-/- in response to LPS and poly I:C stimulation. IRF-3 was induced in 
the  presence  of  M.  tuberculosis  infection  with  varying  kinetics.  There  was  a 
strong  expression  of  IRF-3  in  wild-type  BMDCs  with  the  appearance  of  the 
phosphorylated  form  of  the  protein  at  4  hours  post-infection,  the  overall 
expression of which decreased at 24 hours post-infection. The decrease in protein 
expression of IRF-3 is possibly due to the susceptibility of IRF-3 to proteasome 
mediated degradation. This is similar to the scenario during viral infections,where 
the  phosphorylation  of  IRF-3  also  signals  initiation  of  protein  degradation 
(Hiscott, Pitha et al. 1999). In MyD88
-/- BMDCs there was a slight decrease in 
expression of IRF-3 in response to M. tuberculosis infection in comparison with 
uninfected BMDCs, which further decreased at later time points. It is possible that 
IRF-3 undergoes proteasome degradation even in MyD88
-/- BMDCs at later time 
point’s post-infection similar to the wild-type BMDCs.  
 
IRF-7 is induced in M. tuberculosis infected cells in both wild-type and 
MyD88
-/- BMDCs, albeit at lower levels in the absence of MyD88, at later time 
points  post-infection  (24  hours).  IRF-7  is  expressed  as  two  forms;  the  faster 
migrating 54kDa sub-unit and the slower migrating 100kDa possibly representing 
the dimerised form of IRF-7. In wild-type cells the kinetics of expression of IRF-7 
are quite clear, with no detectable expression at 4 hours and by 24 hours there is a 
clear induction with the appearance of the two forms of IRF-7. It is thought that 
the  homodimer  of  IRF-7  with  an  approximate  band  size  of  100kDa  binds  to 
specific  sequences  in  the  promoters  of  target  genes  and  enhances  their 
transcription (Marie, Smith et al. 2000). IRF-3 is induced at earlier time points 
post-infection with IRF-7 being expressed at later time points in response to M. 
tuberculosis infection, thus there is a delay in the expression of IRF-7 in response 
to M. tuberculosis infection.  
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Chapter 7 
 
 
 
 
 
 
Priming of anti-mycobacterial immune responses in the absence of 
MyD88 
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7.1- Introduction 
   
  The adaptor MyD88 plays a crucial role in TLR signalling as characterised 
by the fact that a number of toll-like receptors like TLR 2, 7 and 9, solely depend 
on  this  adaptor  for  efficient  signalling  (O'Neill  2003).  In  addition,  MyD88 
deficient mice are known to have an impaired ability to activate antigen specific 
Th-1 immune responses and are susceptible to a number of pathogens including 
Listeria  monocytogenes  (Edelson  and  Unanue  2002)  and  Toxoplasma  gondii 
(Scanga, Aliberti et al. 2002). As described previously in this study, microarray 
results showed that dendritic cell responses after M. tuberculosis infection were 
mediated through both MyD88 dependent and independent pathways; in particular 
type I IFN responses which were clearly induced in the absence of MyD88.  
 
 
The experiments described in this chapter were carried out to investigate 
the priming of anti-mycobacterial immune responses in the absence of MyD88, in 
an intravenous model of M. tuberculosis infection.  
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7.2-  M.  tuberculosis  infection  and  immune  responses  in  the 
absence of MyD88   
Wild-type (C57BL/6) and MyD88
-/- mice were divided into two groups, 
one group received 10
6 colony forming units (CFU) of H37Rv as a single dose 
intravenously  and  the  other  group  was  left  uninfected.  The  experimental 
procedure is described in materials and methods (section 2.8). Whole spleen cells 
were isolated at 14 days and 30 days post-infection and cultured in vitro, in the 
presence  or  absence  of  PPD  or  anti-CD3/CD28,  which  served  as  a  positive 
control.  Supernatants  were  collected  at  24  and  72  hours  post-stimulation,  for 
quantification of IL-2 and IFN-g respectively, by ELISA.  
 
As shown in figure 7.1 and 7.2, spleen cells from wild-type and MyD88 
-/- 
infected  mice  produced  IL-2  and  IFN-g  in  response  to  PPD  stimulation. 
Furthermore, the observed cytokine production in response to PPD stimulation 
was due to pre-exposure to mycobacterial antigens as spleen cells from naïve mice 
do not respond to PPD stimulation. 
 
MyD88
-/- T cells displayed a reduced capacity to proliferate in comparison, 
to  wild-type  T  cells  at  both  14  and  30  days  post-infection  (Figure  7.1).  In 
particular, differences were pronounced at 30 days post-infection at a higher PPD 
dose, in the absence of MyD88 (Figure 7.1, B). In response to a high dose of PPD 
stimulation, wild-type and MyD88
-/- T cells produced IFN-g at both 14 and 30 
days post-infection. But in the absence of MyD88, T cells were defective in IFN-g 
production in response to a low dose of antigen, at both 14 and 30 days post-
infection,  although  the  difference  in  IFN-g  production  between  wild-type  and 
MyD88
-/-  T  cells  was  less  prominent  at  30  days  post-infection  (Figure  7.2).  
Hence,  the  data indicates  a  MyD88  independent  route  of  T  cell  priming  with 
comparable IFN-g responses when stimulated with a high antigen dose.  
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Figure 7.1- Production of IL-2 in response to PPD stimulation of spleen cells 
from M. tuberculosis infected mice.  
Whole spleen cells were isolated at A) 14 days B) 30 days post-infection and 
stimulated in vitro with PPD. Levels of IL-2 were assayed using ELISA, 24 hours 
post-stimulation. Data are expressed as a mean ±SD of duplicate wells and are 
representative of two independent experiments.  
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Figure 7.2 – Production of IFN-g g g g  in response to PPD stimulation of spleen 
cells from M. tuberculosis infected mice. 
 Whole spleen cells were isolated ex-vivo at A) 14 days post-infection, B) 30 days 
post-infection and were stimulated using saline, PPD (at 0.1µg/ml, 1µg/ml and 
10µg/ml)  or  anti-CD3/CD28  (1µg/ml).  IFN-g  levels  were  measured  in 
supernatants using ELISA, 72 hours post-stimulation.  Results are representative 
of two independent experiments (mean ±SD of duplicate determinations in one 
experiment).  
 Saline,   PPD- 0.1µg/ml,   PPD- 1.0 µg/ml,   PPD-10µg/ml        
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7.3- Determining M. tuberculosis bacterial loads in the spleens and 
lungs of wild-type and MyD88
-/- mice 
  In the previous section, it was demonstrated that both MyD88 knockout 
mice and wild-type strains of mice were able to prime anti-mycobacterial specific 
T  cells.  To  address  the  ability  of  MyD88
-/-  mice  to  control  the  growth  of  M. 
tuberculosis, wild-type and MyD88
-/- mice were infected intravenously with 10
6 
CFU of H37Rv and bacterial counts were determined at 14 and 30 days post-
infection, in both lungs and spleens.  
 
 
As shown in fig 7.3, there was significant increase in the bacterial load in 
the spleens of MyD88
-/- mice at 14 days post-infection. At 30 days post-infection, 
at least 1 log10 higher bacterial counts were detected in the lungs of MyD88
-/- 
mice. Additionally, at each time point examined there were considerably higher 
bacterial counts in MyD88
-/- mice in comparison to wild-type mice.  
 
 
  Thus, MyD88
-/- mice have increased bacterial burdens in both lungs and 
spleens in comparison to wild-type mice, even though they are able to mount 
specific T cell responses producing high levels of IFN-g.  
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Figure 7.3 –Determining bacterial counts in wild-type and MyD88
-/- mice.  
Mice were injected intravenously with 10
6 colony forming units of H37Rv. At A) 
14 days and B) 30 days post-infection bacterial counts were determined. Results 
are expressed as the mean ±SEM of the bacterial load in each group expressed as 
log10 colony forming units (n=3 mice). *- p value < 0.05 
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7.4 Histological examination of lungs from MyD88
 -/- M. 
tuberculosis infected mice
 
At 30 days post-infection, whole lungs from M. tuberculosis infected wild-
type and MyD88
-/- mice were fixed in 10% formalin and paraffin-embedded lung 
sections were stained using hematoxylin and eosin. Microscopic examination of 
the lungs of MyD88
-/- mice 30 days post-infection revealed substantial interstitial 
inflammation  and  varying  degrees  of  necrosis,  nevertheless  there  was  also 
evidence  of  few  small  granulomas  (Figure  7.5  B).    Lungs  of  wild-type  mice 
showed  no  signs  of  necrosis  and there  was  clear  visible  granuloma  formation 
(Figure 7.4 B). Naïve wild-type and MyD88
-/- mice, which were not infected with 
H37Rv  showed  no  signs  of  granuloma  formation  or  interstitial  inflammation 
(Figures 7.4 A and 7.5 A).  
 
Thus,  in  the  absence  of  MyD88,  there  is  uncontrolled  growth  of  M. 
tuberculosis in the lungs, which is consistent with the increased bacterial counts in 
the lungs of these mice at 30 days post-infection (Figure 7.3, B).  
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Figure 7.4 – Lung histology of wild-type M. tuberculosis infected mice 
 
 Lung tissue sections from A) naïve mice, B) H37Rv infected mice and C) 
H37Rv infected mice (higher magnification x 400), were analysed 30 days post-
infection. Representative lung sections from n=3 mice are displayed.     
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Figure 7.5 – Lung histology of MyD88
-/- M. tuberculosis infected mice 
 
 Lung tissue sections from A) naïve mice, B) H37Rv infected mice and C) 
H37Rv infected mice (higher magnification x 400), were analysed 30 days post-
infection. Representative lung sections from n=3 mice are displayed.     
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7.5- Discussion 
The priming of a T cell immune response and the ability to control the 
growth of M. tuberculosis in the absence of MyD88 was addressed in this chapter. 
MyD88
-/- mice were able to produce comparable IFN-g responses to wild-type 
mice, although differences were observed when stimulating with a low antigen 
dose.  However,  T  cells  from  MyD88
-/-  mice  were  impaired  in  their  ability  to 
proliferate at 30 days post infection although the difference was less obvious at 14 
days  post-infection.  There  is  also  a  defect  in  controlling  bacterial  growth,  as 
shown by the increased levels of bacterial counts in both lungs and spleens of 
MyD88
-/-  mice,  at  14  and  30  days  post-infection.  This  is  reflected  in  the 
histological examination of MyD88
-/- mice at 30 days post-infection, where there 
was  increased  inflammation  and  evidence  of  necrosis  in  the  lungs  which  is 
suggestive of uncontrolled growth. Although, in the absence of MyD88 there is 
priming of T cells this is not protective, as demonstrated by the increased bacterial 
counts, thus the mice succumb to infection.  
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Chapter 8 
 
 
 
 
 
 
Discussion 
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Dendritic  cells  are  sentinels  of  the  immune  system  and  as  antigen 
presenting cells; they play a key role in processing and presenting antigens to 
naïve  T  cells.  Studies  have  reported  that  dendritic  cells  are  infected  with 
mycobacteria in the lungs and lymph nodes and furthermore, it has been proposed 
that  dendritic  cells  contribute  to  the  progression  of  disease  by  promoting 
dissemination of bacilli from the lungs to the draining lymph nodes (Humphreys, 
Stewart et al. 2006; Wolf, Linas et al. 2007). Previous work done in the lab has 
demonstrated that dendritic cells are capable of phagocytosing mycobacteria, thus 
leading to the priming of protective immune responses, which are comparable to 
or better than immune responses primed by BCG (Roy, De Silva et al. 2006) . 
 
The priming  of adaptive  immune responses by  dendritic cells not only 
requires the presentation of antigen on MHC-II but also the expression of co-
stimulatory molecules on the surface and induction of inflammatory cytokines. 
These properties are regulated by signalling pathways triggered by the binding of 
microbial ligands to receptors on dendritic cells.  However, there is very little 
information available regarding the signalling pathways in dendritic cells that play 
determinant  roles  in  modulating  the  protective  responses  following  M. 
tuberculosis infection. Thus, a detailed characterisation of the signalling pathways 
that are induced during the interaction of M. tuberculosis and dendritic cells will 
be crucial in understanding the pathogenesis of infection.  
 
The aim of the work described in this thesis was to use a microarray based 
approach  to  map  the  pattern  of  transcriptional  responses  of  M.  tuberculosis 
infected BMDCs and particular emphasis was placed on identifying  signalling 
pathways  that  are  significantly  represented  during  the  interaction  between  the 
pathogen and dendritic cells. To assist in the dissection of this complex network, 
the responses in dendritic cells from wild-type mice were compared to responses 
from dendritic cells from MyD88
-/- mice, a key adaptor of the TLR signalling 
pathway.     
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8.1- Transcriptional profiling of M. tuberculosis infected BMDCs 
Transcriptional profiling of M. tuberculosis BMDCs was performed using 
microarrays. Using this approach it was possible to have a global overview of the 
changes in gene expression of BMDCs in response to M. tuberculosis infection, as 
39,000 transcripts are represented on a single Affymetrix array.  
 
For this present study, the experimental population of dendritic cells was 
isolated  after  6  days  of  culture  in  GM-CSF.  Using  this  method  of  culture, 
approximately  70%  of  the  cells  were  dendritic  cells  as  identified  by  their 
expression of CD11c. Using this protocol it was possible to generate a highly 
reproducible  cell  population  which  was  suitable  for  microarray  studies.  To 
exclude any possible influence of contaminating cell types, key observations were 
confirmed using real-time PCR analysis on a population of dendritic cells that 
were further purified by positive selection using anti-CD11c magnetic beads.  
 
All  the  microarray  analysis  was  carried  out  at  24  hours  post-infection, 
based on previous knowledge from the lab and time course analysis of cytokine 
induction. The signalling pathways under study are clearly dynamic processes and 
the absence of time course for the microarray analysis represents an important 
limitation.  A  multiplicity  of  infection  of  10  bacteria  per  cell  was  selected  for 
microarray studies, based on initial experiments measuring cytokine expression. 
This  represents  a  relatively  high  dose  of  M.  tuberculosis,  but  was  found  to 
generate clearly detectable and reproducible transcriptional changes.   
 
8.2-  Signalling  pathways  induced  in  M.  tuberculosis  infected 
BMDCs 
An  overview  of  the  transcriptional  pathways  in  both  wild-type  and 
MyD88
-/- M. tuberculosis infected BMDCs, highlighted three major pathways: the 
TLR signalling pathway, the JAK-STAT signalling pathway and the cytokine-
cytokine receptor interaction pathway. The role of TLR signalling in the immune 
response  to  mycobacteria  has  been  extensively  documented.  Thus,  significant   198 
representation  of  the  TLR  signalling  pathway  is  not  surprising,  as  TLRs  are 
important in recognising conserved microbial structures thus playing a critical role 
in  the  induction  of  innate  immune  responses  in  the  host  (Medzhitov  2001). 
Interestingly,  the  expression  of  TLR  2  and  TLR  4  which  are  known  to  be 
important in recognising mycobacterial components were down regulated in the 
absence  of  MyD88  and  up  regulated  in  wild-type  BMDCs  in  response  to  M. 
tuberculosis infection (Figures 4.5 and 5.7). The expression levels of TLRs have 
been previously demonstrated to vary between different populations of immune 
cells.  Monocytes in response to LPS increase TLR 4 expression at 2-4 hour post-
stimulation (Muzio, Bosisio et al. 2000). However, human dendritic cells were 
reported  to  down  regulate  TLRs  during  the  course  of  maturation  (Visintin, 
Mazzoni  et  al.  2001)  and  similarly,  macrophages  down  regulated  TLR4 
expression in response to LPS at early time points, with expression levels almost 
equal to un-stimulated cells by 20 hours post-stimulation (Nomura, Akashi et al. 
2000). So it is evident that the TLR expression varies quite considerably with 
different immune cells and, if down regulation of TLRs is a process associated 
with dendritic cell maturation, then the question remains as to why the wild-type 
BMDCs  which  clearly  mature  in  response  to  M.  tuberculosis  infection,  as 
indicated  by  the  up-regulation  of  co-stimulatory  molecules  and  production  of 
inflammatory cytokines, up regulate TLR 2 and 4.  
 
 
8.2.1- Activation of BMDCs in response to M. tuberculosis infection 
TLR  signalling  results  in  the  activation  of  NFkB  driven  expression  of 
genes encoding a series of inflammatory cytokines and co-stimulatory molecules, 
which are involved in the interaction between mature dendritic cells and T cells. 
Using  a  bioinformatics  approach  it  was  possible  to  screen  for  known 
transcriptional response elements in the upstream region of induced genes (TELiS 
analysis).  This  analysis  highlighted  an  important  role  for  NFkB  and  IRFs. 
Consistent with the induction of NFkB signalling, genes encoding CD80, CD86 
and  MHC-II  (Figure  3.3)  were  up  regulated  in  response  to  M.  tuberculosis 
infection.  The  induction  of  these  activation  markers  was  comparable  between 
wild-type  and  MyD88
-/-  BMDCs  (Figure  5.2)  in  response  to  infection.  These   199 
observations are in accordance with previous studies which demonstrated that up 
regulation  of  co-stimulatory  molecules  is  independent  of  MyD88  (Kaisho  and 
Akira 2001; Fremond, Yeremeev et al. 2004). In contrast to the observations in 
BMDCs,  it  has  been  previously  reported  that  macrophages  infected  with  M. 
tuberculosis or stimulated with the 19kDa lipoprotein are defective in their ability 
to  up-regulate  MHC-II  and  furthermore  that  these  stimulants  reduced  IFN-g 
mediated  expression  of  CD86  expression  on  macrophages  (Pai,  Pennini  et  al. 
2004).   
 
Cytokines are important mediators of immune responses against various 
pathogens.  In  response  to  M.  tuberculosis  infection,  significant  levels  of 
inflammatory cytokines were produced by wild-type BMDCs (Figures 3.4, 3.5 
and 3.6). In contrast, there was impaired production of IL-12p40, IL-6 and TNF-a 
by  M.  tuberculosis  infected  MyD88
-/-  BMDCs  and  IL-10  and  IL-12p70  were 
undetectable in the absence of MyD88 (Figures 5.3 and 5.4). IL-10 expression at 
the  mRNA  and  protein  was  similar  in  both  wild-type  and  MyD88
-/-  M. 
tuberculosis infected macrophages (Shi, Blumenthal et al. 2005) but in response 
to M. tuberculosis infection, BMDCs up regulated IL-10 by a factor of 40.2 fold 
in wild-type BMDCs and 34.39 fold in MyD88
-/- BMDCs, as shown by real-time 
PCR  analysis,  thus  suggesting  a  MyD88  independent  expression  of  IL-10. 
However,  the  production  of  IL-10  cytokine  was  dependent  on  the  MyD88 
signalling pathway as there was no measurable IL-10 in M. tuberculosis infected 
MyD88
-/- BMDCs.  
 
A recent report suggests that dendritic cells are able to induce high levels 
of  IL-12 production by  remodelling the IL-12p40  promoter in response  to M. 
tuberculosis infection signalling via TLR 9 (Pompei, Jang et al. 2007). Induction 
of IL-6 and IL-10 production is predominantly mediated via TLR 2 in response to 
M.  tuberculosis  infection  (Jang,  Uematsu  et  al.  2004).  MyD88  is  an  essential 
adaptor for signalling via a number of TLRs especially TLR 2 and TLR 9 and thus 
in the absence of MyD88 signalling via these TLRs is impaired. This could be a 
contributing factor for the reduction of IL-6 and the reason for the IL-10 being 
undetected in response to infection of MyD88
-/- BMDCs.  
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High  levels  of  IL-6  and  TNF-a  production  following  M.  tuberculosis 
infection were detected as early as 6 hours post-infection in wild-type BMDCs but 
maximum  cytokine  production  was  not  detected  until  48  hours  in  MyD88
-/- 
BMDCs (Figure 5.3), thus clearly indicating a severe delay in the production of 
these cytokines. Since NFkB has been strongly implicated in the transcriptional 
regulation of an array of cytokines including IL-6, the observed delay in cytokine 
production is possibly due to the delayed NFkB activation that is observed during 
induction of signalling via the MyD88 independent pathway (Covert, Leung et al. 
2005). This delay in activation of NFkB has been attributed to the time required 
for  IRF-3  mediated  TNF-a  expression,  which  subsequently  binds  to  the  TNF 
receptors and mediates NFkB activation (Covert, Leung et al. 2005).  
 
The  induction  of  TNF-a  production  in  response  to  M.  tuberculosis 
infection  of  BMDCs  was  considerably  reduced  in  the  absence  of  MyD88  in 
comparison to wild-type BMDCs, which correlates with the reduced induction of 
TNF-a    mRNA  in  the  absence  of  MyD88  (Figure  5.7,  A).  These  results  are 
suggestive of a MyD88 dependent pathway for the induction of TNF-a at the 
mRNA  and  protein  level.  The  dependence  on  MyD88  for  post-transcriptional 
control is in agreement with studies in M. tuberculosis infected macrophages but 
in contrast, the induction of TNF-a gene was found to be independent of MyD88 
in infected macrophages (Shi, Blumenthal et al. 2005).  
 
Studies have suggested that inhibition of phosphoinositide-3 kinase (PI3K) 
leads to the reduction in LPS induced secretion of TNF-a and similar results were 
also obtained for MyD88 independent induction of TNF-a in adenovirus infected 
BMDCs (Philpott, Nociari et al. 2004). PI3K( p85a regulatory subunit) was up 
regulated by a factor of 2.54 in wild-type BMDCs and 4.91 fold in MyD88
-/- 
BMDCs in response to M. tuberculosis infection. Thus it is plausible that TNF-a 
induction in the absence of MyD88 occurs via a PI3K induction pathway during 
M. tuberculosis infection.  
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As illustrated in figure 8.1, it is reasonable to believe that in wild-type 
BMDCs,  triggering  the  MyD88  dependent  pathway  of  NFkB  activation 
(Baltimore, 2005) accounts for the optimal cytokine production in response to 
infection.  However,  the  delay  in  cytokine  production  observed  in  MyD88
-/- 
BMDCs in response to infection correlates with delayed NFkB activation via the 
MyD88  independent  pathway  (Covert,  Leung  et  al.  2005). With  the  increased 
expression of PI3K in MyD88
-/- BMDCs in response to infection, it is plausible 
that signalling via PI3K contributes to the production of TNF-a in response to M. 
tuberculosis infection. But the receptor that is involved in the induction of PI3K 
signalling pathway, in the context of M. tuberculosis infection of BMDCs, has yet 
to be determined. 
 
The production of pro-inflammatory cytokines such as IL-12 by dendritic 
cells clearly has a role in triggering an effective protective immune response to M. 
tuberculosis  .This  inflammatory  response  is  balanced  by  anti-inflammatory 
cytokines  such  as  IL-10,  in  order  to  limit  the  immunopathology  during  M. 
tuberculosis infection. Wild-type BMDCs are activated in response to infection, 
as  shown  by  the  production  of  inflammatory  cytokines  and  up-regulation  of 
CD80, CD86 and MHC-II. In the absence of MyD88, BMDCs up regulate co-
stimulatory molecule expression and enhance their T cell stimulatory activity, but 
it  is  clear  that  optimal  production  of  inflammatory  cytokines  is  dependent  on 
MyD88. Overall, these results confirm and extend previous reports of the role of 
TLR-signalling  and  NFkB  mediated  transcription  of  inflammatory  cytokine 
response to M. tuberculosis infection. 
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Figure 8.1- MyD88 dependent and independent pathway mediated activation 
of NFk k k kB 
Triggering the activation of NFkB can be mediated by the MyD88 dependent 
signalling pathway or independent of MyD88 via the induction of TNF-a.  
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8.3-  Induction  of  IFN  alpha  and  IFN  beta  in  the  absence  of 
MyD88 
While  the  role  of  NFkB  mediated  transcription  in  the  response  to 
mycobacterial  infection  is  well  known,  the  major  contribution  of  IRFs  to  the 
transcription profile was unexpected. In this data, IRF mediated transcription of 
the type I IFN pathway was a significant feature of the microarray data obtained 
in response to M. tuberculosis infection. Type I IFNs are usually associated with 
responses  to  viruses  with  type  II  interferons  being  coupled  to  mycobacterial 
responses. Previous studies have demonstrated, that the Esx-1 secretion system is 
required for the induction of IFN beta in macrophages and a reduction in the 
ability to produce type I IFNs was associated with an increased capacity to limit 
the replication of M. tuberculosis (Stanley, Johndrow et al. 2007). Additionally it 
has been demonstrated that high levels of IFN alpha were induced by HN878 
(Beijing  family),  a  hypervirulent  strain  of  M.  tuberculosis.  This  increased 
induction of IFN alpha has been associated with the decreased induction of IL-12 
(Manca, Tsenova et al. 2001) . The type I IFN response in murine dendritic cells 
in response to M. tuberculosis infection has not been clearly addressed.  
 
Analysis of the microarray expression profile revealed a prominent IFN 
signature  as  part  of  the  dendritic  cell  based  immune  responses,  including  up 
regulation  of  the  major  transcription  factor  IRF-7.  Microarray  results  were 
corroborated with real-time PCR, which showed significant up regulation of IRF-
7  and  IRF-3  (the  other  key  type  I  IFN  pathway  regulator)  at  24  hours  post-
infection  in  both  wild-type  and  MyD88
-/-  BMDCs.  Analysis  at  different  time 
points using real-time PCR demonstrated an initial transient down regulation of 
IRF-3, followed by the up regulation of IRF-3 at 24 hours post-infection (Figures 
4.8 and 5.8). In contrast, the expression of IRF-3 was highly induced at the protein 
level at early time points, with decreased expression at 24 hours post-infection 
(Figure  6.2)  in  both  wild-type  and  MyD88
-/-  BMDCs.  This  is  associated  with 
proteasomal degradation of IRF-3 (Hiscott, Pitha et al. 1999). IRF-7 was induced 
by  24  hours  post-infection  in  both  wild-type  and  MyD88
-/-  BMDCs,  thus 
suggesting a delay in the induction of this transcription factor in comparison to 
IRF-3. This observation is consistent with the biphasic induction of type I IFNs,   204 
where  the  level  of  IRF-7  is  increased  after  the  induction  of  the  type  I  IFN 
mediated amplification loop (Marie, Durbin et al. 1998). 
  
 Type I interferons induce their synthesis by activating both STAT 1 and 
STAT 2, both of which are key players in the type I IFN pathway and are up 
regulated by a factor of 3 fold or more in both wild-type and MyD88
-/- BMDCs 
(Table 5.7). Activation of the type I IFN signalling pathway led to the comparable 
production of IFN beta in both wild-type and MyD88
-/- BMDCs (Tables 4.10 and 
5.10). In contrast, IFN alpha production was detected at later time points post-
infection  only  in  MyD88
-/-  BMDCs  (Figure  5.11),  although  IFN  alpha  was 
induced at the mRNA level in both wild-type and MyD88
-/- dendritic cells (Figure 
5.11).  This  induction  of  type  I  IFNs  in  BMDCs  is  similar  to  a  study,  which 
demonstrated that human dendritic cells can produce type I IFNs in response to M. 
tuberculosis infection (Remoli, Giacomini et al. 2002).   
 
IRF-7 is critical in inducing IFN alpha gene expression (Honda, Yanai et 
al. 2005) and is necessary for the induction of late response IFN alpha genes (non-
IFN alpha 4 genes) which requires ongoing protein synthesis. IFN alpha 4 (early 
response  gene)  expression  and  IFN  alpha  2,  7  and  9  (late  response  gene) 
expression was comparable in both MyD88
-/- and wild-type BMDCs in response 
to infection (Figures 4.10 and 5.10) Thus, it is plausible that the expression of 
IRF-7 even in the absence of MyD88 is responsible for the similar expression of 
IFN  alpha  genes  in  both  wild-type  and  MyD88
-/-  BMDCs  in  response  to  M. 
tuberculosis infection.  
 
  The  results  demonstrate  the  overall  dominance  of  the  IRF  and  NFkB 
mediated  transcription,  which  is  retained  even  in  the  absence  of  MyD88,  in 
response to M. tuberculosis infection. The induction of IFN alpha and beta in 
dendritic cells is independent of MyD88 in response to M. tuberculosis infection.    205 
 
8.4- Expression of type I IFN inducible genes as an integral part of 
the dendritic cell based immune response  
Detailed analysis of the microarray data revealed a subset of type I IFN 
inducible genes which were differentially regulated in wild-type and MyD88
-/- 
BMDCs in response to M. tuberculosis infection.  Key genes involved in anti-viral 
immunity were up regulated in wild-type BMDCs in response to infection which 
included the OAS family of genes which are important in the activation of RNase 
L leading to the degradation of viral RNA , Pkr (RNA dependent protein kinase) 
and  Mx2  (family  of  GTPases),  both  which  are  activated  by  type  I  IFNs.  In 
contrast, these genes did not exhibit a significant change in expression in infected 
MyD88
-/- BMDCs (Table 5.9).  
 
 
In the absence of MyD88, a subset of type I IFN inducible genes are still 
induced in response to M. tuberculosis some of which share similar expression 
patterns to wild-type mice. Type I IFN induced genes commonly induced in wild-
type and MyD88
-/- BMDCs include genes involved in signalling (STAT-1, STAT-
2, IRF-7, Traf3, Ifih1), antiviral activities (G1p2, Isg20), cytokines/chemokines 
(CXCL10,  Ebi3,  IL12b,  IL6,  Ifnb1,  Ifna2,  Ifna4,  Ifna7,  Ifna9),  MHC  antigen 
processing and presentation (H2-q10, Tap1, Psme2) and immune response genes 
(Ifit1, Ifi35).  
 
 
Although a number of IFN beta and IFN alpha genes and key signalling 
molecules (IRF-7) were induced in the absence of MyD88
-/- there still exists an 
clear  defect  in  the  induction  of  OAS,  Pkr,  Mx  proteins,  which  are  well 
characterised  and  considered  to  be  key  anti-viral  immune  response  genes. 
Previous studies have demonstrated that TLR3 and TLR 4 can induce expression 
of a set of IFN inducible genes in macrophages, which were classified as ‘primary 
response genes’- IFN beta, CXCL10, G1p2 and Ifit1 (up regulated by 2 hours in 
response  to  LPS  stimulation  in  the  presence  of  cycloheximide)  or  ‘secondary   206 
response  genes’-Mx1,  Ifi1  and  IRF-7  (induced  after  2  hours,  sensitive  to 
cycloheximide treatment) (Doyle, Vaidya et al. 2002).  
 
 
As illustrated in figure 8.2, type I IFN primary response genes are induced 
in both wild-type and MyD88
-/- BMDCs in response to infection albeit at lower 
levels  in  the  absence  of  MyD88.  It  is  reasonable  to  believe  that  a  delay  or 
suppression in the amplification loop mechanism may lead to the down regulation 
or  lack  of  expression  of  the  secondary  response  genes  in  MyD88
-/-  BMDCs 
(Figure 8.2). This observation is further highlighted by the unchanged expression 
of  the  transcript  for  IRF-9  in  MyD88
-/-  BMDCs.  IRF-9  is  part  of  the 
transcriptional complex in the amplification loop mediating the transcription of 
the secondary response genes. However, the expression of IRF-7 is comparable 
between wild-type and MyD88
-/- BMDCs in response to infection.  
 
 
In general, although minor differences do exist in the induction of type I 
IFN  inducible  genes,  it  can  be concluded  that  the  type  I  IFN  response  to  M. 
tuberculosis infection is predominantly MyD88 independent.  
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Figure 8.2- Induction of type I IFN primary and secondary response genes in 
M. tuberculosis infected BMDCs   
IRF-3 induces the expression of a set of primary response genes including IFN 
beta which binds to the IFN (alpha and beta receptor) and induces the expression 
of  secondary  response  genes.  All  the  fold  change  values  for  the  genes  were 
obtained from microarray and real-time PCR data.  ND- change in expression of 
the gene is not statistically significant. 
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8.5-Priming of anti-mycobacterial T-cells in the absence of MyD88 
The induction of type I IFNs in the absence of MyD88 prompted the study 
of  the role the MyD88  in  priming anti-mycobacterial T  cell responses. Innate 
immune responses were impaired in MyD88
-/- mice infected with M. avium and 
during  H37Rv  infection  even  though  there  was  priming  of  acquired  immune 
responses  (Fremond,  Yeremeev  et  al.  2004;  Scanga,  Bafica  et  al.  2004).  In 
contrast,  (Sugawara,  Yamada  et  al.  2003)  found  that MyD88
-/-  mice were  not 
highly susceptible to M. tuberculosis infection. The difference between the report 
by Sugawara et al and others was attributed to the different M. tuberculosis strains 
that were used for infection and the background strain of the knockout mice.  
 
 
In  this  study,  in  response  to  antigen  stimulation,  there  was  reduced 
proliferation of T cells from MyD88
-/- mice when compared to T cells from wild-
type  mice,  although  T  cells  from  MyD88
-/-  mice  produced  almost  equivalent 
levels  of  IFN-g  to  wild-type  mice  when  stimulated  with  a  high  antigen  dose 
(Figures  7.1  and  7.2)..  However,  there  were  significantly  increased  bacterial 
counts in the spleens at 14 days and lungs at 30 days post-infection which is also 
reflected in the histology. Increased necrotic lesions at 30 days in the lungs of 
MyD88
-/- mice signified the uncontrolled growth of the bacteria in these mice. 
One  of  the  reasons  associated  with  the  inability  of  controlling  bacterial  loads 
could be the defective cytokine production from key antigen presenting cells such 
as dendritic cells. The impaired cytokine production could also contribute to the 
inefficient  T  cell  proliferation  observed  in  MyD88
-/-  mice  (Figure  7.1). 
Furthermore,  the  production  of  IL-6  has  been  suggested  to  be  important  in 
rendering  pathogen  primed  T  cells  refractory  to  T  cell  mediated  suppression 
(Pasare and Medzhitov 2003); the induction of this cytokine is severely impaired 
from MyD88
-/- dendritic cells in response to infection (Figure 5.3, B). Recently, it 
has also been demonstrated that impaired signalling through the IL-1 receptor also 
contributes to the defective control of M. tuberculosis infection which is similar to 
that seen in MyD88
-/- mice (Fremond, Togbe et al. 2007). 
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Thus,  in  the  presence  of  a  strong  T  cell  response  (IFN-γ  production), 
MyD88
-/-  mice  still  had  elevated  levels  of  bacterial  counts  which  were  more 
prominent at 30 days post infection. This phenomenon could be attributed to the 
defective  cytokine  production  from  key  antigen  presenting  cells  like  dendritic 
cells which are required for the long term control of the infection and also to the 
IL-1 receptor signalling pathway which is also impaired in the absence of MyD88.  
 
 
8.6- Conclusions 
Global  gene  expression  analysis  has  enabled  the  identification  of 
signalling pathways known to be important in the dendritic cell based immune 
responses including the TLR signalling pathway and type I IFN pathway, with 
IRFs  and  NFkB  being  the  primary  transcription  factors  responsible  for  the 
modulation of the transcriptional changes in response to infection. This is clearly 
a dynamic process and the focus of the present analysis on a single time point at 
24  hours  after  infection  probably  underestimates  the  overall  complexity. 
Restriction  of  analysis  to  the  transcriptional  responses  also  fails  to  capture 
information about changes in protein phosphorylation and subcellular location.  
 
 
Analysis of the process of M. tuberculosis infection of dendritic cells by 
expression profiling identifies two major transcriptional themes: a prominent pro-
inflammatory cytokine response leading from the activation of the NFkB which 
contributes  to  the  induction  of  a  Th-1  response  associated  with  resistance  to 
mycobacterial infection, and the induction of the type I IFN response which is via 
IRF-mediated  pathways.  Interestingly,  the  induction  of  type  I  IFNs  is 
predominantly  independent  of  MyD88  in  M.  tuberculosis  infected  BMDCs 
although the expression of important anti-viral genes is impaired in the absence of 
MyD88.  
 
 
In  the  absence  of  MyD88,  T  cell  stimulatory  (up  regulation  of  CD80, 
CD86 and MHC-II) and migration capability of mature dendritic cells is intact,   210 
however, another aspect of dendritic cell maturation response including optimum 
inflammatory  cytokine  production  from  BMDCs  is  dependent  on  MyD88.  In 
accord with previous macrophage studies, MyD88
-/- BMDCs retain in large part 
their ability to recognise and respond to mycobacterial infections. It is reasonable 
to speculate that as yet unidentified receptors may contribute to the responses 
observed  in  a  MyD88  independent  manner,  alongside  signalling  via  the 
TRAM/TRIF pathway as described for TLR 4.  
 
 
Thus,  the  type  I  IFN  response  appears  to  be  an  integral  part  of  the 
dendritic cell based immune response and hence understanding the role of these 
cytokines during mycobacterial infections will be crucial. 
 
 
 
In  general,  deciphering  the  mechanisms  of  interaction  between 
mycobacteria  and  dendritic  cells,  with  particular  reference  to  the  signalling 
pathways  that  are  evoked,  will  aid  in  understanding  the  modulation  of  host 
mediated  immune  responses  to  this  highly  adapted  intracellular  pathogen.  An 
understanding of these mechanisms of immune actions can be an important step 
forward in designing new therapeutic approaches as well as improving vaccine 
design.  
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8.7- Future perspectives 
The work presented in this thesis provides an opportunity to characterise 
the type I IFN mediated response which has been demonstrated to be induced in 
the absence of MyD88 in M. tuberculosis infected BMDCs. The role of type I 
IFNs during mycobacterial infection is not well understood. It has been previously 
reported that the HN878, Beijing family of M. tuberculosis induced high levels of 
type I IFNs but in contrast, a recent report suggests that type I IFN production is 
not  unique  to  the  Beijing  family  but  is  also  induced  by  other  strains  of  M. 
tuberculosis (Manca, Tsenova et al. 2001; Ordway, Henao-Tamayo et al. 2007).  
It will be interesting to explore the nature of events responsible for the activation 
of the type I IFN pathway, as it has been reported that the induction of type I IFNs 
involves the esx-1 secretion system which is a major determinant of virulence in 
M. tuberculosis (Stanley, Johndrow et al. 2007).   
 
 
 
If the type I IFN response is indeed deleterious to protective immunity, 
understanding the underlying recognition pathway for the induction of type I IFNs 
would  be crucial.  Interpreting  the  cross-talk  between MyD88  independent  and 
type I IFN pathways will be important in understanding the events that lead to the 
development of cell mediated immunity.   
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Appendix-I – Affymterix quality control plots- Wild-type BMDCs 
 
RNA digestion plot of wild-type BMDCs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The RNA plots are typical of one cycle amplification and there are no apparent 
signs of RNA degradation thus indicating a good quality of RNA. 
 
Box plot of wild-type BMDCs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The box plot indicates some variation in the mean intensity value but this was 
reduced after the normalisation. Generally, the replicates are in good agreement 
with each other.    238 
Appendix-II -Affymterix quality control plots- MyD88
-/- BMDCs 
 
RNA digestion plot of MyD88
-/- BMDCs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The RNA plots are typical of two cycle amplification and the digestion plot 
indicates a good quality of RNA. 
 
Box plot of MyD88
-/- BMDCs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The box plots indicate that the replicates are in good agreement with each other.  
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Appendix- III- Western Blot reagents 
 
 
NuPage LDS (Lithium dodecyl sulphate) Sample buffer 
 
Glycerol-10%, 
Tris Base-141 mM 
Tris HCl-106 mM 
LDS-2% 
EDTA-0.51 mM 
SERVA® Blue G250-0.22 mM 
Phenol Red-0.175 mM 
pH 8.5 
 
 
Tris-Glycine Buffer SDS running buffer 
 
25 mM Tris (pH 8.3) 
192 mM glycine 
0.1% SDS 
 
10% Tris-HCL gels 
 
10% resolving gel 
4% stacking gel 
 
Transfer buffer 
 
25mM Tris (3.03g) 
192mM glycine (14.4g) 
20% v/v methanol (200ml) 
Add distilled water to 1 litre (pH 8.3) 
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Appendix-IV- KEGG pathways- Wild-type BMDCs 
 
KEGG pathway list identified from microarray analysis of M. tuberculosis 
infected BMDCs (wild-type) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genes overlapping with Pathways  p value
 Toll-like receptor signaling pathway  8.68E-12
Jak-STAT signaling pathway 1.17E-10
 Cytokine-cytokine receptor interaction  2.06E-09
 Type I diabetes mellitus 3.44E-06
 Hematopoietic cell lineage  1.14E-04
 Antigen processing and presentation  4.89E-04
Cell adhesion molecules (CAMs) 7.68E-04
Adipocytokine signaling pathway 1.01E-03
 Type II diabetes mellitus 9.52E-03
ABC transporters 1.17E-02
 Apoptosis 2.05E-02
Phosphatidylinositol signaling system  2.25E-02
 B cell receptor signaling pathway 6.45E-02
 mTOR signaling pathway  6.49E-02
T cell receptor signaling pathway  9.62E-02
 Focal adhesion 1.10E-01
Natural killer cell mediated cytotoxicity 1.17E-01
 MAPK signaling pathway  1.47E-01
Notch signaling pathway  1.76E-01
Complement and coagulation cascades  1.80E-01
Cell cycle 2.94E-01
 ECM-receptor interaction  3.04E-01
 Neuroactive ligand-receptor interaction  4.12E-01
Fc epsilon RI signaling pathway  5.36E-01
TGF-beta signaling pathway  5.50E-01
VEGF signaling pathway  5.71E-01
Leukocyte transendothelial migration  5.81E-01
 Regulation of actin cytoskeleton 6.35E-01
Wnt signaling pathway 7.71E-01  241 
Appendix-V- KEGG pathways- MyD88
-/- BMDCs 
 
KEGG pathway list identified from microarray analysis of M. tuberculosis 
infected BMDCs (MyD88
-/-) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KEGG pathways  p-value
 Jak-STAT signaling pathway 6.52E-11
Cytokine-cytokine receptor interaction 1.02E-09
Toll-like receptor signaling pathway  7.45E-09
B cell receptor signaling pathway  1.97E-06
T cell receptor signaling pathway 1.05E-05
Complement and coagulation cascades 4.31E-05
 Focal adhesion  1.32E-04
Leukocyte transendothelial migration 2.94E-04
 Cell cycle  3.27E-04
Apoptosis  4.93E-04
 Hematopoietic cell lineage 1.98E-03
Cell adhesion molecules (CAMs) 2.85E-03
ABC transporters 3.05E-03
 Proteasome 6.12E-03
mTOR signaling pathway  1.54E-02
Natural killer cell mediated cytotoxicity  1.90E-02
ECM-receptor interaction 2.10E-02
SNARE interactions in vesicular transport  2.18E-02
Adipocytokine signaling pathway 2.22E-02
Regulation of actin cytoskeleton 2.56E-02
MAPK signaling pathway  3.91E-02
Fc epsilon RI signaling pathway  4.02E-02
 Phosphatidylinositol signaling system  5.96E-02
 Type II diabetes mellitus  7.29E-02
Type I diabetes mellitus  8.37E-02
 Atrazine degradation  1.42E-01
Gap junction 1.51E-01
TGF-beta signaling pathway 1.76E-01
VEGF signaling pathway  2.14E-01
Tight junction  2.41E-01
 Antigen processing and presentation 3.81E-01
Cell Communication 9.09E-01
Adherens junction  9.80E-01  242 
 
 
Appendix- VI- Normalised gene values   
 
Type I IFN inducible genes commonly represented in both C57BL/6 and 
MyD88
-/- BMDCs 
 
The normalised values for the type I IFN inducible genes (pooled from microarray 
and real-time PCR data) in both uninfected and H37Rv10:1 (infected) groups are 
displayed.  
 
 
 
 
 
 
Affymetrix ID Common name Description 
Wild-type MyD88
-/-
Uninfected Infected Uninfected Infected
1423555_a_at 0.03 3.41 0.37 1.71 A430056A10Rik interferon-induced protein 44
1418240_at 0.5 1.98 0.48 1.41 Gbp2 guanylate nucleotide binding protein 2 Antiviral immunity
1450783_at 0.03 3.05 0.23 1.72 Ifit1 interferon-induced protein with tetratricopeptide repeats 1
1419569_a_at 0.1 3.42 0.18 1.87 Isg20 interferon-stimulated protein 20
1424339_at 0.05 2.84 0.13 1.87 Oasl1 2'-5' oligoadenylate synthetase-like 1
1418587_at 0.7 1.4 0.21 1.67 Traf3 Tnf receptor-associated factor 3
1418930_at 0.03 3.35 0.26 1.89 Cxcl10 chemokine (C-X-C motif) ligand 10 Cytokines and chemokines
1449497_at 0.16 1.91 0.20 2.47 Il12b interleukin 12b
1417244_a_at 0.03 2.25 0.32 1.71 Irf7 interferon regulatory factor 7
1420915_at 0.33 1.79 0.53 1.35 Stat1 signal transducer and activator of transcription 1 IRFs and Type I IFN pathway
1421911_at 0.21 2.14 0.42 1.42 Stat2 signal transducer and activator of transcription 2
1426324_at 0.78 1.4 0.67 1.49 H2-Q10 histocompatibility 2, D region locus 1
Antigen processing and 
presentation via MHC-I
1417189_at 0.73 1.47 0.45 1.43 Psme2 proteasome (prosome, macropain) 28 subunit, beta
1416016_at 0.6 1.74 0.40 1.36 Tap1 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
1434268_at 0.62 1.61 0.78 1.65 Adar adenosine deaminase, RNA-specific Regulation of transcription
1450744_at 0.59 1.56 0.42 1.69 Ell2 elongation factor RNA polymerase II 2
1435446_a_at 0.58 1.56 0.73 1.36 Chpt1 choline phosphotransferase 1
1451426_at 0.2 2.48 0.37 1.52 D11Lgp2e DNA segment, Chr 11, Lothar Hennighausen 2, expressed
1422433_s_at 1.32 0.74 1.70 0.68 Idh1 isocitrate dehydrogenase 1 (NADP+), soluble Miscellenaeous
1421207_at 0.52 1.53 0.20 2.10 Lif
1452178_at 0.37 2.25 0.56 1.26 Plec1 plectin 1
1434015_at 0.48 1.6 0.61 1.24 Slc2a6 solute carrier family 2 (facilitated glucose transporter), member 6
1417961_a_at 0.21 1.78 0.58 1.49 Trim30 tripartite motif protein 30
1418191_at 0.31 2.22 0.34 1.53 Usp18 ubiquitin specific peptidase 18
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Appendix- VII- Complete gene list of differentially regulated 
genes in response to M. tuberculosis infection of wild-type BMDCs  
 
 
 
 
 
 
 
 
 
All genes have a fold change of 1.4 and a p value £ £ £ £0.05.
Affymetrix Id Fold change Common name Affymetrix Id Fold change Common name Affymetrix Id Fold change Common name
1435529_at 136.3 2010002M12Rik 1440866_at 10.62 1426906_at 5.465 Ifi203
1417262_at 136 Ptgs2 1429947_a_at 10.56 Zbp1 1422293_a_at 5.354 4933402K10Rik
1418930_at 91.05 Cxcl10 1444350_at 10.53 9830137M10Rik 1422005_at 5.347 Prkr
1423555_a_at 90.56 A430056A10Rik 1421911_at 10.22 Stat2 1450033_a_at 5.346 Stat1
1450783_at 84.62 Ifit1 1422526_at 10.01 Acsl1 1421307_at 5.335 Car13
1418652_at 81.27 Cxcl9 1441887_x_at 9.822 Sh3bgrl 1425405_a_at 5.305 Adar
1450291_s_at 71.12 Ms4a4c 1449134_s_at 9.729 Spic 1439141_at 5.251 Gpr18
1420671_x_at 68.61 Ms4a4b 1424393_s_at 9.692 Adhfe1 1422668_at 5.228 Serpinb9b
1427381_at 65.92 Irg1 1418825_at 9.655 Ifi1 1434991_at 5.223 1110064L07Rik
1417244_a_at 65.58 Irf7 1451777_at 9.618 BC013672 1448681_at 5.215 Il15ra
1418293_at 62.53 Ifit2 1448918_at 9.557 Slco3a1 1447649_x_at 5.211 Dnajc1
1424339_at 56.58 Oasl1 1452879_at 9.505 Synpo2 1449317_at 5.206 Cflar
1431591_s_at 56.11 G1p2 1455656_at 9.39 Btla 1420915_at 5.099 Stat1
1417263_at 54.26 Ptgs2 1453757_at 9.388 2510038N07Rik 1445271_at 5.037 9230105E10Rik
1417314_at 50.13 H2-Bf 1420664_s_at 9.319 Procr 1419758_at 4.965 Abcb1a
1450322_s_at 48 Slfn4 1450643_s_at 9.295 Acsl1 1448881_at 4.955 Hp
1427102_at 44.39 Slfn4 1441206_at 9.191 Synpo2 1421998_at 4.951 Tor3a
1419043_a_at 43.63 AW111922 1415806_at 8.776 Plat 1421550_a_at 4.95 Trim34
1421009_at 42.1 2510004L01Rik 1436562_at 8.523 Ddx58 1441923_s_at 4.884 Edn3
1422095_a_at 40.94 Tyki 1417961_a_at 8.49 Trim30 1424857_a_at 4.884 Trim34
1419209_at 39.65 Cxcl1 1439620_at 8.429 Car13 1450214_at 4.878 Adora2b
1449009_at 38.22 Tgtp 1450454_at 8.005 Tor3a 1420466_at 4.79 Spt2
1421008_at 36.92 2510004L01Rik 1425065_at 8.005 Oas2 1425686_at 4.768 Cflar
1419042_at 36.25 AW111922 1419149_at 7.801 Serpine1 1460603_at 4.746 AA175286
1455451_at 33.16 AI449310 1451564_at 7.643 1600029O10Rik 1419534_at 4.739 Olr1
1419569_a_at 32.59 Isg20 1458458_at 7.575 Slfn5 1439825_at 4.703 BC023741
1450297_at 31.49 Il6 1456509_at 7.536 1110032F04Rik 1432548_at 4.7 1600029O10Rik
1435792_at 30.93 Csprs 1417141_at 7.456 Igtp 1435340_at 4.686 Jmjd2a
1419282_at 29.13 Ccl12 1434580_at 7.445 Enpp4 1452414_s_at 4.673 D19Ertd678e
1438868_at 28.77 Phf11 1450403_at 7.442 Stat2 1451798_at 4.638 Il1rn
1419604_at 27.05 Zbp1 1417420_at 7.37 Ccnd1 1460014_at 4.588 5031403H21Rik
1425890_at 25.9 Ly6i 1428660_s_at 7.214 Tor3a 1417193_at 4.577 Sod2
1436058_at 24.31 2510004L01Rik 1437176_at 7.181 AI451557 1448610_a_at 4.548 Sod2
1449497_at 23.95 Il12b 1431865_a_at 7.153 4933405K07Rik 1424448_at 4.547 Trim6
1427126_at 23.83 Hspa1b 1418191_at 7.15 Usp18 1448940_at 4.542 Trim21
1438676_at 23.76 AI595338 1421744_at 7.105 Tnfsf4 1434087_at 4.53 Mthfr
1427127_x_at 23.46 Hspa1b 1418612_at 7.073 Slfn1 1422953_at 4.528 Fpr-rs2
1447927_at 21.11 AI595338 1426276_at 7.067 9130009C22Rik 1453472_a_at 4.495 Slamf7
1420768_a_at 21.02 D11Lgp2e 1421308_at 7.043 Car13 1423566_a_at 4.494 Hsp105
1423467_at 20.41 Ms4a4b 1420591_at 6.996 Gpr84 1449168_a_at 4.465 Akap2
1455452_x_at 18.75 AI449310 1451780_at 6.966 Blnk 1448380_at 4.447 Lgals3bp
1452388_at 18.38 Hspa1a 1426774_at 6.944 Zc3hdc1 1421854_at 4.425 Fgl2
1450826_a_at 17.99 Saa3 1424923_at 6.705 Serpina3g 1419026_at 4.402 Daxx
1449399_a_at 17.6 Il1b 1451050_at 6.508 Nt5c3 1450295_s_at 4.354 D7Ertd458e
1451054_at 17.21 Orm1 1425719_a_at 6.491 Nmi 1417300_at 4.34 Smpdl3b
1436172_at 17.06 1422160_at 6.477 H2-T24 1454197_a_at 4.301 D19Ertd678e
1456494_a_at 16.95 LOC209387 1419607_at 6.424 Tnf 1430300_at 4.298 Sco1
1443698_at 16.92 1423017_a_at 6.351 Il1rn 1423905_at 4.284 D7Ertd458e
1425374_at 16.71 Oas3 1450672_a_at 6.335 Trex1 1456164_at 4.269 AW011738
1456288_at 15.62 Slfn5 1426278_at 6.146 2310061N23Rik 1423903_at 4.268 D7Ertd458e
1438716_at 15.32 LOC209387 1423883_at 6.116 Acsl1 1424289_at 4.236 BC010311
1426633_s_at 15.31 D7Ertd760e 1416515_at 6.063 Fscn1 1416572_at 4.21 Mmp14
1418666_at 14.48 Ptx3 1452178_at 6.043 Plec1 1439012_a_at 4.195 Dck
1435331_at 14.48 AI447904 1456890_at 6.026 Ddx58 1422397_a_at 4.171 Il15ra
1452318_a_at 13.98 Hspa1b 1432026_a_at 5.994 2510038N07Rik 1428838_a_at 4.137 Dck
1439831_at 13.66 1426092_a_at 5.987 Trim34 1429563_x_at 4.093 5830484A20Rik
1439114_at 13.51 9830118M07 1448229_s_at 5.876 Ccnd2 1447272_s_at 4.074 Atp10a
1441600_at 13.09 1430802_at 5.85 H2-Q8 1427348_at 4.032 BC036563
1460415_a_at 12.58 Tnfrsf5 1427736_a_at 5.842 Ccrl2 1428484_at 4.025 Osbpl3
1417172_at 12.41 Ube2l6 1421578_at 5.838 Ccl4 1418240_at 3.97 Gbp2
1459913_at 12.33 A330042I21Rik 1434070_at 5.759 Jag1 1434139_at 3.962 5330431N24Rik
1419728_at 11.98 Cxcl5 1417793_at 5.75 AI481100 1450034_at 3.934 Stat1
1451426_at 11.86 D11Lgp2e 1426670_at 5.745 Agrn 1435906_x_at 3.899 Gbp2
1419676_at 11.78 Mx2 1450808_at 5.67 Fpr1 1436899_at 3.856 2700019D07Rik
1420330_at 11.7 Clecsf9 1442130_at 5.636 Hsh2d 1439805_at 3.84 Nfat5
1449473_s_at 11.68 Tnfrsf5 1431095_a_at 5.601 2510038N07Rik 1422054_a_at 3.786 Skil
1439221_s_at 11.51 Tnfrsf5 1428735_at 5.588 Cd69 1449152_at 3.717 Cdkn2b
1422141_s_at 11.43 Csprs 1449591_at 5.587 Casp4 1453299_a_at 3.715 Pnp
1449926_at 11.42 Tnfsf7 1452231_x_at 5.584 Ifi203 1448728_a_at 3.692 AA408868
1419530_at 11.4 Il12b 1427091_at 5.53 AI481105 1448788_at 3.689 Mox2
1436555_at 11.35 AI158848 1449984_at 5.498 Cxcl2 1421571_a_at 3.687 Ly6c
1418686_at 5.487 Oas1c 1426716_at 3.669 Tdrd7  244 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Affymetrix Id Fold change Common name Affymetrix Id Fold change Common name Affymetrix Id Fold change Common name
1426133_a_at 3.665 1500032H18Rik 1426415_a_at 2.809 Trim25 1434715_at 2.384 1600014C10Rik
1416897_at 3.644 BC003281 1424126_at 2.805 Alas1 1422140_at 2.383 Csprs
1418990_at 3.619 Ms4a4d 1417527_at 2.805 Ap3m2 1456251_x_at 2.378 Bzrp
1451330_a_at 3.601 Inpp5b 1426541_a_at 2.805 2310067E08Rik 1418115_s_at 2.374 Ifrg15
1449176_a_at 3.58 Dck 1435454_a_at 2.802 BC006779 1423160_at 2.374 Spred1
1420404_at 3.528 Cd86 1455320_at 2.796 AI480535 1458462_at 2.373 6030405P05Rik
1422006_at 3.51 Prkr 1449130_at 2.788 Cd1d1 1422664_at 2.371 Rab10
1424921_at 3.507 2310015I10Rik 1421855_at 2.77 Fgl2 1454889_x_at 2.367 C630016B22Rik
1431843_a_at 3.505 Nfkbie 1450696_at 2.766 Psmb9 1433617_s_at 2.363 B4galt5
1424290_at 3.5 BC010311 1445888_x_at 2.757 Adprtl3 1450155_at 2.362 Itga4
1451821_a_at 3.487 Sp100 1452834_at 2.752 2600010E01Rik 1419132_at 2.36 Tlr2
1448757_at 3.474 Pml 1426543_x_at 2.749 2310067E08Rik 1426084_a_at 2.36 MGC6357
1417333_at 3.468 Rasa4 1439226_at 2.745 5830472H07Rik 1448607_at 2.359 Pbef1
1445597_s_at 3.468 Hrasls3 1416724_x_at 2.744 Tcf4 1419069_at 2.358 Rabgef1
1425810_a_at 3.467 Csrp1 1445897_s_at 2.739 Ifi35 1450272_at 2.357 Tnfsf8
1451611_at 3.45 Hrasls3 1428324_at 2.732 Gpd2 1435415_x_at 2.356 Mlp
1437432_a_at 3.447 Trim12 1435526_at 2.72 A130072J07 1429193_at 2.353 4631416I11Rik
1460283_at 3.445 Mefv 1444777_at 2.717 Rai14 1449222_at 2.346 Ebi3
1458299_s_at 3.436 Nfkbie 1420816_at 2.708 Ywhag 1433515_s_at 2.345 Etnk1
1434431_x_at 3.418 Adora2b 1433699_at 2.706 Tnfaip3 1454731_at 2.337 Myo10
1446957_s_at 3.377 BC004022 1433944_at 2.702 A630025O09Rik 1428071_at 2.322 1110038D17Rik
1420500_at 3.342 Dnajc1 1455649_at 2.692 1700029M07Rik 1453228_at 2.32 Stx11
1424617_at 3.319 Ifi35 1422512_a_at 2.688 Ogfr 1418116_at 2.316 Ifrg15
1434015_at 3.305 Slc2a6 1421217_a_at 2.684 Lgals9 1415791_at 2.312 Rnf34
1424444_a_at 3.305 1600014C10Rik 1416123_at 2.682 Ccnd2 1433482_a_at 2.309 D3Ertd330e
1424609_a_at 3.276 Xdh 1427974_s_at 2.682 Cacna1d 1422511_a_at 2.304 Ogfr
1448698_at 3.269 Ccnd1 1435446_a_at 2.677 Chpt1 1416653_at 2.296 Stxbp3
1459151_x_at 3.262 Ifi35 1425811_a_at 2.669 Csrp1 1425050_at 2.296 2610034N03Rik
1425078_x_at 3.262 5830484A20Rik 1452225_at 2.662 2010106G01Rik 1435267_at 2.262 A430108E01Rik
1418077_at 3.244 Trim21 1418401_a_at 2.662 Dusp16 1424499_s_at 2.259 5730596K20Rik
1447930_at 3.233 Baz1a 1434148_at 2.66 Tcf4 1433592_at 2.255 Calm1
1417434_at 3.232 Gpd2 1456676_a_at 2.658 Pfkfb3 1440854_at 2.242 2810403A07Rik
1424607_a_at 3.214 Xdh 1459903_at 2.65 Sema7a 1447211_at 2.239 Nrip1
1430996_at 3.192 Etnk1 1450744_at 2.647 Ell2 1424826_s_at 2.233 Mtss1
1451544_at 3.176 Tapbpl 1426970_a_at 2.628 Ube1l 1423025_a_at 2.223 Schip1
1460453_at 3.151 2610315E15Rik 1437467_at 2.625 Alcam 1434149_at 2.218 Tcf4
1441089_at 3.135 Eif2c3 1429165_at 2.617 3110001I22Rik 1438948_x_at 2.215 Bzrp
1448958_at 3.124 Ifrg15 1438214_at 2.615 Trps1 1449996_a_at 2.201 Tpm3
1416432_at 3.116 Pfkfb3 1455070_at 2.614 AL118268 1441476_at 2.198 Socs2
1424041_s_at 3.112 C1s 1423401_at 2.611 Etv6 1436334_at 2.196 Synj1
1451160_s_at 3.103 D7Ertd458e 1455051_at 2.611 Rnf31 1442744_at 2.187 C79248
1426542_at 3.094 2310067E08Rik 1444029_at 2.61 5330431N24Rik 1428061_at 2.186 Hat1
1443536_at 3.086 9930009M05Rik 1456403_at 2.609 Pag 1460206_at 2.186 Grasp
1426587_a_at 3.079 Stat3 1437110_at 2.605 2810474O19Rik 1438682_at 2.184 Pik3r1
1426750_at 3.059 Flnb 1427247_at 2.585 D3Bwg0562e 1454809_at 2.179 9030406N13Rik
1445104_at 3.053 E230029C05Rik 1434268_at 2.584 Adar 1422286_a_at 2.175 Tgif
1449875_s_at 3.047 H2-T10 1450165_at 2.583 Slfn2 1433514_at 2.167 Etnk1
1426971_at 3.039 Ube1l 1450828_at 2.571 Synpo2 1420091_s_at 2.152 Zcwcc3
1448328_at 3.034 Sh3bp2 1428378_at 2.565 Zc3hav1 1435904_at 2.149 Eif2c3
1416530_a_at 3.031 Pnp 1416296_at 2.554 Il2rg 1442745_x_at 2.146 C79248
1418154_at 3.002 BC004022 1425515_at 2.545 Pik3r1 1426208_x_at 2.141 Plagl1
1421321_a_at 2.989 Net1 1452385_at 2.538 AA939927 1418929_at 2.136 Esrrbl1
1429809_at 2.966 8430438D04Rik 1421322_a_at 2.533 Isgf3g 1452013_at 2.135 Atp10a
1421207_at 2.944 Lif 1434706_at 2.533 5730538E15Rik 1423904_a_at 2.134 D7Ertd458e
1421098_at 2.928 AI586015 1436199_at 2.527 Trim14 1425053_at 2.124 2610034N03Rik
1456607_at 2.913 5730538E15Rik 1452833_at 2.505 Rapgef2 1437210_a_at 2.12 Brd2
1452925_a_at 2.908 1810015H18Rik 1437497_a_at 2.497 Hspca 1434290_at 2.119 E330008O22Rik
1416016_at 2.905 Tap1 1429488_at 2.486 Zdhhc21 1428843_at 2.115 1810015H18Rik
1433920_at 2.902 Sema4c 1429475_at 2.481 2810457I06Rik 1422962_a_at 2.105 Psmb8
1417483_at 2.894 AA408868 1450747_at 2.474 Keap1 1416695_at 2.105 Bzrp
1423870_at 2.891 2610208M17Rik 1441855_x_at 2.463 Cxcl1 1448377_at 2.095 Slpi
1450378_at 2.873 Tapbp 1431394_a_at 2.46 4921513O20Rik 1445037_at 2.091 6430510B20Rik
1427742_a_at 2.854 Copeb 1455282_x_at 2.455 Alas1 1431822_a_at 2.091 Azi2
1434253_s_at 2.835 C630016B22Rik 1426210_x_at 2.454 Adprtl3 1433590_at 2.089 Herc3
1449131_s_at 2.834 Cd1d1 1421236_at 2.45 Ripk2 1425329_a_at 2.086 Dia1
1438097_at 2.822 Rab20 1448751_at 2.441 Ap3m2 1435363_at 2.071 Plekhg1
1428346_at 2.821 Fln29 1433606_at 2.435 Mitc1 1433462_a_at 2.059 Pi4k2a
1433766_at 2.813 C330023M02Rik 1439755_at 2.424 Sipa1l1 1416929_at 2.057 Rbm12  245 
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1416412_at 2.055 Nsmaf 1448530_at 0.523 Gmpr 1422438_at 0.316 Ephx1
1416755_at 2.055 Dnajb1 1416034_at 0.516 Cd24a 1436853_a_at 0.315 Snca
1452214_at 2.052 9130011J04Rik 1425718_a_at 0.516 Ivns1abp 1436448_a_at 0.311 Ptgs1
1418772_at 2.044 BC016423 1436026_at 0.515 1110032O19Rik 1437614_x_at 0.31 Zdhhc14
1435160_at 2.043 1110064P04Rik 1428500_at 0.513 2210419D22Rik 1420927_at 0.308 St6gal1
1416944_a_at 2.041 Tlk2 1423104_at 0.513 Irs1 1421562_at 0.306 Cd209c
1450456_at 2.038 Il21r 1415977_at 0.506 Isyna1 1438975_x_at 0.3 Zdhhc14
1434830_at 2.033 Mad 1426380_at 0.505 Eif4b 1438619_x_at 0.3 Zdhhc14
1423681_at 2.032 1300018I05Rik 1425444_a_at 0.503 Tgfbr2 1432198_at 0.296 6330414G02Rik
1434350_at 2.031 Axud1 1447707_s_at 0.501 Pde2a 1428574_a_at 0.292 Chn2
1423392_at 2.028 Clic4 1452277_at 0.5 6330406P08Rik 1430780_a_at 0.289 Pmm1
1433499_at 2.028 2010005J08Rik 1434328_at 0.498 Rpl15 1417481_at 0.283 Ramp1
1460315_s_at 2.02 Tbk1 1450084_s_at 0.496 Ivns1abp 1419589_at 0.281 C1qr1
1427310_at 2.016 Falz 1440195_at 0.493 9330147J08Rik 1431189_a_at 0.281 B430104H02Rik
1417189_at 2.012 Psme2 1455291_s_at 0.49 D6Ertd365e 1422837_at 0.28 Scel
1430353_at 2.009 4833409N03Rik 1436212_at 0.488 AI661017 1460672_at 0.268 2410002F23Rik
1428637_at 2.008 1810038L18Rik 1452933_at 0.486 C030004B10Rik 1456046_at 0.266 C1qr1
1434036_at 2.006 Mtss1 1421182_at 0.486 Clec2 1435203_at 0.265 1700052O22Rik
1435058_x_at 2.005 Stxbp3 1418123_at 0.485 Unc119 1418998_at 0.264 Kmo
1420617_at 2.001 Cpeb4 1432164_a_at 0.484 5730591C18Rik 1429324_at 0.262 1700012A16Rik
1421346_a_at 1.985 Slc6a6 1449183_at 0.483 Comt 1453552_at 0.262 2310014F07Rik
1421812_at 1.982 Tapbp 1427341_at 0.482 E130103I17Rik 1417872_at 0.26 Fhl1
1418587_at 1.977 Traf3 1452846_at 0.481 Ppfia4 1436323_at 0.252 2810001A02Rik
1454736_at 1.975 4921515A04Rik 1426516_a_at 0.48 Lpin1 1436322_a_at 0.252 2810001A02Rik
1420523_at 1.965 2610529H08Rik 1452770_at 0.474 Vkorc1 1426734_at 0.252 BC022623
1450642_at 1.961 3110001I20Rik 1415857_at 0.473 Emb 1449270_at 0.248 Plxdc2
1456114_at 1.96 Cds1 1430889_a_at 0.473 Tpmt 1419747_at 0.238 Asgr2
1431827_a_at 1.957 Tlk2 1425628_a_at 0.472 Gtf2i 1423231_at 0.236 Nrgn
1440984_at 1.952 5830435C13Rik 1416470_a_at 0.471 Rpn1 1425144_at 0.235 Klk21
1417813_at 1.95 Ikbke 1431190_x_at 0.471 B430104H02Rik 1418912_at 0.234 Plxdc2
1437926_at 1.94 E430012M05Rik 1416188_at 0.47 Gm2a 1418405_at 0.226 Hgfac
1452461_a_at 1.922 Mafb 1430656_a_at 0.469 2210409M21Rik 1437025_at 0.223 Cd28
1459896_at 1.915 D1Ertd251e 1438943_x_at 0.468 Rpn1 1420928_at 0.222 St6gal1
1424687_at 1.905 2700008B19Rik 1426378_at 0.468 Eif4b 1431110_at 0.201 5430431D22Rik
1451082_at 1.899 1300018I05Rik 1450048_a_at 0.468 Idh2 1421685_at 0.198 1810046I24Rik
1418911_s_at 1.895 Acsl4 1439257_x_at 0.465 Rpn1 1455885_at 0.188 6530401C20Rik
1435890_at 1.892 AW228836 1426379_at 0.46 Eif4b 1420715_a_at 0.174 Pparg
1430307_a_at 1.89 Mod1 1437046_x_at 0.456 4930504E06Rik 1425182_x_at 0.165 Klk9
1436333_a_at 1.886 Synj1 1420381_a_at 0.454 Rpl31 1454254_s_at 0.152 1600029D21Rik
1460376_a_at 1.881 Cox15 1417664_a_at 0.449 Ndrg3 1460003_at 0.138 AI956758
1425523_at 1.868 2610015J01Rik 1429856_at 0.447 2610042G18Rik 1450430_at 0.134 Mrc1
1438270_at 1.854 1700105P06Rik 1448241_at 0.445 Gm2a 1433719_at 0.0914 Slc9a9
1420901_a_at 1.823 Hk1 1425407_s_at 0.445 Clecsf6 1419605_at 0.071 Mgl1
1428227_at 1.819 2610008J04Rik 1456438_x_at 0.443 Rpn1 1426172_a_at 0.0673 Cd209a
1450973_s_at 1.81 Mapkbp1 1447521_x_at 0.441 D15Wsu169e 1438467_at 0.0593 Mgl2
1426324_at 1.788 H2-Q10 1422603_at 0.438 Rnase4 1425295_at 0.0566 Ear11
1442757_at 1.78 Chdc1 1438321_x_at 0.436 4930504E06Rik
1428593_at 1.775 1700029F09Rik 1434874_x_at 0.433 Centb1
1427040_at 1.763 Kdt1 1420770_at 0.427 Klk21
1451805_at 1.751 Phip 1454646_at 0.425 E430026E19Rik
1420618_at 1.748 Cpeb4 1450095_a_at 0.423 Acyp1
1423393_at 1.74 Clic4 1437052_s_at 0.417 Slc2a3
1434782_at 1.688 D5Ertd591e 1431133_at 0.417 Arhgap18
1415740_at 1.682 Psmc5 1439703_at 0.416 Mox2r
1429797_at 1.657 5730596K20Rik 1455898_x_at 0.415 Slc2a3
1424813_at 1.64 LOC218805 1434470_at 0.41 Syt13
1453582_at 1.637 Chka 1422477_at 0.408 Cables1
1433668_at 1.635 Pnrc1 1416619_at 0.405 4632428N05Rik
1454668_at 1.612 1810009A16Rik 1441907_s_at 0.404 C1qr1
1426270_at 1.612 Smc5l1 1452841_at 0.399 Pgm2l1
1425120_x_at 1.575 1810023F06Rik 1416389_a_at 0.397 Chc1l
1428659_at 0.631 Phf7 1451867_x_at 0.397 Arhgap6
1449878_a_at 0.623 Slc12a6 1422823_at 0.396 Eps8
1455911_x_at 0.62 Np15 1422084_at 0.392 Bmx
1456480_at 0.61 9330186A19Rik 1452956_a_at 0.386 D12Ertd647e
1418560_at 0.607 Pdha1 1421026_at 0.385 Gna12
1427139_at 0.598 Adamts10 1415856_at 0.38 Emb
1428577_at 0.596 Ppfia4 1448471_a_at 0.378 Ctla2b
1441937_s_at 0.591 Pink1 1417399_at 0.377 Gas6
1450649_at 0.584 Gng10 1416319_at 0.376 Adk
1435397_at 0.582 BC038156 1449366_at 0.369 Mmp8
1427138_at 0.576 0610010D24Rik 1456333_a_at 0.366 Arhgap6
1420638_at 0.566 Prps2 1434873_a_at 0.364 Centb1
1422433_s_at 0.562 Idh1 1450097_s_at 0.363 Gna12
1455972_x_at 0.561 Hadhsc 1423414_at 0.36 Ptgs1
1423801_a_at 0.56 Aprt 1451486_at 0.359 1200006F02Rik
1419206_at 0.558 Cd37 1452299_at 0.35 8030445B08Rik
1452202_at 0.558 Pde2a 1426584_a_at 0.337 Sdh1
1435006_s_at 0.557 Abcb7 1451715_at 0.337 Mafb
1448182_a_at 0.555 Cd24a 1417704_a_at 0.335 Arhgap6
1428181_at 0.542 Etfb 1438431_at 0.332 Abcd2
1453109_at 0.533 2810429K17Rik 1427098_at 0.332 8030445B08Rik
1428612_at 0.532 Apg7l 1438666_at 0.33 AI194318
1460733_at 0.529 AA407659 1419748_at 0.326 Abcd2
1458559_at 0.526 A730028G07Rik 1425733_a_at 0.323 Eps8
1424771_at 0.524 E130307C13 1422824_s_at 0.32 Eps8  246 
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-/- BMDCs  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All genes have a fold change of 1.4 and a p value £ £ £ £0.05.
Affymetrix Id Fold change Common name Affymetrix Id Fold change Common name Affymetrix Id Fold change Common name
1436823_x_at 222.4 Hbb-y 1418936_at 18.36 Maff 1435645_at 10.79 Mmd
1436717_x_at 192.5 Hbb-y 1452196_a_at 18.31 Nckap1 1449152_at 10.78 Cdkn2b
1427624_s_at 108.3 Iltifb 1426657_s_at 17.18 Phgdh 1421317_x_at 10.68 Myb
1450297_at 89.89 Il6 1426724_at 17.13 Cnn3 1420572_at 10.62 Ms4a3
1449926_at 81.23 Tnfsf7 1416052_at 16.56 Prps1 1421207_at 10.46 Lif
1438658_a_at 70.25 Edg3 1421775_at 16.48 Fcer1a 1436188_a_at 10.41 Ndrg4
1436870_s_at 64.99 AU041783 1422053_at 15.73 Inhba 1460239_at 10.35 Tm4sf13
1440882_at 59.45 Lrp8 1449168_a_at 15.61 Akap2 1421308_at 10.28 Car13
1421262_at 56.56 Lipg 1427054_s_at 15.46 5033411B22Rik 1419569_a_at 10.24 Isg20
1439221_s_at 51.09 Tnfrsf5 1418003_at 15.45 1190002H23Rik 1451064_a_at 10.19 Psat1
1428947_at 50.5 2010001M09Rik 1455956_x_at 15.41 Ccnd2 1420505_a_at 10.17 Stxbp1
1448804_at 46.65 Cyp11a1 1437173_at 15.4 Edg3 1456509_at 10.14 1110032F04Rik
1449424_at 45.5 Plek2 1434403_at 15.07 Spred2 1432478_a_at 9.821 4930534K13Rik
1447831_s_at 44.6 Mtmr7 1449858_at 15.06 Cd86 1455810_a_at 9.804 E130112L23Rik
1427126_at 44.06 Hspa1b 1431422_a_at 15.02 Dusp14 1420691_at 9.785 Il2ra
1460415_a_at 41.85 Tnfrsf5 1421307_at 14.79 Car13 1423413_at 9.708 Ndrg1
1417184_s_at 41.72 Hbb-b1 1428535_at 14.76 1110056P05Rik 1420710_at 9.667 Rel
1422188_s_at 41.1 Tcrg-V4 1418547_at 14.65 Tfpi2 1452789_at 9.588 Snn
1450521_a_at 39.93 Tcrg-V4 1450194_a_at 14.63 Myb 1420150_at 9.584 4930422J18Rik
1422189_x_at 38.87 Tcrg-V4 1418937_at 14.35 Dio2 1421744_at 9.58 Tnfsf4
1417785_at 36.38 Pla1a 1417220_at 14.31 Fah 1429272_a_at 9.55 2210421G13Rik
1447669_s_at 35.69 Gng4 1447863_s_at 14.06 Nr4a2 1422533_at 9.542 Cyp51
1422706_at 35.24 Tmepai 1425569_a_at 13.96 Slamf1 1416008_at 9.485 Satb1
1436759_x_at 34.94 Cnn3 1432826_a_at 13.95 Cd80 1422734_a_at 9.445 Myb
1449473_s_at 34.12 Tnfrsf5 1417976_at 13.71 Ada 1460469_at 9.291 Tnfrsf9
1442347_at 34.05 AI848122 1427381_at 13.61 Irg1 1450290_at 9.175 Pdcd1lg2
1427127_x_at 33.29 Hspa1b 1425505_at 13.58 Mylk 1430156_at 9.11 4930520O04Rik
1420664_s_at 33.06 Procr 1429668_at 13.52 E130119J07Rik 1455812_x_at 9.089 Slitl2
1437308_s_at 32.98 F2r 1420404_at 13.46 Cd86 1452366_at 9.088 4732435N03Rik
1418449_at 32.11 Lad1 1416271_at 13.33 Perp 1448724_at 8.992 Cish
1454269_s_at 31.73 4930519L02Rik 1416007_at 13.31 Satb1 1436101_at 8.978 2810473M14Rik
1436836_x_at 31.73 Cnn3 1450259_a_at 13.29 Stat5a 1460466_at 8.818 1700047I17Rik
1422639_at 30.14 Calcb 1417928_at 13.28 Pdlim4 1449328_at 8.79 Ly75
1420994_at 29.33 B3gnt5 1449090_a_at 12.94 Yes 1416121_at 8.757 Lox
1428034_a_at 28.77 Tnfrsf9 1424289_at 12.93 BC010311 1448752_at 8.647 Car2
1455570_x_at 28.68 Cnn3 1453470_a_at 12.78 Gna13 1455143_at 8.52 Nlgn2
1428301_at 27.7 2610042L04Rik 1460227_at 12.77 Timp1 1424008_a_at 8.499 2400008B06Rik
1450188_s_at 27.69 Lipg 1440612_at 12.72 9930104E21Rik 1435226_at 8.498 4930534K13Rik
1423135_at 25.52 Thy1 1438354_x_at 12.66 Cnn3 1451804_a_at 8.42 Lrrc16
1456380_x_at 24.21 Cnn3 1424290_at 12.63 BC010311 1423091_a_at 8.369 Gpm6b
1424923_at 24.08 Serpina3g 1418175_at 12.46 Vdr 1449317_at 8.35 Cflar
1430127_a_at 23.88 Ccnd2 1449864_at 12.4 Il4 1434140_at 8.338 Mcf2l
1428735_at 23.04 Cd69 1449497_at 12.24 Il12b 1450922_a_at 8.318 Tgfb2
1452731_x_at 22.91 2610042L04Rik 1422924_at 12.17 Tnfsf9 1450869_at 8.27 Fgf1
1419413_at 21.53 Ccl17 1418652_at 12.14 Cxcl9 1421266_s_at 8.267 Nfkbib
1425570_at 21.36 Slamf1 1416811_s_at 12.07 Ctla2b 1439620_at 8.267 Car13
1434745_at 21.09 Ccnd2 1423289_a_at 11.96 1810029B16Rik 1422668_at 8.266 Serpinb9b
1448229_s_at 20.58 Ccnd2 1428396_at 11.72 4930431E10Rik 1416939_at 8.218 Pyp
1450753_at 20.54 Nkg7 1448788_at 11.51 Mox2 1449033_at 8.194 Tnfrsf11b
1416122_at 20.37 Ccnd2 1429566_a_at 11.28 Hipk2 1448730_at 8.189 Cpa3
1416123_at 20.31 Ccnd2 1420413_at 11.25 Slc7a11 1423418_at 8.183 Fdps
1427878_at 20.12 0610010O12Rik 1438325_at 11.15 Evi1 1416645_a_at 8.138 Afp
1417149_at 19.67 P4ha2 1450173_at 11 Ripk2 1460242_at 8.08 Daf1
1454714_x_at 19.25 Phgdh 1418176_at 10.94 Vdr 1449402_at 8.072 Chst7
1428834_at 18.89 Dusp4 1449824_at 10.92 Prg4 1419530_at 8.071 Il12b
1450852_s_at 18.49 F2r 1460307_at 10.85 Akt3 1418726_a_at 8.069 Tnnt2  247 
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1438274_at 8.057 A630026H08Rik 1428669_at 6.139 Bmyc 1451109_a_at 4.938 Nedd4
1426411_a_at 7.958 Strbp 1455183_at 6.137 Stk38l 1434260_at 4.937 Fchsd2
1456471_x_at 7.956 Phgdh 1422473_at 6.134 Pde4b 1422567_at 4.929 Niban
1431008_at 7.947 0610037M15Rik 1433699_at 6.085 Tnfaip3 1456321_at 4.926 3830408G10Rik
1435792_at 7.932 Csprs 1427893_a_at 6.084 Pmvk 1423041_a_at 4.92 Bzw1
1422437_at 7.924 Col5a2 1451471_at 6.073 3230401I01Rik 1425514_at 4.917 Pik3r1
1421073_a_at 7.917 Ptger4 1421679_a_at 6.068 Cdkn1a 1436196_at 4.914 C030046G05
1455656_at 7.9 Btla 1430221_at 6.058 9130008F23Rik 1423466_at 4.909 Ccr7
1451596_a_at 7.89 Sphk1 1433454_at 6.05 AW539457 1417441_at 4.906 Dnajc12
1418736_at 7.884 B3galt3 1437635_at 6.045 Esdn 1449773_s_at 4.901 Gadd45b
1452757_s_at 7.868 Hba-a1 1423049_a_at 6.023 Tpm1 1428902_at 4.89 1110020P09Rik
1449037_at 7.823 Crem 1419470_at 6.008 Gnb4 1437486_at 4.878 Rai3
1449149_at 7.773 Traf3 1442130_at 5.974 Hsh2d 1417444_at 4.871 E2f5
1460378_a_at 7.683 Tes 1441706_at 5.974 Dscaml1 1423903_at 4.869 D7Ertd458e
1424086_at 7.677 D130038B21Rik 1418643_at 5.968 Tm4sf13 1418402_at 4.833 Adam19
1419202_at 7.603 Cst7 1424246_a_at 5.939 Tes 1448130_at 4.833 Fdft1
1420401_a_at 7.461 Ramp3 1418219_at 5.916 Il15 1435455_at 4.824 C79267
1418926_at 7.456 Zfhx1a 1422054_a_at 5.915 Skil 1451335_at 4.823 Plac8
1419469_at 7.416 Gnb4 1423122_at 5.864 Avpi1 1422474_at 4.814 Pde4b
1444585_at 7.406 4933429I20Rik 1421457_a_at 5.857 Samsn1 1421256_at 4.793 Gzmc
1430352_at 7.405 8430417A20Rik 1444606_at 5.855 Efna2 1420013_s_at 4.791 Lss
1431777_a_at 7.402 Hmgn3 1448713_at 5.854 Stat4 1457342_at 4.779 A630026H08Rik
1458299_s_at 7.387 Nfkbie 1423158_at 5.852 Gnpnat1 1423162_s_at 4.777 Spred1
1421936_at 7.312 Dapp1 1416236_a_at 5.848 Eva 1455048_at 4.776 Igsf2
1450350_a_at 7.312 Jundm2 1429347_at 5.843 Bcl2l14 1437419_at 4.776 Bmp2k
1445597_s_at 7.306 Hrasls3 1443536_at 5.84 9930009M05Rik 1423904_a_at 4.755 D7Ertd458e
1421260_a_at 7.291 Srm 1454809_at 5.832 9030406N13Rik 1429786_a_at 4.754 D10Ertd749e
1452614_at 7.271 LOC229672 1452061_s_at 5.824 Strbp 1425902_a_at 4.747 Nfkb2
1416658_at 7.269 Frzb 1420692_at 5.805 Il2ra 1434267_at 4.745 Nek1
1418718_at 7.261 Cxcl16 1448265_x_at 5.801 Eva 1421828_at 4.74 Kpna3
1431843_a_at 7.253 Nfkbie 1452914_at 5.777 2410024N18Rik 1428323_at 4.708 Gpd2
1418930_at 7.228 Cxcl10 1417398_at 5.77 Rras2 1423392_at 4.707 Clic4
1438511_a_at 7.209 1190002H23Rik 1426615_s_at 5.753 Ndrg4 1448162_at 4.706 Vcam1
1447585_s_at 7.194 Mrps6 1438037_at 5.743 2510038N07Rik 1437111_at 4.696 C230027N18Rik
1441092_at 7.186 9330159M07Rik 1432026_a_at 5.714 2510038N07Rik 1456584_x_at 4.69 Phgdh
1424991_s_at 7.166 Tyms 1427038_at 5.706 Penk1 1450971_at 4.69 Gadd45b
1426750_at 7.152 Flnb 1429667_at 5.702 E130119J07Rik 1418868_at 4.68 En2
1448192_s_at 7.094 Prps1 1418843_at 5.684 Slc30a4 1424414_at 4.673 Ogfrl1
1417558_at 7.081 Fyn 1448873_at 5.66 Ocln 1415922_s_at 4.669 Mlp
1450646_at 7.07 Cyp51 1441536_at 5.654 Hmgcs1 1460458_at 4.665 1810049K24Rik
1459903_at 7.053 Sema7a 1424761_at 5.65 BC011487 1453472_a_at 4.656 Slamf7
1460206_at 7.048 Grasp 1417289_at 5.643 Plekha2 1430640_a_at 4.654 Prkar2b
1419534_at 7.041 Olr1 1448918_at 5.628 Slco3a1 1424824_at 4.654 9630044O09Rik
1457248_x_at 7.031 Hsd17b7 1449109_at 5.616 Socs2 1421065_at 4.647 Jak2
1454607_s_at 7.016 Psat1 1448844_at 5.615 1810044O22Rik 1455181_at 4.645 Rasa2
1419759_at 6.984 Abcb1a 1427025_at 5.607 Mtmr7 1417273_at 4.64 Pdk4
1453590_at 6.959 Arl8 1434794_at 5.604 Rhof 1429549_at 4.634 Col27a1
1429809_at 6.951 8430438D04Rik 1448325_at 5.587 Myd116 1451985_at 4.629 Lrrk1
1416515_at 6.938 Fscn1 1418346_at 5.568 Insl6 1438306_at 4.624 3110001E11Rik
1418990_at 6.93 Ms4a4d 1429140_at 5.564 9830002I17Rik 1420888_at 4.612 Bcl2l1
1449231_at 6.912 Zfp296 1452925_a_at 5.486 1810015H18Rik 1455833_at 4.605 AU041783
1453365_at 6.903 8430421H08Rik 1445452_at 5.469 Traf1 1448885_at 4.581 Rap2b
1422601_at 6.901 Serpinb9 1429564_at 5.463 5830443C21Rik 1451037_at 4.577 Ptpn9
1448865_at 6.841 Hsd17b7 1448681_at 5.462 Il15ra 1449368_at 4.574 Dcn
1423602_at 6.841 Traf1 1418687_at 5.462 Arc 1450976_at 4.54 Ndrg1
1449195_s_at 6.784 Cxcl16 1418371_at 5.447 6720463E02Rik 1453127_at 4.527 Ppp2cz
1425506_at 6.779 9530072E15Rik 1423543_at 5.435 Swap70 1455649_at 4.513 1700029M07Rik
1450337_a_at 6.774 Nek8 1436895_at 5.431 Centd1 1453228_at 4.505 Stx11
1448765_at 6.741 Fyn 1423161_s_at 5.411 Spred1 1416038_at 4.479 AL033314
1433939_at 6.72 A730046J16 1423488_at 5.398 Mmd 1419060_at 4.47 Gzmb
1448656_at 6.711 Cacnb3 1429197_s_at 5.392 5830411O09Rik 1450846_at 4.464 Bzw1
1443923_at 6.695 Akap13 1435966_x_at 5.392 Mrpl13 1448050_s_at 4.463 Map4k4
1440955_at 6.661 LOC333088 1448451_at 5.371 Ak2 1437992_x_at 4.455 Gja1
1444402_at 6.654 C230027N18Rik 1415846_a_at 5.363 Ldh3 1434593_at 4.447 Eif5a2
1428512_at 6.642 2700087I09Rik 1434671_at 5.35 B230337E12Rik 1430259_at 4.445 Tnfrsf11a
1422804_at 6.631 Serpinb6b 1429110_a_at 5.338 2810405F18Rik 1448605_at 4.441 Rhoc
1418734_at 6.599 H2-Q1 1435927_at 5.325 E030003N15Rik 1451160_s_at 4.432 D7Ertd458e
1415810_at 6.558 Uhrf1 1460565_at 5.264 Slc41a1 1422785_at 4.431 Rasa2
1444233_at 6.527 Gpr132 1429196_at 5.258 5830411O09Rik 1448777_at 4.423 Mcm2
1452291_at 6.525 Centd1 1449591_at 5.254 Casp4 1438018_at 4.422 Hook1
1437056_x_at 6.481 1810049K24Rik 1442427_at 5.228 9630026M06Rik 1416730_at 4.419 Rcl1
1436598_at 6.469 Icos 1438097_at 5.223 Rab20 1425806_a_at 4.415 Surb7
1455647_at 6.433 AW320017 1420843_at 5.197 Ptprf 1423040_at 4.41 Bzw1
1436768_x_at 6.431 E130112L23Rik 1434599_a_at 5.195 Tjp2 1423285_at 4.406 Coch
1448452_at 6.423 Icsbp1 1419550_a_at 5.184 Stk39 1418322_at 4.4 Crem
1418507_s_at 6.404 D130043N08Rik 1419031_at 5.179 Fads2 1420760_s_at 4.387 Ndrg1
1431591_s_at 6.4 G1p2 1420499_at 5.176 Gch 1429239_a_at 4.386 Stard4
1448126_at 6.389 Tera 1452815_at 5.171 P2ry10 1422664_at 4.385 Rab10
1434758_at 6.388 1810049K24Rik 1421469_a_at 5.127 Stat5a 1435432_at 4.382 Centg2
1454992_at 6.362 Slc7a1 1456635_at 5.113 5830484A20Rik 1416067_at 4.381 Ifrd1
1422303_a_at 6.341 Tnfrsf18 1417703_at 5.093 Pvrl2 1416036_at 4.356 Fkbp1a
1444089_at 6.335 Spnb2 1423948_at 5.085 Bag2 1451376_at 4.349 5730596K20Rik
1426223_at 6.332 2810439F02Rik 1455899_x_at 5.069 Socs3 1424499_s_at 4.348 5730596K20Rik
1434875_a_at 6.326 Hmgn3 1428869_at 5.053 Nolc1 1418076_at 4.348 St14
1424204_at 6.31 Mrpl13 1438400_at 5.045 4632411B12Rik 1425145_at 4.346 Il1rl1
1433453_a_at 6.309 AW539457 1450850_at 5.02 Vil2 1436305_at 4.346 AI853829
1427053_at 6.296 5033411B22Rik 1417856_at 4.994 Relb 1448301_s_at 4.345 Serpinb1a
1416229_at 6.284 Rfk 1428543_at 4.987 Ppat 1424498_at 4.344 5730596K20Rik
1449799_s_at 6.264 1200008D14Rik 1418030_at 4.984 Slco3a1 1451122_at 4.329 Idi1
1428720_s_at 6.249 2010309G21Rik 1460354_a_at 4.973 Mrpl13 1452741_s_at 4.328 Gpd2
1439766_x_at 6.243 Vegfc 1455434_a_at 4.972 Ktn1 1434381_at 4.326 BC060631
1438322_x_at 6.209 Fdft1 1422177_at 4.972 Il13ra2 1426597_s_at 4.324 C79267
1421653_a_at 6.196 Igh-VJ558 1421236_at 4.969 Ripk2 1423156_at 4.324 Gnpnat1
1418835_at 6.172 Phlda1 1418635_at 4.955 Etv3 1455450_at 4.322 Ptpn3
1451330_a_at 6.16 Inpp5b 1451828_a_at 4.952 Acsl4 1428073_a_at 4.306 Nup88
1435245_at 6.151 Gls2 1424440_at 4.946 Mrps6 1435878_at 4.28 Stk38l  248 
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1415993_at 4.277 Sqle 1452214_at 3.803 9130011J04Rik 1423402_at 3.433 Creb1
1416318_at 4.275 Serpinb1a 1453782_at 3.797 3021401C12Rik 1418128_at 3.432 Adcy6
1424067_at 4.269 Icam1 1456358_at 3.79 Etv3 1430185_at 3.432 5830460E08Rik
1460541_at 4.265 AI643885 1428861_at 3.784 4631422O05Rik 1454849_x_at 3.431 Clu
1416714_at 4.253 Icsbp1 1455250_at 3.781 Sh3bp4 1430634_a_at 3.43 Pfkp
1422705_at 4.25 Tmepai 1425515_at 3.781 Pik3r1 1444619_x_at 3.404 Psmb8
1448140_at 4.246 2810413N20Rik 1448571_a_at 3.778 Gmfb 1436181_at 3.403 LOC211914
1428395_at 4.239 4930431E10Rik 1438016_at 3.776 BC068171 1421103_at 3.4 Bmp2k
1425811_a_at 4.231 Csrp1 1437304_at 3.772 Cblb 1457656_s_at 3.398 C230085N15Rik
1417511_at 4.226 Lyar 1430295_at 3.77 Gna13 1450908_at 3.392 Eif4e
1423137_at 4.225 Rala 1423299_at 3.768 Txnl1 1420522_at 3.38 2610529H08Rik
1448604_at 4.225 AA407809 1449044_at 3.766 Eef1e1 1453240_a_at 3.379 2900054P12Rik
1416796_at 4.222 Nck2 1426607_at 3.765 3110070M22Rik 1437174_at 3.378 A330080J22Rik
1417434_at 4.221 Gpd2 1434388_at 3.765 A630029F06 1426482_at 3.372 Prkrir
1452364_at 4.217 D11Ertd530e 1425927_a_at 3.759 Atf5 1448271_a_at 3.372 Ddx21
1458634_at 4.207 Cd47 1419270_a_at 3.756 Dutp 1416268_at 3.371 Ets2
1460249_at 4.205 Lnx2 1416782_s_at 3.756 DXImx39e 1449300_at 3.371 BC003236
1441947_x_at 4.188 BC033915 1448793_a_at 3.746 Sdc4 1428593_at 3.37 1700029F09Rik
1425773_s_at 4.187 Nmnat 1430445_at 3.729 1700026G02Rik 1447926_at 3.368 2810410P22Rik
1424303_at 4.184 AV216087 1417470_at 3.727 Apobec3 1448968_at 3.366 D7Wsu128e
1426221_at 4.181 5830475I06Rik 1418587_at 3.722 Traf3 1430752_at 3.362 C330006D17Rik
1454931_at 4.179 Cri2 1435693_at 3.713 BC012256 1423269_a_at 3.362 Nedd4l
1428141_at 4.178 Gga2 1460441_at 3.709 Zxda 1438852_x_at 3.358 Mcm6
1422861_s_at 4.167 1110001A05Rik 1451050_at 3.708 Nt5c3 1456429_at 3.356 Malt1
1434339_at 4.164 2610318I01Rik 1448274_at 3.706 C1qbp 1421198_at 3.356 Itgav
1441075_at 4.16 LOC329416 1424412_at 3.704 Ogfrl1 1449433_at 3.352 P2rx5
1427705_a_at 4.152 Nfkb1 1460719_a_at 3.703 P2rx1 1422018_at 3.344 Hivep2
1423143_at 4.146 Gtpbp4 1450333_a_at 3.702 Gata2 1452666_a_at 3.341 1110063G11Rik
1425197_at 4.14 Ptpn2 1427324_at 3.7 LOC330189 1452661_at 3.34 Tfrc
1448175_at 4.127 Ehd1 1423724_at 3.696 D10Ertd749e 1416069_at 3.338 Pfkp
1419029_at 4.127 Ero1l 1430287_s_at 3.692 2310008M14Rik 1415925_a_at 3.336 Nup62
1418626_a_at 4.124 Clu 1434350_at 3.691 Axud1 1448226_at 3.335 Rrm2
1431072_a_at 4.118 2610529H08Rik 1456251_x_at 3.688 Bzrp 1421107_at 3.334 Stk4
1424671_at 4.116 Plekhf1 1451950_a_at 3.683 Cd80 1423681_at 3.334 1300018I05Rik
1433526_at 4.115 Klhl8 1433675_at 3.682 Rnu22 1423828_at 3.33 Fasn
1435766_at 4.114 1600022A19Rik 1419254_at 3.682 Mthfd2 1429682_at 3.323 4930431B09Rik
1450845_a_at 4.108 Bzw1 1457658_x_at 3.679 Anxa4 1455940_x_at 3.322 Wdr6
1417171_at 4.098 Itk 1426299_at 3.675 9130017C17Rik 1423720_a_at 3.316 Sara1
1434600_at 4.095 Tjp2 1423194_at 3.674 Arhgap5 1449287_at 3.316 Srms
1436871_at 4.094 Sfrs7 1416305_at 3.664 Sh3bp4 1416011_x_at 3.316 Ehd1
1460439_at 4.091 BC033915 1450970_at 3.66 Got1 1422675_at 3.309 Smarce1
1456174_x_at 4.079 Ndrg1 1417523_at 3.659 Plek 1416695_at 3.309 Bzrp
1455618_x_at 4.079 1300010A20Rik 1451069_at 3.659 Pim3 1427689_a_at 3.308 Tnip1
1450957_a_at 4.078 Sqstm1 1453181_x_at 3.649 Plscr1 1456739_x_at 3.305 Armcx2
1449108_at 4.075 Fdx1 1454962_at 3.648 SPIRE1 1423078_a_at 3.302 Sc4mol
1452316_at 4.065 1110020M19Rik 1438945_x_at 3.645 Gja1 1425350_a_at 3.301 Myef2
1434364_at 4.064 Map3k14 1450923_at 3.645 Tgfb2 1427062_at 3.298 9930104E21Rik
1424638_at 4.062 Cdkn1a 1451012_a_at 3.64 Csda 1419472_s_at 3.296 Nudc
1423316_at 4.059 2610033C09Rik 1418666_at 3.637 Ptx3 1423054_at 3.29 Wdr1
1423060_at 4.053 Pa2g4 1426609_at 3.635 2810028N01Rik 1420500_at 3.29 Dnajc1
1427922_at 4.052 1110046L09Rik 1453482_at 3.626 A430105C05Rik 1420548_a_at 3.289 2310008H09Rik
1455771_at 4.052 Bzrap1 1448297_a_at 3.621 Tnk2 1441380_at 3.284 2810439F02Rik
1419402_at 4.042 Mns1 1418401_a_at 3.62 Dusp16 1436746_at 3.279 Prkwnk1
1456212_x_at 4.037 Socs3 1448508_at 3.612 AI429613 1418744_s_at 3.278 Tesc
1437325_x_at 4.033 Pycs 1433523_at 3.603 D930005D10Rik 1418831_at 3.276 Pkp3
1434442_at 4.024 D5Ertd593e 1418932_at 3.6 Nfil3 1424839_a_at 3.274 2810405F18Rik
1448133_at 4.013 C87860 1453076_at 3.597 9130211I03Rik 1423769_at 3.274 Ptcd2
1436506_a_at 4.009 1110008H02Rik 1449232_at 3.596 Gata1 1429189_at 3.272 1110007C02Rik
1418093_a_at 4.006 Egf 1422615_at 3.591 Map4k4 1454873_at 3.271 C130032F08Rik
1438664_at 4.004 Prkar2b 1455854_a_at 3.588 AW551225 1417640_at 3.27 Cd79b
1428164_at 3.999 Nudt9 1423036_at 3.584 Txnl5 1438650_x_at 3.27 Gja1
1460207_s_at 3.983 E2f5 1421082_s_at 3.583 Banf1 1448154_at 3.27 Ndrg2
1424724_a_at 3.978 D16Ertd472e 1437296_at 3.576 Pkn2 1437100_x_at 3.25 Pim3
1440739_at 3.974 Vegfc 1423581_at 3.567 Nmt2 1456748_a_at 3.247 Nipsnap1
1433974_at 3.968 Sephs1 1438761_a_at 3.56 Odc 1421623_at 3.24 Il12rb2
1425749_at 3.964 Stxbp6 1435338_at 3.554 AI504062 1423745_at 3.239 1110031B06Rik
1420948_s_at 3.959 4833408C14Rik 1417925_at 3.547 Ccl22 1434580_at 3.232 Enpp4
1450744_at 3.957 Ell2 1426612_at 3.546 Tipin 1416852_a_at 3.229 Ncdn
1435679_at 3.946 Optn 1417166_at 3.543 Psip1 1428071_at 3.229 1110038D17Rik
1429381_x_at 3.944 Igh-VJ558 1433474_at 3.541 Edil3 1448689_at 3.229 Rras2
1429049_at 3.936 1200013B22Rik 1431429_a_at 3.537 Arl4 1425066_a_at 3.228 1110061O04Rik
1435630_s_at 3.929 Acat2 1436216_s_at 3.535 2610204M08Rik 1435955_at 3.224 Siglec10
1450385_at 3.929 Kpna3 1420947_at 3.529 Atrx 1416743_at 3.221 Uap1
1419103_a_at 3.921 Abhd6 1452013_at 3.522 Atp10a 1449523_at 3.216 Bcl7c
1434957_at 3.92 Cdon 1417404_at 3.521 Elovl6 1448396_at 3.215 D1Bwg0491e
1438917_x_at 3.909 Nup62 1427077_a_at 3.517 Ap2b1 1452514_a_at 3.21 Kit
1417056_at 3.9 Psme1 1439348_at 3.5 S100a10 1450786_x_at 3.208 1110001A05Rik
1454637_at 3.896 Klhl8 1456475_s_at 3.496 Prkar2b 1421731_a_at 3.205 Fen1
1450750_a_at 3.896 Nr4a2 1430175_at 3.495 4930588G05Rik 1423643_at 3.204 Ddx39
1418151_at 3.895 Mtmr4 1447272_s_at 3.491 Atp10a 1424396_a_at 3.201 Asrgl1
1424600_at 3.895 Abp1 1416291_at 3.49 Psmc4 1437238_x_at 3.198 C87860
1452132_at 3.893 0610030G03Rik 1449175_at 3.476 Gpr65 1423489_at 3.195 Mmd
1437497_a_at 3.886 Hspca 1427212_at 3.473 Mapkap1 1416129_at 3.194 1300002F13Rik
1433674_a_at 3.881 Rnu22 1416010_a_at 3.472 Ehd1 1434240_at 3.193 4632434I11Rik
1427229_at 3.88 Hmgcr 1448710_at 3.47 Cxcr4 1440801_s_at 3.192 Adrbk2
1420743_a_at 3.878 Ppp3cc 1424942_a_at 3.469 Myc 1455051_at 3.186 Rnf31
1422650_a_at 3.869 Riok3 1416544_at 3.468 Ezh2 1419714_at 3.18 Pdcd1lg1
1419192_at 3.864 Il4i1 1451516_at 3.467 Rhebl1 1460191_at 3.18 0610042I15Rik
1428572_at 3.864 Basp1 1451544_at 3.466 Tapbpl 1429787_x_at 3.177 D10Ertd749e
1433897_at 3.834 AI597468 1460697_s_at 3.465 2610209M04Rik 1435415_x_at 3.177 Mlp
1452223_s_at 3.828 2900054P12Rik 1434080_at 3.463 Aebp2 1457759_at 3.176 A630081D01Rik
1424617_at 3.823 Ifi35 1417541_at 3.463 Hells 1424971_at 3.175 2600001J17Rik
1422893_at 3.82 Sfmbt1 1434180_at 3.46 Plekhc1 1426994_at 3.174 Plekhe1
1451986_s_at 3.809 Lrrk1 1436808_x_at 3.446 Mcm5 1460741_x_at 3.165 D17Wsu92e
1423401_at 3.808 Etv6 1426744_at 3.437 Srebf2 1420028_s_at 3.163 Mcm3
1418280_at 3.803 Copeb 1434437_x_at 3.437 Rrm2 1418854_at 3.162 Birc2  249 
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1451208_at 3.161 Etf1 1456022_at 2.92 B230339E18Rik 1423878_at 2.752 Gypc
1416251_at 3.157 Mcm6 1418183_a_at 2.914 Pscd1 1416130_at 2.751 Prnp
1455902_x_at 3.15 Rhof 1423584_at 2.913 Igfbp7 1451233_at 2.749 Traf2
1451475_at 3.147 Plxnd1 1434184_s_at 2.913 9430080K19Rik 1435800_a_at 2.748 Csda
1417189_at 3.146 Psme2 1453102_at 2.912 Flrt3 1441033_at 2.747 D330034A10Rik
1451082_at 3.145 1300018I05Rik 1424800_at 2.91 Enah 1428585_at 2.746 Actn1
1441855_x_at 3.141 Cxcl1 1417138_s_at 2.91 Polr2e 1420437_at 2.746 Indo
1426712_at 3.14 Slc6a15 1448382_at 2.91 Ehhadh 1415917_at 2.744 Mthfd1
1451065_a_at 3.139 Ddx39 1448350_at 2.906 Asl 1436194_at 2.742 C330008K14Rik
1442586_at 3.129 D130043N08Rik 1448879_at 2.899 Ube2l3 1436656_at 2.74 BC062109
1417406_at 3.126 Sertad1 1422660_at 2.896 Rbm3 1428315_at 2.74 Ebna1bp2
1419069_at 3.12 Rabgef1 1448663_s_at 2.892 Mvd 1452880_at 2.74 Myohd1
1441089_at 3.119 Eif2c3 1420840_at 2.89 Plekha3 1441943_x_at 2.738 2810413N20Rik
1460710_at 3.119 Adora2a 1416844_at 2.89 Hrmt1l1 1448899_s_at 2.738 Rad51ap1
1453129_a_at 3.119 Rgs12 1424541_at 2.889 1110020A09Rik 1417094_at 2.737 Bach
1419030_at 3.118 Ero1l 1427190_at 2.888 2900057D21Rik 1423234_at 2.736 Psmd5
1454161_s_at 3.117 0610007P14Rik 1448184_at 2.886 Fkbp1a 1436805_at 2.735 2810457I06Rik
1429527_a_at 3.114 Plscr1 1449119_at 2.885 Arih2 1439352_at 2.735 Trim7
1426670_at 3.113 Agrn 1426425_at 2.884 Sugt1 1434646_s_at 2.732 Sap18
1426837_at 3.111 Metap1 1451540_at 2.884 Mpi1 1428696_at 2.73 2310015N21Rik
1447818_x_at 3.11 Rhebl1 1448802_at 2.883 Nufip1 1448657_a_at 2.728 Dnajb10
1451379_at 3.11 Rab22a 1439805_at 2.881 Nfat5 1428914_at 2.727 2310014D11Rik
1433781_a_at 3.107 Cldn12 1438682_at 2.881 Pik3r1 1422894_at 2.726 Sfmbt1
1419445_s_at 3.103 Sap18 1423053_at 2.874 Arf4 1453734_at 2.725 4833408C14Rik
1417081_a_at 3.096 Syngr2 1437458_x_at 2.873 Clu 1416981_at 2.723 Foxo1
1425855_a_at 3.094 Crk 1450981_at 2.869 Cnn2 1448261_at 2.721 Cdh1
1415926_at 3.094 Nup62 1416071_at 2.868 Ddx18 1453725_a_at 2.721 Mrps7
1452996_a_at 3.092 Aven 1429100_at 2.867 2010109K11Rik 1452777_a_at 2.721 6330412F12Rik
1450406_a_at 3.087 Siat6 1421957_a_at 2.866 Pcyt1a 1423877_at 2.72 Chaf1b
1433444_at 3.087 Hmgcs1 1415975_at 2.852 Carhsp1 1416641_at 2.72 Lig1
1430404_at 3.085 4833416J08Rik 1419838_s_at 2.849 Plk4 1439399_a_at 2.718 Rnu22
1429149_at 3.083 2700085M18Rik 1460231_at 2.848 Irf5 1428684_at 2.718 1500001M20Rik
1454232_at 3.082 9430027B09Rik 1454812_at 2.847 5730601F06Rik 1421947_at 2.713 Gng12
1418088_a_at 3.078 Stx8 1425255_s_at 2.844 2810036L13Rik 1452254_at 2.711 Mtmr9
1454884_at 3.076 Btbd4 1451346_at 2.841 Mtap 1429193_at 2.711 4631416I11Rik
1424759_at 3.073 Arrdc4 1438168_x_at 2.838 Ddx39 1426208_x_at 2.71 Plagl1
1449855_s_at 3.067 Uchl3 1428378_at 2.838 Zc3hav1 1421861_at 2.706 Clstn1
1438763_at 3.064 D330014H01Rik 1419281_a_at 2.833 Zfp259 1436325_at 2.705 Rora
1420776_a_at 3.062 Auh 1433883_at 2.832 Tpm4 1460691_at 2.704 Zfp598
1428061_at 3.059 Hat1 1456791_at 2.831 AA407452 1433874_at 2.702 AW551225
1433811_at 3.055 AI315037 1428261_at 2.831 2310042L06Rik 1439038_at 2.702 9130227C08Rik
1419036_at 3.054 Csnk2a1 1455320_at 2.829 AI480535 1416595_at 2.699 Mrps22
1417357_at 3.053 Emd 1418889_a_at 2.829 Csnk1d 1449333_at 2.698 Sf3a1
1431050_at 3.052 Rps6ka5 1426904_s_at 2.828 Dnajc10 1448956_at 2.694 Stard10
1448333_at 3.05 Adprh 1427578_a_at 2.827 Itgb4bp 1418242_at 2.692 Faf1
1430307_a_at 3.05 Mod1 1433588_at 2.826 D6Wsu116e 1417426_at 2.69 Prg
1416085_s_at 3.047 Zfp216 1416531_at 2.826 Gsto1 1438011_at 2.689 Pcyt1a
1438716_at 3.047 LOC209387 1426757_at 2.826 Ampd2 1428843_at 2.688 1810015H18Rik
1460711_at 3.045 9930116P15Rik 1433936_at 2.826 0610010E21Rik 1429776_a_at 2.684 Dnajb6
1455082_at 3.043 Cblb 1425157_x_at 2.825 1300010A20Rik 1430536_a_at 2.684 Erh
1417374_at 3.041 Tuba4 1450862_at 2.82 Rad54l 1425027_s_at 2.681 2010005O13Rik
1421118_a_at 3.04 Gpr56 1415800_at 2.819 Gja1 1424318_at 2.68 1110067D22Rik
1434062_at 3.032 8430421H08Rik 1456388_at 2.818 Atp11a 1420342_at 2.677 Gdap10
1426206_at 3.031 Robo4 1421173_at 2.818 Irf4 1437696_at 2.676 BC049807
1422608_at 3.031 Arpp19 1416653_at 2.817 Stxbp3 1438032_at 2.67 Chdc1
1433443_a_at 3.03 Hmgcs1 1424712_at 2.816 Elys 1416331_a_at 2.669 Nfe2l1
1426834_s_at 3.029 D930015E06Rik 1435552_at 2.816 AI462125 1452847_at 2.666 2410008K03Rik
1415945_at 3.029 Mcm5 1422397_a_at 2.815 Il15ra 1416222_at 2.663 Nsdhl
1433445_x_at 3.029 Hmgcs1 1420501_at 2.813 Dnajc1 1451969_s_at 2.662 Adprtl3
1421529_a_at 3.027 Txnrd1 1426533_at 2.813 Nol5a 1453372_at 2.662 4733401K02Rik
1453841_at 3.023 2310050P20Rik 1427892_at 2.81 Myo1g 1434088_at 2.66 2610028M21Rik
1428544_at 3.022 0610007L01Rik 1428579_at 2.81 Fmnl2 1429128_x_at 2.66 Nfkb2
1438606_a_at 3.019 Clic4 1423568_at 2.809 Psma7 1435627_x_at 2.659 Mlp
1423059_at 3.018 Ptk2 1434815_a_at 2.809 AI874665 1438251_x_at 2.659 Prss11
1429475_at 3.018 2810457I06Rik 1435350_at 2.804 Traf6 1429139_at 2.659 2900060B22Rik
1427172_at 3.014 Ofd1 1455821_x_at 2.802 2400006N03Rik 1416061_at 2.657 Tbc1d15
1460319_at 3.012 Fut8 1454109_a_at 2.802 Ptdsr 1435070_at 2.656 Aebp2
1448746_at 3.008 Nbn 1416379_at 2.8 Panx1 1457644_s_at 2.656 Cxcl1
1435526_at 3.007 A130072J07 1427144_at 2.799 2810036L13Rik 1429395_at 2.654 4933434L15Rik
1425263_a_at 3.002 Mbp 1451110_at 2.797 Egln1 1445888_x_at 2.654 Adprtl3
1460356_at 3.001 Esam1 1456355_s_at 2.795 Srr1 1423567_a_at 2.644 Psma7
1421399_at 2.998 Insm1 1454850_at 2.795 1810062O14Rik 1426480_at 2.644 Sbds
1417890_at 2.998 Pdxp 1429370_a_at 2.792 Psmd11 1450873_at 2.641 Gtpbp4
1453287_at 2.993 0610012A05Rik 1422648_at 2.792 Slc7a2 1417629_at 2.641 Prodh
1455904_at 2.993 Gas5 1417500_a_at 2.792 Tgm2 1431688_at 2.641 4833407H14Rik
1436649_at 2.99 Zfpn1a3 1449648_s_at 2.789 Rpo1-1 1432016_a_at 2.641 Idh3a
1426535_at 2.99 9630046K23Rik 1456126_at 2.785 Malt1 1434079_s_at 2.64 Mcm2
1448577_x_at 2.988 Syngr2 1459987_s_at 2.783 Cct3 1423804_a_at 2.638 Idi1
1427253_s_at 2.985 D11Ertd530e 1450067_a_at 2.78 1810034K20Rik 1427061_at 2.637 9930104E21Rik
1426645_at 2.984 Hspca 1436828_a_at 2.777 Tpd52l2 1434113_a_at 2.635 XPMC2H
1416230_at 2.975 Rfk 1450455_s_at 2.776 Akr1c12 1428087_at 2.634 Dnm1l
1418116_at 2.972 Ifrg15 1438948_x_at 2.774 Bzrp 1441107_at 2.634 Dmrta2
1457218_at 2.967 6430510M02Rik 1438008_at 2.771 Gga3 1428851_at 2.634 1300014I06Rik
1459791_at 2.966 Dnajc1 1427913_at 2.769 Rwdd1 1428390_at 2.632 2610318G08Rik
1448794_s_at 2.965 Zrf2 1434419_s_at 2.768 Tardbp 1454791_a_at 2.628 Rbbp4
1438215_at 2.965 Sfrs3 1416020_a_at 2.768 Atp5g1 1435647_at 2.625 Ikbkg
1452233_at 2.96 Abcc1 1452226_at 2.767 2610510H01Rik 1437494_at 2.623 AI874665
1418578_at 2.958 Dgka 1424140_at 2.766 Gale 1416070_a_at 2.621 Ddx18
1455814_x_at 2.958 Ddx39 1440275_at 2.764 Runx3 1424801_at 2.615 Enah
1434910_at 2.941 2310067E24Rik 1434252_at 2.763 C630016B22Rik 1434220_at 2.611 AI849286
1452679_at 2.936 2410129E14Rik 1423393_at 2.762 Clic4 1440770_at 2.609 Bcl2
1416563_at 2.932 Ctps 1450992_a_at 2.761 Meis1 1437869_at 2.607 3222402P14Rik
1417110_at 2.93 Man1a 1451487_at 2.76 9530020D24Rik 1418226_at 2.607 Orc2l
1437222_x_at 2.929 Rrm2b 1422707_at 2.76 Pik3cg 1434929_at 2.606 BC035044
1421459_a_at 2.928 Lrp8 1421052_a_at 2.76 Sms 1433514_at 2.604 Etnk1
1448450_at 2.921 Ak2 1452999_at 2.754 2410004J23Rik 1417679_at 2.599 Gfi1  250 
 
 
 
 
 
 
Affymetrix Id Fold change Common name Affymetrix Id Fold change Common name Affymetrix Id Fold change Common name
1417783_at 2.594 Als2 1454731_at 2.477 Myo10 1437945_x_at 2.369 Nap1l1
1452612_at 2.588 Zfp294 1426923_at 2.475 Hrb 1434482_at 2.369 D4Ertd22e
1431087_at 2.587 2410030K01Rik 1420351_at 2.474 Tnfrsf4 1452309_at 2.369 4933421H10Rik
1416724_x_at 2.585 Tcf4 1459270_at 2.466 1456586_x_at 2.368 Mvp
1416290_a_at 2.58 Psmc4 1427874_at 2.466 Zfp313 1448624_at 2.367 Cd2bp2
1449839_at 2.577 Casp3 1440192_at 2.464 1810054D07Rik 1415720_s_at 2.365 Mad2l1bp
1456494_a_at 2.577 LOC209387 1434143_at 2.463 BC060631 1428816_a_at 2.364 Gata2
1451281_at 2.575 Zfp96 1418070_at 2.463 Cdyl 1422737_at 2.363 Ncoa3
1436509_at 2.575 2410014A08Rik 1447703_x_at 2.463 3110024A21Rik 1422788_at 2.363 Slc43a3
1429005_at 2.574 Mfhas1 1433428_x_at 2.463 Tgm2 1426587_a_at 2.363 Stat3
1449324_at 2.574 Ero1l 1434954_at 2.462 Mpp5 1416585_at 2.36 Ruvbl1
1426147_s_at 2.573 Cldn10 1447837_x_at 2.46 Polh 1419444_at 2.358 Sap18
1451587_a_at 2.573 1810011K17Rik 1423038_at 2.459 Stx6 1418154_at 2.358 BC004022
1423467_at 2.572 Ms4a4b 1449209_a_at 2.456 Rdh11 1423976_at 2.358 4930453N24Rik
1448135_at 2.57 Atf4 1424296_at 2.456 Gclc 1420021_s_at 2.358 D11Ertd530e
1439120_at 2.569 BC010304 1419068_at 2.456 Rabgef1 1419253_at 2.357 Mthfd2
1431020_a_at 2.565 Fgfr1op2 1418962_at 2.455 1110005F07Rik 1451509_at 2.354 4921516M08Rik
1426495_at 2.564 2410042D21Rik 1452111_at 2.454 Mrps35 1449404_at 2.353 Pip5k2a
1427914_a_at 2.56 Tceb1 1439975_at 2.451 BC062109 1416345_at 2.353 Timm8a
1426942_at 2.559 Aim1 1436617_at 2.449 Cetn4 1426187_a_at 2.352 Hs1bp1
1417948_s_at 2.559 Ilf2 1416554_at 2.449 Pdlim1 1425142_a_at 2.351 Hnrpd
1426222_s_at 2.558 5830475I06Rik 1418828_at 2.447 3110010F15Rik 1423884_at 2.349 Tex292
1452162_at 2.556 8430408H12Rik 1428491_at 2.446 Commd10 1428745_a_at 2.348 2310003L22Rik
1453636_at 2.555 5830406C17Rik 1420330_at 2.444 Clecsf9 1451313_a_at 2.348 1110067D22Rik
1449585_at 2.555 Il1rap 1418711_at 2.443 Pdgfa 1423431_a_at 2.347 Mybbp1a
1415894_at 2.55 Enpp2 1460739_at 2.44 D11Bwg0280e 1416076_at 2.345 Ccnb1
1420196_s_at 2.549 D5Ertd110e 1416897_at 2.437 BC003281 1415670_at 2.343 Copg
1433940_at 2.547 Spag7 1454814_s_at 2.435 Prps1 1427448_at 2.342 Rabep1
1428903_at 2.545 3110037I16Rik 1429859_a_at 2.435 Arl2bp 1417035_at 2.342 2410004C24Rik
1418637_at 2.543 Etv3 1422708_at 2.434 Pik3cg 1426300_at 2.341 Alcam
1455840_at 2.542 Rapgef5 1434928_at 2.433 4930500E24Rik 1454817_at 2.339 6230425C22Rik
1435280_at 2.542 AI452195 1417700_at 2.432 Rab38 1451164_a_at 2.338 Mrps18b
1429227_x_at 2.541 Nap1l1 1455000_at 2.432 Gpr68 1427152_at 2.336 4732486I23Rik
1430303_at 2.54 4921537D05Rik 1424681_a_at 2.43 Psma5 1415739_at 2.335 3100004P22Rik
1423596_at 2.54 Nek6 1453589_a_at 2.429 2610005L07Rik 1441814_s_at 2.334 2400006N03Rik
1460556_at 2.538 D15Mit260 1448377_at 2.428 Slpi 1416506_at 2.334 Psma6
1415916_a_at 2.537 Mthfd1 1418627_at 2.425 Gclm 1438369_x_at 2.332 2610318K02Rik
1418025_at 2.536 Bhlhb2 1423212_at 2.424 Phc1 1419368_a_at 2.332 Rnf138
1434159_at 2.535 Stk4 1419280_at 2.424 Pip5k2a 1416606_s_at 2.33 Nola2
1448441_at 2.534 Cks1 1452601_a_at 2.421 Acbd6 1424075_at 2.329 9430016H08Rik
1419639_at 2.534 Efnb2 1438115_a_at 2.42 Slc9a3r1 1421880_at 2.328 Mtmr1
1449089_at 2.534 Nrip1 1416092_a_at 2.419 Mtap4 1431947_at 2.326 Ldlr
1419471_a_at 2.532 Nudc 1452585_at 2.419 Mrps28 1415859_at 2.326 Eif3s8
1450722_at 2.53 Nup50 1417140_a_at 2.419 Ptpn2 1428418_s_at 2.324 3110050N22Rik
1420583_a_at 2.53 Rora 1428300_at 2.417 4932439K10Rik 1435904_at 2.324 Eif2c3
1437277_x_at 2.528 Tgm2 1449446_at 2.417 D10Ertd718e 1433894_at 2.323 AI591476
1426084_a_at 2.528 MGC6357 1422764_at 2.417 Mapre1 1422730_at 2.319 Limd1
1455616_at 2.528 AI586002 1424883_s_at 2.416 Sfrs7 1425550_a_at 2.319 Prkar1a
1420851_at 2.528 Pard6g 1425507_at 2.416 Arfrp1 1417037_at 2.317 Orc6l
1431411_a_at 2.527 Rai12 1454942_at 2.416 AU019833 1415882_at 2.317 Ghitm
1452230_at 2.526 Dnajc10 1417767_at 2.413 1810044O22Rik 1423870_at 2.316 2610208M17Rik
1426210_x_at 2.525 Adprtl3 1419548_at 2.412 Kpna1 1424448_at 2.316 Trim6
1423039_a_at 2.524 Bzw1 1424705_at 2.407 2810411A03Rik 1422429_at 2.316 Rnf14
1427325_s_at 2.524 AI597013 1426716_at 2.406 Tdrd7 1433951_at 2.315 2810410P22Rik
1450028_a_at 2.524 Lancl2 1423306_at 2.405 2010002N04Rik 1456393_at 2.315 Pdcd4
1419385_a_at 2.523 Ubqln1 1428979_at 2.405 Mtf1 1446737_a_at 2.313 Hook3
1435085_at 2.523 AI046348 1427539_a_at 2.404 D10Ertd749e 1438902_a_at 2.311 Hspca
1426256_at 2.523 Timm17a 1426885_a_at 2.402 Cdk2ap1 1438999_a_at 2.31 Nfat5
1419641_at 2.519 Purb 1423810_at 2.401 2700017M01Rik 1456795_at 2.306 D330027G24Rik
1422547_at 2.518 Ranbp1 1437742_at 2.4 Rab21 1426875_s_at 2.305 Npn3
1433789_at 2.517 Rnu17d 1424413_at 2.399 Ogfrl1 1451206_s_at 2.304 Pscdbp
1423773_at 2.513 1700034P14Rik 1418403_at 2.397 Adam19 1428760_at 2.303 Snapc3
1426279_at 2.513 5830415L20Rik 1449362_a_at 2.397 Map4k6 1416723_at 2.302 Tcf4
1448953_at 2.513 Blm 1455039_a_at 2.396 Sin3b 1435901_at 2.302 Dgkd
1436754_at 2.509 AI839735 1425462_at 2.393 Fbxw1b 1454703_x_at 2.301 Rnu22
1452411_at 2.507 Lrrc1 1429328_at 2.393 p47 1452168_x_at 2.301 Gspt1
1436812_at 2.507 Fkrp 1448957_at 2.392 Rbpsuh 1459902_at 2.299 2700007P21Rik
1457376_at 2.506 Itga4 1424169_at 2.392 1300011C24Rik 1423386_at 2.298 Psmd9
1433656_a_at 2.504 C77032 1452833_at 2.392 Rapgef2 1439269_x_at 2.296 Mcm7
1434355_at 2.501 Zfp617 1450735_at 2.391 1810003N24Rik 1418905_at 2.294 Nubp1
1448435_at 2.5 Pcqap 1415817_s_at 2.391 Cct7 1451658_a_at 2.294 Polr3c
1424316_at 2.498 Slc25a19 1424418_at 2.391 BC010801 1448419_at 2.294 Pop4
1417592_at 2.497 Frap1 1451272_a_at 2.391 2510010F15Rik 1426736_at 2.291 Gspt1
1433782_at 2.496 Cldn12 1433451_at 2.389 Cdk5r 1427197_at 2.289 Atr
1416380_at 2.494 Mov10 1437711_x_at 2.389 Odc 1452778_x_at 2.288 Nap1l1
1448536_at 2.494 Lsm3 1426579_at 2.388 BC003262 1438095_x_at 2.288 AI326906
1416979_at 2.494 2510048O06Rik 1448586_at 2.386 Hspa14 1434035_at 2.288 Dnajb6
1427247_at 2.493 D3Bwg0562e 1449705_x_at 2.386 Mcm3 1425331_at 2.288 Zfp106
1420476_a_at 2.493 Nap1l1 1417126_a_at 2.385 3110001N18Rik 1431506_s_at 2.286 Ppih
1422535_at 2.493 Ccne2 1428648_at 2.385 D10Ertd516e 1448430_a_at 2.286 Naca
1450844_at 2.493 Stx6 1434400_at 2.385 Tgif2 1426580_at 2.286 Plk4
1442497_at 2.489 4931400A14Rik 1426503_a_at 2.385 Rnf121 1418730_at 2.285 Rnf12
1454018_at 2.487 Tlk2 1418825_at 2.383 Ifi1 1460360_at 2.283 Asrgl1
1421066_at 2.486 Jak2 1448772_at 2.383 Ube2a 1417190_at 2.283 Pbef1
1417041_at 2.486 Rpo1-1 1423519_at 2.381 2210412D01Rik 1448500_a_at 2.282 2810038K19Rik
1428195_at 2.486 4631427C17Rik 1424095_at 2.379 Rtcd1 1448677_at 2.28 Noc4
1446938_at 2.485 AA408213 1417637_a_at 2.375 Hmg20b 1452759_s_at 2.279 Ppfibp1
1416973_at 2.485 Ssfa1 1424698_s_at 2.375 Gca 1448160_at 2.279 Lcp1
1424710_a_at 2.484 Gorasp2 1449039_a_at 2.374 Hnrpdl 1427944_at 2.276 C1qdc1
1420368_at 2.484 Denr 1419649_s_at 2.374 Myo1c 1450275_x_at 2.275 2510010F15Rik
1454729_at 2.482 B130017P16Rik 1451649_a_at 2.373 2410118I19Rik 1452367_at 2.275 Coro2a
1416214_at 2.481 Mcm4 1416726_s_at 2.373 Ube2s 1449256_a_at 2.275 Rab11a
1446769_at 2.48 2810439F02Rik 1423355_at 2.373 Snap29 1456778_at 2.273 Nrp2
1418384_at 2.48 9430083G14Rik 1454888_at 2.372 Pfdn4 1425572_a_at 2.272 Ddef1
1417517_at 2.48 Plagl2 1428498_at 2.371 2610206B13Rik 1423511_at 2.272 Asf1a
1434666_at 2.478 1110054A01Rik 1425599_a_at 2.371 Odag 1455162_at 2.27 4922503N01Rik  251 
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1454650_at 2.27 Trim35 1435396_at 2.195 C85317 1418961_at 2.104 1110005F07Rik
1416341_at 2.27 Polr2c 1447649_x_at 2.194 Dnajc1 1436947_a_at 2.103 Txnl1
1455137_at 2.269 Rapgef5 1416526_a_at 2.194 Park7 1417192_at 2.101 D16Wsu109e
1422609_at 2.269 Arpp19 1415961_at 2.193 Itm2c 1421914_s_at 2.101 Mrpl19
1421937_at 2.269 Dapp1 1417288_at 2.192 Plekha2 1442793_s_at 2.1 Tbrg4
1452393_at 2.269 AI597013 1426276_at 2.191 9130009C22Rik 1417712_at 2.1 Eif2s2
1452828_at 2.268 Fbxo21 1423661_s_at 2.19 Ctdsp2 1438161_s_at 2.1 Rfc4
1424034_at 2.268 Rora 1424136_a_at 2.189 Ppih 1419886_at 2.098 DXErtd223e
1424597_at 2.268 ORF19 1421821_at 2.189 Ldlr 1434404_at 2.098 C030011O14Rik
1428293_at 2.267 2310022M17Rik 1448122_at 2.188 Tcp1 1434619_at 2.098 4932417H02Rik
1432646_a_at 2.265 2900097C17Rik 1452662_a_at 2.188 Eif2s1 1419447_s_at 2.098 Tbc1d1
1424089_a_at 2.265 Tcf4 1452458_s_at 2.187 Ppil5 1427258_at 2.097 Trim24
1419430_at 2.264 Cyp26a1 1418527_a_at 2.187 Fusip1 1451114_at 2.097 Cklfsf6
1452912_at 2.262 2600005O03Rik 1448172_at 2.186 Mdh1 1423517_at 2.094 Cct6a
1423949_at 2.261 D11Moh35 1448101_s_at 2.181 Trim27 1426918_at 2.094 Itgb1
1449645_s_at 2.261 Cct3 1453256_at 2.179 Polr3c 1415782_at 2.093 Smt3h2
1456056_a_at 2.261 D6Wsu116e 1417622_at 2.178 Slc12a2 1428674_at 2.092 1110021E09Rik
1434273_at 2.26 A830073O21Rik 1418443_at 2.178 Xpo1 1435402_at 2.09 A930008A22Rik
1428132_at 2.256 Spec1 1434880_at 2.177 Etv6 1426436_at 2.089 8430420C20Rik
1416485_at 2.254 Timm23 1454214_a_at 2.177 2410019A14Rik 1424523_at 2.089 Elmo1
1455680_at 2.253 9630025H16Rik 1434790_a_at 2.177 Lta4h 1418369_at 2.089 Prim1
1420661_a_at 2.253 4933439F18Rik 1437468_x_at 2.177 Fbxw1b 1421751_a_at 2.089 Psmd14
1416073_a_at 2.253 Pcnt2 1452884_at 2.177 2610510E10Rik 1459289_at 2.088
1452753_at 2.252 1110054H05Rik 1430594_at 2.17 4833414G05Rik 1427006_at 2.085 Rapgef1
1438562_a_at 2.251 Ptpn2 1423220_at 2.17 Eif4e 1419062_at 2.084 Epb4.1l3
1416742_at 2.25 Cfdp 1448757_at 2.169 Pml 1424452_at 2.084 5730555F13Rik
1427889_at 2.249 Spna2 1452241_at 2.169 2810429C13Rik 1417352_s_at 2.084 Snrpa1
1451339_at 2.248 Suox 1419558_at 2.166 Mdm4 1452257_at 2.083 Bdh
1451296_x_at 2.248 Pabpc4 1417387_at 2.165 3110004H13Rik 1428226_at 2.083 1500001L15Rik
1460498_a_at 2.248 Dnajc5 1422509_at 2.164 U2af1 1456196_x_at 2.081 Fkbp1a
1457687_at 2.248 Bcl2 1422712_a_at 2.161 Ube2i 1450815_s_at 2.079 Chchd2
1438938_x_at 2.246 Bcap37 1417547_at 2.158 Sart3 1424514_at 2.079 Rnf126
1453045_at 2.246 4921537D05Rik 1426486_at 2.158 Ubxd2 1420820_at 2.079 2900073G15Rik
1439972_at 2.243 D6Ertd3e 1449546_a_at 2.155 Zfp617 1460323_at 2.078 Tars
1422430_at 2.243 Fignl1 1415737_at 2.155 Rfk 1437131_x_at 2.078 Mrpl11
1454712_at 2.242 D130005A03Rik 1434708_at 2.154 Vhlh 1424161_at 2.075 Ddx27
1452352_at 2.238 Ctla2b 1424837_at 2.154 2810428C21Rik 1426529_a_at 2.074 Tagln2
1420826_at 2.238 Letm1 1455164_at 2.154 Cdgap 1427992_a_at 2.074 Rab12
1424244_at 2.238 BC016198 1426523_a_at 2.153 Gnpda2 1416084_at 2.073 Zfp216
1423588_at 2.237 Arpc4 1452151_at 2.151 BC021523 1437061_at 2.073 Mbd1
1432416_a_at 2.237 Npm1 1435317_x_at 2.15 Psma6 1428086_at 2.072 Dnm1l
1448178_a_at 2.237 Cct3 1416433_at 2.149 Rpa2 1450013_at 2.072 2900073G15Rik
1416240_at 2.236 Psmb7 1422731_at 2.146 Limd1 1415985_at 2.072 D8Ertd633e
1417200_at 2.236 1300007B12Rik 1431972_a_at 2.146 2900054P12Rik 1428080_at 2.071 2610528A17Rik
1423848_at 2.236 Mphosph6 1416489_at 2.145 Pi4k2b 1417657_s_at 2.07 Zrf2
1434450_s_at 2.235 Adrbk2 1416212_at 2.145 Magoh 1438992_x_at 2.069 Atf4
1426483_at 2.233 Prkrir 1437402_x_at 2.144 D7Ertd743e 1436171_at 2.068 6030405P05Rik
1433722_at 2.233 5730522G15Rik 1429054_at 2.143 4833424P18Rik 1424662_at 2.068 4933435E07Rik
1434488_at 2.232 Arfrp1 1429568_x_at 2.142 2510010F15Rik 1451217_a_at 2.067 1500034J20Rik
1460193_at 2.231 St13 1455643_s_at 2.142 AW550801 1418884_x_at 2.066 Tuba1
1420486_at 2.231 Nol7 1423890_x_at 2.142 Atp1b1 1448246_at 2.065 Hdac1
1426719_at 2.231 Apbb2 1426676_s_at 2.142 D16Wsu109e 1427228_at 2.064 2410003B16Rik
1429129_at 2.23 1200008A14Rik 1417493_at 2.141 Bmi1 1417254_at 2.063 Spata5
1428529_at 2.23 2810026P18Rik 1426739_at 2.141 Donson 1459906_at 2.063 Dgkh
1416024_x_at 2.228 Cct3 1450915_at 2.14 Ap3b1 1417353_x_at 2.062 Snrpa1
1456236_s_at 2.227 Commd10 1417938_at 2.139 Rad51ap1 1422495_a_at 2.062 Hmgn1
1435675_at 2.226 BC033574 1455409_at 2.138 SPIRE1 1423616_at 2.062 Tarbp2
1452179_at 2.225 Phf17 1423373_at 2.137 Rpp30 1439407_x_at 2.059 Tagln2
1444992_at 2.225 AI120166 1450668_s_at 2.137 Hspe1 1452128_a_at 2.059 C6.1A
1452063_at 2.225 2410081M15Rik 1428232_at 2.137 4733401N12Rik 1416336_s_at 2.059 Snrpd1
1438116_x_at 2.224 Slc9a3r1 1417252_at 2.137 Nt5c 1417509_at 2.058 Rnf19
1428915_at 2.224 Sirt5 1449007_at 2.136 Btg3 1421413_a_at 2.056 1110001A05Rik
1429749_at 2.221 9330180L21Rik 1448230_at 2.136 Usp10 1417458_s_at 2.055 Cks2
1437734_at 2.22 Ppp1r12a 1451496_at 2.136 Mtss1 1451359_at 2.054 BC005662
1448259_at 2.22 Fstl1 1422570_at 2.135 Yy1 1416549_at 2.054 AB041549
1429617_at 2.22 Cyld 1428311_at 2.134 2810012H18Rik 1422693_a_at 2.054 Rpo2tc1
1436953_at 2.219 Waspip 1451574_at 2.133 Bcl9 1437859_x_at 2.052 Eif5a
1420024_s_at 2.218 Etf1 1448597_at 2.133 Cstf1 1422627_a_at 2.051 Mkks
1426324_at 2.218 H2-Q10 1436512_at 2.132 A630084M22Rik 1423957_at 2.05 2700083B06Rik
1422959_s_at 2.217 Zfp313 1433766_at 2.13 C330023M02Rik 1426674_at 2.05 Eif3s9
1429849_at 2.216 4632411B12Rik 1416075_at 2.13 Sav1 1417774_at 2.049 Nans
1418946_at 2.215 Siat4a 1423241_a_at 2.128 Tfdp1 1455244_at 2.048 Daam1
1417303_at 2.212 Mvd 1450016_at 2.128 Ccng1 1429307_s_at 2.047 Lzic
1424562_a_at 2.212 Slc25a4 1428806_at 2.127 Csnk1g1 1434058_at 2.047 Pip3ap
1417183_at 2.211 Dnaja2 1428645_at 2.126 Gnai3 1426456_a_at 2.047 Miz1
1454042_a_at 2.21 Srpk1 1436508_at 2.125 2410014A08Rik 1448206_at 2.046 Psma2
1458438_at 2.21 4933415L06Rik 1415740_at 2.123 Psmc5 1419279_at 2.046 Pip5k2a
1454706_at 2.208 Uvrag1 1447909_s_at 2.121 Selk 1436510_a_at 2.046 Lrrfip2
1417985_at 2.208 Nrarp 1448543_at 2.121 2310042G06Rik 1432271_a_at 2.045 4833420K19Rik
1416106_at 2.207 1110001A12Rik 1430271_x_at 2.121 4930553M18Rik 1438955_x_at 2.045 Ppif
1417527_at 2.207 Ap3m2 1460004_x_at 2.117 Stx6 1417096_at 2.044 2810430M08Rik
1419263_a_at 2.206 Adrm1 1451401_a_at 2.115 0610009K11Rik 1455069_x_at 2.043 Slc25a4
1424468_s_at 2.206 D330037A14Rik 1450629_at 2.115 D15Ertd366e 1438977_x_at 2.043 Ran
1420774_a_at 2.206 4930583H14Rik 1422884_at 2.114 Snrpd3 1422443_at 2.042 Xpnpep1
1453993_a_at 2.204 Bnip2 1449406_at 2.113 Cyhr1 1426854_a_at 2.04 Set
1425687_at 2.204 Cflar 1418284_at 2.113 Tcfl1 1444478_at 2.04 2900057D21Rik
1417718_at 2.203 Eif3s4 1422000_at 2.112 Akr1c12 1456308_x_at 2.039 Trim28
1448670_at 2.203 Ube2e3 1450943_at 2.112 2010012C16Rik 1433571_at 2.039 A130038L21Rik
1428873_a_at 2.202 4121402D02Rik 1453554_a_at 2.111 1110001N06Rik 1418372_at 2.038 Adsl
1433970_at 2.199 1810056O20Rik 1453050_at 2.111 2700085M18Rik 1460460_a_at 2.038 Gorasp2
1433696_at 2.199 D17Ertd441e 1438835_a_at 2.11 Snrp116 1422848_a_at 2.038 Pabpn1
1451144_at 2.197 1110064N10Rik 1424344_s_at 2.109 Eif1a 1424305_at 2.038 Igj
1454804_at 2.197 AK129375 1451657_a_at 2.108 Cova1 1428440_at 2.038 Slc25a12
1425030_at 2.196 Zfp622 1417186_at 2.107 Hip2 1448509_at 2.034 3110001A13Rik
1417392_a_at 2.196 Slc7a7 1422103_a_at 2.106 Stat5b 1450650_at 2.034 Myo10
1416026_a_at 2.196 Rpl12 1426846_at 2.106 G630055P03Rik 1417165_at 2.034 Mbd2  252 
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1417865_at 2.034 Tnfaip1 1418524_at 1.958 Pcm1 1415703_at 1.841 Ureb1
1418071_s_at 2.031 Cdyl 1423133_at 1.957 0610040D20Rik 1447016_at 1.837 Tbc1d1
1460339_at 2.03 Psma4 1416612_at 1.956 Cyp1b1 1423969_at 1.836 Nup37
1448234_at 2.029 Dnajb6 1433606_at 1.955 Mitc1 1419258_at 1.833 Tcea1
1434020_at 2.029 Pdap1 1430053_a_at 1.953 2810409H07Rik 1420399_at 1.83 Gfi1b
1427412_s_at 2.028 A530068K01 1437839_x_at 1.953 Mrpl11 1420873_at 1.83 Ptk9
1455084_x_at 2.028 Shmt2 1424343_a_at 1.951 Eif1a 1442761_at 1.826 Tpd52l2
1436040_at 2.028 2310005L22Rik 1451665_a_at 1.951 Ap4s1 1429476_s_at 1.826 Dnaja2
1428468_at 2.028 3110043O21Rik 1453362_x_at 1.95 Rps24 1449968_s_at 1.826 Acate2
1448317_at 2.027 2810021O14Rik 1448896_at 1.95 Pigf 1417311_at 1.826 Crip2
1429528_at 2.026 Rae1 1426471_at 1.949 Zfp52 1426626_at 1.819 Gtf2f2
1453001_at 2.025 2610207P08Rik 1436559_a_at 1.948 Psmd10 1440255_at 1.818 AA589481
1421640_a_at 2.025 Tank 1418010_a_at 1.946 Sh3glb1 1450679_at 1.815 5730470L24Rik
1435975_at 2.024 AI115600 1427439_s_at 1.944 Skb1 1455067_at 1.814 BC046518
1434335_at 2.023 AI317237 1434087_at 1.944 Mthfr 1441843_s_at 1.813 5230400M03Rik
1424132_at 2.022 Hras1 1460396_at 1.944 Ddx54 1431339_a_at 1.812 Efhd2
1415869_a_at 2.021 Trim28 1448884_at 1.94 Gtf2e2 1447752_x_at 1.811 Drg1
1417125_at 2.02 Ahcy 1435863_at 1.939 Commd6 1439030_at 1.805 Gmppb
1435890_at 2.02 AW228836 1424211_at 1.938 5730438N18Rik 1432848_a_at 1.804 1200004M23Rik
1418073_at 2.019 Acate2 1434994_at 1.937 Nit1 1455547_at 1.802 Scrg3
1429188_at 2.017 2010004I09Rik 1460614_at 1.935 D130064H19Rik 1456571_at 1.798 1700001E16Rik
1417026_at 2.016 Pfdn1 1438250_s_at 1.934 Taf9 1420478_at 1.798 Nap1l1
1422688_a_at 2.016 Nras 1426836_s_at 1.934 Metap1 1455341_at 1.798 2010003J03Rik
1448324_at 2.014 Rnps1 1418844_at 1.934 Dibd1 1422836_at 1.797 Mbnl3
1429618_at 2.014 Cyld 1455252_at 1.934 Tsc1 1435343_at 1.795 Dock10
1417974_at 2.013 Kpna4 1416235_at 1.934 AA959742 1456003_a_at 1.793 Slc1a4
1428113_at 2.013 4930403J22Rik 1430515_s_at 1.933 Aasdhppt 1438963_s_at 1.793 Tfpt
1415752_at 2.012 BC031181 1419208_at 1.933 Map3k8 1419452_at 1.792 Uchl5
1424751_at 2.012 Abt1 1419266_at 1.933 Nfyb 1455727_at 1.792 U2af1-rs2
1433547_s_at 2.011 4921532K09Rik 1453257_at 1.932 D8Ertd319e 1460351_at 1.789 S100a11
1424269_a_at 2.01 Myl6 1424164_at 1.931 Mrpl50 1416208_at 1.788 Usp14
1434230_at 2.01 Polb 1453206_at 1.928 Acad9 1438458_a_at 1.788 Sfpq
1416197_at 2.01 Snrp1c 1422624_at 1.927 Rev1l 1437082_at 1.785 Akap9
1453865_a_at 2.009 DXImx46e 1455897_x_at 1.925 Hmgn1 1424897_at 1.781 2900026B03Rik
1455287_at 2.009 5830411I20 1417019_a_at 1.923 Cdc6 1429710_at 1.781 Styx
1423799_at 2.008 Sui1-rs1 1455043_at 1.922 Tnpo1 1430798_x_at 1.78 Mrpl15
1418491_a_at 2.008 2610020J05Rik 1443159_at 1.918 9130221J17Rik 1424850_at 1.779 Map3k1
1418827_at 2.008 3110010F15Rik 1450982_at 1.917 Slc9a3r1 1433768_at 1.778 2410003B16Rik
1455102_at 2.008 D330037H05Rik 1460428_at 1.917 1100001D10Rik 1416209_at 1.771 Glud
1433565_at 2.006 2410002M20Rik 1435697_a_at 1.916 Pscdbp 1439421_x_at 1.767 Cbx3
1427718_a_at 2.005 Mdm2 1452172_at 1.915 2810421I24Rik 1437356_at 1.766 Ebi2
1421985_a_at 2.005 Eif4el3 1435535_at 1.913 Depdc5 1423577_at 1.757 C730024G01Rik
1427332_at 2.005 2410018M14Rik 1448938_at 1.913 Rpa3 1423072_at 1.756 6720475J19Rik
1454975_at 2.004 BC033596 1423545_a_at 1.912 Zfp207 1429769_at 1.749 Pggt1b
1429737_a_at 2.004 0610009I22Rik 1434173_s_at 1.911 D19Bwg1357e 1450425_a_at 1.748 2700062C07Rik
1417840_at 2.004 1500031L02Rik 1448633_at 1.911 1500019O16Rik 1425319_s_at 1.747 6530403A03Rik
1451083_s_at 2.002 Aars 1433590_at 1.91 Herc3 1417111_at 1.741 Man1a
1437749_s_at 2.001 Mrpl9 1420817_at 1.908 Ywhag 1416920_at 1.732 Rbm4
1423781_at 2.001 Appbp1 1427938_at 1.908 Mycbp 1428744_s_at 1.732 Bri3bp
1416874_a_at 2 5730511K23Rik 1444158_at 1.908 Jarid1c 1428953_at 1.723 4930463P07Rik
1419257_at 2 Tcea1 1455436_at 1.907 2900052J15Rik 1456541_x_at 1.718 Atad3a
1415710_at 2 BC038311 1424983_a_at 1.906 2700078E11Rik 1429056_at 1.718 1300019C06Rik
1434432_at 2 1700051E09Rik 1436885_a_at 1.903 Cherp 1456626_a_at 1.717 1110005A23Rik
1436222_at 2 Gas5 1418760_at 1.903 Rdh11 1455801_x_at 1.717 Tbcd
1429384_at 1.999 Csnk1g3 1424206_at 1.902 Smarca5 1445440_at 1.715 A430106J12Rik
1426914_at 1.997 Mrvldc2 1428291_at 1.902 Exosc8 1428880_at 1.715 0610038F07Rik
1451231_a_at 1.995 Cul2 1421326_at 1.9 Csf2rb2 1416354_at 1.711 Rbmx
1460684_at 1.994 Tm7sf2 1428251_at 1.9 4931400A14Rik 1417947_at 1.706 Pcna
1433668_at 1.994 Pnrc1 1429711_at 1.9 Styx 1428729_at 1.705 Ccm1
1455988_a_at 1.992 Cct6a 1428154_s_at 1.899 2310022A04Rik 1453631_at 1.695 Stx8
1423089_at 1.99 Tmod3 1415730_at 1.899 5730453I16Rik 1421046_a_at 1.693 Pabpc4
1453545_at 1.989 5730492I20Rik 1435779_at 1.897 Cep1 1440972_at 1.689 Nsd1
1436955_at 1.988 D12Ertd604e 1428213_at 1.896 2410003A14Rik 1452198_at 1.677 Fbxl10
1456738_s_at 1.987 Brp16 1434434_s_at 1.896 Tcerg1 1423898_a_at 1.676 Gtl6
1428294_at 1.987 Zfp259 1429183_at 1.892 1200008D14Rik 1429080_at 1.674 Mphosph10
1441415_at 1.986 Spred2 1416415_a_at 1.892 H2afz 1416037_a_at 1.672 Cct2
1428959_at 1.986 5830405N20Rik 1437432_a_at 1.89 Trim12 1451457_at 1.671 Sc5d
1428207_at 1.985 Bcl7a 1430778_a_at 1.889 Nubp1 1423492_at 1.664 Mrpl45
1460590_s_at 1.984 Ywhaq 1439901_at 1.889 2610208M17Rik 1425373_a_at 1.662 Tnfsf5ip1
1452681_at 1.982 Dtymk 1430134_a_at 1.887 2210023C10Rik 1434743_x_at 1.649 Rusc1
1423642_at 1.981 4930542G03Rik 1433537_at 1.886 4833408C14Rik 1428527_at 1.645 Snx7
1430292_a_at 1.981 1810030N24Rik 1432842_s_at 1.885 Ywhaq 1451076_s_at 1.643 Ga17
1415775_at 1.98 Rbbp7 1429897_a_at 1.884 D16Ertd472e 1423916_s_at 1.639 Mlf2
1448511_at 1.979 Ptprcap 1434892_x_at 1.883 Rbbp4 1436037_at 1.635 Cerkl
1455914_at 1.978 AI987944 1436419_a_at 1.879 1700097N02Rik 1416881_at 1.633 Mcl1
1433850_at 1.978 Ppp4r2 1424621_at 1.879 AA792894 1450649_at 0.624 Gng10
1435342_at 1.978 Kcnk6 1438267_x_at 1.878 Rnps1 1428490_at 0.622 2210410E06Rik
1422491_a_at 1.977 Bnip2 1426787_at 1.878 2310047I15Rik 1422449_s_at 0.617 Rcn2
1417801_a_at 1.977 Ppfibp2 1460113_at 1.878 B930093H17Rik 1419499_at 0.615 Gpam
1418790_at 1.976 Zfp312 1415934_at 1.873 Cops8 1424215_at 0.609 1500005J14Rik
1438958_x_at 1.976 Fkbp1a 1435446_a_at 1.873 Chpt1 1428327_at 0.609 2310001H13Rik
1423235_at 1.974 Ap3b1 1415965_at 1.869 Scd1 1423955_a_at 0.608 Lass2
1417367_at 1.973 Ppp2ca 1450386_at 1.868 Kpna3 1416253_at 0.607 Cdkn2d
1459842_x_at 1.972 Nubp2 1423815_at 1.867 Ddx56 1436900_x_at 0.606 Obrgrp
1429491_s_at 1.971 D2Ertd145e 1416748_a_at 1.866 Mre11a 1416668_at 0.601 4921531G14Rik
1428858_at 1.971 4833422F06Rik 1435661_at 1.864 AI853305 1454941_at 0.597 AW536594
1448575_at 1.968 Il7r 1425140_at 1.856 Lactb2 1418842_at 0.597 Hcls1
1439256_x_at 1.968 Tm7sf1 1454756_at 1.853 2210409B11Rik 1418366_at 0.597 Hist2h2aa1
1448527_at 1.967 Pdcd10 1426485_at 1.852 Ubxd2 1456177_x_at 0.597 3110006P09Rik
1422186_s_at 1.967 Dia1 1426366_at 1.851 Eif2c2 1451071_a_at 0.595 Atp1a1
1420089_at 1.965 Nfkbia 1453095_at 1.851 Rab10 1455312_at 0.594 Phc3
1449670_x_at 1.962 Tm7sf1 1418397_at 1.848 Zfp275 1447784_x_at 0.59 9130023D20Rik
1439270_x_at 1.962 Ran 1419374_at 1.845 Wbp4 1426244_at 0.587 Mapre2
1424237_at 1.962 6230400O18Rik 1421043_s_at 1.845 Arhgef2 1455486_at 0.586 Pias1
1425508_s_at 1.959 Arfrp1 1427876_at 1.845 2610312B22Rik 1448892_at 0.581 Dock7
1426351_at 1.959 Hspd1 1437317_at 1.844 Ube1l 1455266_at 0.581 Kif5c  253 
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1449841_at 0.58 Kif3a 1456039_at 0.519 Snx14 1448434_at 0.481 Rnf103
1454606_at 0.579 4933426M11Rik 1438673_at 0.518 Slc4a7 1439502_at 0.481 4930573I19Rik
1440559_at 0.577 Hmga2-ps1 1440880_at 0.518 Mppe1 1428194_at 0.48 Usp9x
1428484_at 0.577 Osbpl3 1438396_at 0.518 9530014D17Rik 1420384_at 0.48 Col4a3bp
1434205_at 0.575 Ppp2r5c 1424887_at 0.518 BC012312 1433743_at 0.479 Dach1
1451123_at 0.574 C330016O10Rik 1433747_at 0.516 2010309L07Rik 1443896_at 0.479 Tbc1d5
1436714_at 0.574 Lpp 1420621_a_at 0.516 App 1448111_at 0.479 Ctps2
1429108_at 0.574 Msl2 1423083_at 0.515 Rab33b 1417315_at 0.478 DXImx47e
1428681_at 0.571 5530400K22Rik 1437117_at 0.515 Centb1 1447150_at 0.478 Phr1
1429642_at 0.57 Anubl1 1423759_a_at 0.515 1190006A08Rik 1450955_s_at 0.477 Sort1
1428710_at 0.57 Rit1 1436316_at 0.514 9430029L20Rik 1434767_at 0.477 C79407
1437287_at 0.57 1110020G09Rik 1452446_a_at 0.514 2010008E23Rik 1429116_at 0.477 Slc17a5
1449668_s_at 0.57 A730024A03Rik 1418894_s_at 0.514 Pbx2 1420649_at 0.476 Atbf1
1448812_at 0.57 2410018L13Rik 1460363_at 0.514 9930033H14Rik 1446444_at 0.475 D930043C02Rik
1434855_at 0.569 5730457F11Rik 1446636_at 0.514 F830010I22Rik 1419971_s_at 0.475 Slc35a5
1455031_at 0.569 2700084L06Rik 1429429_s_at 0.513 A030012M09Rik 1448534_at 0.474 Ptpns1
1439094_at 0.568 Cltc 1428147_at 0.513 0610011B16Rik 1424350_s_at 0.474 BC013667
1435616_at 0.567 Cyp20a1 1435397_at 0.512 BC038156 1460672_at 0.474 2410002F23Rik
1423126_at 0.566 Atp1b3 1419931_at 0.512 Abcb7 1430774_at 0.474 A430106A12Rik
1435637_at 0.565 D8Wsu49e 1425769_x_at 0.511 1700001C14Rik 1452737_at 0.474 2810008M24Rik
1435754_at 0.564 D6Bwg1452e 1429094_at 0.511 1700027M01Rik 1434373_at 0.473 B930006L02Rik
1457797_at 0.564 AI605517 1425525_a_at 0.511 P2rx4 1416324_s_at 0.473 2410004N11Rik
1441937_s_at 0.564 Pink1 1455737_at 0.51 C030002B11Rik 1417405_at 0.473 Stard3
1433568_at 0.563 Papd4 1457793_a_at 0.509 Whsc1l1 1424275_s_at 0.473 Trim41
1418838_at 0.563 Abcd1 1439314_at 0.508 Clock 1450686_at 0.473 Pon2
1428829_at 0.562 6820401H01Rik 1426022_a_at 0.508 Villp 1438731_at 0.473 Sgsh
1428848_a_at 0.56 Macf1 1436614_at 0.508 AI843639 1455065_x_at 0.472 Gnpda1
1422064_a_at 0.56 Zfp288 1434860_at 0.508 Narg3 1435315_s_at 0.472 2900034E22Rik
1460224_at 0.559 Snx2 1433495_at 0.507 2810024B22Rik 1441986_at 0.472 Zcchc6
1433757_a_at 0.557 Nisch 1427991_s_at 0.507 4930550B20Rik 1417930_at 0.471 Nab2
1431189_a_at 0.556 B430104H02Rik 1449087_at 0.507 Rnf141 1440878_at 0.471 Runx1
1416252_at 0.556 Stk38 1448864_at 0.505 Snrk 1457628_at 0.471 2900091E11Rik
1446433_at 0.554 Acbd5 1452167_at 0.505 2810407C02Rik 1434548_at 0.47 Tde1
1419883_s_at 0.554 Atp6v1b2 1418096_at 0.505 AI450713 1434520_at 0.469 Sc5d
1459344_at 0.553 9630019E01Rik 1426576_at 0.504 9530058O11Rik 1453061_at 0.469 2610018O07Rik
1423574_s_at 0.55 Srd5a2l 1435869_s_at 0.504 Ap2a2 1423457_at 0.469 Slc35a5
1434166_at 0.55 9330151L19Rik 1416795_at 0.504 Cryl1 1449714_at 0.469 5730472N09Rik
1450410_a_at 0.549 4930570C03Rik 1436460_at 0.504 BC030440 1426293_at 0.469 6330581L23Rik
1426840_at 0.549 9130022A11Rik 1434828_at 0.503 1600010D10Rik 1460592_at 0.468 Epb4.1l1
1439511_at 0.546 5830436D01Rik 1455597_at 0.503 AI585793 1437244_at 0.467 8430435B07Rik
1440214_at 0.546 A630001G21Rik 1436215_at 0.503 Impk 1439323_a_at 0.467 Map4k1
1436301_at 0.544 A930019K20Rik 1423702_at 0.503 H1f0 1435173_at 0.465 Ate1
1416735_at 0.543 Asah1 1416935_at 0.502 Trpv2 1436640_x_at 0.465 Agpat4
1447708_x_at 0.542 Pde2a 1449275_at 0.501 2310038H17Rik 1422414_a_at 0.465 Calm2
1420374_at 0.542 Foxj2 1421873_s_at 0.501 Rab24 1460733_at 0.465 AA407659
1428580_at 0.541 Blvra 1426589_at 0.501 Gab3 1435143_at 0.465 Elk3
1433614_at 0.54 Snx27 1455729_at 0.501 Gnaq 1436883_at 0.465 AI662535
1455261_at 0.54 Luc7l 1428667_at 0.501 Maoa 1454816_at 0.463 Rp2h
1420895_at 0.54 Tgfbr1 1454685_at 0.5 BC003323 1434218_at 0.463 C330019G07Rik
1448549_a_at 0.539 Dpagt1 1422896_at 0.5 Vamp4 1454655_at 0.462 Dgkd
1438045_at 0.539 Eea1 1428010_at 0.5 2810011L15Rik 1422637_at 0.462 Rassf5
1422881_s_at 0.539 Sypl 1430077_at 0.5 2610019N13Rik 1436200_at 0.462 A830039N02Rik
1453145_at 0.539 4933439C20Rik 1442576_at 0.499 Creb5 1442824_at 0.462 8030497I03Rik
1430672_at 0.539 5033418A18Rik 1454836_at 0.499 BC024093 1426368_at 0.462 Rin2
1452820_at 0.539 Wdr11 1451074_at 0.498 Rnf13 1455405_at 0.461 Pstpip2
1418434_at 0.539 Mkrn1 1426940_at 0.498 BC023957 1451190_a_at 0.461 Sbk
1448225_at 0.538 Gpaa1 1436088_at 0.497 0910001A06Rik 1418847_at 0.461 Arg2
1445827_at 0.535 3632413B07Rik 1436705_at 0.497 BC032271 1422880_at 0.461 Sypl
1419221_a_at 0.535 Rgs14 1424129_at 0.496 1200003O06Rik 1417878_at 0.459 E2f1
1424022_at 0.535 1700012B18Rik 1452866_at 0.496 Nars 1442182_at 0.459 1810055D05Rik
1455196_s_at 0.534 AA987161 1439181_at 0.494 BC043301 1418809_at 0.459 Pira1
1455534_s_at 0.534 Osbpl11 1454982_at 0.493 Arfgef2 1454182_at 0.459 5430417C01Rik
1456006_at 0.533 Bcl2l11 1460203_at 0.492 Itpr1 1451980_at 0.459 Cast1
1452664_a_at 0.532 Tm7sf3 1440267_at 0.492 E330005K07Rik 1434241_at 0.458 D330013L20Rik
1427097_at 0.532 8030445B08Rik 1451558_at 0.492 Fbxw7 1436841_at 0.458 B230380D07Rik
1422653_at 0.531 C030018L16Rik 1416279_at 0.492 Ap1b1 1417978_at 0.457 1300018P11Rik
1424604_s_at 0.531 AI463102 1436890_at 0.492 5730445F03Rik 1452053_a_at 0.457 1600019D15Rik
1421023_at 0.531 Pik3c2a 1428662_a_at 0.491 Hod 1460656_a_at 0.456 5630401J11Rik
1424438_a_at 0.53 Obrgrp 1448210_at 0.49 Rab1 1447537_at 0.456 1500032P08Rik
1421014_a_at 0.53 Clybl 1454741_s_at 0.49 AW547186 1449353_at 0.455 Wig1
1436756_x_at 0.53 Hadhsc 1427990_at 0.49 4930550B20Rik 1444009_at 0.455 Rassf4
1451154_a_at 0.529 Cugbp2 1452341_at 0.49 Echs1 1437200_at 0.455 5832424M12
1435157_at 0.529 5830454D03Rik 1448853_at 0.489 Synj2bp 1419228_at 0.455 Elac1
1424637_s_at 0.528 2610204L23Rik 1448020_at 0.489 Rap1a 1434714_at 0.455 1300013B24Rik
1424893_at 0.528 Ndel1 1459868_x_at 0.489 Il11ra1 1421977_at 0.454 Mmp19
1431158_at 0.528 8430406H22Rik 1439406_x_at 0.488 Fars1 1424743_at 0.454 2610003J06Rik
1417104_at 0.527 Emp3 1435672_at 0.488 3830612M24 1438259_at 0.454 Strn3
1455972_x_at 0.526 Hadhsc 1428412_at 0.488 Smbp 1428280_at 0.454 Fip1l1
1435982_at 0.526 Stx12 1448402_at 0.487 Tln 1460390_at 0.454 Sorl1
1451099_at 0.526 Mbc2 1434839_s_at 0.487 8030499H02Rik 1435666_at 0.454 BC024265
1457582_at 0.525 Uty 1428963_at 0.487 Rwdd2 1442714_at 0.454 D130037M23Rik
1440260_at 0.525 A930007B11Rik 1460024_at 0.487 D230019K20Rik 1424024_at 0.454 Mcfd2
1437121_at 0.525 4432409M07Rik 1455308_at 0.487 Tmem16f 1455206_at 0.453 C130006E23
1424124_at 0.524 Mospd2 1452922_at 0.487 2610024M03Rik 1435353_a_at 0.453 4933439C20Rik
1440847_at 0.523 Mtss1 1417857_at 0.486 Mmaa 1423963_at 0.452 Wdr26
1457709_a_at 0.523 A930005H10Rik 1421252_a_at 0.486 Mef2a 1454609_x_at 0.452 6430527G18Rik
1417044_at 0.522 Lcmt1 1428769_at 0.485 1500010M24Rik 1448294_at 0.451 Litaf
1452733_at 0.522 2810473M14Rik 1455333_at 0.485 BC023928 1459560_at 0.451 4921517N04Rik
1430546_at 0.521 Cryzl1 1460631_at 0.485 Ogt 1430700_a_at 0.45 Pla2g7
1460596_at 0.521 Agtrap 1437119_at 0.485 Ern1 1433854_at 0.449 AW547186
1420611_at 0.521 Prkacb 1416440_at 0.483 Cd164 1418774_a_at 0.448 Atp7a
1434399_at 0.52 Galnt6 1424707_at 0.483 1110014C03Rik 1436027_at 0.448 Osbpl11
1453864_at 0.52 Rdh14 1447813_x_at 0.482 Sla 1436387_at 0.448 C330006P03Rik
1422814_at 0.519 Calmbp1 1416904_at 0.482 Mbnl1 1423760_at 0.447 Cd44
1433618_at 0.482 C330006A16Rik 1450701_a_at 0.447 Gtf2h2
1430195_at 0.481 2810043O03Rik 1425678_a_at 0.447 Snrk  254 
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1434515_at 0.447 Ncoa1 1427368_x_at 0.416 Fes 1455876_at 0.388 Slc4a7
1424654_at 0.447 Acp2 1452410_a_at 0.415 Fes 1447757_x_at 0.388 Inpp5f
1426584_a_at 0.447 Sdh1 1449455_at 0.415 Hck 1448106_at 0.388 1200016B17Rik
1437642_at 0.447 Hrbl 1434402_at 0.415 1110053F04Rik 1429088_at 0.387 Lbh
1451350_a_at 0.446 Obrgrp 1419181_at 0.414 Zfp326 1422106_a_at 0.387 Grcc9
1437357_at 0.446 BC037178 1452347_at 0.414 Mef2a 1429265_a_at 0.387 Rnf130
1418594_a_at 0.444 Ncoa1 1450095_a_at 0.414 Acyp1 1438328_at 0.387 1700129L13Rik
1451738_at 0.444 Ogt 1416840_at 0.414 3110038L01Rik 1417706_at 0.386 Naglu
1438809_at 0.443 Atp5c1 1456338_at 0.414 9130023D20Rik 1431038_at 0.386 Rassf4
1436786_at 0.442 1110069O07Rik 1452169_a_at 0.413 Dgkz 1434150_a_at 0.386 3300001H21Rik
1448538_a_at 0.442 D4Wsu53e 1423066_at 0.412 Dnmt3a 1428479_at 0.386 Nfatc1
1452994_at 0.442 5230400C17Rik 1425529_s_at 0.412 D19Wsu162e 1418658_at 0.385 2410005O16Rik
1424862_s_at 0.442 2210008I11Rik 1438788_at 0.412 D5Wsu152e 1428517_at 0.385 Wdfy3
1428508_at 0.442 1810061M12Rik 1452288_at 0.412 BB128963 1434017_at 0.383 Znrf2
1425406_at 0.442 Clecsf6 1430030_at 0.411 5330426P16Rik 1453054_at 0.383 Scamp1
1444726_at 0.442 Hrb2 1453795_at 0.411 B430104H02Rik 1416094_at 0.383 Adam9
1450688_at 0.442 Rab2l 1417087_at 0.411 Glg1 1423076_at 0.382 Snx9
1426051_a_at 0.441 Cenpb 1433501_at 0.411 Ctso 1455990_at 0.382 Kif23
1423297_at 0.441 Add3 1417669_at 0.411 6330583M11Rik 1436702_at 0.382 BC034068
1420699_at 0.441 Clecsf12 1426123_a_at 0.41 Rrbp1 1420375_at 0.382 Kif3a
1428725_at 0.441 Miz1 1449622_s_at 0.41 Atp6ap1 1418907_at 0.381 F5
1447947_at 0.44 4930405M20Rik 1426220_at 0.41 4930471M23Rik 1416655_at 0.381 1500002I11Rik
1450660_at 0.439 Pts 1455482_at 0.409 Ap2a2 1417395_at 0.381 Klf4
1427075_s_at 0.439 5330414D10Rik 1416703_at 0.409 Mapk14 1452217_at 0.38 1110004P15Rik
1424378_at 0.439 AA691260 1457266_at 0.409 AW322671 1441145_at 0.38 D030065N23Rik
1435543_at 0.439 Apc 1452271_at 0.409 Xpr1 1452209_at 0.38 Pkp4
1422628_at 0.439 4632417K18Rik 1428822_a_at 0.409 Snx24 1454746_at 0.379 Plekhm1
1438755_at 0.438 C80068 1448188_at 0.408 Ucp2 1460456_at 0.379 2010316F05Rik
1416206_at 0.438 Sipa1 1435008_at 0.408 Slc9a6 1423871_at 0.378 BC014795
1415937_s_at 0.438 Pdcd6ip 1441830_x_at 0.408 Akap10 1428847_a_at 0.378 Macf1
1443773_at 0.437 Zap3 1419296_at 0.408 Arhgap4 1417565_at 0.377 Abhd5
1419193_a_at 0.437 Gmfg 1436499_at 0.407 9530058O11Rik 1451247_at 0.377 1200003O06Rik
1417750_a_at 0.437 Mscp 1421022_x_at 0.407 Acyp1 1428117_x_at 0.377 Tctex1
1417073_a_at 0.436 Qk 1429337_at 0.407 2810431I02Rik 1431218_at 0.376 B230110O18Rik
1444103_at 0.436 2310046K10Rik 1455711_at 0.406 Dtx4 1426052_at 0.376 Mlh3
1420928_at 0.436 St6gal1 1455549_at 0.405 Sestd1 1435485_at 0.376 C230096C10Rik
1452867_at 0.436 Col4a3bp 1438962_s_at 0.405 Ddx31 1436590_at 0.375 Ppp1r3b
1427313_at 0.436 Ptgir 1428680_at 0.405 Cds1 1459433_at 0.375 C130051F05Rik
1419272_at 0.436 Myd88 1429237_at 0.404 6330500A18Rik 1433925_at 0.374 AA409702
1429652_at 0.435 3110038B19Rik 1435536_at 0.404 1700027M01Rik 1439948_at 0.374 BC046401
1429019_s_at 0.435 Pon2 1417648_s_at 0.404 Snx5 1423282_at 0.373 Pitpn
1445729_at 0.435 Sirt3 1422433_s_at 0.404 Idh1 1431143_x_at 0.373 Amid
1428094_at 0.434 Lamp2 1434571_at 0.404 Coh1 1453384_at 0.373 4632404N19Rik
1428723_at 0.433 2310047M10Rik 1458491_at 0.403 4930422I07Rik 1449141_at 0.373 2410043F08Rik
1452767_at 0.433 Rrbp1 1451288_s_at 0.403 1810043G02Rik 1425628_a_at 0.372 Gtf2i
1428236_at 0.433 Acbd5 1427186_a_at 0.403 Mef2a 1428833_at 0.371 4930406D14Rik
1423573_at 0.433 Srd5a2l 1421604_a_at 0.403 Klf3 1424242_at 0.371 Bphl
1447853_x_at 0.433 Kif13a 1423722_at 0.403 4930579A11Rik 1456567_x_at 0.37 Grn
1456510_x_at 0.433 3300001H21Rik 1425311_at 0.402 4930432F04Rik 1417135_at 0.37 Srpk2
1454299_at 0.433 4833422B07Rik 1451006_at 0.401 Xdh 1439272_at 0.369 Mlr1
1421857_at 0.431 Adam17 1460329_at 0.401 B4galt6 1436616_at 0.369 R74740
1416958_at 0.43 Nr1d2 1436858_at 0.401 Mbnl2 1422467_at 0.369 Ppt1
1436697_at 0.43 Dscr3 1424639_a_at 0.401 Hmgcl 1436189_at 0.369 Serpinb6a
1416614_at 0.43 Cri1 1439980_at 0.401 D14Ertd725e 1435274_at 0.368 E430033K04Rik
1440187_at 0.43 Taf3 1433632_at 0.401 Irf2bp2 1418546_a_at 0.368 1700095N21Rik
1428655_at 0.43 1110018J12Rik 1429881_at 0.4 Arhgap15 1418888_a_at 0.368 Sepr
1458347_s_at 0.429 Tmprss2 1448405_a_at 0.4 Cri1 1426833_at 0.367 Eif4g3
1418296_at 0.428 Fxyd5 1433503_at 0.4 1810016I24Rik 1439773_at 0.367 Ly6e
1417676_a_at 0.428 Ptpro 1417605_s_at 0.4 Camk1 1450734_at 0.367 Rgpr
1433505_a_at 0.428 Lrrc5 1455113_at 0.4 1200015K23Rik 1453512_at 0.366 5430437C10Rik
1438443_at 0.428 Zfp288 1441879_x_at 0.399 Mkrn1 1453412_a_at 0.366 Sec14l1
1426376_at 0.428 Dp1 1435836_at 0.398 D530020C15Rik 1439293_at 0.365 C130047D21Rik
1425156_at 0.427 9830147J24Rik 1417848_at 0.398 Gig1 1425956_a_at 0.365 Cdadc1
1455980_a_at 0.427 8430435B07Rik 1451141_at 0.398 BC004636 1434151_at 0.364 3300001H21Rik
1452969_at 0.427 2810442I22Rik 1419235_s_at 0.398 Helb 1433639_at 0.364 5730593F17Rik
1422932_a_at 0.427 Vav1 1455551_at 0.397 Attp 1439830_at 0.364 Map3k5
1437041_at 0.427 5730406M06Rik 1417134_at 0.397 Srpk2 1435326_at 0.363 AW112037
1423835_at 0.426 Zfp503 1416035_at 0.396 Hif1a 1435006_s_at 0.362 Abcb7
1440219_at 0.426 4930413O22Rik 1426258_at 0.396 Sorl1 1417604_at 0.362 Camk1
1434328_at 0.426 Rpl15 1439102_at 0.396 Falz 1438519_at 0.362 4930429H24Rik
1434021_at 0.426 C230096C10Rik 1450112_a_at 0.395 Gas2 1450626_at 0.361 Manba
1422818_at 0.425 Nedd9 1447707_s_at 0.395 Pde2a 1415743_at 0.361 Hdac5
1452277_at 0.425 6330406P08Rik 1456261_at 0.395 Sh3kbp1 1448318_at 0.361 Adfp
1416382_at 0.424 Ctsc 1449852_a_at 0.394 Ehd4 1439263_at 0.361 Fin15
1417538_at 0.423 Slc35a1 1450694_at 0.394 Fkbp2 1450647_at 0.361 Hps3
1442256_at 0.423 Prkcd 1435475_at 0.393 Lman2l 1432543_a_at 0.361 Klf13
1452832_s_at 0.423 Cds2 1456898_at 0.393 Pura 1450868_at 0.361 D8Ertd354e
1435926_at 0.423 E030003F13Rik 1451791_at 0.393 Tfpi 1447284_at 0.36 Trem1
1438971_x_at 0.422 Ube2h 1440195_at 0.393 9330147J08Rik 1420822_s_at 0.36 Sgpp1
1436982_at 0.422 AI848765 1424988_at 0.392 Mylip 1423924_s_at 0.36 D14Ertd226e
1415827_a_at 0.421 D3Ucla1 1424077_at 0.392 2610020H15Rik 1437132_x_at 0.36 Nedd9
1434286_at 0.421 Trps1 1440417_at 0.392 D19Ertd409e 1417647_at 0.36 Snx5
1452527_a_at 0.42 P2rx4 1437797_at 0.392 D5Wsu150e 1428325_at 0.36 2610019P18Rik
1428410_at 0.42 Mak3 1420974_at 0.391 1810034K20Rik 1422645_at 0.359 Hfe
1434517_at 0.42 Wdfy2 1458951_at 0.391 Vrk1 1454858_x_at 0.359 3300001H21Rik
1453416_at 0.419 8430435B07Rik 1438151_x_at 0.391 Zdhhc14 1434236_at 0.359 AI448102
1434561_at 0.419 Asxl1 1425814_a_at 0.391 Calcrl 1434407_at 0.359 9930124L22Rik
1433999_at 0.419 Stk2 1420464_s_at 0.391 Pirb 1436033_at 0.358 BC031353
1433745_at 0.418 Trio 1417884_at 0.39 Slc16a6 1435478_at 0.358 AU044014
1416654_at 0.418 Slc31a2 1454711_at 0.39 Trio 1452202_at 0.357 Pde2a
1434235_at 0.418 Slc20a2 1429336_at 0.39 2610301K12Rik 1415948_at 0.357 Creg
1425185_at 0.418 5830417C01Rik 1430681_at 0.39 Cryl1 1436395_at 0.357 Card6
1415677_at 0.418 Dhrs1 1429943_at 0.389 Ctbs 1430776_s_at 0.357 D10Bur2e
1451326_at 0.418 1810013B01Rik 1421410_a_at 0.389 Pstpip2 1451507_at 0.356 5430401D19Rik
1448313_at 0.418 Cln2 1426574_a_at 0.389 Add3 1459740_s_at 0.356 Ucp2
1436767_at 0.416 Luc7l2 1418996_a_at 0.388 4930469P12Rik 1436842_at 0.356 B230380D07Rik  255 
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1441548_at 0.356 6030440G05Rik 1417291_at 0.327 Tnfrsf1a 1418569_at 0.297 2410043F08Rik
1430561_at 0.355 5730496F10Rik 1437113_s_at 0.327 Pld1 1458501_at 0.297 Vapb
1425516_at 0.355 Ogt 1441558_at 0.327 D230044B12Rik 1417136_s_at 0.296 Srpk2
1434700_at 0.355 6030408C04Rik 1451318_a_at 0.327 Lyn 1437124_at 0.296 A630052C17Rik
1417630_at 0.355 Mknk1 1428859_at 0.326 Paox 1425598_a_at 0.296 Lyn
1453156_s_at 0.355 1810016I24Rik 1454973_at 0.326 2610204M12Rik 1418398_a_at 0.296 Phemx
1449229_a_at 0.354 Cdkl2 1423086_at 0.326 Npc1 1430037_at 0.295 Snx27
1420967_at 0.354 Slc25a15 1455731_at 0.326 Slc29a3 1424048_a_at 0.293 1500005G05Rik
1451254_at 0.354 Ikbkap 1439622_at 0.325 Rassf4 1418553_at 0.292 Arhgef18
1415986_at 0.354 Clcn4-2 1450129_a_at 0.325 Socs6 1428937_at 0.292 2810442I22Rik
1422444_at 0.354 Itga6 1448995_at 0.325 Cxcl4 1434112_at 0.292 Lphn2
1425245_a_at 0.354 Rgs11 1449062_at 0.325 Khk 1421811_at 0.291 Thbs1
1419768_at 0.354 Cd22 1434315_at 0.325 9130020G22Rik 1449183_at 0.291 Comt
1425517_s_at 0.353 Ogt 1429728_at 0.324 4930429M06Rik 1420635_a_at 0.291 Tcirg1
1420824_at 0.353 Sema4d 1433488_x_at 0.324 Gns 1448328_at 0.291 Sh3bp2
1419394_s_at 0.352 S100a8 1454773_at 0.323 Rxra 1417399_at 0.291 Gas6
1416866_at 0.351 Bet1 1429360_at 0.323 Klf3 1429468_at 0.29 1110018F16Rik
1419194_s_at 0.351 Gmfg 1424524_at 0.323 1200002N14Rik 1434089_at 0.29 Synpo
1442098_at 0.35 AU022434 1422859_a_at 0.323 Rpl23 1422821_s_at 0.29 Stard5
1435445_at 0.35 Ccnt2 1423824_at 0.322 5031439A09Rik 1416013_at 0.29 Pld3
1434768_at 0.35 Cln2 1424249_a_at 0.322 Arhgap9 1437279_x_at 0.29 Sdc1
1448079_at 0.35 1110031E24Rik 1434472_at 0.32 5031436O03Rik 1453836_a_at 0.29 Mgll
1451555_at 0.35 Nln 1440778_x_at 0.32 4921504N20Rik 1419315_at 0.289 Slamf9
1425733_a_at 0.349 Eps8 1452016_at 0.32 Alox5ap 1448919_at 0.289 1110055L24Rik
1440885_at 0.349 Evl 1451867_x_at 0.32 Arhgap6 1430388_a_at 0.289 Sulf2
1434386_at 0.348 Atp2c1 1428749_at 0.319 6430411K14Rik 1438214_at 0.288 Trps1
1449110_at 0.348 Rhob 1416471_at 0.318 Cept1 1428122_s_at 0.288 2610528K11Rik
1455109_at 0.348 8030499H02Rik 1427691_a_at 0.318 Ifnar2 1437551_at 0.287 4930504E06Rik
1453012_at 0.348 5530402M19Rik 1423063_at 0.318 Dnmt3a 1450702_at 0.286 Hfe
1416046_a_at 0.347 0610025O11Rik 1423425_at 0.317 1300012G16Rik 1428780_at 0.286 1300017K07Rik
1425496_at 0.347 Abca3 1460688_s_at 0.315 AA407659 1418540_a_at 0.285 Ptpre
1448124_at 0.347 Gus 1417811_at 0.315 Slc24a6 1428622_at 0.285 Depdc6
1426952_at 0.347 Arhgap18 1452299_at 0.315 8030445B08Rik 1423597_at 0.284 Atp8a1
1448200_at 0.347 Tcn2 1453731_a_at 0.314 2610318G18Rik 1455112_at 0.283 Amid
1438052_at 0.345 A130071D04Rik 1415901_at 0.314 Plod3 1438234_at 0.283 Wdr26
1460283_at 0.345 Mefv 1421899_a_at 0.314 Mr1 1448161_a_at 0.283 Clcn4-2
1440268_at 0.345 Trim41 1459741_x_at 0.314 Ucp2 1460674_at 0.282 Mpra
1429321_at 0.344 Rnf149 1429093_at 0.314 1700027M01Rik 1448620_at 0.282 Fcgr3
1419494_a_at 0.344 Tpd52 1433542_at 0.313 Inpp5f 1445647_at 0.282 AI447881
1445438_at 0.344 4921528E07Rik 1435786_at 0.313 Klhl12 1454728_s_at 0.281 Atp8a1
1428612_at 0.344 Apg7l 1453244_at 0.313 5830416P10Rik 1438814_at 0.281 1700056O17Rik
1419493_a_at 0.344 Tpd52 1417779_at 0.313 2310079N02Rik 1420671_x_at 0.281 Ms4a4b
1426794_at 0.344 Ptprs 1433657_at 0.313 A130092J06Rik 1434754_at 0.281 Garnl4
1439571_at 0.344 E230008J23Rik 1436906_at 0.313 1110031E24Rik 1433968_a_at 0.28 Egfl5
1436097_x_at 0.344 Arhgap9 1426623_a_at 0.312 Arhgap17 1416050_a_at 0.28 Scarb1
1416381_a_at 0.343 Prdx5 1433827_at 0.312 Atp8a1 1455538_at 0.28 6330403M23Rik
1447880_x_at 0.342 Edg5 1427098_at 0.312 8030445B08Rik 1422468_at 0.28 Ppt1
1433964_s_at 0.342 BC032204 1417513_at 0.311 Evi5 1438021_at 0.28 BC013481
1437055_x_at 0.342 1200003O06Rik 1416165_at 0.311 1700093E07Rik 1435746_at 0.279 Srpk2
1435313_at 0.342 F630107N04Rik 1449269_at 0.311 F5 1427002_s_at 0.279 6330406P08Rik
1457445_at 0.342 Trps1 1444670_at 0.311 A130004G11Rik 1460036_at 0.278 Ap1s2
1434406_at 0.342 Fnbp2 1424259_at 0.311 2400010G15Rik 1450476_at 0.278 Cnr2
1435171_at 0.341 2810416G20Rik 1419481_at 0.311 Sell 1433905_at 0.278 Akap7
1440586_at 0.341 B430203I24Rik 1433751_at 0.31 Slc39a10 1417490_at 0.278 Ctsb
1431067_at 0.341 6330404A07Rik 1418497_at 0.309 Fgf13 1441516_a_at 0.277 C130050O18Rik
1422806_x_at 0.34 Ing3 1438156_x_at 0.309 Cpt1a 1449024_a_at 0.276 Hexa
1424655_at 0.34 Acp2 1425294_at 0.308 Slamf8 1424163_at 0.276 0610039K22Rik
1456153_at 0.34 BC030940 1436323_at 0.308 2810001A02Rik 1460409_at 0.276 Cpt1a
1431960_at 0.34 Wwox 1422438_at 0.308 Ephx1 1429083_at 0.275 Agl
1442590_at 0.339 Tnfrsf22 1453289_at 0.308 Eif2c4 1433159_at 0.275 5330429L19Rik
1455033_at 0.339 B430201A12Rik 1453851_a_at 0.308 Gadd45g 1434930_at 0.274 Tpcn1
1433930_at 0.339 Hpse 1428657_at 0.307 1110037N09Rik 1455487_at 0.274 2600014M03Rik
1417777_at 0.339 Ltb4dh 1434261_at 0.307 Sipa1l2 1460359_at 0.274 Armcx3
1450332_s_at 0.337 Fmo5 1428064_at 0.306 Centd2 1427318_s_at 0.274 Fer1l3
1424560_at 0.337 Pstpip1 1453367_a_at 0.306 6330583M11Rik 1434303_at 0.273 9430025M21Rik
1451674_at 0.336 Slc12a5 1430808_at 0.306 Tbc1d5 1448456_at 0.273 Cln8
1436478_at 0.336 3010002C02Rik 1428758_at 0.305 1810054O13Rik 1435357_at 0.273 D4Wsu53e
1434408_at 0.335 AI463012 1456479_at 0.305 4732481H14Rik 1437874_s_at 0.273 Hexb
1424336_at 0.335 8430432M10Rik 1433559_at 0.304 9330175B01Rik 1435972_at 0.273 Cast
1435194_at 0.335 Hspa4 1441850_x_at 0.304 Tcn2 1449619_s_at 0.272 Arhgap9
1457539_at 0.335 D10Ertd709e 1453386_at 0.304 2200001D17Rik 1440384_at 0.272 3632431M01Rik
1455286_at 0.335 Btbd1 1460180_at 0.304 Hexb 1421525_a_at 0.271 Birc1e
1454843_at 0.334 Prps2 1420919_at 0.304 Sgk3 1417551_at 0.271 Cln3
1428025_s_at 0.334 1110020B03Rik 1451621_at 0.304 5830417C01Rik 1460006_at 0.271 Atbf1
1436766_at 0.334 Luc7l2 1427351_s_at 0.303 Igh-6 1457063_at 0.27 Phospho1
1416333_at 0.334 Dok2 1423298_at 0.303 Add3 1435680_a_at 0.27 Dpp7
1419455_at 0.333 Il10rb 1435066_at 0.303 1110020B03Rik 1428615_at 0.27 P2y5
1417741_at 0.333 Pygl 1438321_x_at 0.302 4930504E06Rik 1455712_at 0.27 Hist3h2a
1416551_at 0.333 Atp2a2 1430000_at 0.302 B230117O15Rik 1458142_at 0.27 Zdhhc9
1434378_a_at 0.332 2810410A03Rik 1435560_at 0.301 Itgal 1433963_a_at 0.269 BC032204
1424420_at 0.332 D9Ertd392e 1420641_a_at 0.301 Sqrdl 1455291_s_at 0.267 D6Ertd365e
1435251_at 0.332 Snx13 1442855_at 0.301 B130005I07Rik 1451486_at 0.267 1200006F02Rik
1434461_at 0.332 2610041B18Rik 1448303_at 0.3 Gpnmb 1422822_at 0.267 Stard5
1427434_at 0.331 Birc1f 1454837_at 0.3 Cln6 1426505_at 0.266 Evi2b
1418162_at 0.33 Tlr4 1418539_a_at 0.3 Ptpre 1433500_at 0.266 B930096L08Rik
1456533_at 0.33 1100001I19Rik 1428651_at 0.299 1110046J11Rik 1417663_a_at 0.266 Ndrg3
1428917_at 0.329 9030425C21Rik 1429503_at 0.299 2900024C23Rik 1431355_s_at 0.265 Trpm7
1449221_a_at 0.329 Rrbp1 1418505_at 0.299 Nudt4 1415977_at 0.265 Isyna1
1436678_at 0.329 Sgcb 1429771_at 0.299 3110073H01Rik 1425362_at 0.265 Hrbl
1440831_at 0.329 6230421P05Rik 1439168_at 0.298 Camk2d 1454086_a_at 0.263 Lmo2
1436844_at 0.329 AW046287 1434487_at 0.298 2210408E11Rik 1433242_at 0.263 5830415B17Rik
1417481_at 0.329 Ramp1 1418163_at 0.297 Tlr4 1415936_at 0.262 Bcar3
1434414_at 0.329 D15Bwg0759e 1434014_at 0.297 Apg4c 1430125_s_at 0.262 2310009N05Rik
1431316_at 0.328 Itch 1455321_at 0.297 4921528E07Rik 1433546_at 0.261 Gns
1432006_at 0.328 Ap2a2 1436008_at 0.297 Tpd52 1450939_at 0.261 Entpd1
1419537_at 0.328 Tcfec 1435741_at 0.297 B230331L10Rik 1438614_x_at 0.26 Osbpl9  256 
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1434674_at 0.26 Lyst 1423233_at 0.229 Cebpd 1433740_at 0.198 2610301K12Rik
1429359_s_at 0.26 Rbpms 1419219_at 0.229 Cyp4f18 1451161_a_at 0.198 Emr1
1452117_a_at 0.259 Fyb 1454286_at 0.229 1110004M10Rik 1429959_at 0.197 6620401D04Rik
1448143_at 0.259 Aldh2 1426389_at 0.229 Camk1d 1437072_at 0.197 Arhgap25
1419810_x_at 0.258 Arhgap9 1455659_at 0.229 3632431M01Rik 1424250_a_at 0.195 Arhgef3
1444254_at 0.258 9930017A07Rik 1420965_a_at 0.228 Enc1 1446861_at 0.195 Gns
1434866_x_at 0.258 Cpt1a 1420747_at 0.228 Ppnr 1436026_at 0.195 1110032O19Rik
1415850_at 0.258 Rasa3 1435704_at 0.228 C920006O11Rik 1459897_a_at 0.195 Sbsn
1435959_at 0.257 Arhgap15 1455073_at 0.227 Cdadc1 1417394_at 0.194 Klf4
1429831_at 0.257 Pik3ap1 1425298_a_at 0.227 Birc1a 1418049_at 0.193 Ltbp3
1427243_at 0.256 AA536743 1455612_at 0.226 AI848218 1426785_s_at 0.193 Mgll
1452841_at 0.256 Pgm2l1 1451731_at 0.226 Abca3 1451716_at 0.193 Mafb
1425530_a_at 0.256 Stx3 1416875_at 0.225 Parvg 1417696_at 0.192 Soat1
1454984_at 0.256 AW061234 1436212_at 0.224 AI661017 1459744_at 0.192 Cd53
1449124_at 0.256 Rgl1 1449027_at 0.224 Rhou 1422573_at 0.192 Ampd3
1455594_at 0.255 Sec6l1 1423363_at 0.224 Sort1 1435584_at 0.192 AI662791
1417704_a_at 0.254 Arhgap6 1417512_at 0.223 Evi5 1435748_at 0.192 Gda
1434311_at 0.254 4932442K20Rik 1453109_at 0.223 2810429K17Rik 1435749_at 0.192 Gda
1444735_at 0.254 Znrf2 1427912_at 0.223 Cbr3 1426603_at 0.191 Rnasel
1422259_a_at 0.254 Ccr5 1417070_at 0.223 Cyp4v3 1424433_at 0.191 Mrsb
1448686_at 0.253 Il16 1417932_at 0.222 Il18 1426775_s_at 0.191 Scamp1
1419234_at 0.252 Helb 1434302_at 0.221 9430025M21Rik 1442798_x_at 0.19 Unc5a
1454666_at 0.252 Klf3 1436322_a_at 0.221 2810001A02Rik 1433655_at 0.19 Rnf141
1417813_at 0.251 Ikbke 1426992_at 0.221 Xpr1 1455796_x_at 0.19 Olfm1
1423768_at 0.251 Unc93b 1455221_at 0.22 Abcg1 1433986_at 0.187 BC024659
1450678_at 0.251 Itgb2 1423586_at 0.219 Axl 1441727_s_at 0.187 Zfp467
1415904_at 0.251 Lpl 1430612_at 0.219 1810033B17Rik 1425037_at 0.186 Fgd4
1453003_at 0.251 Sorl1 1420703_at 0.219 Csf2ra 1419480_at 0.186 Sell
1441229_at 0.251 D230019N24Rik 1455331_at 0.219 A230102O09Rik 1433711_s_at 0.185 Sesn1
1424920_at 0.25 Slc37a3 1450291_s_at 0.219 Ms4a4c 1438312_s_at 0.185 Ltbp3
1448409_at 0.25 Lrmp 1433543_at 0.219 Anln 1432946_at 0.184 5230400M06Rik
1456500_at 0.25 4632417K02 1435477_s_at 0.218 Fcgr2b 1435903_at 0.184 B230315M08Rik
1436272_at 0.25 1110059F07Rik 1437776_at 0.218 3632431M01Rik 1434499_a_at 0.184 Ldh2
1437833_at 0.25 Ltbp3 1448118_a_at 0.218 Ctsd 1426917_s_at 0.184 4833415E20Rik
1419097_a_at 0.249 Epb7.2 1433965_at 0.218 AI853962 1438910_a_at 0.184 Epb7.2
1460063_at 0.249 D5Ertd798e 1418123_at 0.216 Unc119 1452592_at 0.183 Mgst2
1444119_at 0.249 B930006L02Rik 1450061_at 0.216 Enc1 1443894_at 0.183 Evi2a
1455332_x_at 0.248 Fcgr2b 1452948_at 0.216 1810019A08Rik 1417471_s_at 0.183 D1Ertd622e
1450070_s_at 0.248 Pak1 1423465_at 0.215 Sdfr2 1432007_s_at 0.182 Ap2a2
1428936_at 0.248 2810442I22Rik 1434945_at 0.215 A330042H22 1449383_at 0.182 Adss
1455820_x_at 0.248 Scarb1 1437885_at 0.213 D030029J20Rik 1438931_s_at 0.182 Sesn1
1433750_at 0.247 Slc31a1 1426743_at 0.213 Dip3b 1422662_at 0.182 Lgals8
1422411_s_at 0.246 Ear2 1451563_at 0.213 Emr4 1456888_at 0.182 C230090D14
1430264_at 0.246 2610030P05Rik 1422782_s_at 0.213 Tlr3 1455095_at 0.181 Hist2h2bb
1459900_at 0.246 C79468 1434034_at 0.213 Cerk 1448647_at 0.181 Man2a1
1450391_a_at 0.246 Mgll 1428431_at 0.212 2310047A01Rik 1436618_at 0.181 Sfxn5
1449878_a_at 0.245 Slc12a6 1454646_at 0.212 E430026E19Rik 1430367_at 0.181 8230401J17Rik
1437378_x_at 0.245 Scarb1 1439153_at 0.212 Ibrdc2 1417160_s_at 0.181 Expi
1429324_at 0.245 1700012A16Rik 1456328_at 0.212 A530094C12Rik 1417071_s_at 0.181 Cyp4v3
1454670_at 0.244 Rere 1435937_at 0.211 Sptlc2 1457163_at 0.18 D730035F11Rik
1452359_at 0.244 AA536743 1436781_at 0.211 Man2b1 1449049_at 0.18 Tlr1
1427076_at 0.243 Mpeg1 1416441_at 0.211 Pgcp 1426397_at 0.18 Tgfbr2
1431296_at 0.243 4933439K08Rik 1445545_at 0.211 2610318G18Rik 1455251_at 0.18 E130012M19Rik
1447602_x_at 0.242 Sulf2 1429742_at 0.211 Chc1l 1453007_at 0.18 3110082I17Rik
1456307_s_at 0.242 Adcy7 1440370_at 0.21 Abca13 1424714_at 0.179 Aldo3
1417590_at 0.242 Cyp27a1 1419627_s_at 0.21 Clecsf10 1426440_at 0.179 Dhrs7
1428577_at 0.242 Ppfia4 1440684_at 0.21 A330042H22 1434557_at 0.178 Hip1
1416700_at 0.242 Rhoe 1427050_at 0.21 5730420B22Rik 1448390_a_at 0.178 Dhrs3
1427041_at 0.241 BC013712 1425736_at 0.209 Cd37 1429673_at 0.178 5830407E08Rik
1435822_at 0.241 D830012I24Rik 1435144_at 0.209 Fyb 1451413_at 0.178 Cast
1457528_at 0.241 Slc4a7 1451782_a_at 0.208 Slc29a1 1449846_at 0.177 Ear2
1455204_at 0.241 1110020B03Rik 1455795_at 0.208 Sart2 1428391_at 0.177 Rab3il1
1459735_at 0.241 C430014M02Rik 1450941_at 0.208 Sdcbp 1429058_at 0.177 1110004B13Rik
1457806_at 0.24 Dock1 1434575_at 0.208 Epb4.1l1 1415855_at 0.176 Kitl
1420821_at 0.24 Sgpp1 1438975_x_at 0.208 Zdhhc14 1453915_a_at 0.176 Slc37a3
1460016_at 0.239 AW547186 1448316_at 0.207 Cklfsf3 1419132_at 0.175 Tlr2
1444097_at 0.239 BC019776 1415943_at 0.207 Sdc1 1460436_at 0.175 Ndst1
1415944_at 0.239 Sdc1 1450919_at 0.207 Mpp1 1460324_at 0.175 Dnmt3a
1455285_at 0.238 Slc31a1 1455590_at 0.207 Serpinb6a 1417697_at 0.174 Soat1
1452059_at 0.238 Slc35f5 1430097_at 0.207 8430436C05Rik 1434846_at 0.174 1700065A05Rik
1440383_at 0.238 Dclre1b 1427929_a_at 0.206 2310036D04Rik 1450065_at 0.174 Adcy7
1416607_at 0.237 4931406C07Rik 1448104_at 0.206 Aldh6a1 1418394_a_at 0.174 Cd97
1451364_at 0.237 2010003I19Rik 1448944_at 0.205 Nrp 1449153_at 0.173 Mmp12
1439616_at 0.237 AV026040 1420804_s_at 0.205 Clecsf8 1455214_at 0.173 Mitf
1425784_a_at 0.236 Olfm1 1418741_at 0.205 Itgb7 1435490_at 0.173 Hk3
1417693_a_at 0.236 Gab1 1450106_a_at 0.205 Evl 1421547_at 0.172 Ly78
1448167_at 0.236 Ifngr 1430257_at 0.205 0610008L17Rik 1456918_at 0.172 9430025M21Rik
1438702_at 0.235 Flrt2 1433885_at 0.204 A630053O10 1424998_at 0.172 Emr4
1417995_at 0.235 Ptpn8 1449065_at 0.204 Cte1 1421694_a_at 0.171 Cspg2
1444456_at 0.235 9030425P06Rik 1416985_at 0.204 Ptpns1 1436778_at 0.171 Cybb
1433864_at 0.235 C820005L12Rik 1418998_at 0.204 Kmo 1444090_at 0.171 4632424B03Rik
1440169_x_at 0.234 Ifnar2 1416340_a_at 0.204 Man2b1 1451263_a_at 0.17 Fabp4
1419985_s_at 0.234 D11Ertd461e 1423478_at 0.203 Prkcb 1419764_at 0.17 Chi3l3
1460419_a_at 0.234 Prkcb 1418701_at 0.203 Comt 1430447_a_at 0.17 Lair1
1434967_at 0.233 Zswim6 1418826_at 0.202 Ms4a6b 1418196_at 0.169 Tep1
1420382_at 0.233 Apob48r 1417000_at 0.201 Abtb1 1458869_at 0.169 2900076A13Rik
1455290_at 0.232 D6Ertd365e 1457648_x_at 0.201 BC004044 1428790_at 0.169 4921501M20Rik
1441779_at 0.232 9530006C21Rik 1430148_at 0.201 Rab19 1451750_at 0.167 Irak4
1434283_at 0.231 Arid5b 1448721_at 0.2 D1Ertd622e 1419247_at 0.167 Rgs2
1441195_at 0.231 6030487A22Rik 1434547_at 0.2 Cpd 1418806_at 0.167 Csf3r
1451755_a_at 0.231 Apobec1 1447521_x_at 0.199 D15Wsu169e 1424782_at 0.167 2610318G18Rik
1420973_at 0.231 Arid5b 1452764_at 0.199 Socs6 1438619_x_at 0.167 Zdhhc14
1419811_at 0.23 D16Wsu65e 1423668_at 0.199 Zdhhc14 1451310_a_at 0.166 Ctsl
1417203_at 0.23 Ethe1 1436056_at 0.199 C130021D12Rik 1437614_x_at 0.166 Zdhhc14
1431142_s_at 0.23 Amid 1450769_s_at 0.199 Stard5 1424965_at 0.165 Lpxn
1451361_a_at 0.229 BC027342 1436164_at 0.199 C130040I11Rik 1431374_at 0.165 6330407A03Rik  257 
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1417695_a_at 0.165 Soat1 1456480_at 0.125 9330186A19Rik 1434848_at 0.0877 Gpr27
1415897_a_at 0.164 Mgst1 1424186_at 0.125 2610001E17Rik 1427481_a_at 0.0874 Atp1a3
1419609_at 0.164 Ccr1 1420725_at 0.125 Tmlhe 1440840_at 0.0872 D630004K10Rik
1435375_at 0.164 BC052328 1447903_x_at 0.124 Ap1s2 1456195_x_at 0.0866 Itgb5
1435745_at 0.163 5031439G07Rik 1421352_at 0.124 Tlr6 1424304_at 0.0858 Tpcn2
1416289_at 0.163 Plod1 1440285_at 0.123 Ppp1r9a 1439067_at 0.0858 Lair1
1456437_x_at 0.163 C1r 1447854_s_at 0.122 Hist2h2bb 1422978_at 0.0853 Cybb
1430252_at 0.161 3110027N22Rik 1424111_at 0.122 Igf2r 1416619_at 0.0851 4632428N05Rik
1459894_at 0.161 A630053O10 1434129_s_at 0.121 Lhfpl2 1422542_at 0.0843 Gpr34
1418018_at 0.16 Cpd 1420127_s_at 0.121 D9Ertd392e 1430172_a_at 0.0841 Cyp4f16
1442233_at 0.16 Fyb 1454067_a_at 0.12 4931406C07Rik 1432198_at 0.0841 6330414G02Rik
1451832_at 0.16 1700001C14Rik 1448128_at 0.119 Ppgb 1459992_x_at 0.0835 Cln8
1425888_at 0.159 Klra17 1422191_at 0.119 Mox2r 1427747_a_at 0.0832 Lcn2
1434298_at 0.159 Zfhx1b 1449193_at 0.117 Cd5l 1417694_at 0.0827 Gab1
1443088_at 0.159 9930031P18Rik 1444073_at 0.117 Maf 1435492_at 0.0824 1500012M23Rik
1436996_x_at 0.159 Lyzs 1421923_at 0.117 Sh3bp5 1456046_at 0.0822 C1qr1
1417108_at 0.159 1200014P03Rik 1434881_s_at 0.116 Kctd12 1434850_at 0.0822 D030034H08
1423394_at 0.158 Pcyox1 1420726_x_at 0.115 Tmlhe 1425546_a_at 0.0813 Trf
1428176_at 0.158 Edg5 1453586_at 0.115 Entpd1 1416986_a_at 0.0806 Ptpns1
1445711_at 0.158 BB163080 1435134_at 0.115 B230106I24Rik 1419589_at 0.0805 C1qr1
1457017_at 0.158 2410005O16Rik 1448595_a_at 0.115 Rex3 1433662_s_at 0.0803 Timp2
1448881_at 0.158 Hp 1440879_at 0.114 Abca9 1450731_s_at 0.08 Tnfrsf21
1460302_at 0.158 Thbs1 1434314_s_at 0.113 D6Ertd32e 1422041_at 0.0799 Pilrb
1448148_at 0.157 Grn 1452657_at 0.113 Ap1s2 1434111_at 0.0799 Lphn2
1460694_s_at 0.156 Svil 1450377_at 0.112 Thbs1 1419610_at 0.079 Ccr1
1416978_at 0.156 Fcgrt 1436368_at 0.112 Slc16a10 1418634_at 0.0788 Notch1
1455123_at 0.155 St18 1448732_at 0.111 Ctsb 1434277_a_at 0.0787 6430570G24
1429779_at 0.154 Eif2c4 1417534_at 0.111 Itgb5 1418993_s_at 0.0787 F10
1450822_at 0.154 Lyzs 1438034_at 0.111 6430576D04Rik 1436324_at 0.0776 4831403C07Rik
1450726_at 0.154 Asah2 1436225_at 0.111 Trpm2 1415856_at 0.0774 Emb
1416188_at 0.154 Gm2a 1444040_at 0.11 Lair1 1436501_at 0.0769 Mtus1
1457753_at 0.154 Tlr13 1425714_a_at 0.11 4921501M20Rik 1424076_at 0.0766 2610020H15Rik
1458941_at 0.154 D130016B08Rik 1450876_at 0.109 Cfh 1431056_a_at 0.076 Lpl
1430534_at 0.153 Rnase6 1429524_at 0.109 Myo1f 1423326_at 0.0752 Entpd1
1445539_at 0.153 Pde7b 1435203_at 0.109 1700052O22Rik 1419519_at 0.075 Igf1
1452210_at 0.153 E130315B21Rik 1416389_a_at 0.109 Chc1l 1446354_at 0.0747 C130098B18Rik
1417133_at 0.153 Pmp22 1420498_a_at 0.109 Dab2 1456150_at 0.0747 A630082K20Rik
1425951_a_at 0.153 Clecsf10 1419482_at 0.108 C3ar1 1433741_at 0.0745 Cd38
1423362_at 0.152 Sort1 1454838_s_at 0.108 AW548124 1441440_at 0.0744 Apg4c
1435842_at 0.152 1110038O08Rik 1429466_s_at 0.108 0610008A10Rik 1454200_at 0.0742 Zfhx1b
1421385_a_at 0.15 Myo7a 1447277_s_at 0.108 Pcyox1 1422748_at 0.0741 Zfhx1b
1426734_at 0.15 BC022623 1422823_at 0.108 Eps8 1423414_at 0.0733 Ptgs1
1435386_at 0.15 Vwf 1450652_at 0.108 Ctsk 1450764_at 0.0733 Aoah
1415687_a_at 0.149 Psap 1426604_at 0.107 Rnasel 1450199_a_at 0.073 Stab1
1423140_at 0.149 Lip1 1417580_s_at 0.107 Selenbp1 1438435_at 0.0729 Phca
1456133_x_at 0.146 Itgb5 1417533_a_at 0.107 Itgb5 1430345_at 0.0726 5530402H23Rik
1415857_at 0.146 Emb 1452416_at 0.106 Il6ra 1435828_at 0.0724 2810401A20Rik
1429693_at 0.144 Dab2 1429525_s_at 0.106 Myo1f 1419298_at 0.0724 Pon3
1416635_at 0.144 Smpdl3a 1455337_at 0.106 9030023J02Rik 1415996_at 0.0721 Txnip
1439189_at 0.144 D630023B12Rik 1427405_s_at 0.106 D6Ertd32e 1427327_at 0.0708 Pilra
1450699_at 0.144 Selenbp1 1452068_at 0.105 Asahl 1426501_a_at 0.0704 T2bp
1419248_at 0.144 Rgs2 1451970_at 0.105 E330036I19Rik 1434903_s_at 0.0703 Il1rl2
1429672_at 0.143 5830407E08Rik 1425451_s_at 0.105 Chi3l3 1428157_at 0.0696 Gng2
1452301_at 0.143 Aldh3b1 1431032_at 0.105 Agl 1456812_at 0.0694 Abcd2
1420905_at 0.142 Il17r 1430878_at 0.104 2210406H18Rik 1428628_at 0.0694 1190002A17Rik
1452050_at 0.142 Camk1d 1417877_at 0.104 2310005P05Rik 1428340_s_at 0.0693 1110012E06Rik
1427994_at 0.141 F730004D16Rik 1423153_x_at 0.104 Cfh 1434362_at 0.0687 AW550831
1455915_at 0.141 AV011803 1450872_s_at 0.104 Lip1 1444987_at 0.0674 Ctsb
1444003_at 0.141 Lincr 1418345_at 0.103 Tnfsf13 1449305_at 0.067 F10
1439703_at 0.14 Mox2r 1454617_at 0.102 Arrdc3 1435135_at 0.0665 B230106I24Rik
1448890_at 0.14 Klf2 1425295_at 0.101 Ear11 1422760_at 0.0662 Padi4
1438475_at 0.14 LOC382062 1452283_at 0.1 AW123240 1452746_at 0.066 1110012E06Rik
1443145_at 0.139 Apbb1ip 1457724_at 0.1 Ctsl 1430886_at 0.0659 1700112E06Rik
1423704_at 0.139 Lypla3 1449282_at 0.0996 Cysltr1 1434484_at 0.0656 1100001G20Rik
1428367_at 0.138 Ndst1 1421840_at 0.0987 Abca1 1418992_at 0.0655 F10
1439426_x_at 0.137 Lzp-s 1443302_at 0.0984 6720403M19Rik 1422603_at 0.0654 Rnase4
1428663_at 0.136 5133401H06Rik 1456424_s_at 0.0978 Pltp 1427306_at 0.0652 Ryr1
1427256_at 0.136 Cspg2 1436448_a_at 0.0978 Ptgs1 1421408_at 0.0631 Igsf6
1450241_a_at 0.135 Evi2a 1420361_at 0.0976 Slc11a1 1435043_at 0.0625 Plcb1
1437181_at 0.134 Peli2 1444599_at 0.0975 1700056O17Rik 1456887_at 0.0617 1700030P01Rik
1416827_at 0.134 Tbxas1 1439364_a_at 0.0969 Mmp2 1442082_at 0.0612 C3ar1
1420970_at 0.134 Adcy7 1416041_at 0.0966 Sgk 1418612_at 0.0599 Slfn1
1425639_at 0.134 Centa2 1417688_at 0.0964 BC004044 1422062_at 0.0599 Msr1
1417277_at 0.134 Cyp4f16 1448407_at 0.096 4632428N05Rik 1424832_at 0.0596 4732429D16Rik
1427072_at 0.134 Stard8 1441972_at 0.0953 6230424C14Rik 1441975_at 0.0596 Acpp
1421618_at 0.133 Myo1f 1416136_at 0.0938 Mmp2 1416029_at 0.0586 Tieg1
1455009_at 0.132 Cpd 1451353_at 0.0935 Tm6sf1 1419687_at 0.0584 D930010J01Rik
1434720_at 0.132 9530033F24Rik 1448455_at 0.0935 Cln8 1437245_at 0.0583 9930117H01Rik
1421027_a_at 0.132 Mef2c 1434920_a_at 0.0934 Evl 1450967_at 0.0583 4933428I03Rik
1448550_at 0.132 Lbp 1428988_at 0.0933 Abcc3 1419483_at 0.0567 C3ar1
1422868_s_at 0.131 Gda 1439808_at 0.093 A130090K04Rik 1450234_at 0.0566 Ms4a6c
1427996_at 0.131 L259 1447830_s_at 0.0929 Rgs2 1428793_at 0.0565 5830411H19Rik
1454699_at 0.131 Sesn1 1442368_at 0.0926 Kctd12b 1422010_at 0.0564 Tlr7
1431609_a_at 0.131 Acp5 1435996_at 0.0923 Card11 1423422_at 0.0563 Asb4
1420407_at 0.131 Ltb4r1 1431033_x_at 0.0918 Agl 1424852_at 0.0556 5430401D19Rik
1421168_at 0.129 Abcg3 1422875_at 0.0917 Cd84 1442804_at 0.0529 Fgr
1436625_at 0.129 Fcgr1 1418084_at 0.091 Nrp 1439819_at 0.0528 AU015263
1436193_at 0.129 Man1c1 1434308_at 0.0909 BC042513 1455227_at 0.0528 B230106I24Rik
1436989_s_at 0.129 Slc12a6 1418944_at 0.0905 Cysltr1 1418912_at 0.0527 Plxdc2
1448943_at 0.128 Nrp 1452067_at 0.09 Asahl 1455885_at 0.0523 6530401C20Rik
1435884_at 0.128 Itsn 1434387_at 0.0892 AI429612 1444176_at 0.0511 Atp6v0d2
1429097_at 0.127 C030044C12Rik 1417074_at 0.0892 Ceacam10 1452279_at 0.0508 Pfc
1460735_at 0.127 Svil 1422824_s_at 0.0887 Eps8 1452353_at 0.0507 Gpr155
1434911_s_at 0.127 AI120128 1454901_at 0.0884 6430570G24 1432757_at 0.0504 2900011L18Rik
1446505_at 0.127 Cd84 1424443_at 0.0882 Tm6sf1 1428573_at 0.05 Chn2
1421963_a_at 0.126 Cdc25b 1452338_s_at 0.0881 Itsn 1440355_at 0.0498 Kctd12b  258 
 
Affymetrix Id Fold change Common name Affymetrix Id Fold change Common name
1423547_at 0.0494 Lyzs 1420701_at 0.0104 Klk1
1425128_at 0.0493 MGC32391 1433678_at 0.01 AI132321
1448929_at 0.0481 F13a 1453152_at 0.01 Mamdc2
1421813_a_at 0.0474 Psap 1436521_at 0.00961 Slc36a2
1423805_at 0.0467 Dab2 1456060_at 0.00921 Maf
1457270_at 0.0467 B230343A10Rik 1425144_at 0.00783 Klk21
1460437_at 0.0464 Pscd4 1449454_at 0.00771 Bst1
1438431_at 0.0461 Abcd2 1425225_at 0.0073 Fcrl3
1419599_s_at 0.0456 Ms4a6d 1417491_at 0.00716 Ctsb
1425407_s_at 0.045 Clecsf6 1448025_at 0.00696 9930027N05Rik
1423141_at 0.0448 Lip1 1417381_at 0.00656 C1qa
1454677_at 0.0442 Timp2 1425182_x_at 0.00635 Klk9
1449164_at 0.0442 Cd68 1460003_at 0.00608 AI956758
1423593_a_at 0.044 Csf1r 1434413_at 0.00573 Igf1
1419691_at 0.0438 Camp 1425214_at 0.00571 P2ry6
1422869_at 0.0436 Mertk 1432466_a_at 0.00492 Apoe
1433933_s_at 0.0425 Slco2b1 1458683_at 0.00467 9930027N05Rik
1449015_at 0.0419 Retnla 1429954_at 0.00436 3110037K17Rik
1417492_at 0.0414 Ctsb 1434366_x_at 0.00429 C1qb
1416683_at 0.0411 Plxnb2 1437726_x_at 0.00417 C1qb
1455646_at 0.0411 2010004M13Rik 1449401_at 0.00331 C1qg
1444537_at 0.0404 AI429363 1417063_at 0.00318 C1qb
1437218_at 0.0399 Fn1
1448786_at 0.0389 1100001H23Rik
1426642_at 0.0389 Fn1
1419872_at 0.0379 Csf1r
1422953_at 0.0371 Fpr-rs2
1456072_at 0.0367 Ppp1r9a
1436999_at 0.0364 AL024069
1449270_at 0.0363 Plxdc2
1419598_at 0.0358 Ms4a6d
1428156_at 0.0358 Gng2
1422046_at 0.0356 Itgam
1422013_at 0.0354 Clecsf6
1423266_at 0.0339 2810405K02Rik
1442849_at 0.0337 Lrp1
1456389_at 0.0336 9130203F04Rik
1421188_at 0.0334 Ccr2
1417061_at 0.033 Slc40a1
1428700_at 0.0323 Gpr86
1454824_s_at 0.0322 Mtus1
1416298_at 0.0319 Mmp9
1444546_at 0.0309 BC027057
1430379_at 0.0292 5830411K21Rik
1449976_a_at 0.0285 Gpr35
1448566_at 0.0281 Slc40a1
1438467_at 0.0278 Mgl2
1438936_s_at 0.0267 Ang1
1440209_at 0.0266 2900024D24Rik
1448502_at 0.0263 Slc16a7
1449106_at 0.026 Gpx3
1431110_at 0.0257 5430431D22Rik
1437025_at 0.0253 Cd28
1433719_at 0.0243 Slc9a9
1434955_at 0.0242 2900024D24Rik
1448061_at 0.0242 Msr1
1449310_at 0.0241 Ptger2
1437463_x_at 0.024 Tgfbi
1450808_at 0.0237 Fpr1
1424987_at 0.0236 5430435G22Rik
1428018_a_at 0.0235 Igsf7
1417963_at 0.0232 Pltp
1424754_at 0.023 A430103C15Rik
1417702_a_at 0.023 Hnmt
1417597_at 0.0229 Cd28
1416390_at 0.0227 Chc1l
1436397_at 0.0223 BC027057
1424842_a_at 0.0221 Arhgap24
1447849_s_at 0.0217 Maf
1434798_at 0.0212 Atp6v0d2
1419873_s_at 0.0212 Csf1r
1449453_at 0.0209 Bst1
1419549_at 0.0203 Arg1
1449366_at 0.0195 Mmp8
1419605_at 0.0193 Mgl1
1424727_at 0.0191 Ccr5
1448891_at 0.019 Msr2
1456250_x_at 0.0185 Tgfbi
1438937_x_at 0.0181 Ang1
1421187_at 0.0179 Ccr2
1422412_x_at 0.0167 Ear2
1433919_at 0.0166 Asb4
1448655_at 0.0153 Lrp1
1452014_a_at 0.015 Igf1
1436520_at 0.015 AI450948
1415871_at 0.0146 Tgfbi
1448123_s_at 0.014 Tgfbi
1452141_a_at 0.0134 Sepp1
1436317_at 0.0127 9030223K07Rik
1437401_at 0.0121 Igf1
1421186_at 0.0118 Ccr2
1417876_at 0.0115 Fcgr1
1419321_at 0.0112 F7
1450430_at 0.0111 Mrc1
1448005_at 0.0106 2500002E12Rik
1448291_at 0.0104 Mmp9